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Total Syntheses of Fastigiatine and the Hibarimicin Aglycons 
 
 
Abstract 
 Part one of this two-part thesis describes my efforts toward the total syntheses of the complex 
polycyclic alkaloids (–)-himeradine A and (+)-fastigiatine, which are members of the Lycopodium 
family of natural products. A cascade reaction sequence featuring a biosynthesis-inspired transannular 
Mannich reaction was planned to construct the strained and densely functionalized pentacyclic cores 
of the molecules from acyclic starting materials. After difficulties were encountered in a first-
generation synthesis plan toward (–)-himeradine A, a second-generation synthesis plan was 
eventually successful in accomplishing the first total synthesis of (+)-fastigiatine via a formal [3+3]-
cycloaddition reaction and a retro-aldol tandem transannular Mannich reaction sequence. 
 In part two of this thesis, syntheses of the hibarimicin aglycons, including HMP-Y1, atrop-
HMP-Y1, hibarimicinone, atrop-hibarimicinone, and HMP-P1, are reported. These natural products 
are amongst the largest and most complex type-II polyketides isolated. A novel benzylic fluoride 
Michael–Claisen reaction sequence was developed to construct the complete carbon skeleton of 
HMP-Y1 and atrop-HMP-Y1 via a symmetrical bidirectional double annulation reaction. Through 
efforts to convert HMP-Y1 derivatives to hibarimicinone and HMP-P1, a biomimetic mono-oxidation 
to desymmetrize protected HMP-Y1 was realized. A bidirectional unsymmetrical double annulation 
and biomimetic etherification were developed to construct the polycyclic and highly-oxidized 
skeleton of hibarimicinone, atrop-hibarimicinone, and HMP-P1. Lastly, a pH-dependent rotational 
barrier about the C2–C2' bond of hibarimicinone was discovered, which provides valuable 
information for achieving the syntheses of the glycosylated congeners of hibarimicinone. 
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Chapter 1 
Introduction to the Lycopodium Alkaloids 
  
1
  
Introduction 
 The Lycopodium alkaloids are a diverse family of complex natural products isolated from the 
Lycopodium club mosses. The first Lycopodium alkaloid to be studied and isolated was lycopodine (1, 
Figure 1.1), which was separated by Bödeker in 18811 from Lycopodium complanatum. Since then, 
over 250 Lycopodium alkaloids have been identified and characterized to date, and are the subject of 
active biomedical and synthetic organic research.2 
 
 
Figure 1.1 Representative Lycopodium alkaloids. 
 The Lycopodium alkaloids have been broadly classified into four related structural classes: 
the lycopodine class, the lycodine class, the fawcettimine class, and the miscellaneous class.2c 
Representative members of each class are depicted in Figure 1.1, where the positional numbering 
system depicted is in accordance with Conroy’s original biosynthesis hypothesis.3 Although Conroy’s 
proposed skeletal connections have been generally corroborated, 14C- and 13C-feeding studies have 
led to a revised biosynthesis of the Lycopodium alkaloids.4 Initially, lysine is decarboxylated and 
oxidatively cyclized to form Δ1-piperideine (7, Figure 1.2). 7 is then proposed to undergo a Mannich 
                                                                                                                                                  
1 Bödeker, K. Justus Liebigs Ann. Chem. 1881, 208, 363–367. 
 
2 For reviews of the Lycopodium alkaloids, see: (a) Kobayashi, J.; Morita, H. In The Alkaloids; Cordell, G. A., 
Ed.; Academic Press: New York; 2005, Vol. 61, pp 1–57. (b) Ma, X.; Gang, D. R. Nat. Prod. Rep. 2004, 21, 
752–772. (c) Ayer, W. A.; Trifonov, L. S. In The Alkaloids; Cordell, G. A., Brossi, A., Eds.; Academic Press: 
New York, 1994; Vol. 45, pp 233–266. 
 
3 Conroy, H. Tetrahedron Lett. 1960, 1, 34–37. 
 
4 (a) Hemscheidt, T.; Spenser, I. D. J. Am. Chem. Soc. 1996, 118, 1799–1800; (b) Hemscheidt, T.; Spenser, I. D. 
J. Am. Chem. Soc. 1993, 115, 3020–3021, and references therein. 
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reaction with 3-oxoglutaric acid, which after subsequent decarboxylation would afford pelleterine (9). 
9, or an oxidized derivative, could then be dimerized via an intermolecular aldol reaction to yield 
dimer 10. Subsequent oxidation and an intramolecular aldol reaction would then form the C7–C12 
bond to yield the phlegmarine carbon skeleton 12. 12 is poised to undergo an intramolecular Mannich 
reaction to establish the C4–C13 bond to construct tetracycle 13, which forms the basic carbon 
skeleton of the lycodine structural class. Further hydrolysis of the C5–Nα imine of 13, followed by 
deamination and formation of the C1–Nβ bond, is then proposed to lead to the lycopodine structural 
class. Oxidation of 1 at C12 would yield lycodoline (14), which upon migration of C4 from C13 to 
C12 is proposed to yield the fawcettimine structural class.5 Each structural class can then undergo 
further oxidation and rearrangement, ultimately leading to the large and diverse Lycopodium alkaloid 
family of natural products. 
 
 
Figure 1.2 Proposed biosynthesis of the Lycopodium alkaloids. 
  
                                                                                                                                                  
5 Blumenkopf, T. A.; Heathcock, C. H. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., 
Ed.; John Wiley and Sons: New York, 1983; Chapter 5. 
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Selected Total Syntheses of Related Lycopodium Alkaloids 
 The Lycopodium alkaloids have a longstanding and rich history in organic synthesis. Since 
Stork’s6 and Ayer’s7 inaugural syntheses of lycopodine (1) in 1968, these natural products have 
continued to attract interest from the organic synthesis community due to their complex polycyclic 
architecture and diverse biological activities. In this section, four selected total syntheses of the 
Lycopodium alkaloids will be briefly discussed to provide context and background for chapter two. 
 Our discussion begins with the classic synthesis of (±)-lycopodine (1) by Stork and 
coworkers. Their synthesis commenced with the 1,4-conjugate addition of the organocuprate derived 
from methylmagnesium iodide and copper(I) chloride to 2-cyclohexenone 15 to afford cyclohexanone 
16 as a single diastereomer (Scheme 1.1).8 Treatment of 16 with pyrrolidine and p-toluenesulfonic 
acid led to the formation of the corresponding Stork pyrrolidinenamine, which upon exposure to 
acrylamide led to two regioisomeric quinolones. Fortunately, the desired quinolone 17 could be 
readily separated and carried forward. Next, Stork anticipated that protonation of 17 with acid would 
lead to formation of acyliminum ions 18 and 19, which would be trapped in situ with the pendant 
methoxybenzyl group via an intramolecular Friedel–Crafts reaction to form the C4–C13 bond. Two 
epimeric products at C12, tetracycles 20 and 21, are potentially accessible from this reaction sequence 
given that the initial protonation of 17 is either unselective or reversible. However, Stork predicted 
that if the protonation of enamide 17 is reversible and faster than the subsequent Friedel–Crafts 
alkylation, then only the desired epimer 20 would be formed via acyliminium ion 19 due to the 
unfavorable conformation needed for acyliminium ion 18 to react. Indeed, this application of the 
                                                                                                                                                  
6 Stork, G.; Kretchmer, R. H.; Schlessinger, J. J. Am. Chem. Soc. 1968, 90, 1647–1648. 
 
7 Ayer, W. A.; Bowman, W. R.; Joseph, T. C.; Smith, P. J. Am. Chem. Soc. 1968, 90, 1648–1650. 
 
8 The high anti-diastereoselectivity of this transformation can be rationalized by stereoelectronically favored 
axial attack of the nucleophile onto a half-chair conformation of 15 that is anchored by the pseudo-equatorial 
C7-substituent. This anti-diastereoselectivity observed in additions to 5-substituted 2-cyclohexenones is quite 
general and is exploited in numerous syntheses of varying Lycopodium alkaloids (vide infra). See: Allinger, N. 
L.; Riew, C. K. Tetrahedron Lett. 1966, 12, 1269–1272. 
4
  
Curtin-Hammett principle proved to be correct, as desired epimer 20 was the only product observed 
aside from the o-cyclization isomer. Stork and coworkers completed the synthesis of (±)-lycopodine 
(1) from 20, accomplishing a pioneering achievement in natural product total synthesis. 
 
 
Scheme 1.1 Highlights from Stork’s total synthesis of (±)-lycopodine (1). 
 A decade later, Heathcock and coworkers reported another synthesis of (±)-lycopodine (1).9 
Their synthesis began with the 1,4-conjugate addition of the lithium anion of N,N-dimethylhydrazone 
23 to cyclohexenone 22, to yield cyclohexanone 24 after hydrazone hydrolysis (Scheme 1.2). The 
initial 1,4-conjugate addition occurred exclusively anti to the C16-methyl group,8 but the subsequent 
protonation of the resultant copper enolate was unselective and yielded a ~1:1 mixture of C12-
epimers. This mixture of C12-epimers would later prove inconsequential due to a Curtin-Hammett 
kinetic situation analogous to what Stork had observed previously (vide infra). Global carbonyl 
protection and reduction of the nitrile led to primary amine 25. Exposure of 25 to hydrochloric acid 
                                                                                                                                                  
9 (a) Heathcock, C. H.; Kleinman, E.; Binkley, E. S. J. Am. Chem. Soc. 1978, 100, 8036–8037; (b) Heathcock, 
C. H.; Kleinman, E.; Binkley, E. S. J. Am. Chem. Soc. 1982, 104, 1054–1068. 
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triggered a cascade of reactions involving: (1) global ketal deprotection, (2) iminium ion formation, 
and (3) an intramolecular Mannich reaction to form the C4–C13 bond to yield tricycle 26 as a single 
diastereomer, despite the initial mixture of C12-epimers. Heathcock rationalized that the C12-epimers 
of the intermediate C13-iminium ion can rapidly interconvert via the Nβ–C13–C12 enamine tautomer 
but that only one C12-epimer can favorably cyclize via the intramolecular Mannich reaction, an 
argument very similar to that put forth by Stork.6 (±)-Lycopodine (1) was then completed in two 
straightforward steps from 26. The Heathcock synthesis of (±)-lycopodine (1) proved to be more 
efficient than Stork’s prior synthesis, since the use of a Mannich reaction rather than a Friedel–Crafts 
alkylation to form the C4–C13 obviated further downstream manipulations. Nonetheless, the 
synthesis relied on a similar set of bond disconnections that Stork had pioneered earlier. 
 
 
Scheme 1.2 Heathcock’s synthesis of (±)-lycopodine (1). 
Schumann and coworkers accomplished an elegant synthesis of (±)-N-desmethyl-α-obscurine 
(30) that employed a similar set of bond formations as Heathcock’s synthesis of lycopodine but 
executed as a single cascade reaction (Scheme 1.3).10 Heating α,β-unsaturated imine 27 with enamide 
28 in the presence of perchloric acid led to a cascade of tandem reactions involving: (1) 
                                                                                                                                                  
10 Schumann, D.; Naumann, A. Liebigs Ann. Chem. 1983, 220–225. 
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tautomerization of 28 to the exocyclic Nα–C5–C6 enamide,11 (2) diastereoselective 1,4-conjugate 
addition of the exocyclic enamide to 27 anti to the C16-methyl group, (3) subsequent protonation of 
the resultant Nβ–C13–C12 enamine to yield iminium ion 29, and (4) an intramolecular Mannich 
reaction to form the C4–C13 bond, affording 30. Again, only one C12-epimer of 30 was observed for 
an analogous Curtin-Hammett kinetic argument as described earlier. This one-pot transformation 
constitutes a formal [3+3]-cycloaddition, similar variants of which have been developed and 
employed by others in complex molecule synthesis.12 
 
 
Scheme 1.3 Schumann’s synthesis of N-desmethyl-α-obscurine (30). 
To conclude this chapter, key transformations from the more recent syntheses of the 
miscellaneous group Lycopodium alkaloid (+)-lyconadin A (31) and (–)-lyconadin B (32) by Smith 
and Beshore will be discussed (Scheme 1.4).13 The lyconadins are more unusual members of the 
Lycopodium alkaloids in that they possess an additional C4–C10 linkage, which forms a 7-membered 
ring. In the key step of the Smith synthesis, treatment of ketoaldehyde 33 with hydrochloric acid led 
to a cascade of tandem reactions involving: (1) Robinson annulation to form cyclohexenone 34, (2) 
stereoselective 7-endo-trig intramolecular 1,4-conjugate addition to form the C6–C7 bond, and (3) 
                                                                                                                                                  
11 Sarpong and Fischer later demonstrated that 28 may convert to the open-chain carboxamide methyl ketone 
with perchloric acid, and that this intermediate then enolizes and undergoes the formal [3+3]-cycloaddition. See 
Fischer, D. F.; Sarpong, R. J. Am. Chem. Soc. 2010, 132, 5926–5927. 
 
12 For other examples of formal [3+3]-cycloadditions see: (a) Ghosh, S. K.; Buchanan, G. S.; Long, Q. A.; Wei, 
Y.; Al-Rashid, Z. F.; Sklenicka, H. M.; Hsung, R. P. Tetrahedron 2008, 64, 883–893, and references therein; (b) 
Movassaghi, M.; Chen, B. Angew. Chem. Int. Ed. 2007, 46, 565–568. 
 
13 (a) Beshore, D. C.; Smith, A. B., III. J. Am. Chem. Soc. 2007, 129, 4148–4149; (b) Beshore, D. C.; Smith, A. 
B., III. J. Am. Chem. Soc. 2008, 130, 13778–13789. 
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protonation of the resultant enol 35 to afford tricycle 36 as a single diastereomer in 84% overall yield. 
As reminiscent of before, the C16-methyl group controlled the stereoselective formation of the C7-
stereocenter by enforcing a pseudo-axial 1,4-conjugate addition reaction, except this time in the 
context of an intramolecular cyclization. The authors further argue that pseudo-equatorial attack onto 
cyclohexenone 34 is precluded due to developing 1,3-allylic strain between the C7- and C12-
substituents in the transition state, rendering the process highly diastereoselective.14 Unfortunately, 
the protonation at C12 was completely selective for the undesired epimer, and could not be directly 
epimerized under a variety of conditions. This is interesting since a Curtin-Hammett kinetic situation 
allowed the three previously discussed syntheses to obtain the desired C12-stereochemistry 
exclusively, suggesting that the unique structure of 35 is responsible for the observed selectivity. 
 
 
Scheme 1.4 Highlights from Smith’s syntheses of (+)-lyconadin A (31) and (–)-lyconadin B (32). 
Together, these synthetic studies demonstrate the utility of the C16-methyl group for the 
stereoselective introduction of the C6–C7 bond, the facile ability to form the crucial C4–C13 bond via 
an intramolecular addition of a π-nucleophile to either an acyliminium or iminium ion, and how in 
such a reaction the initial C12-stereocenter is inconsequential due to a Curtin-Hammett kinetic 
situation. It is perhaps not surprising how facile and stereoselective the iminium ion mediated C4–
                                                                                                                                                  
14 This argument is most likely operative in the aforementioned syntheses developed by Heathcock and 
Schumann, which also contain substituents at C12 during the conjugate addition reaction. 
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C13 bond formation sequence is, since the bonds constructed mirror those formed during the 
proposed biosynthesis of the Lycopodium alkaloids. The above aspects of the aforementioned total 
syntheses heavily influenced the work described in the following chapter. These four selected 
syntheses are just a very small sample of the numerous syntheses of the Lycopodium alkaloids, which 
continue to be a rich family of targets for organic synthesis. 
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I. Total Synthesis of (+)-Fastigiatine 
 
 
 
 
 
 
Chapter 2 
Progress Toward a Total Synthesis of (–)-Himeradine A 
and the Total Synthesis of (+)-Fastigiatine  
10
 Introduction 
 A small subset of the Lycopodium alkaloids contains a pentacyclic core structure (Figure 2.1). 
Among these, (+)-fastigiatine (37)15 and (–)-himeradine A (38)16 belong to the lycodine structural 
class. Both molecules have an unprecedented pentacyclic core with a C4–C10 bond (highlighted in 
red), in contrast to lycodine (2). The additional strained C4–C10 linkage adds considerable 
complexity to these molecules, creating a densely functionalized pyrrolidine ring and an array of five 
contiguous stereocenters, which includes two vicinal all-substituted carbons. Himeradine A (38) 
contains an additional quinolizidine moiety appended to the pentacyclic core via a methylene linker. 
 
 
Figure 2.1 Lycopodium alkaloids containing a pentacyclic core with a C4–C10 bond. 
The relative stereochemistry of fastigiatine (37) was unambiguously determined by X-ray 
crystallography.15 In contrast, the structure and relative stereochemistry of each individual polycyclic 
subunit of 38 were only assigned on the basis of 1H, 13C, COSY, HMQC, HMBC, and NOESY NMR 
experiments as well as IR and FABMS/MS data.16 Due to the relative isolation of the pentacyclic core 
and quinolizidine moiety, the relative stereochemistry between them remains ambiguous. However, 
the large vicinal coupling constants observed between C1' with C1 and C2', respectively, suggest that 
the relative conformation between the two subunits is rigidly locked. A Monte Carlo simulation 
followed by minimization was consistent with the NOESY data and coupling constants observed, 
leading the authors to propose that himeradine A (38) has the structure depicted in Figure 2.1.16 
                                                                                                                                                  
15 For isolation, see: (a) Gerard, R. V.; MacLean, D. B.; Fagianni, R.; Lock, C. J. Can. J. Chem. 1986, 64, 943–
949; (b) Gerard, R.V.; MacLean D. B. Phytochemistry 1986, 25, 1143–1150. 
 
16 For isolation, see: Morita, H.; Hirasawa, Y.; Kobayashi, J. J. Org. Chem. 2003, 68, 4563–4566. 
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  The biosynthesis of the pentacyclic core of fastigiatine (37) and himeradine A (38), as 
proposed by MacLean,15a is shown in Figure 2.2 (top left to right). It was proposed that the lycodane 
skeleton 44 is first oxidatively functionalized at C10 to yield tetracycle 45. Next, the pentacyclic core 
46 could be derived from 45 by an enamine SN2 cyclization to form the key C4–C10 bond. While 
plausible, the efficiency of the predicted alkylation reaction required to form 46 seems unfavorable, 
requiring 45 to adopt a strained boat-like conformation in order to achieve proper orbital overlap with 
a rather unactivated electrophile. 
 
 
Figure 2.2 Proposed biosynthesis of the pentacyclic core of fastigiatine (37) and himeradine A (38). 
Due to these considerations, we proposed an alternative biosynthesis shown in Figure 2.2 (top 
left and down). As detailed in chapter one in Figure 1.2, phelgmarine type skeleton 43 is the proposed 
precursor to the lycodine structural class via an intramolecular Mannich reaction to form the C4–C13 
bond (i.e., 43 → 44).4,5 However, it is also possible that the C4–C10 bond of 37 and 38 is installed 
first at this stage to yield tetracycle 47, prior to formation of the C4–C13 bond. This could also 
potentially take place via an intramolecular enamine SN2 reaction of an oxidatively functionalized 
derivative of 43 at C10; however, the conformation of 43 needed for such a reaction to occur is less 
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 strained than that needed for 45. Tetracycle 47, suggestively redrawn in a 3D-perspective, is next 
poised to undergo an intramolecular transannular Mannich reaction to form the core of fastigiatine 
(37) and himeradine A (38), in close analogy to the canonical Mannich reaction proposed in the 
Lycopodium alkaloid biosynthesis. Alternatively, intermediate 47 could be intercepted via reduction 
of the C13-iminium ion to give the core structure of lucidine B (48), a Lycopodium alkaloid isolated 
alongside himeradine A (38) from Lycopodium chinense.16 Several other Lycopodium alkaloids 
possess structures containing a C4–C10 bond, such as the lyconadins,13 and our alternative proposed 
biosynthesis could clearly explain their common origin with and divergence from the pentacyclic 
Lycopodium alkaloids. If the C4–C10 bond of lucidine B (38) and related alkaloids were to be 
generated via the originally proposed biosynthesis of fastigiatine (37) and himeradine A (38), this 
would necessitate a retro-Mannich reaction of core 46 to 47, which would then be intercepted via a 
hydride equivalent. While this scenario is possible, we believe that our alternative proposed 
biosynthesis is equally plausible. 
Given the structural complexity of the unprecedented pentacyclic core structure of fastigiatine 
(37) and himeradine A (38) as well as the biosynthetic questions surrounding their origin, I embarked 
on the total syntheses of these two molecules. Specifically, we wished to address whether a 
transannular Mannich reaction could be employed to synthesize these two molecules and thus test the 
feasibility of our proposed biosynthetic hypothesis. Prior to our published efforts17 and the work 
described herein, no other synthetic studies toward 37 or 38 had been published. 
  
                                                                                                                                                  
17 Liau, B. B.; Shair, M. D. J. Am. Chem. Soc. 2010, 132, 9594–9595. 
13
 First-Generation Synthesis Plan 
Our initial synthesis plan was designed to target himeradine A (38), with the plan that such a 
strategy could later be adapted to a synthesis of fastigiatine (37). In the interest of accomplishing a 
convergent synthesis, we proposed that the pentacyclic core 46 could be linked with quinolizidine 49 
via a late-stage coupling reaction (Scheme 2.1). At this stage of planning, the coupling reaction was 
considered flexible, as we imagined that numerous strategies were possible. Next, as previously 
mentioned, we specifically wanted to address whether the pentacyclic core 46 could be constructed 
from tetracycle 47 via a transannular Mannich reaction to form the C4–C13 bond. Furthermore, we 
envisioned that 47 could be disassembled to linear precursor 51 via a cascade sequence of reactions. 
Briefly, this sequence of reactions would involve: (1) Robinson annulation to generate 2-
cyclohexenone 50,18 (2) condensation of Nα and Nβ with the C5- and C13-carbonyls, respectively, 
and (3) subsequent intramolecular 1,4-conjugate addition to form the C6–C7 bond. At this point, 
numerous permutations of the aforementioned bond-forming events were potentially possible; 
however, we considered the specific order flexible and perhaps programmable through the use of 
different protecting group schemes. A more detailed analysis of specific cascade scenarios will be 
discussed (vide infra). 51 could arise via a coupling between “western” fragment 52 and “eastern” 
fragment 53. Alternatively, the 2-cyclohexenone of 50 could be introduced as one complete subunit 
by coupling 2-cyclohexenone anion equivalent 54 with 52 directly. After the appropriate functional 
group manipulations, we imagined that 52 could be efficiently constructed by a convergent three-
component coupling involving nucleophilic opening of cyclopropane 5519 with sodium azide and 
alkylation of the resultant dicarbonyl anion intermediate with iodide 56. 
                                                                                                                                                  
18 The Nβ–C13–C12-enamine could also be employed to facilitate the Robinson annulation to directly construct 
the desired α,β-unsaturated imine. 
 
19 For a review on electrophilic cyclopropanes, see: Danishefsky, S. Acc. Chem. Res. 1979, 12, 66–72. 
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Scheme 2.1 First-generation retrosynthesis of himeradine A (38). 
Several features concerning the chemo- and stereoselectivity of the proposed cascade to 
construct 46 deserve comment. We planned for two likely scenarios or sequence of events that are 
described in Scheme 2.2 and Scheme 2.3, which we could hopefully execute through the judicious 
choice of nitrogen protecting groups. In Scheme 2.2, we envisioned that condensation of Nα and Nβ 
with the C5- and C13-carbonyls in 57 would precede any carbon-carbon bond forming event to give 
58. While the presence of two amino groups and three carbonyls allows for many possible imine 
products, the only plausible bis-condensation product is 58. Condensation of Nβ with the C5-carbonyl 
is the only other plausible unproductive reaction, but we envisioned that this process would be 
competitive with Nα so long as the process was reversible.20 If necessary, orthogonal nitrogen 
protecting groups could possibly be employed to control the condensation reactions. Next the Nβ–
C13–C12-enamine can engage in a Robinson-type annulation with the C7-aldehyde to give α,β-
                                                                                                                                                  
20 This would turn out to be a very naïve hypothesis. 
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 unsaturated iminium ion 59.21 Next, the Nα–C5–C4-endocyclic enamine of 59 could then tautomerize 
to Nα–C5–C6-exocyclic enamine 60. It is important to note that although the endocyclic enamine 
tautomer is thermodynamically preferred over the exocyclic tautomer in similar 6-membered systems, 
the exocyclic enamine is accessible and reactive.12b However, inevitable formation of the endocyclic 
enamine tautomer would most likely render the C4-stereocenter subject to rapid epimerization, and 
thus the C4-stereocenter of synthetic precursors to 60 would most likely be inconsequential to the 
cascade reaction. 
 
 
Scheme 2.2 Proposed cascade sequence to form the pentacyclic core 46 where imine formation 
precedes carbon-carbon bond formation. 
  
                                                                                                                                                  
21 A similar disconnection was used by Smith and Beshore in ref. 13. We anticipated that the use of the Nβ–
C13–C12-enamine would greatly facilitate this transformation. 
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 Next, stereoelectronically preferred axial attack of 60 onto the α,β-unsaturated iminium ion 
would afford tetracycle 61 via 7-endo-trig cyclization.22 Importantly, 5-endo-trig cyclization from 59 
should not be competitive since the resultant enamine after the initial addition is an anti-Bredt 
product. 61 is then proposed to tautomerize to afford enamine 47 as a single diastereomer; the 
stereochemistry generated at C7 and C12 during this process are the only stereochemical outcomes 
possible due to topological constraints. 6-membered enamine 47 is then poised to undergo the 
transannular Mannich reaction, thereby delivering the pentacyclic core 46. 
A less ambitious sequence of events, which is illustrated in Scheme 2.3, was also planned. 
This sequence would begin with 2-cyclohexenone 62, which would result from either Robinson 
annulation of 51/5721 or direct coupling of 2-cyclohexenone anion equivalent 54 with iodide 52 
(Scheme 2.1). Condensation of Nα with the C5-ketone would result in imine 63, which could then 
tautomerize to the exocyclic Nα–C5–C6 enamine tautomer 64/65 and similarly undergo 7-endo-trig 
intramolecular cyclization to form the C6–C7 bond.22 In this scenario, the newly formed C7-
stereocenter is no longer controlled by explicit topological constraints due to the lack of the C13–Nβ 
bond. However, pseudo-axial attack at C7 by the enamine is again stereoelectronically required since 
pseudo-equatorial attack results in an intermediate that suffers severe 1,3-allylic strain. Thus only two 
conformations, 64 and 65, can potentially react to form a 7-membered ring. 1,4-Conjugate addition 
anti to the C16-methyl group in 65 should be favored over syn 1,4-addition in 64, which is blocked by 
steric hindrance.23 This stereoelectronic argument predicts the desired stereogenicity at C7, regardless 
of whether a rigid topological constraint exists. After the cyclization, we anticipated that stereo-
electronically favored axial protonation at C12 of the resultant enol 66 would lead to tricycle 67. 
                                                                                                                                                  
22 As discussed in chapter one, a similar 7-endo-trig cyclization was employed by Smith and Beshore in ref. 13. 
 
23 This analysis is supported by past syntheses of Lycopodium alkaloids as discussed in chapter one; in 
particular the work of Smith and Beshore (see ref. 13) on the lyconadins clearly suggests that a 7-endo-trig 
cyclization should be stereoselective.  
17
  
Scheme 2.3 An alternative proposed cascade sequence where the C16-methyl group controls the 
stereoselectivity of the 1,4-conjugate addition reaction. 
At this juncture, it was unclear whether 67 would exist as the keto-enamine form or would 
react further via a transannular aldol reaction to form tetracycle 68. We hypothesized that if the C13-
ketone was kinetically accessible, then we could next initiate condensation of Nβ with the C13-
ketone.24 Notwithstanding, successful condensation would intercept intermediate 47, which would 
again be poised to undergo the desired transannular Mannich reaction to form pentacyclic core 46. 
If successful, our proposed cascade reaction sequence could potentially construct up to three 
σ carbon-carbon bonds, two σ carbon–nitrogen bonds, and one σ carbon-hydrogen bond. We were 
comforted by the belief that, in practice, we could potentially break up the cascade into discrete 
isolable steps, and influence the order of steps by judiciously employing the appropriate nitrogen 
                                                                                                                                                  
24 One complication is that only the C12-epimer depicted (67, Scheme 2.3) can condense with Nβ due to 
topological constraints of the molecule. Whether the C12-stereocenter could epimerize was unknown and 
potentially problematic.  
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 protecting groups. As Professor Evans stated, one “pays up front” building up and maintaining all of 
the reactive functionality needed to execute a cascade reaction. This wisdom certainly applied to our 
proposed cascade, as only two possible scenarios are described out of the multitude of reaction 
pathways possible with a substrate like 51/57. Nonetheless, we were encouraged by past literature 
precedence in the arena of Lycopodium alkaloid synthesis, which heavily supported our proposal 
(albeit unbeknownst to us at the time). Interestingly, the transformation of 60 to the pentacyclic core 
47 (Scheme 2.2) is in essence a formal [3+3]-cycloaddition, which is an intramolecular variant of that 
applied by Schumann as described in chapter one.10 However, addition of the single C4–C10 bond 
added considerable challenges in not only building the correct substrate but maintaining the reactive 
functionality correctly poised for the ensuing cascade reaction (vide infra). In fact, the intramolecular 
[3+3]-cycloaddition in analogy to Schumann’s work was never successful for these reasons, as will 
be discussed in the upcoming sections of this chapter. 
  
19
 First-Generation Approach to the Core of (–)-Himeradine A and (+)-Fastigiatine 
 The project commenced with the synthesis of the more complex eastern fragment 52 (Scheme 
2.1). This endeavor began with the construction of the requisite enantiopure building blocks, 
cyclopropane 55 and primary iodide 56, which were prepared in high enantiopurity on multi-gram 
scale according to literature protocol.25 With both 55 and 56 in hand, the three-component coupling of 
these building blocks and sodium azide was next investigated. Practically, this was done in a step-
wise fashion. First, 55 underwent smooth cyclopropane opening when heated with sodium azide, 
triethylamine, and acetic acid (Scheme 2.4). I then found that the resultant crude primary azide 
underwent efficient alkylation with 56 in the presence of cesium carbonate to afford coupled product 
69 in a >10:1 mixture of diastereomers. Next, saponification of both the butyrolactone and the 
carboethoxy group of 69 with lithium hydroxide, followed by in situ acidification with hydrochloric 
acid and subsequent warming, led to decarboxylation and relactonization to afford butyrolactone 70 
as a 3:1 mixture of trans:cis C4-epimers. At this stage, all that was required to complete the desired 
coupling fragment 52 was the addition of the C6-carbon unit and functionalization of the latent C11-
primary hydroxyl. The former objective was accomplished with addition of methyllithium to 70, 
which led to hemi-ketal 71 as a complex mixture of diastereomers. All attempts to directly silylate or 
sulfonylate the latent primary alcohol of 71—presumably via accessing the open chain keto-hydroxy 
form in situ—were unsuccessful. Formation of byproducts such as dihydrofuran 72 and ketal 73 
(Scheme 2.4, box) suggested that the open chain form of 71 was not accessible and that silylation or 
sulfonylation of the hemi-ketal hydroxyl of 71 had occurred instead. Subsequent oxocarbenium ion 
formation could then result in generation of either 72 or 73. 
                                                                                                                                                  
25 See Experimental Section for more details. 
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Scheme 2.4 Three-component coupling of 55, 56, and sodium azide, as well as attempted synthesis of 
coupling fragment 52. 
 In order to access and functionalize the C11-primary hydroxyl, formation of the Weinreb 
amide derivative of 70 was next pursued (Scheme 2.5). The trans:cis ratio of 70 was first enriched by 
epimerizing the C4-stereocenter with DBU to attain a >20:1 ratio of trans:cis C4-epimers. Although 
the C4-stereocenter is potentially inconsequential for the downstream cascade reaction, I sought to 
work with one diastereomer for the immediate forthcoming steps. Next, treatment of 70 with the 
aluminum amide derived from trimethylaluminum and N,O-dimethylhydroxylamine hydrochloride 
led to formation of the desired Weinreb amide 74.26 Unfortunately, 74 was extremely sensitive, as it 
readily cyclized back to 70 upon acidic workup or purification. Attempted sulfonylation or 
halogenation of the C11-primary hydroxyl of 74 was plagued with eventual problems of re-
lactonization back to 70, presumably by SN2 displacement of a C11-activated derivative by the C5-
carbonyl.27 
                                                                                                                                                  
26 Basha, A.; Lipton, M.; Weinreb, S. M. Tetrahedron Lett. 1977, 18, 4171–4172. 
 
27 Forebodingly, this unusual tendency of the C11-hydroxyl or amino derivative to engage a C5-carbonyl 
derivative would turn out to be a recurring problem in our synthetic efforts toward himeradine A (38) and 
fastigiatine (37). 
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Scheme 2.5 Synthesis of the eastern fragment via the formation of a bicyclic aminal. 
At this juncture, it seemed logical that the C5-carbonyl had to be masked to prevent its 
cyclization with the proximal C11-primary hydroxyl group or its derivative. Thus silyl protection of 
crude 74 gave the resultant TIPS-ether and subsequent addition of methyllithium resulted in clean 
formation of methyl ketone 75. Several choices of C5-carbonyl protecting groups seemed plausible, 
but the use of bicyclic aminal 76 (Scheme 2.5, box) was particularly interesting. Since formation of 
the C5–Nα bond is eventually required, formation of bicyclic aminal 76 served not only the purpose 
of protecting the C5-ketone but would also preemptively reduce the complexity of the upcoming 
cascade. After extensive experimentation, I discovered that treatment of 75 with anhydrous 
hydrochloric acid in chloroform led to formation of bicyclic aminal 76 in 75% yield and a mixture of 
mixed ketal derivatives. Re-exposure of the mixed ketal mixture to anhydrous hydrogen chloride 
resulted in an additional 10% of 76. To our satisfaction, deprotection of the TIPS-ether afforded C11-
primary hydroxyl 77 cleanly, which could then be either iodinated, triflated, or oxidized to the 
aldehyde to deliver eastern coupling fragments 78, 79, and 80, respectively. 
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 With the aforementioned eastern coupling fragments in hand, I first investigated their 
potential coupling with an arsenal of 2-cyclohexenone anion equivalents 54 (Scheme 2.6). The 
enantiopure 5-methycyclohexanone derivatives shown were generally synthesized from (R)-pulegone 
according to literature protocol,28 and in the interest of brevity the detailed synthesis of each 
nucleophile will not be fully discussed. All of the nucleophiles tested were ultimately unsuccessful in 
accessing cascade substrate 82. Attempted alkylation reactions with 78 and 79 were generally 
unsuccessful or low yielding; this poor reactivity was attributed to the steric hindrance surrounding 
the C11-leaving group (vide infra). More success was realized with aldol reactions with 80. However, 
difficulty in cleanly eliminating the resultant hydroxyl and with the necessary subsequent alkene 
isomerization led us to ultimately abandon these strategies. I briefly explored the possibility of 
generating an organometallic species from iodide 78. Attempted lithium halogen exchange reactions  
 
 
Scheme 2.6 Attempted couplings of 2-cyclohexenone anion equivalents with the eastern fragment 
were ultimately unsuccessful. 
                                                                                                                                                  
28 (a) Kozak, J. A.; Dake, G. R. Angew. Chem. Int. Ed. 2008, 47, 4221–4223; (b) Linghu, X.; Kennedy-Smith, J. 
J.; Toste, F. D. Angew. Chem. Int. Ed. 2007, 46, 7671–7673, and references therein. 
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Scheme 2.7 Attempts to cross-couple an organometallic derived from iodide 78. 
followed by transmetallation and cross-coupling with 2-iodocyclohexenone 8329 were unsuccessful 
(Scheme 2.7, Eq. 1, conditions a-b), presumably due to the instability of the intermediate alkyl 
lithium species in the presence of the neighboring azide. I was able to successfully insert zinc via a 
palladium-mediated zinc insertion (Scheme 2.7, Eq. 2);30 however, attempts to cross-couple 84 were 
unsuccessful. 
Due to the difficulties I encountered with alkylation of iodide 78 with bulkier cyclic 
nucleophiles, I turned my attention to the use of smaller acyclic nucleophiles where the 2-
cyclohexenone, or functional equivalent, would instead be formed by an eventual condensation 
between C12 and C7 as depicted earlier in Scheme 2.2 (i.e., 58 → 59). With the acyclic 
dimethylhydrazone 86, I was able to achieve alkylation with iodide 78 to afford 87 after hydrazone 
cleavage, albeit in low yield (Figure 2.3, Eq. 1). This result was somewhat surprising, given the 
successful alkylation reaction with the same hydrazone 86 employed by Smith and Beshore (Figure 
2.3, Eq. 2).13 This dichotomy could be rationalized by inspecting a simple 3D model of 78, which 
                                                                                                                                                  
29 For the synthesis of 83, see Scheme 2.10 and ref. 28b. 
 
30 Stadtmueller, H.; Lentz, R.; Tucker, C. E.; Stuedemann, T.; Doerner, W.; and Knochel, P. J. Am. Chem. Soc. 
1993, 115, 7027–7028. 
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 most likely exists in a low energy conformation where approach of nucleophiles to σ*-C–I is 
occluded (Figure 2.3, box). In contrast, the substituents in 88 are effectively pinned back by 
association in a 6-membered ring, reducing the steric constraint. However, nucleophiles attacking 
aldehyde 80 should not suffer from the same steric occlusion since the trajectory angle is 107° and the 
aldehyde has two accessible faces. Furthermore, additions to 80 may benefit from closed transition 
states with chelation between the aldehyde and the nucleophile. These rationales are supported by our 
prior observations that 80 underwent aldol reactions rather efficiently. Thus logically, the use of a 
smaller acyclic western fragment with aldehyde 80 could potentially allow for a robust coupling 
reaction that did not suffer from the same downstream problems in forming the 2-cyclohexenone 
moeity associated with using a cyclic precursor (i.e., introducing the C12–C7 unsaturation). 
 
 
 
Figure 2.3 Simple rationale for the poor reactivity of iodide 78. 
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Scheme 2.8 Synthesis of cascade substrate 96. 
Professor Evans instinctively proposed utilizing a Horner–Wadsworth–Emmons olefination 
as the key coupling reaction with aldehyde 80 and phosphonate 92 (Scheme 2.8). The synthesis of 
phosphonate 92 began with the lipase-mediated desymmetrization of 3-methylglutaric anhydride with 
n-propanol to provide carboxylic acid 90 in 93% ee (Scheme 2.8).31 The carboxylic acid of 90 was 
transformed to dimethyl acetal 91 in a three-step process involving: (1) chemoselective reduction with 
borane dimethylsulfide complex, (2) oxidation of the resultant primary carbinol, and (3) dimethyl 
acetal formation. Subsequent conversion of 91 to the corresponding Weinreb amide32 followed by 
addition of lithiated methylphosphonate afforded β-ketophosphonate 92. To our satisfaction, Horner–
                                                                                                                                                  
31 Prepared according to the procedure in: Marcoux, D.; Bindschädler, P.; Speed, A. W. H.; Chiu, A.; Pero, J. 
E.; Borg, G. A.; Evans, D. A. Org. Lett. 2011, 13, 3758–3761. 
 
32 Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling U.-H.; Grabowski, E. J. J. Tetrahedron 
Lett. 1995, 36, 5461–5464. 
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 Wadsworth–Emmons reaction between 92 and aldehyde 80 using Masamune-Roush conditions33 
cleanly provided base-sensitive enone 93.34 I next attempted to simultaneously unmask the β-amino 
nitrogen and reduce the superfluous C11–C12 unsaturation via hydrogenation. To our delight, imine 
95 was isolated as the major product from the reaction, finally delivering a desired cascade substrate. 
However, substantial over-reduction to the corresponding piperidine was also observed, which could 
not be circumvented under a variety of conditions. A workable alternative was discovered, which 
involved chemoselective hydrosilylation of enone 93 with catalytic Karstedt’s catalyst and 
triethylsilane to yield enolsilyl ether 94.35 Desilylation of crude 94 with TBAF, followed by treatment 
of the resultant ketone with triphenylphosphine on a polystyrene solid support, led to clean formation 
of imine 95. 
Exposure of 95 to a variety of acidic conditions led to rapid formation of crude α,β-
unsaturated imine 9636 (Scheme 2.8), which proved to be quite unstable to air, prolonged handling, 
and purification. Unfortunately, attempts to drive the cascade reaction further under a variety of 
conditions proved fruitless. Practically, a large source of difficulty was due to the instability and 
highly polar nature of the products formed. Enamines are notorious for their facile aerobic oxidation 
and subsequent decomposition, and any cascade involving two latent basic primary amines 
simultaneously unmasked would prove considerably challenging. After substantial investigation, I 
elected to focus on a promising alternative route that was concurrently being pursued at the time. 
                                                                                                                                                  
33 Blanchette, M. A.; Choy, W.; Davis, J. T.; Essenfeld, A. P.; Masamune, S.; Roush, W. R.; Sakai, T. 
Tetrahedron Lett. 1984, 25, 2183–2186. 
 
34 The use of Hünig’s base was crucial, as triethylamine readily induced β- and γ-elimination of hydrogen azide 
from 80 and 93, respectively. 
 
35 Johnson, C. R.; Raheja, R. K. J. Org. Chem. 1994, 59, 2287–2288. 
 
36 Interestingly, 96 could also be accessed from 93 directly via hydrogenation under acidic conditions. See 
Experimental Section for more details. 
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 Second-Generation Synthesis Plan 
 Due to difficulties encountered in the first-generation synthesis plan described in chapter two, 
a second-generation retrosynthesis of fastigiatine (37) and himeradine A (38) was designed. Both 
synthesis plans would still incorporate the same proposed cascade reaction sequence to generate the 
pentacyclic core 46 via a transannular Mannich reaction, and thus both routes would target similar 
cascade substrates, such as 50 (Scheme 2.9). Setbacks in reaching 50 via the original synthesis plan 
(Scheme 2.9, route 1) arose from two major difficulties: (1) generating a suitable precursor to form 
the C11–C12 bond and (2) efficient formation of the C11–C12 bond itself. A clumsy sequence had to 
be developed to protect the C5-carbonyl as a bicyclic aminal in order to appropriately functionalize 
the C11-hydroxyl, which would otherwise be bound in a closed 5-membered ring system and hence 
inaccessible. Additionally, the C1-hydroxymethyl group, which was installed to introduce the 
quinolizidine of himeradine A (38), was now an integral part of the bicyclic aminal and thus is critical 
to the success of forming the C11–C12 bond. A synthesis of fastigiatine (37), which lacks any  
 
 
Scheme 2.9 A second-generation retrosynthesis of cascade substrate 50. 
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 additional carbon appendage at C1, would thus require later excision of the superfluous C1-
hydroxymethyl group. Lastly, although a Horner–Wadsworth–Emmons reaction eventually proved 
successful in forming the C11–C12 bond of 97, it required additional oxidation/reduction sequences 
at C11 and delayed installation of the C7–C12 bond. 
 We reasoned that if we installed the more challenging C11–C12 bond earlier in the synthesis 
that many of the difficulties we encountered previously could be circumvented. In particular, we 
hypothesized that one could exploit a hidden pseudo-C2-symmetry evident in 50: both C11 and C9 are 
functionalized methylenes where nucleophiles, a 2-cyclohexenone anion equivalent and a nitrogen 
moeity, have been incorporated, respectively. In the original synthesis plan, the Nβ-azide is initially 
introduced via nucleophilic cyclopropane opening of 55 and the C11–C12 bond is later installed. 
However, one could use the nucleophilic cyclopropane opening to form the C11–C12 bond earlier via 
the addition of organometallic 99 to cyclopropane 100, which already contains the β-nitrogen but in a 
5-membered 2-pyrrolidinone. This second-generation strategy effectively mirrors the first-generation 
strategy in that it uses similar transformations as its predecessor but reassigns how the C11 and C9 
substituents are introduced, and simply requires the enantiomer of cyclopropane 55 as the ultimate 
starting material. Lastly, this new strategy would potentially be amenable to a synthesis of both 
fastigiatine (37) and himeradine A (38). 
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 Synthesis of (+)-Fastigiatine 
 The second-generation route began with the synthesis of enantiopure cyclopropane 100 and 
vinyl iodide 99 (Scheme 2.10). First, a modified literature protocol was employed to construct 2-
pyrrolidinone 103 and its Boc protected derivative 104. 37  Alternatively, addition of excess 
(trimethylsilyl)methyllithium to 103 cleanly installed the C6-carbon unit as a methyl ketone38 and 
final Boc protection afforded cyclopropane 100. The synthesis of vinyl iodide 99 began with the 
preparation of 2-cyclohexenone 106 according to literature protocol,28b which was subsequently α-
iodinated and protected as a ketal using Noyori’s conditions39 to afford 99. 
 
 
Scheme 2.10 Synthesis of cyclopropane 100 and vinyl iodide 99. 
With the requisite partners cyclopropane 100 and vinyl iodide 99 in hand, I next investigated 
the crucial nucleophilic cyclopropane opening to form the C11–C12 bond. I discovered that treatment 
of 99 with t-butyllithium followed by addition of the copper t-butyl-acetylide afforded mixed 
diorganocuprate 107, which regioselectively added to C11 of cyclopropane 100 to give coupled 
product 108 (Scheme 2.11) in modest yield.40 I next turned to formation of the C4–C5 bond via an 
                                                                                                                                                  
37 Medda, A. K.; Lee, H.-S. Synlett 2009, 6, 921–924 and references therein. 
 
38 Demuth, M. Helv. Chim. Acta 1978, 61, 3136–3138. 
 
39 Tsunoda, T.; Suzuki, M.; Noyori, R. Tetrahedron Lett. 1980, 21, 1357–1358. 
 
40 Majetich, G.; Leigh, A. J.; Condon, S. Tetrahedron Lett. 1991, 32, 605–608. 
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 alkylation reaction, as was accomplished in the previous synthesis plan. However, we elected to target 
fastigiatine (37) over himeradine A (38) in the interest of starting with the simplest cascade reaction 
possible, uncomplicated by the additional C1-stereocenter. Unfortunately, I soon found that attempted 
alkylation of 108 with iodide 109 or its bromide analog under a variety of conditions led to at best 
equimolar ratios of desired alkylation product 110 and a mixture of byproducts 111 that appeared to 
be products of O-alkylation. This result was not surprising, given the steric congestion surrounding 
the C4-reacting center.41 
 
 
Scheme 2.11 Coupling of iodide 99 with cyclopropane 100 and subsequent alkylation reactions. 
Fortunately, I concurrently found that exposure of ethyl ester 104 to mixed organocuprate 107 led to 
clean nucleophilic cyclopropane opening to yield coupled product 112. Furthermore, 112 underwent 
exclusive C-alkylation with 1-chloro-3-iodopropane to afford desired alkylated product 113 in high 
overall yield (Scheme 2.12). In order to obtain all of the carbon units needed for the upcoming 
cascade reaction, all that remained was introduction of the C6-carbon unit. I envisioned that this 
would be possible via the chemoselective mono-addition of an organometallic to the endocyclic C5-
carbonyl of imide 113, a reaction widely conducted with N-Boc protected 2-pyrrolidinones and 
                                                                                                                                                  
41 Kurts, A. L.; Genkina, N. K.; Macias, A.; Beletskaya, I. P.; Reutov, O. A. Tetrahedron 1971, 27, 4777–4785. 
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 valerolactams. However, several exploratory reactions with numerous organometallics, such as 
methylmagnesium bromide, methyllithium, and trimethylsilylmethyl lithium, led to predominant 
formation of Boc cleaved product 114. In hindsight, these observations were not surprising. 
Chemoselective organometallic addition to the endocyclic imide carbonyl of N-Boc 2-pyrrolidinone is 
predicated on the bulky t-butyl group sterically protecting the exocyclic carbonyl.42 However, in our 
system the endocyclic carbonyl is adjacent to the sterically congested C4-all carbon quaternary 
center, rendering it less available to 1,2-addition than the Boc carbonyl. I thus hypothesized that this 
regioselectivity could be circumvented if the C4-carboethoxy group of 113 was simply removed prior 
to introduction of the C6-carbon unit. Unfortunately, the C4-carboethoxy group of 113 proved 
recalcitrant to hydrolysis under various conditions, resulting only in Boc cleaved products. I therefore 
elected to replace the C4-carboethoxy group of cyclopropane 104 at an earlier stage with a 
carboxyester that could be easily cleaved at the appropriate time. 
 
 
Scheme 2.12 Successful nucleophilic cyclopropane opening and subsequent C-alkylation. 
                                                                                                                                                  
42 Giovannini, A.; Savoia, D.; Umani-Ronchi, A. J. Org. Chem. 1989, 54, 228–234. 
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Scheme 2.13 Successful introduction of the C6-methyl group using a TMSE carboxyester. 
Transesterification of 103 with 2-(trimethysilyl)ethanol,43  followed by N-Boc formation 
afforded cyclopropane 115 (Scheme 2.13). Upon exposure to mixed organocuprate 107, cyclopropane 
115 similarly underwent facile opening at C11 to provide imide 116. Conveniently, this convergent 
fragment coupling could be conducted on >5-gram scale. Imide 116 was then transformed to azide 
117 via alkylation with 1-chloro-3-iodopropane and displacement of the resultant primary chloride 
with sodium azide. As hoped, exposure of 117 to TBAF induced rapid TMSE carboxyester cleavage 
with concomitant decarboxylation.44 Running the decarboxylation in the presence of DBU allowed in 
situ base-catalyzed epimerization to yield a >10:1 mixture of C4-epimers of N-Boc-2-pyrrolidinone 
118.45 Gratifyingly, addition of methylmagnesium bromide led to exclusive addition to the C5-
carbonyl to give hemi-aminal 119 as a mixture of diastereomers. 
 
                                                                                                                                                  
43 Nicolaou, K. C.; Hwang, C.-K.; Duggan, M. E.; Nugiel, D. A.; Abe, Y.; Bal Reddy, K.; DeFrees, S. A.; 
Reddy, D. R.; Awartani, R. A.; Conley, S. R.; Rutjes, F. P. J. T.; Theodorakis, E. A. J. Am. Chem. Soc. 1995, 
117, 10227–10238. 
 
44 Knobloch, E; Brückner, R. Synlett 2008, 12, 1865–1869. 
 
45 Although the C4-stereocenter of 118 is inconsequential, this epimerization facilitated characterization. 
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Scheme 2.14 Attempted cascade reaction with dihydropyrrole 120. 
Upon attempted purification of 119, partial dehydration to the corresponding enamide 
occurred. This transformation was promoted by acid, and treatment of 119 with CSA followed by 
Staudinger reduction of the C1-azide yielded dihydropyrrole 120 (Scheme 2.14). I hypothesized that 
although the C–N bond connectivity of 120 was incorrect, 120 may still serve as a potential cascade 
substrate. As depicted in Scheme 2.14, I speculated that under the appropriate conditions, the more 
nucleophilic Nα-amine may be able to interchange with the Nβ-carbamate to give imine 121. This 
was predicated on the assumption that 120 should be unable to cyclize to form the undesired C4–C7 
bond since 5-endo-trig cyclization is in violation of Baldwin’s rules.46 The cascade reaction would 
then proceed as originally intended, potentially affording tetracycle 123 after the subsequent 
transannular aldol reaction of 122. Heating 120 with pyridinium p-toluenesulfonic acid in ethanol led 
to clean formation of a new single product that had incorporated ethanol but contained roughly all of 
the predicted carbon and proton peaks consistent with 124. However, upon closer inspection of 
HSQC and HMBC NMR data, the structure of the new product was instead consistent with the 
constitutional isomer 125. 
                                                                                                                                                  
46 (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun., 1976, 734–736; (b) Johnson, C. D. Acc. Chem. Res. 1993, 
26, 476–482. 
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Scheme 2.15 5-Endo-trig cyclization is facile. 
In hindsight, the formation of 125 can be easily rationalized by the mechanism outlined in 
Scheme 2.15. Initial formation of an oxocarbenium ion triggers a 5-endo-trig cyclization to form the 
C4–C7 bond and afford 126; although this transformation is disfavored by Baldwin’s rules, the highly 
charged character of the reactive species allowed an exception in this particular case. This initial bond 
formation is completely diastereoselective, occurring anti to the C16-methyl group as predicted and 
where the C4-stereogenecity is governed by formation of the less strained cis-5,5-ring fusion. The 
nitrogen atoms can then interchange to afford imine 127, which can tautomerize to an exocyclic 
enamine and cyclize via a transannular aldol reaction to afford 125. This disheartening result provided 
two important lessons: (1) the correct C–N bond connectivity was most likely required for the cascade 
reaction since (2) 5-endo-trig cyclization was facile. In fact, upon closer inspection of all of the 
byproducts isolated during the dehydration of 119, exocyclic enamide 130—the product of 5-endo-
trig cyclization—was also isolated (Scheme 2.15). 
 With these lessons learned, I turned my attention toward obtaining a cascade substrate 
containing the desired C–N bond connectivity. Unfortunately, attempts to form the requisite C5–Nα 
bond and 6-membered imine from crude hemi-aminal 119 were unsuccessful (Scheme 2.16, Eq. 1). I 
suspected that these failures were again indicative of the strong thermodynamic preference for the 5-
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 original synthesis plan with the analogous hemi-ketal. Attempts to hydrolyze the C5–Nβ bond of 118 
or form the corresponding Weinreb amide were also ultimately unsuccessful, again due to problems 
with recyclization back to 118. However, I eventually found that Staudinger reduction of the C1-azide 
led to in situ lactamization to afford valerolactam 132 (Scheme 2.16, Eq. 2), which contained the 
correct C–N connectivity. 
 
 
Scheme 2.16 Lactamization to valerolactam 132 allows formation of the correct C–N connectivity. 
A cascade one-pot sequence was developed to access valerolactam 132 from imide 116 
(Scheme 2.17). Alkylation with alkyl bromide 133, which contains a stabase-protected primary 
amine, followed by dilution with THF and addition of TBAF led directly to 132 in 88% overall yield. 
Introduction of the C6-carbon unit was next required. Attempts to form the thioamide from 132 for a 
subsequent Eschenmoser coupling reaction were unsuccessful; this difficulty was attributed to the 
proximal β-nitrogen, which may intercept any reactive intermediates or the thioamide itself in situ. In 
order to incorporate the C6-carbon unit, the lactam of 132 was Boc protected to give imide 135. I 
planned to use the Petasis reagent47 to incorporate the C6-carbon unit, which would also directly 
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 deliver the necessary exocyclic enamide.48 However, heating 135 with Petasis reagent unfortunately 
led to translactamization to 136. Attempts to introduce the required C6-methylene directly with 
lactam 132, such as through a Hua reaction,49 were also unsuccessful. It became clear that another 
strategy was needed to generate and maintain the correct C–N connectivity. 
 
 
Scheme 2.17 Attempts to incorporate the C6-carbon unit from valerolactam 132. 
 I postulated that replacement of the Nβ-Boc group with a Ns group would inductively 
deactivate the nitrogen atom and thus reduce its propensity to form the cyclic 5-membered ring 
system. Mild Lewis acidic conditions employing magnesium perchlorate chemoselectively removed 
the Boc group of 118 in the presence of the C13-ketal (Scheme 2.18).50 Deprotonation of the resultant 
amide with LiHMDS, followed by treatment with NsCl, led to clean formation of the N-Ns-
pyrrolidinone 137. Gratifyingly, treatment of 137 with the lithium enolate of t-butylacetate led to 
clean formation of β-ketoester 138 with Nβ completely disengaged from the C5-ketone. Exposure of 
                                                                                                                                                  
48 For an example of methylenation of an N-Boc-valerolactam, see: Langlois, N. Org. Lett. 2002, 4, 185–187. 
 
49 (a) Ahn, Y.; Cardenas, G. I.; Yang, J.; Romo, D. Org. Lett. 2001, 3, 751–754; (b) Hua, D. H.; Miao, S. W.; 
Bharathi, S. N.; Katsuhira, T.; Bravo, A. A. J. Org. Chem. 1989, 55, 3682–3684. 
 
50 Stafford, J. A.; Brackeen, M. F.; Karanewsky, D. S.; Valvano, N. L. Tetrahedron Lett. 1993, 34, 7873–7876. 
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 138 to triphenylphosphine then triggered an intramolecular Staudinger reaction to construct 
vinylogous urethane 139 as an inconsequential ~3:2 ratio of C4-epimers.51 It is important to note that 
the C6-t-butyloxycarbonyl served two main purposes: (1) it induced preferential formation of the 
exocyclic Nα–C5–C6 enamine, which would help to prevent the otherwise facile 5-endo-trig 
cyclization that was observed previously, and (2) it introduced greater ease of handling since 
vinylogous urethanes are stable, non-basic, and easily purified in comparison to their enamine 
counterparts. 
 
Scheme 2.18 Inductive deactivation of Nβ allows for formation of the correct C–N connectivity. 
I next sought to deprotect the Nβ-Ns group and C13-ketal, and subsequently form the C13–
Nβ bond and resultant iminium ion to initiate the cascade sequence. However, deprotection of the 
Nβ-Ns of 139 under standard conditions52 afforded 5-membered vinylogous urethane 140 after a 
facile transamination reaction (Scheme 2.18). Clearly, the Nβ-Ns group was crucial to maintaining 
the correct C–N bond connectivity, and would have to be removed at a later stage. Consequently, I 
attempted direct 1,4-conjugate addition to the latent 2-cyclohexenone of 139. Remarkably, exposure 
                                                                                                                                                  
51 Lambert, P. H.; Vaultier, M.; Carrié, R. J. Org. Chem. 1985, 50, 5352–5356. 
 
52 Fukuyama, T.; Jow, C.-K.; Cheung, M. Tetrahedron Lett. 1995, 36, 6373–6374. 
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 of 139 to aqueous hydrochloric acid led to tetracycle 144 as a single diastereomer in 92% yield 
(Scheme 2.19). As discussed previously, this formal [3+3]-cycloaddition12 is believed to occur via 
initial C13-dioxolane cleavage, 7-endo-trig intramolecular 1,4-conjugate addition to form the C6–C7 
bond, stereoelectronically favored axial protonation to secure the C12 stereocenter, and finally a 
transannular aldol reaction to form the C4–C13 bond. Again, the high diastereoselectivity of the 
initial 7-endo-trig cyclization can be rationalized by stereoelectronically favored axial attack anti to 
the C16-methyl group. 
 
 
Scheme 2.19 A formal [3+3]-reaction efficiently constructs tetracycle 144. 
Completion of the pentacyclic core of fastigiatine (37) required exchanging the C13-tertiary 
hydroxyl with Nβ, presumably via an initial retro-aldol reaction, subsequent iminium ion formation, 
and final transannular Mannich reaction. To this end, alkylation of 144 with iodomethane in the 
presence of potassium carbonate, followed by subsequent addition of thiophenol, yielded tetracyclic 
N-methylamine 145 (Scheme 2.20).52 Up until this point, there was no evidence that 145 or prior 
tetracyclic intermediates were in equilibrium with the retro-aldol product 146. However, submission 
of 145 to electrospray ionization mass spectrometry revealed a large ion with mass corresponding to 
the molecular formula M–H2O, which is the mass of the desired pentacycle 148. 
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Scheme 2.20 Completion of (+)-fastigiatine (37). 
This result hinted that the desired transformation had occurred during the ionization 
conditions in the mass spectrometer. Inspired, I attempted heating 145 in various common solvents. 
Unfortunately, heating under neutral conditions led to no reaction while the use of acids led to clean 
decarboxylation to the corresponding imine. I postulated that while an acid catalyst may facilitate the 
retro-aldol reaction, it would also protonate Nβ, thus disfavoring formation of the charged 
intermediates involved in the requisite retro-aldol reaction. Therefore, the use of a strong hydrogen-
bond donor that was not a strong acid may logically facilitate the desired reaction. Gratifyingly, 
heating 145 in rigorously deoxygenated 2,2,2-trifluoroethanol cleanly afforded pentacycle 148 in 85% 
yield. Treatment of 148 with p-toluenesulfonic acid induced facile t-butyloxycarbonyl loss to yield 
the corresponding imine, which upon treatment with acetic anhydride and triethylamine afforded (+)-
fastigiatine (37) ([α]24D = +375 (c = 1.4, CHCl3)).53 The 1H and 13C NMR spectra for synthetic (+)-37 
matched those reported for the natural compound, and the structure of synthetic (+)-37 was 
unequivocally established via single crystal X-ray diffraction analysis (Figure 2.4). 
 
                                                                                                                                                  
53  The reported optical rotation for (+)-fastigiatine (37), which contains a minor amount of des-N-
methylfastigiatine, is ([α]23D = +290 (c = 1.36, CHCl3). See ref 15a. 
then PhSH,
0 °C to RT
(87%)
13
4
Me
H
N
HO
144
CO2t-Bu
NHNs
β
13
Me
H
N
HO
145
CO2t-Bu
NHMe
β
MeI, K2CO3, DMF,
0 °C to RT;
CO2t-Bu
Me
H
N
N
147
Me
Me
H
N
N
148
Me
1. p-TsOH•H2O,
    PhH, 80 °C
2. Ac2O, Et3N,
    CH2Cl2
    (81%, 2 steps)
Me
N
N
(+)-fastigiatine (37)
Me
O Me
(~85%)
13
Me
H
N
O
146
CO2t-Bu
NHMe
β
CO2t-Bu
CF3CH2OH,
80 °C
Retro-Aldol
RXN
Iminium Ion
Formation
Transannular
Mannich RXN
40
  
Figure 2.4 X-Ray crystal structure of (+)-fastigiatine (37).  
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 Conclusion 
 In conclusion, the first total synthesis of (+)-fastigiatine (37) was completed. As described in 
chapter two, a first-generation synthesis plan utilizing a unique bicyclic aminal allowed us to obtain 
the desired cascade substrate containing the correct C–N connectivity. However, the cascade substrate 
ultimately proved impractical due to the difficulties associated with handling basic nitrogen 
compounds and air-sensitive imine/enamine tautomers. The second-generation synthesis plan 
described within this chapter benefited from the lessons learned from the original plan, and a similar 
but more streamlined design allowed for the more efficient synthesis of the cascade substrate. This 
redesign led to a convergent fragment coupling utilizing a nucleophilic cyclopropane coupling, which 
is one of the most complex reported to date. 
Yet problems with attaining the correct C–N connectivity—neatly solved in the first-
generation route with the bicyclic aminal—almost derailed the second-generation synthetic effort. 
The simple use of a strongly electron-withdrawing Ns group ultimately allowed for the successful 
formal [3+3]-cycloaddition reaction, which generated four contiguous stereocenters of fastigiatine 
(37). An unsual retro-aldol, iminium ion formation, and transannular Mannich reaction sequence was 
then achieved for the construction of the strained pentacyclic core of 37. The ease of the transannular 
Mannich reaction sequence suggests that iminium ion 47 is at the very least a feasible biosynthetic 
intermediate. Overall, the second-generation synthesis plan accomplished a total synthesis of 37 in 
fifteen steps from known cyclopropane 104 in ~30% overall yield. 
With the knowledge gained from both the first-generation and second-generation route, I am 
confident that a synthetic route employing the originally proposed cascade sequence with both amines 
working in concert could eventually be accomplished to complete a synthesis of both fastigiatine (37) 
and himeradine A (38). However, I decided that the pursuit of other target molecules may prove more 
interesting, and those efforts are described in the upcoming chapter. 
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 Experimental Section 
 General Procedures. All reactions were performed in oven-dried or flame-dried glassware 
under a positive pressure of argon unless otherwise noted. Where necessary (so noted), reactions were 
performed in Schlenk tubes fitted with a PTFE stopcock or pressure tubes fitted with a PTFE bushing. 
Flash column chromatography was performed as described by Still et al. employing silica gel 60 (40-
63 μm, Whatman).54 Where necessary (so noted), silica gel was neutralized by treatment of the silica 
gel prior to chromatography with the eluent containing triethylamine (Et3N) or 30% (w/v) ammonium 
hydroxide (NH4OH). Analytical thin-layer chromatography (TLC) was performed using 0.25 mm 
silica gel 60 F254 plates. TLC plates were visualized by exposure to ultraviolet light (UV) and/or 
exposure to an acidic solution of p-anisaldehyde (anis), an aqueous solution of ceric ammonium 
molybdate (CAM), an aqueous solution of potassium permanganate (KMnO4), or a solution of 
ninhydrin in n-butanol followed by heating on a hot plate. 
 
Materials. Commercial reagents and solvents were used as received with the following 
exceptions: tetrahydrofuran (THF), diethyl ether (Et2O), dichloromethane (CH2Cl2), acetonitrile 
(MeCN), HMDS, benzene (PhH), toluene (PhMe), and N,N-dimethylformamide (DMF) were 
degassed with argon and passed through a solvent purification system (designed by J.C. Meyer of 
Glass Contour) utilizing alumina columns as described by Grubbs et al.55 Et3N and diisopropylamine 
were distilled over calcium hydride immediately before use. TMSOTf was distilled before use. 
Potassium hydride was washed with pentane and dried under reduced pressure before use. The 
molarities of n-butyllithium, t-butyllithium, methyllithium, and trimethylsilylmethyllithium solutions 
were determined by titration using 1,10-phenanthroline as an indicator (average of at least three 
                                                                                                                                                  
54 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
 
55 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 
1518–1520. 
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 determinations). Where necessary (so noted), solutions were degassed by alternating freeze (liquid 
nitrogen)/evacuation/thaw cycles (FPT, three iterations). 
 
Instrumentation. Proton nuclear magnetic resonance (1H NMR) spectra were recorded on 
Varian INOVA 600 or Varian INOVA 500 spectrometers. Proton chemical shifts are expressed in 
parts per million (δ scale) and are calibrated using residual undeuterated solvent as an internal 
reference (CHCl3: δ 7.26, C6D5H: δ 7.16, CD2HCN: δ 1.94). Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicities are 
reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = 
apparent, or combinations thereof. Carbon nuclear magnetic resonance (13C NMR) spectra were 
recorded on Varian INOVA 500 or Varian Mercury 400 spectrometers. Carbon chemical shifts are 
expressed in parts per million (δ scale) and are referenced from the carbon resonances of the solvent 
(CDCl3: δ 77.0, C6D6: δ 128.4, CD3CN; δ 118.7). Infrared (FTIR) spectra were recorded on a 
Shimadzu 8400S FT-IR spectrophotometer referenced to a polystyrene standard. FTIR Data is 
reported in frequency of absorption (cm-1). High-resolution mass spectra (HRMS) were recorded 
using electrospray ionization (ESI) mass spectroscopy (MS) experiments on an Agilent 6210 TOF 
LC/MS. Optical rotations were measured on a Jasco P-2000 digital polarimeter with a sodium lamp. 
Reported readings are the average of at least three measurements for each sample. The structure of 
(+)-fastigiatine (37) was obtained with the assistance of Dr. Shao-Liang Zheng at the X-ray 
diffraction facility of the Department of Chemistry and Chemical Biology, Harvard University. 
 
 (For clarity, intermediates that have not been assigned numbers in the text are numbered 
sequentially in the experimental section beginning with S1). 
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Iodide 56: Iodine (28.7 g, 113 mmol, 1.36 equiv) was added in a single portion to a stirred solution of 
triphenylphosphine (26.1 g, 100 mmol, 1.20 equiv) and imidazole (8.48 g, 125 mmol, 1.50 equiv) in 
toluene (150 mL). The solution was stirred for 5 min before a solution of S156 (20.4 g, 83.0 mmol, 
1.00 equiv) in toluene (100 mL) was added dropwise via cannula. The transfer was completed with 
two additional portions of toluene (2 × 25 mL). The resultant heterogeneous red solution was stirred 
vigorously in the dark. After 2 h, saturated aqueous Na2SO3 solution (200 mL) was added to the 
reaction mixture. The layers were separated, and the aqueous layer was extracted with Et2O (3 × 250 
mL). The combined organic layers were then dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, 
eluent: gradient, 5% → 20% EtOAc in hexanes) to afford known iodide 5657 (27.5 g, 90%) as a red 
solid.  
                                                                                                                                                  
56 Prepared in four steps from L-lysine on multi-gram scale following a literature protocol: Paintner, F. F.; 
Allmendinger, L.; Bauschke, G.; Klemann, P. Org. Lett. 2005, 7, 1423–1426. 
 
57 For full characterization data, see: Suhartono, M.; Schneider, A. E.; Dürner, G.; Göbel, M. W. Synthesis 2010, 
2, 293–303. 
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Azide S2:58 Sodium azide (6.16 g, 94.7 mmol, 1.30 equiv) was added in a single portion to a stirred 
solution of cyclopropane 5559 (12.4 g, 72.9 mmol, 1.00 equiv) in DMF (80 mL). Et3N (2.03 mL, 14.6 
mmol, 0.20 equiv) and glacial acetic acid (5.42 mL, 94.7 mmol, 1.30 equiv) were then added 
sequentially dropwise via syringe to the stirred reaction mixture. The resultant vigorously stirred 
reaction mixture was then heated to 70 °C. After 7.5 h, the reaction mixture was cooled to ambient 
temperature, and then cautiously poured into a stirred solution of 1:1 Et2O/saturated aqueous NaHCO3 
solution (~200 mL) at 0 °C. After gas evolution had ceased, the layers were separated and the 
aqueous layer was extracted with Et2O (4 × 200 mL). The combined organic layers were then washed 
with water (5 × 400 mL) and brine (400 mL), dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure to afford analytically pure azide S260 (12.0 g, 77%) as a light tan oil that was 
carried forward without further purification. 
                                                                                                                                                  
58 This procedure was adapted from: Ok, T.; Jeon, A.; Lee, J.; Lim, J. H.; Hong, C. S.; Lee, H.-S. J. Org. Chem. 
2007, 7390–7393. 
 
59 Prepared in one step from diethylmalonate and (R)-epichlorohydrin according to ref. 58. 
 
60 For full characterization data, see ref. 58. 
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Butyrolactone 70: Cesium carbonate (37.2 g, 113 mmol, 2.00 equiv) was added in a single portion to 
a stirred solution of azide S2 (12.0 g, 56.5 mmol, 1.00 equiv) in DMSO (140 mL). After 1 h, a 
solution of iodide 56 (27.5 g, 77.4 mmol, 1.37 equiv) in DMSO (30 mL) was added dropwise via 
cannula to the stirred reaction mixture. The transfer was completed with two additional portions of 
DMSO (2 × 10 mL). After 45 h, the reaction mixture was partitioned with saturated aqueous NH4Cl 
solution (200 mL) and Et2O (250 mL). The aqueous layer was extracted with Et2O (4 × 250 mL), and 
the combined organic layers were washed with water (5 × 400 mL) and brine (400 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to afford crude alkylated 
product S3 as a >10:1 mixture of C4-epimers that was used without further purification. 
 An aqueous solution of LiOH (1 M, 125 mL, 124 mmol, 2.20 equiv) was added to a stirred 
solution of crude S3 in THF (550 mL). After 4.5 h, the reaction mixture was acidified with aqueous 
HCl (1 M) until the pH was adjusted to between pH 4 and pH 5. The resultant vigorously stirred 
biphasic solution was heated to 60 °C. After 13 h, the layers were separated, and the aqueous layer 
was extracted with Et2O (3 × 250 mL). The combined organic layers were washed with brine (500 
mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to afford crude 
butyrolactone 70 as a ~3:1 mixture of trans:cis C4-epimers, which was used without further 
purification. 
DBU (1.69 mL, 11.3 mmol, 0.20 equiv) was added dropwise via syringe to a stirred solution 
of crude 70 in CH2Cl2 (550 mL), and the resultant reaction mixture was then refluxed at 40 °C. After 
16.5 h, the reaction mixture was cooled to ambient temperature before the solution was concentrated 
under reduced pressure. The residue was then directly purified by flash column chromatography 
(silica gel, eluent: gradient, 20% → 33% EtOAc in hexanes) to afford butyrolactone 70 (13.5 g) as a 
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 >20:1 mixture of trans:cis C4-epimers. The mixed fractions containing lower trans:cis ratios were 
combined, concentrated, and re-subjected to the aforementioned experimental procedure. Flash 
column chromatography (silica gel, eluent: gradient, 20% → 33% EtOAc in hexanes) afforded 
additional material (2.4 g), which when combined with the previous batch provided butyrolactone 70 
(15.9 g, 76%) as an off-white solid. 1H NMR (600 MHz, CD3CN, 65 °C) δ: 4.35 (t, J = 8.6 Hz, 1H), 
3.96–3.92 (m, 2H), 3.82 (br. s., 1H), 3.73 (dd, J = 1.5, 8.8 Hz, 1H), 3.58 (dd, J = 5.6, 12.6 Hz, 1H), 
3.50 (dd, J = 7.0, 12.9 Hz, 1H), 2.59–2.51 (m, 1H), 2.42 (td, J = 5.9, 8.6 Hz, 1H), 1.80–1.67 (m, 3H), 
1.66–1.58 (m, 1H), 1.54 (s, 3H), 1.47 (s, 9H), 1.45 (s, 3H), 1.11–1.07 (m, 1H). 13C NMR (126 MHz, 
CD3CN, 65 °C) δ: 179.8, 153.8, 95.1, 81.1, 70.4, 68.6, 58.9, 54.2, 44.0, 42.0, 32.2, 29.5, 28.2, 27.3, 
25.0. FTIR (thin film) cm-1: 2978, 1774, 1689, 1389, 1365, 1256, 1169, 1094, 1022. HRMS (ESI) 
(m/z) calc’d for C17H29N4O5 [M+H]+: 369.2133, found 369.2135. TLC (33% EtOAc in hexanes), Rf: 
0.34 (KMnO4). 
NOESY1D (500 MHz, CD3CN): 
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Hemi-ketal 71: A solution of methyllithium in Et2O (1.51 M, 265 µL, 0.400 mmol, 1.20 equiv) was 
added dropwise via syringe to a stirred solution of butyrolactone 70 (123 mg, 0.330 mmol, 1.00 
equiv) in THF (3.3 mL) at –78 °C. The resultant stirred reaction mixture was slowly allowed to warm 
to –30 °C over 3 h, at which point saturated aqueous NH4Cl solution (5 mL) and Et2O (5 mL) were 
added to the stirred reaction mixture. The layers were separated, and the aqueous layer was extracted 
with Et2O (3 × 5 mL). The combined organic layers were washed with brine (15 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel, eluent: gradient, 10% → 35% EtOAc in CH2Cl2) to afford 
recovered 70 (15 mg, 12%) and hemi-ketal 71 (85 mg, 67%) as a white solid. 1H NMR (500 MHz, 
CDCl3, complex mixture of diastereomers; major diastereomer reported) δ: 3.98–3.88 (m, 2H), 3.84–
3.70 (m, 2H), 3.53–3.47 (m, 2H), 3.44 (br. s., 1H), 3.29 (dd, J = 8.2, 12.3 Hz, 1H), 2.26–2.19 (m, 
1H), 2.17 (s, 3H), 1.77–1.64 (m, 1H), 1.63–1.48 (m, 5H), 1.46–1.41 (m, 12H), 1.37 (s, 3H). 13C NMR 
(126 MHz, CD3CN, 65 °C) δ: 153.2, 108.1, 106.5, 105.9, 94.6, 80.8, 80.3, 69.4, 68.2, 67.7, 62.0, 61.0, 
59.1, 58.5, 55.7, 55.4, 52.5, 52.3, 52.2, 51.3, 51.1, 45.8, 43.4, 34.0, 33.1, 32.7, 32.1, 31.2, 29.1, 28.4, 
27.5, 27.3, 27.1, 26.7, 25.4, 24.3, 23.9. FTIR (thin film) cm-1: 3441, 2978, 2933, 1691, 1390, 1377, 
1256, 1172, 1093. HRMS (ESI) (m/z) calc’d for C18H32N4NaO5 [M+Na]+: 407.2265, found 407.2268. 
TLC (33% EtOAc in hexanes), Rf: 0.29 (anis). 
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Weinreb amide S4: A solution of trimethylaluminum in hexanes (2.0 M, 49 mL, 98 mmol, 3.1 
equiv) was added dropwise via syringe to a stirred solution of N,O-dimethylhydroxylamine 
hydrochloride (9.71 g, 97.6 mmol, 3.07 equiv) in THF (120 mL) at 0 °C. The resultant stirred solution 
was allowed to warm to ambient temperature, and after 30 min was cooled back to –15 °C before a 
solution of butyrolactone 70 (11.7 g, 31.8 mmol, 1.00 equiv) in THF (25 mL) was added dropwise via 
cannula. The resultant stirred reaction mixture was slowly allowed to warm to ambient temperature 
over the course of 3.5 h. After an additional 12.5 h, the reaction mixture was cooled to 0 °C and then 
subsequently added dropwise via cannula to a stirred solution of 2:1 saturated aqueous potassium 
sodium tartrate solution and saturated aqueous NaHCO3 solution (750 mL) at –5 °C. The stirred 
solution was then diluted with Et2O (250 mL) and the layers were separated. The aqueous layer was 
extracted with Et2O (3 × 250 mL), and the combined organic layers were then washed with water 
(500 mL) and brine (2 × 500 mL), dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to afford crude Weinreb amide 74, which was used without further purification. 
 Triisopropylsilyl trifluoromethanesulfonate (9.70 mL, 36.1 mmol, 1.14 equiv) was added 
dropwise via syringe to a stirred solution of crude 74 and diisopropylethylamine (7.20 mL, 41.3 
mmol, 1.30 equiv) in CH2Cl2 (160 mL) at 0 °C. After 2 h, saturated aqueous NaHCO3 solution (200 
mL) and CH2Cl2 (200 mL) were added to the stirred solution, which was subsequently allowed to 
warm to ambient temperature. The layers were separated, and the aqueous layer was extracted with 
CH2Cl2 (2 × 250 mL). The combined organic layers were then washed with aqueous HCl (1 M, 3 × 
250 mL) and a saturated aqueous NaHCO3 solution (250 mL), dried over anhydrous MgSO4, filtered, 
and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 11% → 17% EtOAc in hexanes) to afford TIPS-
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 protected Weinreb amide S4 (15.9 g, 85%) as a colorless oil. 1H NMR (500 MHz, C6D6, 70 °C) δ: 
3.88–3.74 (m, 3H), 3.72 (dd, J = 5.7, 8.7 Hz, 1H), 3.69–3.62 (m, 2H), 3.33 (dd, J = 5.6, 12.2 Hz, 1H), 
3.27 (s, 3H), 3.18–3.11 (m, 1H), 2.91 (s, 3H), 2.24–2.16 (m, 1H), 1.92–1.53 (m, 7H), 1.51 (br. s., 
3H), 1.46 (s, 9H), 1.41–1.28 (m, 2H), 1.18–1.06 (m, 21H). 13C NMR (126 MHz, C6D6, 70 °C) δ: 
176.2, 152.6, 94.3, 79.7, 67.8, 63.1, 61.4, 58.3, 50.8, 44.6, 40.3, 32.8, 32.6, 29.0, 27.9, 26.3, 24.6, 
18.6, 12.9. FTIR (thin film) cm-1: 2940, 2866, 1695, 1661, 1462, 1387, 1365, 1257, 1175, 1097. 
HRMS (ESI) (m/z) calc’d for C28H56N5O6Si [M+H]+: 586.3994, found 586.4002. TLC (33% EtOAc 
in hexanes), Rf: 0.59 (KMnO4). 
  
51
  
Methyl ketone 75: A solution of methyllithium in Et2O (1.75 M, 5.14 mL, 9.00 mmol, 3.00 equiv) 
was added dropwise via syringe to a stirred solution of Weinreb amide S4 (1.76 g, 3.00 mmol, 1.00 
equiv) in THF (30 mL) at –78 °C. After 3.5 h, a saturated aqueous NH4Cl solution (12 mL) was 
added rapidly via syringe to the stirred reaction mixture, which was subsequently allowed to warm to 
ambient temperature. The reaction mixture was diluted with Et2O (50 mL) and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers 
were washed with brine (150 mL), dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to afford analytically pure methyl ketone 75 (1.62 g, quant.) as a pale yellow oil. 1H 
NMR (600 MHz, CD3CN, 65 °C) δ: 3.92 (dd, J = 5.9, 8.8 Hz, 1H), 3.79 (br. s., 1H), 3.72–3.66 (m, 
3H), 3.52 (dd, J = 5.0, 12.6 Hz, 1H), 3.38 (dd, J = 6.4, 12.3 Hz, 1H), 2.79–2.72 (m, 1H), 2.15 (s, 3H), 
2.10–2.06 (m, 1H), 1.64–1.56 (m, 1H), 1.51 (s, 3H), 1.46 (s, 9H), 1.55–1.44 (m, 3H), 1.44 (s, 3H), 
1.16–1.07 (m, 21H). 13C NMR (100 MHz, CD3CN, 65 °C) δ: 212.0, 153.8, 95.1, 81.1, 68.6, 64.2, 
59.0, 52.7, 51.8, 44.4, 33.1, 31.3, 29.6, 28.3, 25.6, 25.1, 19.3, 13.8. FTIR (thin film) cm-1: 2941, 
2866, 1694, 1462, 1364, 1256, 1173, 1093, 882, 682. HRMS (ESI) (m/z) calc’d for C27H53N4O5Si 
[M+H]+: 541.3780, found 541.3785. TLC (25% EtOAc in hexanes), Rf: 0.58 (anis). 
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Bicyclic aminal 76: A solution of anhydrous HCl in dioxane (4.0 M, 3.6 mL, 14 mmol, 1.3 equiv) 
was added dropwise via syringe to a stirred solution of methyl ketone 75 (5.91 g, 10.9 mmol, 1.00 
equiv) in CHCl3 (350 mL) at 0 °C, which was subsequently allowed to warm to ambient temperature. 
After 1.5 h, a saturated aqueous NaHCO3 solution (250 mL) was added to the stirred reaction mixture. 
The layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 × 100 mL). The 
combined organic layers were dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash column chromatography (silica gel, eluent: gradient, 10% 
→ 100% EtOAc in hexanes) to afford bicyclic aminal 76 (4.15 g, 79%) as a colorless gel and a 
mixture of byproducts (~1 g). The mixture of byproducts was re-subjected to the aforementioned 
experimental procedure to yield additional 76 (0.32 g, 6%), which was combined with the previous 
material. 1H NMR (500 MHz, CD3CN) δ: 4.27–4.21 (m, 1H), 3.87–3.76 (m, 4H), 3.61 (dd, J = 9.0, 
10.0 Hz, 1H), 3.15 (dd, J = 9.7, 12.7 Hz, 1H), 2.39–2.30 (m, 1H), 2.10–2.00 (m, 1H), 1.78–1.69 (m, 
1H), 1.68–1.61 (m, 1H), 1.58 (s, 3H), 1.60–1.54 (m, 1H), 1.43 (s, 9H), 1.15–1.02 (m, 21H). 13C NMR 
(126 MHz, CDCl3) δ: 153.3, 96.3, 80.9, 69.9, 64.0, 57.2, 50.7, 43.7, 42.6, 29.2, 29.0, 24.4, 19.5, 18.9, 
13.2. FTIR (thin film) cm-1: 2942, 2866, 1698, 1365, 1161, 1091, 882, 681. HRMS (ESI) (m/z) 
calc’d for C24H47N4O4Si [M+H]+: 483.3361, found 483.3367. TLC (11% EtOAc in hexanes), Rf: 0.26 
(anis).  
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Iodide 78: A solution of TBAF in THF (1.0 M, 0.96 mL, 0.96 mmol, 1.2 equiv) was added to a 
stirred solution of bicyclic aminal 76 (385 mg, 0.800 mmol, 1.00 equiv) in THF (4 mL). After 2.5 h, 
brine (10 mL) and EtOAc (10 mL) were added to the stirred reaction mixture. The layers were 
separated, and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic 
layers were washed with brine (40 mL), dried over anhydrous Na2SO4, and concentrated under 
reduced pressure to afford the corresponding crude primary alcohol, which was used without further 
purification. 
 Iodine (406 mg, 1.60 mmol, 2.00 equiv) was added in a single portion to a stirred solution of 
triphenylphosphine (409 mg, 1.56 mmol, 1.95 equiv) and imidazole (272 mg, 4.00 mmol, 5.00 equiv) 
in CH2Cl2 (5 mL). The solution was stirred for 5 min before a solution of crude primary alcohol in 
CH2Cl2 (2 mL) was added dropwise via cannula. The transfer was completed with two additional 
portions of CH2Cl2 (2 × 500 µL). After 4 h, water (20 mL) and CH2Cl2 (20 mL) were added to the 
stirred reaction mixture, and the layers were separated. The aqueous layer was extracted with CH2Cl2 
(2 × 20 mL), and the combined organic layers were washed with water (2 × 50 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel, eluent: gradient, 5% → 10% EtOAc in pentane) to afford 
iodide 78 (320 mg, 92%) as a colorless oil. 1H NMR (500 MHz, C6D6) δ: 4.06 (br. s., 1H), 3.59 (dd, J 
= 3.8, 12.7 Hz, 1H), 3.56 (ddd, J = 1.5, 5.2, 7.0 Hz, 1H), 3.23 (d, J = 7.3 Hz, 1H), 3.15 (dd, J = 5.2, 
10.0 Hz, 1H), 2.77 (br. s., 1H), 2.50 (t, J = 9.8 Hz, 1H), 2.32 (ddd, J = 3.3, 5.1, 11.5 Hz, 1H), 1.92 
(dq, J = 3.5, 8.9 Hz, 1H), 1.79–1.67 (m, 1H), 1.58 (s, 3H), 1.45 (s, 9H), 1.09–0.99 (m, 3H). 13C NMR 
(126 MHz, C6D6) δ: 152.6, 95.0, 80.4, 69.1, 56.3, 52.1, 45.9, 41.8, 28.8, 28.1, 24.0, 18.2, 8.0. FTIR 
(thin film) cm-1: 2940, 1695, 1366, 1312, 1172, 1091, 864. HRMS (ESI) (m/z) calc’d for C15H26IN4O3 
[M+H]+: 437.1044, found 437.1046. TLC (25% EtOAc in hexanes), Rf: 0.54 (anis). 
2. I2, PPh3, Imid,
    CH2Cl2, 4 h
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Zinc–Iodine Exchange: Diethylzinc (11.0 µL, 0.100 mmol, 2.00 equiv) was added dropwise via 
syringe to a stirred solution of iodide 78 (21.8 mg, 0.0500 mmol, 1.00 equiv) and [1,1'-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with CH2Cl2 (4.0 mg, 0.005 mmol, 
0.10 equiv) in THF (150 µL) at –78 °C, which was subsequently allowed to warm to ambient 
temperature after 5 min. After 24 h, the stirred reaction mixture was cooled to –78 °C before 
additional diethylzinc (11.0 µL, 0.100 mmol, 2.00 equiv) was added dropwise via syringe. The 
resultant stirred reaction mixture was then allowed to warm to ambient temperature. After an 
additional 19 h, saturated aqueous NH4Cl solution (5 mL) and Et2O (5 mL) were added to the stirred 
reaction mixture. The layers were separated, and the aqueous layer was extracted with Et2O (3 × 5 
mL). The combined organic layers were washed with saturated aqueous NH4Cl solution (15 mL) and 
brine (15 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. 1H 
NMR analysis of the crude residue showed >90% conversion of iodide 78 to reduced product 85. An 
analytical sample of 85 was obtained by flash column chromatography (silica gel, 13% EtOAc in 
hexanes). 1H NMR (500 MHz, C6D6) δ: 4.04 (br. s., 1H), 3.65–3.56 (m, 2H), 3.26 (d, J = 7.3 Hz, 1H), 
2.76 (t, J = 10.1 Hz, 1H), 1.97–1.81 (m, 2H), 1.74 (s, 3H), 1.71–1.60 (m, 1H), 1.41 (s, 9H), 1.26–1.16 
(m, 2H), 1.09 (dd, J = 2.7, 13.0 Hz, 1H), 0.77 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, C6D6) δ: 
152.5, 95.5, 79.9, 69.1, 56.3, 54.6, 48.1, 34.2, 28.8(2), 24.0, 18.8, 17.1. FTIR (thin film) cm-1: 2925, 
1701, 1366, 1259, 1164, 1091. HRMS (ESI) (m/z) calc’d for C15H27N4O3 [M+H]+: 333.1897, found 
333.1896. TLC (25% EtOAc in hexanes), Rf: 0.58 (anis).  
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Ketone 87: A solution of freshly prepared LDA in THF/hexanes (1.00 M, 180 µL, 0.180 mmol, 1.50 
equiv) was added dropwise via syringe to a stirred solution of hydrazone 8661 (51.6 mg, 0.180 mmol, 
1.50 equiv) in THF (300 µL) at –78 °C, which was subsequently allowed to warm to 0 °C. After 1 h, 
the stirred reaction mixture was cooled to –78 °C before HMPA (70 µL) was added dropwise via 
syringe. After an additional 1 h, a solution of iodide 78 (52.4 mg, 0.120 mmol, 1.00 equiv) in THF 
(100 µL) was added dropwise via syringe to the stirred reaction mixture at –78 °C. The transfer was 
completed with two additional portions of THF (2 × 100 µL). After 3 h, the stirred reaction mixture 
was allowed to warm to ambient temperature before water (10 mL) and Et2O (10 mL) were added. 
The layers were separated, and the aqueous layer was extracted with Et2O (3 × 5 mL). The combined 
organic layers were washed with water (4 × 10 mL) and brine (10 mL), dried over anhydrous MgSO4, 
filtered, and concentrated to afford crude hydrazone S5, which was used without further purification. 
 Silica gel (0.45 g) was added in a single portion to a stirred solution of crude hydrazone S5 in 
CH2Cl2 (2.5 mL). After 12 h, the reaction mixture was filtered and concentrated under reduced 
pressure. The residue was purified by flash column chromatography (silica gel, eluent: gradient, 5% 
→ 10% EtOAc in hexanes) to afford ketone 87 (27 mg, 41%). 1H NMR (500 MHz, C6D6) δ: 4.05 (br. 
s., 1H), 3.72 (dd, J = 3.1, 12.5 Hz, 1H), 3.64–3.53 (m, 3H), 3.30 (d, J = 7.1 Hz, 1H), 2.89 (dd, J = 8.6, 
12.2 Hz, 1H), 2.27 (dt, J = 7.2, 13.2 Hz, 1H), 2.16 (dd, J = 5.8, 16.4 Hz, 1H), 2.12–2.06 (m, 2H), 
2.04–1.92 (m, 2H), 1.78 (s, 3H), 1.82–1.72 (m, 2H), 1.68 (br. s., 1H), 1.57–1.49 (m, 1H), 1.44 (s, 
9H), 1.43–1.24 (m, 5H), 1.09 (tdd, J = 2.3, 4.5, 13.1 Hz, 1H), 1.00 (s, 9H), 0.90 (d, J = 6.6 Hz, 3H), 
                                                                                                                                                  
61 For brevity, the synthesis of known hydrazone 86 is not shown. For a procedure for the preparation of 86, see 
ref. 13. 
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 0.09 (s, 3H), 0.08 (s, 3H). 13C NMR (100 MHz, C6D6) δ: 208.5, 152.6, 95.5, 80.0, 69.1, 61.7, 56.4, 
53.4, 50.5, 45.7, 41.6, 40.3, 38.6, 30.6, 28.8, 26.6, 26.5, 25.5, 24.1, 20.5, 18.8, 18.7, –4.81, –4.84. 
HRMS (ESI) (m/z) calc’d for C28H53N4O5Si [M+H]+: 553.3780, found 533.3786. TLC (25% EtOAc 
in hexanes), Rf: 0.35 (anis). 
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β-Ketophosphonate 92: Borane dimethyl sulfide complex (2.75 mL, 27.5 mmol, 1.02 equiv) was 
added dropwise via syringe to a stirred solution of carboxylic acid 9062 (5.08 g, 27.0 mmol, 1.00 
equiv) in THF (70 mL) at 0 °C, which was subsequently allowed to warm to ambient temperature. 
After 4 h, an additional portion of borane dimethyl sulfide complex (135 µL, 1.35 mmol, 0.05 equiv) 
was added dropwise via syringe to the stirred reaction mixture. After an additional 3 h, an additional 
portion of borane dimethyl sulfide complex (135 µL, 1.35 mmol, 0.05 equiv) was added dropwise via 
syringe to the stirred reaction mixture. After an additional 1 h, the stirred reaction mixture was cooled 
to 0 °C before water (20 mL) was added. The resultant mixture was vigorously stirred and allowed to 
warm to ambient temperature. The solution was partially concentrated under reduced pressure to 
remove most of the THF, and was then partitioned with Et2O (500 mL). The layers were separated, 
and the organic layer was washed with saturated aqueous NaHCO3 solution (2 × 200 mL) and brine 
(200 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to afford 
crude alcohol S6, which was used without further purification. 
 Oxalyl chloride (4.57 mL, 54.0 mmol, 2.00 equiv) was added dropwise via syringe to a 
stirred solution of DMSO (4.80 mL, 67.5 mmol, 2.50 equiv) in CH2Cl2 (220 mL) at –78 °C. After 30 
                                                                                                                                                  
62  Prepared in one step from 3-methylglutaric anhydride according to the procedure in: Marcoux, D.; 
Bindschädler, P.; Speed, A. W. H.; Chiu, A.; Pero, J. E.; Borg, G. A.; Evans, D. A. Org. Lett. 2011, 13, 3758–
3761. The enantiopurity of 90 was determined to be 93% ee by chiral HPLC using authentic (±)-90 with kind 
assistance from Dr. P. Bindschädler. 
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 min, a solution of crude alcohol S6 in CH2Cl2 (50 mL) was added via cannula down the flask wall 
into the stirred reaction mixture at –78 °C. The transfer was completed with two additional portions 
of CH2Cl2 (2 × 5 mL). After 2 h, Et3N (26.3 mL, 189 mmol, 7.00 equiv) was added down the flask 
wall into the stirred reaction mixture, which after 20 min was allowed to warm to 0 °C. After an 
additional 1 h at 0 °C, water (270 mL) was added to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The layers were separated, and the aqueous 
phase was extracted with CH2Cl2 (2 × 100 mL). The combined organic layers were then dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to afford crude aldehyde S7, 
which was used without further purification. 
 p-Toluenesulfonic acid monohydrate (205 mg, 1.08 mmol, 0.040 equiv) was added in a single 
portion to a stirred solution of crude aldehyde S7 and trimethyl orthoformate (8.86 mL, 81.0 mmol, 
3.00 equiv) in MeOH (270 mL). After 1 h, a saturated aqueous NaHCO3 solution (200 mL) was 
added to the stirred reaction mixture. After 15 min, the stirred reaction mixture was partitioned with 
Et2O (600 mL) and the layers were separated. The aqueous layer was extracted with Et2O (100 mL) 
and EtOAc (2 × 100 mL). The combined organic layers were then washed with water (2 × 400 mL) 
and brine (400 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure 
to afford crude dimethyl acetal 91, which was used without further purification. 
 Batch 1. A solution of isopropylmagnesium chloride in THF (1.68 M, 5.36 mL, 9.00 mmol, 
3.80 equiv) was added dropwise via syringe to a stirred solution of crude 91 (517 mg, 2.37 mmol, 
1.00 equiv) and N,O-dimethylhydroxylamine hydrochloride (468 mg, 5.35 mmol, 2.26 equiv) in THF 
(6 mL) at –20 °C. After 1 h, water (5 mL) was added to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The resultant mixture was partitioned with 
Et2O (20 mL) and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 10 
mL), and the combined organic layers were washed brine (50 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure to afford crude Weinreb amide S8. 
59
  Batch 2. A solution of isopropylmagnesium chloride in THF (1.68 M, 51.6 mL, 86.6 mmol, 
3.80 equiv) was added dropwise via syringe to a stirred solution of crude 91 (4.98 g, 22.8 mmol, 1.00 
equiv) and N,O-dimethylhydroxylamine hydrochloride (4.45 g, 45.6 mmol, 2.00 equiv) in THF (46 
mL) at –20 °C. After 1 h, water (50 mL) was added to the vigorously stirred reaction mixture, which 
was subsequently allowed to warm to ambient temperature. The resultant mixture was partitioned 
with Et2O (100 mL) and the layers were separated. The aqueous layer was extracted with 9:1 
EtOAc/hexanes solution (3 × 50 mL), and the combined organic layers were washed with water (2 × 
200 mL) and brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was combined with material from batch 1, passed through a short plug of silica 
gel (Et2O), and concentrated under reduced pressure to afford Weinreb amide S8, which was used 
without further purification. 
 A solution of n-butyllithium in hexanes (2.66 M, 29.3 mL, 75.0 mmol, 3.60 equiv) was added 
dropwise via syringe to a stirred solution of dimethyl methylphosphonate (8.67 mL, 80.0 mmol, 3.83 
equiv) in THF (200 mL) at –78 °C. After 1 h, a solution of Weinreb amide S8 (4.58 g, 20.9 mmol, 
1.00 equiv) in THF (40 mL) was added dropwise via cannula to the stirred reaction mixture at –78 °C. 
The transfer was completed with two additional portions of THF (2 × 5 mL). After 1 h, a saturated 
aqueous NH4Cl solution (250 mL) was added to the stirred reaction mixture, which was subsequently 
allowed to warm to ambient temperature. Et2O (300 mL) was added to resultant mixture and the 
layers were separated. The aqueous layer was extracted with EtOAc (3 × 200 mL), and the combined 
organic layers were washed with water (3 × 500 mL) and brine (500 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The residue (~3.5 g)63 was purified by 
flash column chromatography (silica gel, eluent: gradient, 0% → 2% → 10% MeOH in EtOAc) to 
afford β-ketophosphonate 92 (3.17 g, 42%) as a tan oil. 1H NMR (500 MHz, C6D6) δ: 4.40 (dd, J = 
                                                                                                                                                  
63 The unexpected poor mass recovery may be in part due to partial water solubility of 92. 
60
 5.0, 6.6 Hz, 1H), 3.39 (d, J = 2.3 Hz, 3H), 3.37 (d, J = 2.3 Hz, 3H), 3.15 (s, 3H), 3.12 (s, 3H), 2.82–
2.70 (m, 2H), 2.51–2.43 (m, 1H), 2.33–2.22 (m, 2H), 1.66 (td, J = 6.3, 14.0 Hz, 1H), 1.42 (ddd, J = 
4.8, 7.3, 14.0 Hz, 1H), 0.89 (d, J = 6.4 Hz, 3H). 13C NMR (126 MHz, C6D6) δ: 201.0 (d, J = 6.0 Hz), 
103.5, 52.71 (d, J = 5.0 Hz), 52.67 (d, J = 5.0 Hz), 52.2, 51.5 (d, J = 0.9 Hz), 42.4 (d, J = 126 Hz), 
39.6, 25.8, 20.7. FTIR (thin film) cm-1: 2955, 1712, 1256, 1124, 1021, 803. HRMS (ESI) (m/z) 
calc’d for C11H23NaO6P [M+Na]+: 305.1125, found 305.1126. TLC (5% MeOH in CH2Cl2), Rf: 0.29 
(anis).  
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Enone 93: A solution of TBAF in THF (1.0 M, 7.1 mL, 7.1 mmol, 1.2 equiv) was added to a stirred 
solution of bicyclic aminal 76 (2.85 g, 5.90 mmol, 1.00 equiv) in THF (59 mL). After 1.5 h, brine 
(100 mL) and Et2O (100 mL) were added to the stirred reaction mixture. The layers were separated, 
and the aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were 
washed with brine (200 mL), dried over anhydrous Na2SO4, and concentrated under reduced pressure. 
The residue was purified by flash column chromatography (silica gel, eluent: gradient, 20% → 25% 
EtOAc in hexanes) to afford alcohol 77 (1.81 g, 94%) as a colorless oil, which was used directly in 
the next reaction. 
 DMSO (1.97 mL, 27.8 mmol, 5.00 equiv) was added dropwise via syringe to a stirred 
solution of oxalyl chloride (940 µL, 11.1 mmol, 2.00 equiv) in CH2Cl2 (40 mL) at –78 °C. After 1 h, a 
solution of alcohol 77 (1.81 g, 5.55 mmol, 1.00 equiv) in CH2Cl2 (10 mL) was added via cannula 
down the flask wall into the stirred reaction mixture at –78 °C. The transfer was completed with two 
additional portions of CH2Cl2 (2 × 2.5 mL). After 1.5 h, diisopropylethylamine (9.70 mL, 55.5 mmol, 
10.0 equiv) was added down the flask wall into the stirred reaction mixture, which after 5 min was 
allowed to warm to 0 °C. After an additional 1.5 h at 0 °C, aqueous HCl (1.2 M, 60 mL) was added to 
the stirred reaction mixture, which was subsequently allowed to warm to ambient temperature. The 
resultant mixture was diluted with Et2O (150 mL) and the layers were separated. The aqueous phase 
was extracted with Et2O (3 × 60 mL), and the combined organic layers were washed with saturated 
aqueous NH4Cl solution (2 × 200 mL), aqueous pH 7.5 phosphate buffer (0.1 M, 2 × 200 mL), and 
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 brine (200 mL), dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure to 
afford crude aldehyde 80, which was used without further purification. 
 A round-bottom flask was charged with crude aldehyde 80 and β-ketophosphonate 92 (2.53 
g, 9.70 mmol, 1.75 equiv), which were then azeotropically dried with three portions of benzene 
before MeCN (10 mL) was introduced via syringe. A separate round-bottom flask was charged with 
lithium chloride (705 mg, 16.6 mmol, 3.00 equiv). The flask was then flame-dried under vacuum 
(~0.1 torr), purged with argon, and allowed to cool to ambient temperature, and this process was 
repeated twice before MeCN (10 mL) was introduced into the flask via syringe. The aforementioned 
solution of crude aldehyde 80 and β-ketophosphonate 92 was then transferred via cannula to the 
stirred solution of lithium chloride in MeCN. The transfer was completed with three additional 
portions of MeCN (3 × 10 mL). Diisopropylethylamine (2.90 mL, 16.6 mmol, 3.00 equiv) was then 
added dropwise via syringe to the stirred reaction mixture. After 15 h, saturated aqueous NH4Cl 
solution (100 mL) and Et2O (150 mL) were added to the stirred reaction mixture. The layers were 
separated, and the aqueous layer was extracted with EtOAc (3 × 60 mL). The combined organic 
layers were washed with saturated aqueous NH4Cl solution (100 mL) and brine (100 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was then purified 
by flash column chromatography (silica gel, eluent: gradient, 13% → 17% → 20% → 25% EtOAc in 
hexanes) to afford (E)-enone 9364 (2.55 g, 96%) as a colorless oil. 1H NMR (500 MHz, C6D6) δ: 6.68 
(dd, J = 8.2, 15.8 Hz, 1H), 6.04 (d, J = 15.8 Hz, 1H), 4.43 (dd, J = 5.0, 6.6 Hz, 1H), 3.98 (br. s., 1H), 
3.62–3.54 (m, 2H), 3.25 (d, J = 7.3 Hz, 1H), 3.17 (s, 3H), 3.14 (s, 3H), 2.96 (dd, J = 10.1, 12.6 Hz, 
1H), 2.56–2.48 (m, 1H), 2.41–2.30 (m, 2H), 2.16–2.04 (m, 2H), 1.73 (s, 3H), 1.74–1.67 (m, 1H), 
1.62–1.53 (m, 1H), 1.48–1.40 (m, 1H), 1.38 (s, 9H), 1.28–1.19 (m, 2H), 1.03 (tdd, J = 2.3, 4.3, 13.3 
Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, C6D6) δ: 198.3, 152.4, 145.6, 132.3, 103.5, 
                                                                                                                                                  
64 The olefin geometry was assigned as E by the 15.8 Hz value of the C11–H and C12–H coupling constant. 
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 94.9, 80.2, 69.2, 56.3, 52.6, 52.2, 51.5, 48.7, 47.1, 43.6, 39.8, 28.8, 26.5, 24.3, 20.9, 20.2. FTIR (thin 
film) cm-1: 2942, 1695, 1626, 1365, 1310, 1158, 1124, 1052, 863. HRMS (ESI) (m/z) calc’d for 
C24H41N4O6 [M+H]+: 481.3021, found 481.3024. TLC (25% EtOAc in hexanes), Rf: 0.24 (anis). 
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Ketone S9: A solution of platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex in xylenes 
(2 wt. %, 6 drops) was added to a stirred solution of triethylsilane (330 µL, 2.07 mmol) in toluene 
(400 µL). This stock solution was stirred for 15 min, before an aliquot (367 µL, 1.04 mmol, 5.00 
equiv) was removed and added to a stirred solution of enone 93 (96 mg, 0.21 mmol, 1.0 equiv) in 
toluene (300 µL). The resultant stirred reaction mixture was then heated to 70 °C. After 1 h, the 
stirred reaction mixture was allowed to cool to ambient temperature before it was concentrated under 
reduced pressure to afford crude enol silyl ether 94. THF (2 mL) was then introduced into the flask 
via syringe and the subsequent stirred solution was cooled to 0 °C. A solution of TBAF in THF (1.0 
M, 300 µL, 0.30 mmol, 1.5 equiv) was added dropwise via syringe to the stirred reaction mixture at 0 
°C, which was subsequently allowed to warm to ambient temperature. After 30 min, brine (5 mL) and 
Et2O (5 mL) were added to the stirred reaction mixture, and the layers were separated. The aqueous 
layer was extracted with EtOAc (3 × 10 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient, 13% → 20% EtOAc in hexanes) to afford ketone S9 (83 mg, 86%). 1H NMR (500 MHz, 
C6D6) δ: 4.44 (dd, J = 4.9, 6.8 Hz, 1H), 4.04 (br. s., 1H), 3.71 (dd, J = 3.1, 12.5 Hz, 1H), 3.61 (ddd, J 
= 1.5, 5.2, 7.0 Hz, 1H), 3.30 (d, J = 7.1 Hz, 1H), 3.19 (s, 3H), 3.15 (s, 3H), 2.89 (dd, J = 8.4, 12.2 Hz, 
1H), 2.37–2.24 (m, 1H), 2.13 (dd, J = 6.2, 16.5 Hz, 1H), 2.09–2.03 (m, 2H), 2.03–1.96 (m, 1H), 1.92 
(dd, J = 7.3, 16.7 Hz, 1H), 1.77 (s, 3H), 1.81–1.61 (m, 4H), 1.43 (s, 9H), 1.48–1.35 (m, 2H), 1.32–
1.24 (m, 2H), 1.09 (tdd, J = 2.1, 4.3, 13.0 Hz, 1H), 0.90 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, 
C6D6) δ: 208.3, 152.6, 103.5, 95.5, 80.0, 69.1, 56.4, 53.4, 52.7, 52.2, 50.3, 45.7, 41.5, 39.8, 38.6, 28.8, 
26.0, 25.4, 24.1, 20.9, 18.7. HRMS (ESI) (m/z) calc’d for C24H43N4O6 [M+H]+: 483.3177, found 
483.3188. TLC (25% EtOAc in hexanes), Rf: 0.29 (anis).  
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Imine 95: Triphenylphosphine on a polystyrene solid support (~3.0 mmol/g, 133 mg, 0.400 mmol, 
3.00 equiv) was added in a single portion to a stirred solution of ketone S9 (0.064 g, 0.133 mmol, 
1.00 equiv) in benzene (3 mL), which was subsequently warmed to 50 °C. After 21 h, the stirred 
reaction mixture was allowed to cool to ambient temperature before it was filtered through a pad of 
Celite. The Celite pad was washed with 10 mL of EtOAc, and the resultant mixture was concentrated 
under reduced pressure to afford analytically pure imine 95 (57.2 mg, 99%). 1H NMR (600 MHz, 
C6D6) δ: 4.55 (dd, J = 5.0, 6.7 Hz, 1H), 4.20 (d, J = 17.3 Hz, 1H), 4.06 (br. s., 1H), 3.66 (ddd, J = 1.6, 
5.2, 7.0 Hz, 1H), 3.53–3.45 (m, 1H), 3.34 (d, J = 7.0 Hz, 1H), 3.21 (s, 3H), 3.18 (s, 3H), 2.29 (sxtd, J 
= 6.8, 13.8 Hz, 1H), 2.16 (dd, J = 6.6, 14.5 Hz, 1H), 2.01 (s, 3H), 1.92–1.88 (m, 1H), 1.85 (s, 3H), 
1.88–1.83 (m, 1H), 1.83–1.69 (m, 3H), 1.51 (ddd, J = 5.0, 8.4, 13.8 Hz, 1H), 1.48–1.42 (m, 9H), 
1.48–1.42 (m, 1H), 1.23 (td, J = 5.2, 13.5 Hz, 1H), 1.19–1.10 (m, 3H), 1.02 (d, J = 6.7 Hz, 3H). 13C 
NMR (126 MHz, C6D6) δ: 167.5, 152.6, 103.7, 95.6, 79.7, 69.1, 56.4, 52.7, 52.2, 51.0, 48.5, 47.7, 
40.1, 34.1, 31.9, 28.8, 27.5, 25.4, 24.0, 20.9, 18.9. FTIR (thin film) cm-1: 2938, 1694, 1366, 1162, 
1126, 1076. HRMS (ESI) (m/z) calc’d for C24H42N2NaO5 [M+Na]+: 461.2986, found 461.2997. TLC 
(9% MeOH and 1% NH4OH in CHCl3), Rf: 0.45 (ninhydrin).  
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α ,β-Unsaturated imine 96: Palladium on carbon (5 wt. %, 0.078 g, 0.037 mmol, 0.100 equiv) was 
added in one portion to a stirred solution of enone 93 (0.176 g, 0.370 mmol, 1.00 equiv) and aqueous 
HCl (1.2 M, 4.0 mL) in THF (32 mL). The stirred reaction mixture was then placed under a balloon 
of hydrogen. After 3 h, the hydrogen balloon was removed, and the stirred reaction mixture was 
sparged with argon for 5 min before saturated aqueous NaHCO3 solution (5 mL) and Et2O (10 mL) 
were added. The reaction mixture was filtered through a pad of Celite, and the layers were separated. 
The aqueous layer was extracted with EtOAc (3 × 10 mL), and the combined organic layers were 
washed with brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure to afford crude air-sensitive α,β-unsaturated imine 96 (52 mg, 38%) as a white foam, which 
was unstable to flash column chromatography and prolonged storage. 1H NMR (500 MHz, C6D6) δ: 
5.52 (dd, J = 2.3, 5.0 Hz, 1H), 4.39 (d, J = 16.6 Hz, 1H), 4.10–3.99 (m, 1H), 3.65 (ddd, J = 1.6, 5.2, 
7.1 Hz, 1H), 3.53 (dd, J = 9.0, 18.1 Hz, 1H), 3.32 (d, J = 7.3 Hz, 1H), 2.82–2.72 (m, 1H), 2.15 (t, J = 
13.3 Hz, 1H), 1.81 (br. s., 3H), 2.09–1.68 (m, 5H), 1.66–1.57 (m, 1H), 1.52–1.34 (m, 3H), 1.43 (s, 
9H), 1.26 (td, J = 5.5, 12.5 Hz, 1H), 1.12 (tdd, J = 1.7, 5.9, 12.9 Hz, 1H), 0.82 (d, J = 6.6 Hz, 1H). 13C 
NMR (126 MHz, C6D6) δ: 163.8, 152.6, 132.2, 130.9, 95.7, 79.7, 69.2, 56.4, 52.0, 47.3, 43.5, 35.0, 
34.8, 33.7, 30.6, 30.3, 28.8, 24.1, 21.5, 19.4. HRMS (ESI) (m/z) calc’d for C22H35N2O3 [M+H]+: 
375.2642, found 375.2656. TLC (9% MeOH and 1% NH4OH in CHCl3), Rf: 0.40 (ninhydrin). 
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Methyl ketone 100: A solution of trimethylsilylmethyllithium in pentane (0.71 M, 20 mL, 14 mmol, 
4.0 equiv) was added dropwise via syringe pump over 30 min to a solution of ethylester 10365 (0.600 
g, 3.55 mmol, 1.00 equiv) in THF (17.7 mL) at –78 °C. After the addition was completed, the 
reaction mixture was stirred for an additional 1 h at –78 °C before MeOH (6 mL) was added. The 
reaction mixture was subsequently allowed to warm to ambient temperature and was stirred for an 
additional 1 h before brine (7 mL) was added. The resultant solution was partially concentrated under 
reduced pressure to remove THF, and the resultant mixture was extracted with CH2Cl2 (8 × 20 mL). 
The combined organic layers were then dried over MgSO4, filtered, and concentrated to afford crude 
methyl ketone S10, which was used without further purification. 
 Di-tert-butyl dicarbonate (1.01 g, 4.65 mmol, 1.40 equiv) was added in one portion to a 
stirred solution of crude S10 (462 mg, 3.32 mmol, 1.00 equiv), 4-dimethylaminopyridine (40.6 mg, 
0.332 mmol, 0.100 equiv), and Et3N (1.40 mL, 10.0 mmol, 3.00 equiv) in CH2Cl2 (16 mL). After 19 
h, the reaction mixture was concentrated under reduced pressure. The residue was then directly 
purified by flash column chromatography (silica gel, eluent: gradient, 20% → 33% EtOAc in 
hexanes) to afford methyl ketone 100 (714 mg, 84%) as a white solid. 1H NMR (600 MHz, CDCl3) δ: 
3.78 (dd, J = 5.7, 11.3 Hz, 1H), 3.69 (d, J = 11.4 Hz, 1H), 2.58 (s, 3H), 2.45 (td, J = 5.6, 7.9 Hz, 1H), 
1.98 (dd, J = 4.1, 7.9 Hz, 1H), 1.52 (s, 9H), 1.29 (dd, J = 4.2, 5.4 Hz, 1H). 13C NMR (126 MHz, 
CDCl3) δ: 201.8, 170.0, 150.2, 83.4, 46.1, 40.0, 29.7, 28.0, 24.4, 24.2. FTIR (thin film) cm-1: 2979, 
1779, 1744, 1694, 1366, 1303, 1255, 1148, 971, 851, 781. HRMS (ESI) (m/z) calc’d for 
C12H17NNaO4 [M+Na]+: 262.1050, found 262.1051. TLC (25% EtOAc in hexanes), Rf: 0.25 (anis). 
                                                                                                                                                  
65 Prepared from (S)-epichlorohydrin in four steps on multigram scale following a modified literature procedure: 
Medda, A. K.; Lee, H.-S. Synlett 2009, 6, 921–924. 
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(–)-(R)-5-methyl-2-iodo-2-cyclohexen-1-one ethylene ketal (99): TMSOTf (0.200 mL, 1.11 mmol, 
0.050 equiv) was added dropwise via syringe to a stirred solution of 1,2-bis(trimethylsilyloxy)ethane 
(6.52 mL, 26.6 mmol, 1.20 equiv) and S1166 (5.23 g, 22.2 mmol, 1.00 equiv) in CH2Cl2 (37 mL) at –
78 °C. The resultant reaction mixture was then allowed to warm to –20 °C. After 40 h, Et3N (750 µL) 
was added via syringe to the reaction mixture at –78 °C, which was subsequently allowed to warm to 
room temperature. The resultant mixture was then concentrated under reduced pressure and the 
residue directly purified by flash column chromatography (silica gel treated with 1% Et3N in [5% 
EtOAc in hexanes], eluent: 1% Et3N in [5% EtOAc in hexanes]) to afford vinyl iodide (–)-99 (5.72 g, 
92%) as a white solid and S11 (0.140 g, 3%) as a white solid. 1H NMR (600 MHz, CDCl3) δ: 6.64 
(dd, J = 2.3, 5.9 Hz, 1H), 4.26–4.16 (m, 2H), 4.02 (dt, J = 4.1, 6.6 Hz, 1H), 3.96 (q, J = 7.1 Hz, 1H), 
2.12 (ddd, J = 2.1, 4.1, 17.6 Hz, 1H), 2.06–2.01 (m, 1H), 1.99 (dd, J = 2.6, 12.9 Hz, 1H), 1.76 (ddd, J 
= 2.3, 10.6, 17.8 Hz, 1H), 1.59 (t, J = 12.9 Hz, 1H), 0.97 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ: 144.1, 106.8, 103.2, 66.0, 65.3, 42.6, 37.6, 27.4, 21.0. FTIR (thin film) cm-1: 2953, 1325, 
1148, 1060, 972. HRMS (ESI) (m/z) calc’d for C9H14IO2 [M+H]+: 281.0033, found 281.0047. [α]D24: 
–103 (c = 1.0, CHCl3). TLC (17% EtOAc in hexanes), Rf: 0.62 (UV, anis). 
                                                                                                                                                  
66 Prepared from (R)-pulegone in 5 steps on multigram scale following literature protocols: Linghu, X.; 
Kennedy-Smith, J. J.; Toste, F. D. Angew. Chem. Int. Ed. 2007, 46, 7671–7673 and references therein. 
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β-Ketoimide 108: A round-bottom flask was charged with vinyl iodide 99 (177 mg, 0.630 mmol, 
1.50 equiv) and azeotropically dried with three portions of benzene. Et2O (1 mL) was then 
introduced, and the resultant solution was cooled to –78 °C. A solution of t-butyllithium in pentane 
(1.61 M, 780 µL, 1.25 mmol, 3.00 equiv) was then added dropwise via syringe over 10 min to the 
stirred solution at –78 °C. The reaction mixture was stirred for an additional 1.5 h at –78 °C. A 
separate pear-shaped flask was charged with 3,3-dimethyl-1-butyne (78.0 µL, 0.630 mmol, 1.50 
equiv) and THF (100 µL) and cooled to 0 °C. A solution of n-butyllithium in hexanes (2.50 M, 252 
µL, 0.630 mmol, 1.50 equiv) was added dropwise to the stirred solution at 0 °C. After 10 min, the 
resultant homogeneous solution was added dropwise via cannula into a stirred slurry of copper(I) 
iodide (120 mg, 0.630 mmol, 1.50 equiv) in THF (200 µL) at 0 °C. The transfer was completed with 
two additional portions of THF (2 × 200 µL). After 1 h, the resultant red solution of copper acetylide 
at 0 °C was added dropwise via cannula over 20 min to the vigorously stirred heterogeneous solution 
of vinyl lithium at –78 °C. The transfer was completed with two additional portions of THF (2 × 250 
µL). After 2 h, a cooled solution of methyl ketone 100 (100 mg, 0.420 mmol, 1.00 equiv), which was 
azeotropically dried with three portions of benzene, in THF (250 µL) was added dropwise via syringe 
to the vigorously stirred off-white reaction mixture at –78 °C. The transfer was completed with two 
additional portions of THF (2 × 125 µL). The reaction mixture was allowed to gradually warm to 0 
°C over 3 h, during which time it became orange in color. After 23 h, a saturated aqueous NH4Cl 
solution (1 mL) was added to the stirred reaction mixture at 0 °C, which was allowed to warm to 
ambient temperature. The resultant mixture was diluted with Et2O (10 mL), and the layers were 
separated. The organic phase was extracted with a 9:1 mixture of saturated aqueous NH4Cl solution 
and 30% (w/v) aqueous NH4OH solution (3 × 5 mL). The combined aqueous layers were extracted 
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 with Et2O (4 × 5 mL). The combined organic layers were washed with a 9:1 mixture of saturated 
aqueous NH4Cl solution and 30% (w/v) aqueous NH4OH solution (2 × 25 mL), water (25 mL), and 
brine (25 mL). The organic layers were then dried over anhydrous MgSO4 and concentrated under 
reduced pressure. The resulting oil was then purified by flash column chromatography (silica gel 
treated with 1% Et3N in CH2Cl2, eluent: gradient, 1% Et3N in [0% EtOAc in CH2Cl2] → 1% Et3N in 
[10% EtOAc in CH2Cl2]) to afford β-ketoimide 108 (93 mg, 56%) as a >4:1 mixture of C4-epimers. 
1H NMR (500 MHz, CDCl3, >4:1 mixture of epimers; major C4-epimer reported) δ: 5.70 (d, J = 5.0 
Hz, 1H), 4.07–4.01 (m, 2H), 4.00–3.88 (m, 2H), 3.83 (dd, J = 8.0, 10.8 Hz, 1H), 3.41 (d, J = 7.8 Hz, 
1H), 3.28 (dd, J = 6.9, 10.8 Hz, 1H), 3.00 (qd, J = 7.7, 15.3 Hz, 1H), 2.36 (s, 3H), 2.19 (dd, J = 7.1, 
14.0 Hz, 1H), 2.10 (td, J = 4.9, 17.7 Hz, 1H), 2.04 (dd, J = 8.5, 14.2 Hz, 1H), 1.90–1.78 (m, 2 H), 
1.62 (dd, J = 9.2, 17.9 Hz, 1H), 1.50 (s, 9H), 1.27 (t, J = 13.2 Hz, 1H), 0.94 (d, J = 6.6 Hz, 1H). 13C 
NMR (126 MHz, CDCl3, >4:1 mixture of epimers; major C4-epimer reported) δ: 202.1, 169.2, 150.0, 
134.1, 131.9, 107.9, 83.3, 65.3, 64.1, 63.1, 49.9, 41.9, 33.9, 33.6, 31.7, 30.4, 27.9, 27.4, 21.4. FTIR 
(thin film) cm-1: 2929, 1781, 1715, 1677, 1368, 1307, 1254, 1151, 967, 850. HRMS (ESI) (m/z) 
calc’d for C21H31NNaO6 [M+Na]+: 416.2044, found 416.2043. TLC (33% EtOAc in hexanes), Rf: 
0.35 (anis).  
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Representative Example of Alkylation of β-Ketoimide 108: Cesium carbonate (16.6 mg, 0.051 
mmol, 2.00 equiv) was added in a single portion to a vigorously stirred solution of β-ketoimide 108 
(10 mg, 0.025 mmol, 1.0 equiv) and N-(3-iodopropyl)phthalimide (16.1 mg, 0.051 mmol, 2.00 equiv) 
in DMF (200 µL). After 2 h, Et2O (5 mL) and saturated aqueous NH4Cl solution (5 mL) were added 
to the reaction mixture. The layers were separated, and the aqueous layer was extracted with Et2O (3 
× 5 mL). The combined organic layers were washed with water (4 × 20 mL) and brine (20 mL), dried 
with anhydrous MgSO4, filtered, and concentrated under reduced pressure. 1H NMR analysis of the 
crude residue showed an ~1:1 ratio of desired C-alkylated phthalimide 110 to a mixture of 
byproducts, which are tentatively assigned as products corresponding to O-alkylation. An analytical 
sample of 110, as a single C4-diastereomer, was obtained by flash column chromatography (silica gel, 
eluent: 17% EtOAc in hexanes). 1H NMR (600 MHz, CDCl3) δ: 7.84–7.82 (m, 2H), 7.74–7.70 (m, 
2H), 5.68 (d, J = 4.4 Hz, 1H), 4.06–3.99 (m, 2H), 3.92–3.86 (m, 2H), 3.79–3.71 (m, 2H), 3.67 (td, J = 
7.0, 13.5 Hz, 1H), 3.39 (t, J = 10.3 Hz, 1H), 2.62–2.54 (m, 1H), 2.38 (dd, J = 3.4, 14.2 Hz, 1H), 2.19 
(s, 3H), 2.17–2.04 (m, 2H), 1.85–1.79 (m, 3H), 1.73 (d, J = 13.2 Hz, 1H), 1.64–1.55 (m, 2H), 1.52 (s, 
9H), 1.27–1.13 (m, 2H), 0.90 (d, J = 6.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ: 206.1, 172.5, 
168.3, 150.1, 133.9, 133.9, 132.2, 132.1, 123.2, 108.1, 83.2, 65.9, 65.4, 64.0, 49.4, 41.7, 38.1, 37.7, 
34.0, 29.8, 29.7, 29.3, 28.0, 27.4, 23.8, 21.4. FTIR (thin film) cm-1: 2926, 1772, 1711, 1436, 1396, 
1367, 1154, 967, 721. HRMS (ESI) (m/z) calc’d for C32H40N2NaO8 [M+Na]+: 603.2677, found 
603.2685. TLC (33% EtOAc in hexanes), Rf: 0.62 (KMnO4).  
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β-Carboethoxyimide 112: A round-bottom flask was charged with vinyl iodide 99 (390 mg, 1.39 
mmol, 1.50 equiv) and azeotropically dried with three portions of benzene. Et2O (2.2 mL) was then 
introduced, and the resultant solution was cooled to –78 °C. A solution of t-butyllithium in pentane 
(1.58 M, 1.77 mL, 2.79 mmol, 3.00 equiv) was then added dropwise via syringe over 10 min to the 
stirred solution at –78 °C. The reaction mixture was stirred for an additional 1.5 h at –78 °C. A 
separate pear-shaped flask was charged with 3,3-dimethyl-1-butyne (172 µL, 1.39 mmol, 1.50 equiv) 
and THF (500 µL) and cooled to 0 °C. A solution of n-butyllithium in hexanes (2.38 M, 585 µL, 1.39 
mmol, 1.50 equiv) was added dropwise to the stirred solution at 0 °C. After 10 min, the resultant 
homogeneous solution was added dropwise via syringe into a stirred slurry of copper(I) iodide (266 
mg, 1.39 mmol, 1.50 equiv) in THF (500 µL) at 0 °C. The transfer was completed with two additional 
portions of THF (2 × 250 µL). After 1 h, the resultant red solution of copper acetylide at 0 °C was 
added dropwise via cannula over 20 min to the vigorously stirred heterogeneous solution of vinyl 
lithium at –78 °C. The transfer was completed with two additional portions of THF (2 × 500 µL). 
After 1.5 h, a cooled solution of ethylester 10467 (250 mg, 0.928 mmol, 1.00 equiv), which was 
azeotropically dried with three portions of benzene, in THF (500 µL) at –78 °C was added dropwise 
via cannula to the vigorously stirred off-white reaction mixture. The transfer was completed with two 
additional portions of THF (2 × 500 µL). The reaction mixture was allowed to gradually warm to 0 
°C over 1 h, during which time it became orange in color. After 25 h, a saturated aqueous NH4Cl 
solution (3 mL) was added to the reaction mixture at 0 °C, which was allowed to warm to ambient 
                                                                                                                                                  
67 Pyrrolidinone 103 was N-Boc protected to afford ethylester 104 in quantitative yield following the same 
procedure used to N-Boc protect methyl ketone 100. 
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 temperature. The resultant mixture was diluted with Et2O (20 mL), and the layers were separated. The 
organic phase was extracted with a 9:1 mixture of saturated aqueous NH4Cl solution and 30% (w/v) 
aqueous NH4OH solution (3 × 20 mL). The combined aqueous layers were extracted with Et2O (3 × 
20 mL). The combined organic layers were washed with a 9:1 mixture of saturated aqueous NH4Cl 
solution and 30% (w/v) aqueous NH4OH solution (4 × 50 mL) and brine (50 mL). The organic layers 
were then dried over anhydrous MgSO4 and concentrated under reduced pressure. The resulting oil 
was then purified by flash column chromatography (silica gel treated with 1% Et3N in [17% EtOAc in 
hexanes], eluent: gradient, 1% Et3N in [17% EtOAc in hexanes] → 1% Et3N in [25% EtOAc in 
CH2Cl2]) to afford β-carboethoxyimide 112 (378 mg, 96%) as a >5:1 mixture of C4-epimers. 1H 
NMR (500 MHz, CDCl3, >5:1 mixture of epimers; major C4-epimer reported) δ: 5.72 (d, J = 3.4 Hz, 
1H), 4.25–4.14 (m, 2H), 4.07–3.99 (m, 2H), 3.96–3.86 (m, 3H), 3.26 (dd, J = 7.9, 10.9 Hz, 1H), 3.22 
(d, J = 9.2 Hz, 1H), 3.00–2.91 (m, 1H), 2.31 (dd, J = 6.4, 14.2 Hz, 1H), 2.11 (td, J = 4.5, 17.6 Hz, 
1H), 2.05 (dd, J = 8.7, 14.0 Hz, 1H), 1.92–1.82 (m, 1H), 1.81 (td, J = 1.4, 12.9 Hz, 1H), 1.61 (ddd, J 
= 1.4, 10.8, 17.8 Hz, 1H), 1.51 (s, 9H), 1.31–1.23 (m, 4H), 0.94 (d, J = 6.6 Hz, 7H). 13C NMR (126 
MHz, CDCl3, >5:1 mixture of epimers; major C4-epimer reported) δ: 168.6, 168.4, 150.0, 133.9, 
131.8, 107.9, 83.2, 65.4, 64.1, 61.6, 56.7, 50.1, 41.8, 34.4, 33.9, 33.9, 28.0, 27.4, 21.4, 14.1. FTIR 
(thin film) cm-1: 2924, 1788, 1757, 1720, 1369, 1306, 1256, 1154, 1045, 966, 850. HRMS (ESI) (m/z) 
calc’d for C22H33NNaO7 [M+Na]+: 446.2149, found 446.2152. TLC (33% EtOAc in hexanes), Rf: 
0.42 (anis).  
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Alkyl chloride 113: 1-Chloro-3-iodopropane (192 µL, 1.79 mmol, 2.00 equiv) was added dropwise 
to a vigorously stirred solution of cesium carbonate (583 mg, 1.79 mmol, 2.00 equiv) and 112 (378 
mg, 0.890 mmol, 1.00 equiv) in DMF (5 mL). After 3 h, Et2O (10 mL) and saturated aqueous NH4Cl 
solution (10 mL) were added to the reaction mixture. The layers were separated, and the aqueous 
layer was extracted with Et2O (3 × 10 mL). The combined organic layers were washed with water (4 
× 30 mL) and brine (30 mL), dried with anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The residue was then purified by flash column chromatography (silica gel treated with 1% 
Et3N, eluent: 1% Et3N in [17% EtOAc in hexanes]) to afford alkyl chloride 113 (414 mg, 93%) as a 
>4:1 mixture of C4-epimers. 1H NMR (500 MHz, CDCl3, >4:1 mixture of epimers; major C4-epimer 
reported) δ: 5.75 (dd, J = 1.8, 5.2 Hz, 1H), 4.26 (dd, J = 7.2, 10.9 Hz, 1H), 4.17–4.07 (m, 2H), 4.04–
3.90 (m, 3H), 3.82 (dd, J = 8.1, 10.5 Hz, 1H), 3.62–3.50 (m, 2H), 3.36 (t, J = 10.4 Hz, 1H), 2.63–2.54 
(m, 1H), 2.46 (d, J = 13.9 Hz, 1H), 2.12 (td, J = 5.0, 17.6 Hz, 1H), 2.07–1.79 (m, 4H), 1.75 (dd, J = 
11.1, 14.0 Hz, 1H), 1.66 (dd, J = 10.5, 18.1 Hz, 1H), 1.54 (s, 9H), 1.30–1.25 (m, 4H), 0.96 (d, J = 6.3 
Hz, 3H). 13C NMR (126 MHz, CDCl3, >4:1 mixture of epimers; major C4-epimer reported) δ: 171.8, 
169.3, 150.2, 133.5, 132.1, 108.1, 83.2, 65.3, 63.9, 61.5, 60.1, 49.5, 45.2, 41.6, 37.6, 34.0, 29.6, 29.3, 
28.0, 27.9, 27.4, 27.3, 21.4, 14.2. FTIR (thin film) cm-1: 2954, 1786, 1752, 1716, 1679, 1368, 1310, 
1153, 1044, 966, 851, 777. HRMS (ESI) (m/z) calc’d for C15H26IN4O3 [M+H]+: 437.1044, found 
437.1046. TLC (33% EtOAc in hexanes), Rf: 0.25 (anis). 
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Cyclopropane 115: A solution of 10365 (2.54 g, 15.0 mmol, 1.00 equiv) in THF (25 mL) was added 
dropwise via cannula to a stirred solution of potassium hydride (90 mg, 2.25 mmol, 0.15 equiv) and 
2-(trimethylsilyl)ethanol (21.5 mL, 150 mmol, 10.0 equiv) in THF (50 mL) at ambient temperature. 
The transfer was completed with two additional portions of THF (2 × 5 mL). After 1.5 h, brine (50 
mL) and CH2Cl2 (300 mL) were added to the reaction mixture. The layers were separated, and the 
aqueous layer was extracted with CH2Cl2 (5 × 100 mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The resulting oil was then 
distilled via Kugelrohr (50 °C, ~1 torr) to remove excess 2-(trimethylsilyl)ethanol. Residual 2-
(trimethylsilyl)ethanol was then removed by azeotropic distillation with three portions of toluene to 
yield crude S12 (3.51 g) as a pale-yellow solid, which was used without further purification. 
 Di-tert-butyl dicarbonate (4.76 g, 21.8 mmol, 1.50 equiv) was added in one portion to a 
stirred solution of crude S12 (3.51 g, 14.5 mmol, 1.00 equiv), 4-dimethylaminopyridine (0.178 g, 
1.45 mmol, 0.100 equiv), and Et3N (6.08 mL, 43.6 mmol, 3.00 equiv) in CH2Cl2 (75 mL) at 0 °C. The 
resultant reaction mixture was allowed to warm to ambient temperature. After 12 h, the reaction 
mixture was concentrated under reduced pressure. The residue was then directly purified by flash 
column chromatography (silica gel, eluent: gradient, 17% → 20% EtOAc in hexanes) to afford 
cyclopropane (+)-115 (4.27 g, 83%) as a white solid. 1H NMR (500 MHz, CDCl3) δ: 4.33–4.21 (m, 
2H), 3.81 (dd, J = 5.6, 11.2 Hz, 1H), 3.68 (d, J = 11.5 Hz, 1H), 2.34 (td, J = 5.5, 8.1 Hz, 1H), 1.98 
(dd, J = 4.6, 8.1 Hz, 1H), 1.50 (s, 9H), 1.27–1.23 (m, 1H), 1.11–1.01 (m, 2H), 0.03 (s, 9H). 13C NMR 
(126 MHz, CDCl3) δ: 167.7, 167.4, 150.3, 83.2, 64.2, 46.0, 32.8, 28.0, 22.0, 20.4, 17.4, –1.6. FTIR 
(thin film) cm-1: 2955, 1791, 1761, 1715, 1308, 1157, 837. HRMS (ESI) (m/z) calc’d for 
C16H27NNaO5Si [M+Na]+: 364.1551, found 364.1565. [α]D24: +84 (c = 4.4, CHCl3)). TLC (17% 
EtOAc in hexanes), Rf: 0.23 (KMnO4).  
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β-Carbo-2-(trimethylsilyl)ethoxyimide 116: A round-bottom flask was charged with 99 (4.97 g, 
17.7 mmol, 1.42 equiv) and azeotropically dried with four portions of benzene. Et2O (36 mL) was 
then introduced, and the resultant solution was cooled to –78 °C. A solution of t-butyllithium in 
pentane (1.78 M, 19.9 mL, 35.5 mmol, 2.85 equiv) was then added dropwise over 20 minutes to the 
stirred solution at –78 °C. The reaction mixture was stirred for an additional 2.5 h at –78 °C. A 
separate pear-shaped flask was charged with 3,3-dimethyl-1-butyne (2.18 mL, 17.7 mmol, 1.42 
equiv) and THF (6 mL) and cooled to 0 °C. A solution of n-butyllithium in hexanes (2.69 M, 6.60 
mL, 17.7 mmol, 1.42 equiv) was added dropwise to the stirred solution at 0 °C. After 15 min, the 
resultant homogeneous solution was added via cannula into a stirred slurry of copper(I) iodide (3.38 
g, 17.7 mmol, 1.42 equiv) in THF (6 mL) at 0 °C. The transfer was completed with two additional 
portions of THF (2 × 3 mL). After 1 h, the resultant red solution of copper acetylide at 0 °C was 
added via cannula dropwise over 20 minutes to the vigorously stirred heterogeneous solution of vinyl 
lithium at –78 °C. The transfer was completed with two additional portions of THF (2 × 9 mL). After 
2 h, a cooled solution of 115 (4.27 g, 12.5 mmol, 1.00 equiv), which was dried by azeotroping with 
three portions of benzene, in THF (10 mL) at –78 °C was added via cannula dropwise to the 
vigorously stirred off-white reaction mixture. The transfer was completed with two additional 
portions of THF (2 × 5 mL). The reaction mixture was allowed to gradually warm to 0 °C over 3 h, 
during which time it became orange in color. After 24 h, a solution of saturated aqueous NH4Cl (50 
mL) was added to the reaction mixture at 0 °C, which was allowed to warm to room temperature. The 
resultant mixture was diluted with Et2O (200 mL), and the layers were separated. The organic phase 
was extracted with an 8:1 mixture of saturated aqueous NH4Cl solution and 30% (w/v) aqueous 
NH4OH solution (3 × 180 mL). The combined aqueous layers were extracted with Et2O (4 × 200 mL). 
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 The combined organic layers were washed with an 8:1 mixture of saturated aqueous NH4Cl solution 
and 30% (w/v) aqueous NH4OH solution (2 × 180 mL), water (200 mL), and brine (200 mL). The 
organic layers were then dried over anhydrous MgSO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash column chromatography (silica gel treated with 1% Et3N 
in [9% EtOAc in hexanes], eluent: gradient, 1% Et3N in [9% EtOAc in hexanes] → 1% Et3N in [14% 
EtOAc in hexanes]) to afford imide 116 (5.74 g, 93%) as a white solid. 1H NMR (600 MHz, CDCl3, 
>10:1 mixture of epimers; major C4-epimer reported) δ: 5.73 (d, J = 4.1 Hz, 1H), 4.23 (ddd, J = 2.9, 
6.8, 10.5 Hz, 2H), 4.08–4.00 (m, 2H), 3.97–3.88 (m, 3H), 3.27 (dd, J = 7.6, 10.8 Hz, 1H), 3.21 (d, J = 
9.1 Hz, 1H), 2.96 (sxt, J = 8.0 Hz, 1H), 2.31 (dd, J = 5.6, 14.1 Hz, 1H), 2.12 (td, J = 5.1, 17.7 Hz, 
1H), 2.05 (dd, J = 8.8, 14.1 Hz, 1H), 1.92–1.84 (m, 1H), 1.82 (dd, J = 1.5, 13.2 Hz, 1H), 1.62 (dd, J = 
11.1, 17.3 Hz, 1H), 1.51 (s, 9H), 1.28 (t, J = 13.0 Hz, 1H), 1.07–1.00 (m, 2H), 0.95 (d, J = 6.7 Hz, 
3H), 0.03 (s, 9H). 13C NMR (126 MHz, CDCl3) δ: 168.7, 168.6, 150.1, 134.0, 131.7, 108.0, 83.2, 
65.4, 64.1, 64.1, 56.9, 50.1, 41.9, 34.4, 34.0, 33.9, 28.0, 27.4, 21.4, 17.4, –1.6. FTIR (thin film) cm-1: 
2953, 1790, 1757, 1721, 1308, 1250, 1153, 837. HRMS (ESI) (m/z) calc’d for C25H41NNaO7Si 
[M+Na]+: 518.2545, found 518.2513. TLC (33% EtOAc in hexanes), Rf: 0.53 (anis). 
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N-Boc-2-pyrrolidinone 118: 1-Chloro-3-iodopropane (1.61 mL, 15.0 mmol, 1.30 equiv) was added 
dropwise to a vigorously stirred solution of cesium carbonate (7.49 g, 23.0 mmol, 2.00 equiv) and 
116 (5.70 g, 11.5 mmol, 1.00 equiv) in DMF (38 mL). After 20 h, Et2O (200 mL) and saturated 
aqueous NH4Cl solution (100 mL) were added to the reaction mixture. The layers were separated, and 
the aqueous layer was extracted with Et2O (4 × 150 mL). The combined organic layers were washed 
with water (4 × 150 mL) and brine (150 mL), dried with anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The resulting oil was azeotropically dried with five portions of toluene to 
remove residual 1-chloro-3-iodopropane and placed under reduced pressure for 36 h to afford crude 
alkyl chloride S13 (6.87 g) as an off-white solid that used without further purification. 
Sodium azide (2.24 g, 34.5 mmol, 3.00 equiv) and sodium iodide (1.72 g, 11.5 mmol, 1.00 
equiv) were sequentially added to a vigorously stirred solution of crude S13 (6.87 g, 11.5 mmol, 1.00 
equiv) in DMF (46 mL), and the resultant reaction mixture was heated to 65 °C. After 45 h, the 
reaction mixture was cooled to ambient temperature before Et2O (200 mL), saturated aqueous 
NaHCO3 solution (50 mL), and water (50 mL) were sequentially added. The layers were separated 
and the aqueous layer was extracted with Et2O (4 × 150 mL). The combined organic layers were 
washed with water (4 × 150 mL) and brine (150 mL), dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure to afford crude alkyl azide 117 (6.53 g), which was used without 
further purification. 
A solution of TBAF in THF (1.0 M, 11 mL, 11 mmol, 1.0 equiv) was added to a stirred 
solution of DBU (0.427 mL, 2.82 mmol, 0.250 equiv) and crude 117 (6.53 g, 11.3 mmol, 1.00 equiv) 
in THF (56 mL) at room temperature, and the resultant reaction mixture was heated to 50 °C. After 24 
h, the reaction mixture was cooled to ambient temperature before Et2O (150 mL) and water (150 mL) 
116
O
O O
Me
TMSE O
NBoc
O
Cs2CO3, DMF, 20 h
I Cl
O
O O
Me
TMSE O
NBoc
O
X
S13: X = Cl
117: X = N3
NaN3, NaI, DMF,
65 °C, 45 h
THF, 50 °C, 24 h
(89%, 3 steps)
TBAF, DBU,
118, > 10:1 trans:cis
4S
O O
Me
NBoc
O
N3
79
 were sequentially added. The layers were separated, and the aqueous layer was extracted with EtOAc 
(3 × 100 mL). The combined organic layers were washed with brine (150 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The resulting oil was purified by flash 
column chromatography (silica gel treated with 1% Et3N in [17% EtOAc in hexanes], eluent: 
gradient, 1% Et3N in [17% EtOAc in hexanes] → 1% Et3N in [25% EtOAc in hexanes]) to afford N-
Boc-2-pyrrolidinone 118 (4.43 g, 89%) as a white flocculent solid (>10:1 mixture of epimers at C4). 
1H NMR (500 MHz, CDCl3, >10:1 mixture of (4S)- and (4R)-epimers; major (4S)-epimer reported) δ: 
5.73 (d, J = 3.7 Hz, 1H), 4.11–4.03 (m, 1H), 3.93 (s, 3H), 3.81 (dd, J = 7.6, 11.0 Hz, 1H), 3.32–3.26 
(m, 2H), 3.20 (dd, J = 7.6, 11.0 Hz, 1H), 2.37 (dd, J = 5.4, 14.2 Hz, 1H), 2.29–2.09 (m, 3H), 1.99 (dd, 
J = 9.0, 14.2 Hz, 1H), 1.93–1.74 (m, 3H), 1.74–1.59 (m, 4H), 1.51 (s, 9H), 1.29 (t, J = 12.9 Hz, 1H), 
0.95 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, CDCl3, >10:1 mixture of C4-epimers; major (4S)-
epimer reported) δ: 175.5, 150.4, 134.3, 131.4, 108.1, 82.8, 65.3, 64.0, 51.4, 50.2, 49.1, 41.8, 35.4, 
34.2, 34.0, 28.0, 27.4, 26.5, 26.1, 21.4. FTIR (thin film) cm-1: 2951, 2095, 1783, 1746, 1713, 1310, 
1254, 1155, 966. HRMS (ESI) (m/z) calc’d for C22H34KN4O5 [M+K]+: 473.2161, found 473.2148. 
TLC (33% EtOAc in hexanes), Rf: 0.40 (anis). 
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Dihydropyrrole 129: A solution of methylmagnesium bromide in Et2O (3.0 M, 400 µL, 1.2 mmol, 
3.0 equiv) was added dropwise via syringe to a stirred solution of N-Boc-2-pyrrolidinone 118 (172 
mg, 0.400 mmol, 1.00 equiv) and TMEDA (232 µL, 2.00 mmol, 5.00 equiv) in THF (4 mL) at –78 
°C. After 1 h, the resultant stirred reaction mixture was allowed to slowly warm to –20 °C over 2 h, 
whereupon the temperature was maintained at –20 °C. After an additional 1.5 h, the stirred solution 
was cooled to –78 °C before isopropanol (100 µL) and saturated aqueous NH4Cl solution (5 mL) 
were added sequentially via syringe. The resultant mixture was then allowed to warm to ambient 
temperature before Et2O (10 mL) and water (10 mL) were added. The layers were separated, and the 
aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed 
with brine (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure 
to afford crude aminal 119, which was used without further purification. 
 CSA (9.3 mg, 0.040 mmol, 0.10 equiv) was added in a single portion to a vigorously stirred 
solution of crude aminal 119 in benzene (8 mL). After 2 h, an additional portion of CSA (9.3 mg, 
0.040 mmol, 0.10 equiv) was added to the vigorously stirred reaction mixture. After an additional 1 h, 
an additional portion of CSA (8.0 mg, 0.034 mmol, 0.090 equiv) was added to the vigorously stirred 
reaction mixture. After an additional 30 min, saturated aqueous NaHCO3 solution (10 mL) was added 
to the stirred reaction mixture and the layers were separated. The aqueous layer was extracted with 
EtOAc (3 × 10 mL), and the combined organic layers were washed with saturated aqueous NaHCO3 
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 solution (25 mL) and brine (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient, 8% → 50% EtOAc in hexanes) to afford dihydropyrrole 129 (95 mg) and a mixture of 
intermediate products (37 mg). The mixture of intermediate products was re-exposed to the 
aforementioned experimental procedure to give additional 129 (13 mg) after flash column 
chromatrography, which when combined with the previous material yielded 129 (108 mg, 70%). 1H 
NMR (500 MHz, C6D6, 70 °C) δ: 6.13 (dd, J = 2.1, 5.0 Hz, 1H), 3.62 (dd, J = 9.8, 11.5 Hz, 1H), 3.55 
(dd, J = 4.9, 11.5 Hz, 1H), 2.89–2.77 (m, 2H), 2.88–2.77 (m, 1H), 2.74 (br. s., 1H), 2.62 (d, J = 13.7 
Hz, 1H), 2.30 (d, J = 13.7 Hz, 1H), 2.10 (s, 3H), 2.04 (dd, J = 7.1, 14.6 Hz, 1H), 2.00–1.92 (m, 1H), 
1.85–1.76 (m, 2H), 1.76–1.69 (m, 2H), 1.62–1.52 (m, 1H), 1.52–1.38 (m, 11H), 0.67 (d, J = 6.1 Hz, 
3H). 13C NMR (126 MHz, C6D6, 70 °C) δ: 198.0, 152.9, 144.8, 137.8, 135.0, 120.3, 79.8, 52.9, 51.5, 
47.1, 41.0, 34.8, 34.1, 30.9, 29.0, 28.0, 23.2, 21.3, 13.6. HRMS (ESI) (m/z) calc’d for C21H33N4O3 
[M+H]+: 389.2547, found 389.2550. TLC (33% EtOAc in hexanes), Rf: 0.63 (anis). 
Enamide 130 was characterized as a minor byproduct from this reaction. 1H NMR (500 
MHz, C6D6) δ: 5.93 (br. s., 1H), 4.09 (s, 1H), 3.40–3.33 (m, 2H), 2.69–2.59 (m, 2H), 2.40 (q, J = 7.8 
Hz, 1H), 2.14 (dd, J = 4.9, 14.2 Hz, 1H), 1.99–1.92 (m, 1H), 1.89 (q, J = 7.5 Hz, 1H), 1.84–1.70 (m, 
3H), 1.54 (td, J = 7.8, 12.7 Hz, 1H), 1.46 (s, 9H), 1.41–1.28 (m, 3H), 1.21 (dt, J = 3.9, 12.9 Hz, 1H), 
0.99 (dt, J = 3.9, 12.7 Hz, 1H), 0.94–0.83 (m, 1H), 0.73 (d, J = 7.3 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ: 210.4, 152.6, 147.9, 92.7, 80.6, 61.3, 54.9, 54.1, 52.1, 51.2, 46.1, 42.4, 38.4, 34.9, 31.7, 
30.6, 28.7, 24.9, 20.6. HRMS (ESI) (m/z) calc’d for C21H32N4NaO3 [M+Na]+: 411.2367, found 
411.2344. TLC (33% EtOAc in hexanes), Rf: 0.57 (CAM).  
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Primary amine 120: Triphenylphosphine (84 mg, 0.32 mmol, 1.5 equiv) was added in a single 
portion to a stirred solution of dihydropyrrole 129 (83 mg, 0.21 mmol, 1.0 equiv) in 8:1 THF/water 
(2.1 mL). After 1 h, the resultant stirred reaction mixture was heated to 60 °C. After an additional 14 
h, the stirred reaction mixture was cooled to ambient temperature before additional 
triphenylphosphine (39 mg, 0.15 mmol, 0.71 equiv) was added in a single portion. The resultant 
stirred reaction mixture was subsequently heated to 60 °C. After an additional 9 h, the stirred reaction 
mixture was cooled to ambient temperature before the solvent was removed under reduced pressure. 
The residue was then directly purified by flash column chromatography (silica gel treated with 1% 
Et3N in CH2Cl2, eluent: gradient, 1% Et3N in [2% MeOH in CH2Cl2] → 1% Et3N in [8% MeOH in 
CH2Cl2]) to afford primary amine 120 (73 mg, 96%). 1H NMR (500 MHz, C6D6, 70 °C) δ: 6.16 (br. 
s., 1H), 3.66 (t, J = 9.8 Hz, 1H), 3.59 (dd, J = 4.9, 11.7 Hz, 1H), 2.85 (br. s., 1H), 2.72 (d, J = 13.4 
Hz, 1H), 2.62–2.49 (m, 2H), 2.31 (d, J = 13.4 Hz, 1H), 2.15 (s, 3H), 2.20–2.11 (m, 1H), 2.10–2.03 
(m, 1H), 1.87–1.70 (m, 4H), 1.63–1.53 (m, 1H), 1.47 (s, 9H), 1.53–1.42 (m, 2H), 1.25 (br. s., 2H), 
0.67 (d, J = 6.1 Hz, 3H). 13C NMR (126 MHz, C6D6, 70 °C) δ: 198.0, 153.0, 144.7, 137.9, 134.1, 
121.9, 79.6, 52.9, 47.1, 42.4, 41.3, 34.9, 34.0, 32.9, 30.9, 29.1, 23.5, 21.3, 13.6. HRMS (ESI) (m/z) 
calc’d for C21H35N2O3 [M+H]+: 363.2642, found 363.2640. TLC (18% MeOH and 2% NH4OH in 
CHCl3), Rf: 0.40 (ninhydrin).   
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Tetracycle 125: A Schlenk tube was charged with primary amine 120 (25 mg, 0.069 mmol, 1.0 
equiv), which was azeotropically dried with five portions of benzene. The reaction vessel was then 
further charged with pyridinium p-toluenesulfonic acid (3.5 mg, 0.014 mmol, 0.20 equiv) and ethanol 
(4 mL) and the resultant mixture was sparged with a stream of argon for 10 min. The tube was sealed, 
and heated to 60 °C. After 5 h, the stirred reaction mixture was further heated to 80 °C. After 61 h, 
the stirred solution was cooled to ambient temperature and concentrated under reduced pressure. The 
residue was then directly purified by flash column chromatography (silica gel treated with 0.5% 
NH4OH in [5% MeOH in CHCl3], eluent: 0.5% NH4OH in [5% MeOH in CHCl3]) to afford tetracycle 
125 (23 mg, 84%). 1H NMR (500 MHz, C6D6) δ: 4.20 (br. s., 1H), 3.73 (d, J = 16.8 Hz, 1H), 3.32–
3.23 (m, 1H), 3.20–3.13 (m, 2H), 3.09 (td, J = 5.4, 12.6 Hz, 1H), 2.75–2.66 (m, 1H), 2.58 (d, J = 14.9 
Hz, 1H), 2.46 (d, J = 15.1 Hz, 1H), 2.13–2.04 (m, 2H), 1.96 (dd, J = 6.1, 14.2 Hz, 1H), 1.68–1.60 (m, 
1H), 1.50 (s, 9H), 1.57–1.46 (m, 2H), 1.37 (d, J = 13.7 Hz, 1H), 1.34–1.18 (m, 3H), 1.16–1.03 (m, 
6H), 0.75 (d, J = 6.3 Hz, 3H), 0.39 (dt, J = 5.9, 13.3 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ: 171.5, 
156.3, 79.0, 76.5, 56.0, 51.2, 50.6, 49.1, 44.3, 44.2, 42.9, 42.6, 40.1, 31.9, 29.9, 28.9, 27.8, 25.4, 22.3, 
21.0, 16.8. FTIR (thin film) cm-1: 3337, 2927, 1707, 1648, 1523, 1454, 1364, 1250, 1165, 1101, 735. 
HRMS (ESI) (m/z) calc’d for C23H39N2O3 [M+H]+: 391.2955, found 391.2961. TLC (9% MeOH and 
1% NH4OH in CHCl3), Rf: 0.48 (ninhydrin).   
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Valerolactam 132: 1-(3-bromopropyl)-2,2,5,5-tetramethyl-1-aza-2,5-disilacyclopentane (195 µL, 
0.780 mmol, 1.30 equiv) was added dropwise via syringe to a stirred solution of 116 (300 mg, 0.600 
mmol, 1.00 equiv) and cesium carbonate (391 mg, 1.20 mmol, 2.00 equiv) in DMF (1.5 mL). After 8 
h, THF (6 mL) and a solution of TBAF in THF (1.0 M, 2.0 mL, 2.0 mmol, 3.3 equiv) was added 
dropwise via syringe to the stirred reaction mixture, which was subsequently warmed to 60 °C. After 
an additional 24 h, the stirred reaction mixture was allowed to cool to ambient temperature before 5% 
(w/v) sodium chloride solution (8 mL) and Et2O (20 mL) were added. The layers were separated and 
the aqueous layer was extracted with EtOAc (4 × 20 mL). The combined organic layers were washed 
with 5% (w/v) sodium chloride solution (4 × 50 mL) and brine (50 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was then purified by flash 
column chromatography (silica gel treated with 1% Et3N in EtOAc, eluent: gradient, 1% Et3N in [2% 
MeOH in EtOAc] → 1% Et3N in [8% MeOH in EtOAc]) to afford valerolactam 132 (216 mg, 88%) 
as a white foam. 1H NMR (600 MHz, CDCl3, 3:2 mixture of C4-epimers; major epimer noted by *) 
δ: 5.80 (d, J = 4.1 Hz, 1H*), 5.77 (d, J = 4.4 Hz, 1H), 5.73 (br. s., 1H*; 1H), 5.07–4.98 (m, 1H*; 1H), 
4.14–3.87 (m, 4H*; 4H), 3.31–3.21 (m, 2H*; 2H), 3.21–3.12 (m, 1H*; 1H), 3.11–3.04 (m, 1H*; 1H), 
2.80–2.72 (m, 1H), 2.61–2.53 (m, 1H*), 2.48–2.41 (m, 1H*), 2.40–2.34 (m, 1H), 2.21 (d, J = 13.8 
Hz, 1H*), 2.15–2.07 (m, 1H*; 2H), 2.06–1.97 (m, 1H*), 1.96–1.53 (m, 7H*; 8H), 1.41 (s, 9H*; 9H), 
1.35–1.27 (m, 1H*; 1H), 0.94 (d, J = 6.4 Hz, 3H; 3H*). 13C NMR (126 MHz, CDCl3) δ: 174.5, 173.9, 
156.1, 155.9, 135.1, 135.0, 131.7, 130.4, 108.4, 108.3, 78.5, 65.4, 64.1, 64.0, 60.3, 43.2, 42.8, 42.6, 
42.4, 42.3, 42.0, 41.9, 38.7, 37.1, 34.2, 34.0, 30.3, 30.1, 28.42, 28.38, 27.5, 27.4, 22.6, 22.4, 21.7, 
21.4, 21.0, 19.1, 14.1, 13.6. FTIR (thin film) cm-1: 3316, 2929, 1707, 1655, 1491, 1364, 1248, 1171, 
4
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 1122, 1090, 1045, 966, 679. HRMS (ESI) (m/z) calc’d for C22H36N2NaO5 [M+Na]+: 431.2516, found 
431.2502. TLC (5% MeOH in CH2Cl2), Rf: 0.25 (anis).   
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N-Boc-protected Valerolactam 135: Di-tert-butyl dicarbonate (44 mg, 0.20 mmol, 1.5 equiv) was 
added in one portion to a stirred solution of valerolactam 132 (54 mg, 0.13 mmol, 1.0 equiv), 4-
dimethylaminopyridine (17.7 mg, 0.145 mmol, 1.10 equiv), and Et3N (56 µL, 0.40 mmol, 3.0 equiv) 
in CH2Cl2 (660 µL). After 24 h, additional di-tert-butyl dicarbonate (44 mg, 0.20 mmol, 1.5 equiv) 
and 4-dimethylaminopyridine (17.7 mg, 0.145 mmol, 1.10 equiv) were added to the stirred reaction 
mixture. After 14 h, additional di-tert-butyl dicarbonate (44 mg, 0.20 mmol, 1.5 equiv) and Et3N (56 
µL, 0.40 mmol, 3.0 equiv) were added to the stirred reaction mixture. After an additional 12 h, the 
reaction mixture was concentrated under reduced pressure. The residue was then directly purified by 
flash column chromatography (silica gel treated with 1% Et3N in hexanes, eluent: gradient, 1% Et3N 
in [10% EtOAc in hexanes] → 1% Et3N in [17% EtOAc in hexanes]) to afford N-Boc-protected 
valerolactam 135 (50 mg, 75%). 1H NMR (600 MHz, CDCl3, 2:1 mixture of C4-epimers; major 
epimer noted by *) δ: 5.82 (d, J = 4.7 Hz, 1H*), 5.76 (d, J = 3.8 Hz, 1H), 5.00–4.94 (m, 1H*), 4.86–
4.80 (m, 1H), 4.14–3.87 (m, 4H*; 4H), 3.73–3.65 (m, 1H*; 1H), 3.56–3.45 (m, 1H*; 1H), 3.22–3.04 
(m, 2H*; 2H), 2.83–2.77 (m, 1H), 2.59–2.44 (m, 2H*; 1H), 2.22 (d, J = 13.8 Hz, 1H*), 2.15–2.07 (m, 
1H*; 2H), 2.05–1.99 (m, 1H*), 1.96–1.55 (m, 7H*; 8H), 1.52 (s, 9H), 1.51 (s, 9H*), 1.41 (s, 9H*), 
1.40 (s, 9H), 1.35–1.27 (m, 1H*; 1H), 0.94 (d, J = 6.7 Hz, 3 H). 13C NMR (126 MHz, CDCl3) δ: 
174.0, 173.5, 156.2, 156.0, 152.7, 135.1, 131.8, 130.6, 108.3, 82.7, 82.6, 78.7, 65.5, 65.4, 64.2, 64.1, 
46.4, 46.3, 46.0, 45.4, 42.4, 42.3, 42.1, 41.9, 39.5, 37.4, 36.6, 34.2, 34.1, 30.5, 30.2, 29.7, 28.4, 28.0, 
27.6, 27.5, 22.5, 22.4, 22.0, 21.5, 20.9. FTIR (thin film) cm-1: 3370, 2929, 1763, 1707, 1514, 1366, 
1249, 1146, 852, 734. HRMS (ESI) (m/z) calc’d for C27H44N2NaO7 [M+Na]+: 531.3041, found 
531.3022. TLC (50% EtOAc in hexanes), Rf: 0.69 (anis).  
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N-2-Nitrobenzenesulfonyl-2-pyrrolidinone 137: Magnesium perchlorate (48 mg, 0.22 mmol, 0.20 
equiv) was added in a single portion to a stirred solution of 116 (467 mg, 1.08 mmol, 1.00 equiv) in 
MeCN (10 mL), and the resultant stirred reaction mixture was heated to 60 °C. After 22 h, the 
reaction mixture was allowed to cool to ambient temperature before Et2O (10 mL) and saturated 
aqueous NH4Cl solution (10 mL) were added. The layers were separated and the aqueous layer was 
extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with brine (10 mL), 
dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford crude 2-
pyrrolidinone S14 (342 mg) as a light pink solid, which was used without further purification. 
 A round-bottom flask was charged with crude S14 (342 mg, 1.02 mmol, 1.00 equiv), 
azeotropically dried with three portions of benzene, and then charged with THF (6.8 mL). A solution 
of freshly prepared lithium bis(trimethylsilyl)amide in THF/hexanes (1.00 M, 1.23 mL, 1.23 mmol, 
1.20 equiv) was added dropwise via syringe to the stirred reaction mixture. After 40 min, the reaction 
mixture was cooled to 0 °C and 2-nitrobenzenesulfonylchloride (295 mg, 1.33 mmol, 1.30 equiv) was 
added in a single portion. After 5 min, the reaction mixture was allowed to warm to ambient 
temperature. After 1 h, saturated aqueous NH4Cl (5 mL) and Et2O (8 mL) were added to the stirred 
reaction mixture. The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 8 
mL). The combined organic layers were washed with brine (15 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel treated with 1% Et3N in [20% EtOAc in hexanes], eluent: gradient, 1% 
Et3N in [20% EtOAc in hexanes] → 1% Et3N in [25% EtOAc in hexanes] → 1% Et3N in [33% 
EtOAc in hexanes]) to afford N-Ns-2-pyrrolidinone 137 (498 mg, 89%) as a pale-yellow flocculent 
solid (>10:1 mixture of epimers at C4). 1H NMR (500 MHz, CDCl3, >10:1 mixture of C4-epimers; 
116:
S14:
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 major (4S)-epimer reported) δ: 8.47–8.41 (m, 1H), 7.81–7.71 (m, 3H), 5.81 (d, J = 3.4 Hz, 1H), 4.16–
4.06 (m, 2H), 4.06–3.99 (m, 1H), 3.99–3.90 (m, 2H), 3.54 (dd, J = 7.9, 10.1 Hz, 1H), 3.23 (t, J = 6.6 
Hz, 2H), 2.54–2.42 (m, 2H), 2.25 (td, J = 6.0, 9.2 Hz, 1H), 2.17 (td, J = 4.7, 17.7 Hz, 1H), 2.07 (dd, J 
= 9.5, 14.2 Hz, 1H), 1.97–1.87 (m, 1H), 1.86 (dd, J = 1.5, 13.2 Hz, 1H), 1.80–1.71 (m, 1H), 1.71–
1.60 (m, 3H), 1.59–1.49 (m, 1H), 1.30 (t, J = 12.9 Hz, 1H), 0.97 (d, J = 6.6 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ: 175.3, 148.0, 134.9, 134.4, 133.8, 132.1, 132.0, 131.6, 124.2, 108.0, 65.3, 64.0, 51.2, 
51.0, 48.4, 41.6, 37.2, 34.1, 34.0, 27.4, 26.0, 25.8, 21.4. FTIR (thin film) cm-1: 2951, 2097, 1734, 
1543, 1366, 1173, 1126, 592. HRMS (ESI) (m/z) calc’d for C23H29N5NaO7S [M+Na]+: 542.1680, 
found 542.1680. TLC (33% EtOAc in hexanes), Rf: 0.28 (UV, anis). 
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Vinylogous urethane (Z)-14: A solution of n-butyllithium in hexanes (2.54 M, 1.13 mL, 2.88 mmol, 
3.00 equiv) was added dropwise via syringe to a stirred solution of diisopropylamine (0.443 mL, 3.16 
mmol, 3.30 equiv) in THF (5.6 mL) at –78 °C. After 10 min, the stirred reaction mixture was allowed 
to warm to 0 °C, and after 30 min it was re-cooled to –78 °C. t-Butylacetate (0.389 mL, 2.88 mmol, 
3.00 equiv) was then added dropwise via syringe to the stirred reaction mixture at –78 °C. After 1 h, a 
cooled solution of 137 (498 mg, 0.958 mmol, 1.00 equiv), which was azeotropically dried with three 
portions of benzene, in THF (2 mL) at –78 °C was added dropwise via a dry-ice wrapped cannula to 
the stirred reaction mixture at –78 °C. The transfer was completed with two additional portions of 
THF (2 × 5 mL). After 85 min, saturated aqueous NH4Cl solution (10 mL) was added to the red 
reaction mixture at –78 °C, and the resultant suspension was allowed to warm to ambient 
temperature. Et2O (10 mL) was added, the layers were separated, and the aqueous layer was extracted 
with EtOAc (3 × 10 mL). The combined organic layers were washed with brine (15 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford crude β-ketoester 138 
(590 mg) as a pale-yellow flocculent solid, which was used without further purification. 
 Triphenylphosphine (365 mg, 1.39 mmol, 1.50 equiv) was added in a single portion to a 
stirred solution of crude 138 (590 mg, 0.928 mmol, 1.00 equiv) in benzene (9.3 mL), and the resultant 
stirred reaction mixture was subsequently heated to 50 °C. After 12 h, the stirred reaction mixture was 
allowed to cool to ambient temperature before being concentrated under reduced pressure. The 
residue was then directly purified by flash column chromatography (silica gel treated with 1% Et3N in 
[20% EtOAc in hexanes], eluent: gradient, 1% Et3N in [20% EtOAc in hexanes] → 1% Et3N in [33% 
EtOAc in hexanes] → 1% Et3N in [50% EtOAc in hexanes]) to afford vinylogous urethane (Z)-139 
(500 mg, 88%) as a pale-yellow flocculent solid (~3:2 mixture of epimers at C4). 1H NMR (500 
then 13, THF,
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 MHz, C6D6, 3:2 mixture of C4-epimers; major epimer noted by *) δ: 9.27 (br. s., 1H), 9.23 (br. s., 1 
H*), 7.97 (dd, J = 1.3, 7.9 Hz, 1 H*), 7.92 (dd, J = 1.2, 7.8 Hz, 1H), 6.95 (dd, J = 1.2, 8.1 Hz, 1 H*), 
6.97 (dd, J = 1.0, 8.1 Hz, 1H), 6.78 (dt, J = 1.2, 7.7 Hz, 1 H*), 6.74 (dt, J = 1.2, 7.7 Hz, 1H), 6.58 (dt, 
J = 1.3, 7.8 Hz, 1 H*), 6.53 (dt, J = 1.5, 7.8 Hz, 1H), 6.01 (t, J = 5.7 Hz, 1H), 5.90 (t, J = 6.2 Hz, 1 
H*), 5.55 (d, J = 4.2 Hz, 1 H*), 5.45 (d, J = 3.4 Hz, 1H), 4.86 (s, 1H), 4.54 (s, 1 H*), 3.97–3.89 (m, 1 
H*), 3.81–3.71 (m, 1 H; 2 H*), 3.68–3.58 (m, 2H), 3.56–3.48 (m, 1 H*), 3.48–3.41 (m, 1H), 3.30 (td, 
J = 5.5, 13.2 Hz, 1 H*), 3.14 (td, J = 4.2, 12.8 Hz, 1H), 3.03–2.92 (m, 1 H; 1 H*), 2.66–2.58 (m, 2H), 
2.58–2.47 (m, 2 H*), 2.47–2.36 (m, 2 H*), 2.37–2.28 (m, 2H), 2.27–2.19 (m, 1 H*), 2.17–2.12 (m, 
2H), 2.00–1.80 (m, 2 H; 2 H*), 1.77 (d, J = 12.9 Hz, 1 H*), 1.71 (d, J = 12.9 Hz, 1H), 1.61 (dd, J = 
11.7, 13.7 Hz, 1 H*), 1.55 (s, 9H), 1.53 (s, 9 H*), 1.47–1.33 (m, 3 H; 2 H*), 1.33–1.16 (m, 2 H; 2 
H*), 1.15–0.95 (m, 1 H; 2 H*), 0.80 (d, J = 6.6 Hz, 3 H)*, 0.78 (d, J = 6.6 Hz, 3H). 13C NMR (126 
MHz, C6D6) δ: 171.8, 171.7, 164.8, 164.6, 148.8, 135.9, 135.3, 135.0, 134.6, 133.1, 132.9, 132.3, 
132.2, 131.7, 131.4, 125.2, 125.2, 108.9, 108.8, 83.7, 82.9, 78.0, 77.6, 65.7, 65.4, 64.5, 64.1, 45.6, 
44.6, 42.5, 42.4, 41.3, 41.2, 41.1, 40.5, 40.1, 39.7, 34.8, 34.6, 31.5, 30.4, 29.3, 28.0, 21.9, 21.9, 21.7, 
21.3. FTIR (thin film) cm-1: 3273, 2951, 1638, 1597, 1541, 1364, 1148, 588. HRMS (ESI) (m/z) 
calc’d for C29H41N3NaO8S [M+Na]+: 614.2507, found 614.2502. TLC (33% EtOAc in hexanes), Rf: 
0.23 (UV, anis). 
1D NOESY (500 MHz, C6D6): 
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5-membered vinylogous urethane 140: Thiophenol (26 µL, 0.25 mmol, 3.0 equiv) was added 
dropwise via syringe to a stirred solution of 139 (48 mg, 0.085 mmol, 1.00 equiv) and cesium 
carbonate (420 µL) at 0 °C, which was subsequently allowed to warm to ambient temperature after 5 
min. After 5 h, water (5 mL) and EtOAc (5 mL) were added to the stirred reaction mixture. The layers 
were separated and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic 
layers were washed with water (3 × 10 mL) and brine (10 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel treated with 0.2% NH4OH in [1.8% MeOH in CHCl3], eluent: 1% NH4OH 
in [9% MeOH in CHCl3]) to afford 5-membered vinylogous urethane 14068 (25 mg, 76%) as a yellow 
flocculent solid (~2:1 mixture of C4-epimers). 1H NMR (500 MHz, CDCl3, ~2:1 mixture of C4-
epimers; major epimer noted by *) δ: 7.81–7.69 (m, 1H*; 1H), 5.70–5.65 (m, 1H*; 1H), 4.40 (s, 1H*; 
1H), 4.09–3.88 (m, 4H*; 4H), 3.57 (dd, J = 7.0, 10.1 Hz, 2H*), 3.37 (dd, J = 6.3, 9.8 Hz, 1H), 3.24 
(ddd, J = 0.7, 4.6, 10.0 Hz, 1H), 3.10 (ddd, J = 1.0, 4.3, 10.1 Hz, 1H*), 2.73–2.66 (m, 2H*; 2H), 2.62 
(q, J = 6.8 Hz, 1H), 2.57–2.49 (m, 1H), 2.40–2.34 (m, 1H*), 2.32–2.24 (m, 1H*), 2.21 (dd, J = 5.5, 
15.0 Hz, 1H*; 1H), 2.16–2.07 (m, 1H*; 1H), 1.98 (dd, J = 9.6, 14.3 Hz, 1H*), 1.93–1.71 (m, 5H*; 
6H), 1.69–1.43 (m, 13H*; 13H), 1.35–1.23 (m, 1H*; 1H), 0.95 (d, J = 6.6 Hz, 3H*; 3H). 13C NMR 
(126 MHz, CDCl3) δ: 171.2, 170.9, 168.9, 168.3, 135.3, 135.2, 130.6, 130.5, 108.2, 108.2, 78.3, 78.1, 
77.8, 65.4, 65.3, 64.1, 63.9, 51.0, 49.7, 49.4, 46.6, 42.2, 42.0, 41.8, 39.5, 38.0, 34.4, 34.1, 34.0, 31.4, 
30.6, 29.7, 28.7, 27.5, 27.4, 27.0, 23.7, 21.5. FTIR (thin film) cm-1: 2441, 2978, 2933, 1691, 1390, 
                                                                                                                                                  
68 NOESY1D experiments revealed coupling between C6–H and presumably the C4/C3–H atoms, but due to the 
overlapping peaks in the spectrum, the stereochemistry of the vinylogous urethane could not be unambiguously 
assigned. 
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 1377, 1256, 1172, 1093, 847. HRMS (ESI) (m/z) calc’d for C23H39N2O4 [M+H]+: 407.2904, found 
407.2902. TLC (9% MeOH and 1% NH4OH in CHCl3), Rf: 0.58 (UV, anis). 
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Tetracyclic 2-nitrobenzenesulfonamide (–)-144: Aqueous HCl (1.2 M, 20 mL) was added to a 
stirred solution of 139 (500 mg, 0.845 mmol, 1.00 equiv) in THF (156 mL). After 4.5 h, Et2O (100 
mL) and saturated aqueous NaHCO3 (100 mL) were added to the stirred reaction mixture. The layers 
were separated, and the aqueous layer was extracted with EtOAc (3 × 75 mL). The combined organic 
layers were washed with saturated aqueous NaHCO3 (75 mL) and brine (75 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel treated with 1% Et3N in [25% EtOAc in hexanes], eluent: 
gradient, 1% Et3N in [25% EtOAc in hexanes] → 1% Et3N in [33% EtOAc in hexanes] → 1% Et3N 
in [40% EtOAc in hexanes] → 1% Et3N in [50% EtOAc in hexanes]) to afford tetracyclic 2-
nitrobenzenesulfonamide (–)-144 (425 mg, 92%) as an orange flocculent solid. 1H NMR (500 MHz, 
C6D6) δ: 9.41 (br. s., 1H), 7.90 (dd, J = 1.0, 7.9 Hz, 1H), 6.96 (dd, J = 0.9, 8.0 Hz, 1H), 6.74 (dt, J = 
1.1, 7.8 Hz, 1H), 6.57 (dt, J = 1.4, 7.8 Hz, 1H), 6.29 (t, J = 4.8 Hz, 1H), 3.26–3.11 (m, 2H), 2.89 (d, J 
= 2.1 Hz, 1H), 2.70–2.64 (m, 1H), 2.54 (dt, J = 4.1, 12.0 Hz, 1H), 2.04 (qd, J = 4.6, 11.8 Hz, 1H), 
1.89 (td, J = 3.5, 11.3 Hz, 1H), 1.75–1.62 (m, 3H), 1.57–1.51 (m, 2H), 1.50 (s, 9H), 1.43 (dd, J = 9.5, 
12.9 Hz, 1H), 1.36–1.21 (m, 1H), 1.14–1.06 (m, 2H), 0.86 (dt, J = 1.8, 12 Hz, 1H), 0.80 (d, J = 6.4 
Hz, 3H), 0.77 (br. s, 1H), 0.58 (dd, J = 12.1, 13.3 Hz, 1H). 13C NMR (126 MHz, C6D6) δ: 170.6, 
164.6, 148.8, 135.0, 132.9, 132.1, 131.2, 125.0, 88.7, 80.5, 78.1, 51.4, 49.3, 49.0, 46.2, 43.1, 41.2, 
40.8, 40.2, 31.5, 29.1, 26.8, 22.7, 20.8, 20.6. FTIR (thin film) cm-1: 3273, 3374, 3252, 2926, 1634, 
1591, 1541, 1362, 1263, 1161, 1144, 731. HRMS (ESI) (m/z) calc’d for C27H37NaN3O7S [M+Na]+: 
570.2244, found 570.2241. [α]D25: –86 (c = 1.0, CHCl3). TLC (33% EtOAc in hexanes), Rf: 0.23 
(UV, KMnO4).  
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Tetracyclic N-methylamine 145: Iodomethane (71 μL, 1.13 mmol, 2.00 equiv) was added dropwise 
via syringe to a vigorously stirred solution of anhydrous potassium carbonate (391 mg, 2.83 mmol, 
5.00 equiv) and (–)-144 (310 mg, 0.566 mmol, 1.00 equiv) in DMF (3.8 mL) at 0 °C, and the resultant 
reaction mixture was allowed to warm to ambient temperature. After 14 h, the reaction mixture was 
cooled to 0 °C before thiophenol (291 μL, 2.83 mmol, 5.00 equiv) was added dropwise via syringe, 
and the resultant vigorously stirred mixture was allowed to warm to ambient temperature. After 4 h, 
water (4 mL) was added to the stirred reaction mixture, which was then extracted with EtOAc (4 × 10 
mL). The combined organic layers were washed with water (3 × 15 mL) and brine (1 × 15 mL), dried 
over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified 
by flash column chromatography (silica gel treated with 0.5% NH4OH in [5% MeOH in CHCl3], 
eluent: gradient, 0.5% NH4OH in [5% MeOH in CHCl3] → 1% NH4OH in [9% MeOH in CHCl3] → 
2% NH4OH in [18% MeOH in CHCl3]) to afford 145 (186 mg, 87%) as a white flocculent solid. 1H 
NMR (500 MHz, CDCl3) δ: 9.12 (br. s, 1H), 3.31–3.25 (m, 1H), 3.19–3.12 (td, J = 11.7, 4.2 Hz, 1H), 
2.79–2.76 (m, 1H), 2.73 (dd, J = 4.4, 14.2 Hz, 1H), 2.51 (dd, J = 2.4, 14.2 Hz, 1H), 2.42 (s, 3H), 
2.42–2.37 (m, 1H), 1.94–1.87 (m, 2H), 1.85–1.79 (m, 1H), 1.79–1.57 (m, 7H), 1.43 (s, 9H), 1.14 (dd, 
J = 12.2, 14.2 Hz, 1H), 0.93 (dt, J = 2.2, 12.5 Hz, 1H), 0.85 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ: 170.6, 165.9, 88.4, 77.7, 77.7, 52.1, 50.3, 49.9, 49.4, 41.1, 40.8, 40.6, 39.6, 36.8, 29.2, 
28.7, 25.8, 22.4, 20.9, 20.6. FTIR (thin film) cm-1: 3248, 3148, 2924, 1630, 1589, 1261, 1248, 1163, 
1140, 733. HRMS (ESI) (m/z) calc’d for C22H37N2O3 [M+H]+: 377.2799, found 377.2826. TLC (2% 
NH4OH in [18% MeOH in CHCl3]), Rf: 0.20 (ninhydrin). 
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Pentacycle (–)-148: A Schlenk flask was charged with 145 (163 mg, 0.430 mmol, 1.00 equiv) and 
2,2,2-trifluoroethanol (8.6 mL), and the resultant solution was degassed via FPT (four iterations). The 
Schlenk flask was then sealed under an argon atmosphere, and heated to 80 °C. After 4 h, the stirred 
reaction mixture was cooled to ambient temperature, transferred to a round-bottom flask, and 
concentrated under reduced pressure to afford crude pentacyclic vinylogous urethane (–)-148 (136 
mg) as a slightly pink solid, which contained ~12% TFE by 1H NMR but was otherwise pure. This 
corresponds to approximately 131 mg of pure 148 and an ~85% yield. Crude 148 was carried onto the 
next reaction without further purification, but an analytical sample could be prepared by 
azeotropically distilling 148 with three portions of benzene and three portions of CDCl3. 1H NMR 
(500 MHz, CDCl3) δ: 9.05 (br. s, 1H), 3.34–3.22 (m, 2H), 2.71 (dd, J = 3.7, 6.9 Hz, 1H), 2.32 (s, 3H), 
2.25 (m, 1H), 2.19–2.12 (m, 2H), 2.02 (d, J = 13.5 Hz, 1H), 1.87–1.71 (m, 3H), 1.68 (dd, J = 1.6, 13.0 
Hz, 1H), 1.59–1.53 (m, 2H), 1.52–1.45 (m, 1H), 1.44 (s, 9H), 1.29 (dd, J = 8.0, 12.6 Hz, 1H), 1.14 (t, 
J = 13.0 Hz, 1H), 0.87 (d, J = 6.6 Hz, 3H), 0.83–0.77 (dt, J = 2.3, 12.5 Hz, 1H), 0.06 (s, 1H). 13C 
NMR (126 MHz, CDCl3) δ: 170.4, 162.4, 90.3, 77.8, 66.3, 59.9, 52.2, 44.4, 41.6, 39.1, 38.7, 38.3, 
35.1, 34.7, 33.6, 28.7, 24.7, 22.5, 20.6, 20.5. FTIR (thin film) cm-1: 3248, 3163, 2926, 1636, 1597, 
1454, 1234, 1168, 1148, 1123. HRMS (ESI) (m/z) calc’d for C22H35N2O2 [M+H]+: 359.2693, found 
359.2718. [α]D25: –90 (c = 1.0, CHCl3). TLC (9% MeOH and 1% NH4OH in CHCl3), Rf: 0.49 
(ninhydrin).  
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Pentacyclic imine S15: A round-bottom flask equipped with a cold-finger was charged with crude 
148 (38 mg, 0.11 mmol, 1.0 equiv) and benzene (11 mL). p-Toluenesulfonic acid monohydrate (61 
mg, 0.32 mmol, 3.0 equiv) was added as a single portion to the stirred solution, and the resultant 
stirred reaction mixture was subsequently heated to 80 °C. After 3 h, the reaction was allowed to cool 
to ambient temperature and concentrated under reduced pressure. The residue was then directly 
purified by flash column chromatography (silica gel treated with 1% NH4OH in [9% MeOH in 
CHCl3], eluent: 1% NH4OH in [9% MeOH in CHCl3]) to afford S15 (26 mg, 95%) as a yellow oil 
that was carried forward immediately. 1H NMR (500 MHz, CDCl3) δ: 3.66 (br. d, J = 17.8 Hz, 1H), 
3.61–3.51 (m, 1H), 3.38 (td, J = 3.1, 9.0 Hz, 1H), 2.73 (dddd, J = 3.4, 7.8, 15.4, 18.3 Hz, 1H), 2.34 (s, 
3H), 2.28 (t, J = 6.6 Hz, 1H), 2.20 (d, J = 18.3 Hz, 1H), 2.12–2.08 (m, 1H), 2.09 (d, J = 9.3 Hz, 1H), 
2.05 (t, J = 3.9 Hz, 1H), 1.90–1.83 (m, 1H), 1.79–1.49 (m, 7H), 1.41 (dd, J = 8.3, 13.4 Hz, 1H), 1.16 
(t, J = 12.8 Hz, 1H), 1.04 (dt, J = 2.7, 12.5 Hz, 1H), 0.88 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ: 174.4, 68.7, 61.6, 54.4, 50.0, 44.2, 41.4, 39.2, 38.8, 35.3, 34.6, 33.7, 32.1, 25.5, 23.0, 21.9, 
21.6. FTIR (thin film) cm-1: 2916, 1636, 1454, 1150. HRMS (ESI) (m/z) calc’d for C17H27N2 
[M+H]+: 259.2169, found 259.2157. TLC (9% MeOH and 1% NH4OH in CHCl3), Rf: 0.36 
(ninhydrin). 
Me
N
N
S15
Me
CO2t-Bu
Me
H
N
N
148
Me PhH, 80 °C, 3 h(95%)
p-TsOH•H2O
97
  
(+)-Fastigiatine (37): Acetic anhydride (95 μL, 1.0 mmol, 10 equiv) was added dropwise via syringe 
to a stirred solution of S15 (26.1 mg, 0.101 mmol, 1.00 equiv) and Et3N (140 μL, 1.0 mmol, 10 
equiv) in CH2Cl2 (1 mL). After 3 h, the stirred reaction mixture was concentrated under reduced 
pressure. The residue was then directly purified by flash column chromatography (silica gel treated 
with 0.5% NH4OH in [5% MeOH in CHCl3], eluent: 0.5% NH4OH in [5% MeOH in CHCl3]) to 
afford (+)-fastigiatine (37) (25.7 mg, 85%) as a colorless solid. Crystals suitable for X-ray diffraction 
were obtained by slow evaporation of a solution of (+)-37 in Et2O at ambient temperature. 1H NMR 
(500 MHz, CDCl3) δ: 5.19 (d, J = 5.4 Hz, 1H), 3.82 (dt, J = 5.9, 11.8 Hz, 1H), 3.29–3.22 (m, 2H), 
2.42–2.38 (m, 1H), 2.33 (s, 3H), 2.20 (d, J = 9.3 Hz, 1H), 2.18–2.15 (m, 1H), 2.15 (s, 3H), 2.08 (br. d, 
J = 15.1 Hz, 1H), 2.05–1.95 (m, 1H), 1.94–1.90 (m, 1H), 1.79–1.72 (m, 1H), 1.70 (dd, J = 4.8, 14.3 
Hz, 1H), 1.61–1.54 (m, 3H), 1.45–1.32 (m, 2H), 1.20 (t, J = 12.9 Hz, 1H), 1.02 (dt, J = 2.6, 12.6 Hz, 
1H), 0.91 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ: 170.2, 139.3, 123.3, 65.6, 59.8, 55.2, 
45.6, 45.5, 40.3, 38.5, 37.5, 35.2, 34.7, 34.0, 25.7, 23.1, 22.5, 21.7, 21.3. FTIR (thin film) cm-1: 2943, 
1651, 1454, 1383. HRMS (ESI) (m/z) calc’d for C19H28NaN2O [M+Na]+: 323.2094, found 323.2095. 
[α]D24: +375 (c = 1.4, CHCl3). TLC (9% MeOH and 1% NH4OH in CHCl3), Rf: 0.44 (ninhydrin). 
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Introduction 
 In 1993, a new class of natural products, the angelmicins, was identified from the rare 
actinomycete Microbispora subsp. AA9966 by a team of Japanese scientists during a screen for novel 
microbial inhibitors of cellular oncogenic transformation.69 They found that angelmicins A and B (1 
and 2, respectively, Figure 3.1) inhibited the growth of Src and Abl transformed NIH3T3 cells with 
IC50 values between 1-5 µg/mL and inhibited Src kinase activity. In 1996, a more comprehensive 
biological study revealed that angelmicins A–D dose-dependently inhibited the growth of several 
human cancer cell leukemia lines in a four-day growth assay.70 In particular, angelmicin B (2) has the 
most potent anti-proliferative activity in HL-60 cells (IC50 = 58 nM) and induces their differentiation. 
Interestingly, the Japanese team also determined that the IC50 concentration of angelmicin B (2) 
needed for Src kinase inhibition was on the order of 100-fold higher than that for growth inhibition, 
suggesting that the cellular target responsible for the cytotoxic effects of 2 is not Src. 
 That same year, the two-dimensional structure of angelmicin B (2) was elucidated by 1H, 13C, 
COSY, TOCSY, HMBC, and NOESY NMR experiments as well as by FABMS, IR, and UV–vis 
data.71 The data revealed that 2 was an extraordinary complex type-II polyketide that was pseudo-C2-
symmetric about its highly hindered C2–C2' bond and contained six 2-deoxyglycosides. The C2-
symmetry of 2 is broken by oxidation of the B-, C-, and D-rings relative to the G-, F-, and E-rings, 
respectively. More specifically, the B-ring contains a cyclic ether bridging C8' and C13', the C-ring 
contains a hydroxyl group at C6', and the D-ring is a quinone. In 1998, a Hori and coworkers isolated 
hibarimicins A–G from the culture broth of the rare actinomycete Microbispora rosea subsp. hibaria 
                                                                                                                                                                       
69 (a) Uehara, Y.; Li, P. M.; Fukazawa, H.; Mizuno, S.; Nihei, Y.; Nishio, M.; Hanada, M.; Yamamoto, C.; 
Furumai, T.; Oki, T. J. Antibiot. 1993, 46, 1306–1308. (b) The angelmicins are structurally identical to the 
hibarimicins (vide infra). 
 
70 Yokoyama, A.; Okabe-Kado, J.; Uehara, Y.; Oki, T.; Tomoyasu, S.; Tsuruoka, N.; Honma, Y. Leukemia Res. 
1996, 20, 491–497. 
 
71 Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. Tetrahedron Lett. 1996, 37, 2785–
2788. 
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TP-A0121. 72  It was soon determined that the hibarimicins are structurally identical to the 
angelmicins, and these natural products from hereon are referred to as the hibarimicins. Hibarimicins 
A–G structurally differ by variation of the 2-deoxy-glycosides that adorn a shared unprecedented 
highly-oxidized aglycon, hibarimicinone (6). The relative stereochemistry of the hibarimicins was 
determined by NOESY correlations. However, the relative stereochemistry between the “eastern” and 
“western” halves of 6 as well as between the carbohydrates and 6 could not be determined due to their 
relative isolation from one another. Nonetheless, the pseudo-C2-symmetry of 6, together with 
additional studies investigating the biosynthesis of the hibarimicins, strongly supported the 
 
 
Figure 3.1 Structures of hibarimicins A–G (1-5) and hibarimicinone (6). 
                                                                                                                                                                       
72 (a) Kajiura, T.; Furumai, T.; Igarashi, Y.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, 
T. J. Antibiot. 1998, 51, 394–401. (b) Hori, H.; Igarashi, Y.; Kajiura, T.; Furumai, T.; Higashi, K.; Ishiyama, T.; 
Uramoto, M.; Uehara, Y.; Oki, T. J. Antibiot. 1998, 51, 402–417. 
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hypothesis that each half possessed the same absolute stereochemistry (vide infra). 73 
In 2004, another study by Hori and coworkers tentatively assigned the absolute 
stereochemistry of the hibarimicins.74a The 2-deoxy-glycosides were cleaved from 2 and their 
absolute stereochemistry was confirmed by comparison to authentic samples. The absolute 
stereochemistry of hibarimicinone (6) was assigned by synthesis of a multi-MPTA ester derivative at 
the C1-, C10-, and C11'-hydroxyls, and comparison to a simple B/G-ring model system. Lastly, it was 
demonstrated that 6 exhibits axial chirality about its highly congested C2–C2' bond, and that 6 is 
isolated as a single atropisomer. The axial stereochemistry of 6 was assigned the aS configuration by 
the CD exciton chirality method. Interestingly, heating a solution of 6 in methanol to 60 °C led to 
rapid isomerization about the C2–C2' bond and ultimately a mixture of 6 and its atrop-diastereomer, 
atrop-hibarimicinone (7). Whether the glycosylated hibarimicins also easily isomerize about the C2–
C2' bond has not yet been reported. 
 
 
Figure 3.2 13C-Labeling studies on Microbispora rosea subsp. hibaria TP-A0121. 
                                                                                                                                                                       
73 (a) Hori, H.; Kajiura, T.; Igarashi, Y.; Furumai, T.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, 
T. J. Antibiot. 2002, 55, 46–52. (b) Kajiura, T.; Furumai, T.; Igarashi, Y.; Hori, H.; Higashi, K.; Ishiyama, T.; 
Uramoto, M.; Uehara, Y.; Oki, T. J. Antibiot. 2002, 55, 53–60. (c) Igarashi, Y.; Kajiura, T.; Furumai, T.; Hori, 
H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. J. Antibiot. 2002, 55, 61–70. (d) Cho, S. I.; 
Fukazawa, H.; Honma, Y.; Kajiura, T.; Hori, H.; Igarashi, Y.; Furumai, T.; Oki, T.; Uehara, Y. J. Antibiot. 
2002, 55, 270–278. 
 
74 (a) Hori, H.; Igarashi, Y.; Kajiura, T.; Sato, S.; Furumai, T.; Higashi, K.; Ishiyama, T.; Uehara, Y.; Oki, T. 
Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 2004, 46, 49–54. (b) Personal communication with Prof. H. 
Hori and Prof. Y. Igarashi. 
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The biosynthesis of the hibarimicins was investigated by 13C-acetate labeling and blocked 
mutant studies with Microbispora rosea subsp. hibaria TP-A0121.73 The 13C-acetate labeling studies 
were conducted with sodium [1-13C], [2-13C], or [1,2-13C2] acetate and hibarimicin B (2) was isolated 
and probed by 13C and 1D-INADEQUATE NMR experiments; the results are summarized in Figure 
3.2. Enrichment of [2-13C] at both C2 and C2' clearly suggested that 2 arises from a dimerization of 
two separate polyketide-derived monomers. This proposal is also directly supported by the blocked 
mutant studies. Mutagenesis of Microbispora rosea subsp. hibaria TP-A0121 led to the identification 
of novel metabolites, including HMP-Y1 (8) and HMP-P1 (10), as well as their glycosylated 
derivatives HMP-Y6 (9) and HMP-P4 (11) (Figure 3.3). After additional feeding studies with 13C-
acetate labeled C2-symmetric 8, it was discovered that 8 is a precursor to hibarimicinone (6), which is 
subsequently glycosylated to yield hibarimicins A–G. As one would expect, the C2–C2' chiral axis of 
9 was assigned the aR stereochemistry by the CD exciton chirality method,74b which corresponds to 
the same relative stereochemistry as 6.75 The axial stereochemistry of 8 was not rigorously assigned 
since its CD-spectrum was not obtained; however, 8 is derived from glycolysis of 9 and—barring 
isomerization occurring during glycolysis—8 should therefore also possess the aR configuration 
about C2–C2' as depicted in Figure 3.3. 
 
 
Figure 3.3 Metabolites from blocked mutants of Microbispora rosea subsp. hibaria TP-A0121. 
                                                                                                                                                                       
75 Although 6 is assigned aS stereochemistry while 8 possesses aR stereochemistry, this is merely because of a 
switch in group priorities in accordance with Cahn–Ingold–Prelog sequence rules. 
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Based on their studies, Hori and coworkers proposed the biosynthesis shown in Scheme 3.1. 
1D-INADEQUATE NMR experiments on [1,2-13C2] acetate labeled 2 led the authors to propose that 
each monomeric half of the aglycon was most likely derived from linear precursor 12. The lack of 
one bond 13C–13C coupling between C14 and C15 as well as between C9 and C10 supports this model 
where C10 and C15 are originally linked and derived from the same original acetate unit in 12. Linear 
precursor 12 then cyclizes and the C10–C15 bond is ultimately fragmented to give tetracyclic carbon 
skeleton 13. Excision of the extra carbon unit, followed by functionalization, is then proposed to give 
monomer 14, which is the eastern half of hibarimicinone (6) and half of HMP-Y1 (8). Dimerization 
of 14 then yields HMP-Y1 (8). A subsequent series of oxidations on the western half of 8 would then 
eventually afford hibarimicinone (6). Ostensibly, this conversion (8 → 6) proceeds by breaking the 
C2-symmetry of 8 via oxidation of the B-, C-, and D-rings with concomitant demethylation of the 
C4'–OMe methyl group. Interestingly, HMP-Y6 (9) is not a precursor to hibarimicins A–G, and thus 
oxidation of 8 to 6 should precede glycosylation to give hibarimicins A–G. HMP-P1 (10) arises from 
6 via cyclization of C1–OH onto C3' of the D-ring quinone and subsequent expulsion of methanol. 
 
 
Scheme 3.1 Proposed biosynthesis of the hibarimicin natural products.  
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Selected Synthetic Efforts toward the Hibarimicin Natural Products 
The hibarimicin natural products and the corresponding aglycons are challenging targets for 
organic synthesis. Despite efforts by various groups, these targets had resisted total synthesis76 until 
2012 when Tatsuta et al. reported the first synthesis77 of hibarimicinone (6) and we later reported the 
synthesis of hibarimicinone (6) and the first total syntheses of atrop-hibarimicinone (7), HMP-Y1 (8), 
 
 
Figure 3.4 Summary of synthetic efforts toward the hibarimicins from other groups. 
                                                                                                                                                                       
76 For studies towards the hibarimicins or their related natural products, see: (a) Lee, C.-S.; Audelo, M. Q.; 
Reibenpies, J.; Sulikowski, G. A. Tetrahedron 2002, 58, 4403–4409. (b) Maharoof, U. S.; Sulikowski, G. A. 
Tetrahedron Lett. 2003, 44, 9021–9023. (c) Kim, K.; Mahroof, U. S.; Raushel, J.; Sulikowski, G. A. Org. Lett. 
2003, 5, 2777–2780. (d) Narayan, S.; Roush, W. R. Org. Lett. 2004, 6, 3789–3792. (e) Lambert, W. T; Roush, 
W. R. Org. Lett. 2005, 7, 5501–5504. (f) Lee, W. D.; Kim, K.; Sulikowski, G. A. Org. Lett. 2005, 7, 1687–
1689. (g) Li, J.; Todaro, L. J.; Mootoo, D. R. Org. Lett. 2008, 10, 1337–1340. (h) Li, J.; Todaro, L.; Mootoo, D. 
R. Eur. J. Org. Chem. 2011, 6281–6287. (i) Romaine, I. M.; Hempel, J. E.; Shanmugam, G.; Hori H.; Igarashi, 
Y.; Polavarapu, P. L.; Sulikowski, G. A. Org. Lett. 2011, 13, 4538–4541. 
 
77 Tatsuta, K.; Fukuda, T.; Ishimori, T.; Yachi, R.; Yoshida, S.; Hashimoto, H.; Hosokawa, S. Tetrahedron Lett. 
2012, 53, 422–425. 
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atrop-HMP-Y1, and HMP-P1 (10).78 In this section, I will briefly cover selected prior synthetic 
efforts toward the hibarimicins—stressing strategies that constructed the central ring system with the 
C2–C2' bond—in order to provide sufficient context for the next chapter. 
Roush and coworkers reported syntheses of CDE-ring system 1576d and of AB-enone 1676e 
(Figure 3.4). The CDE-ring system synthesis was accomplished via a Suzuki cross-coupling reaction 
between naphthazarin 22 and boronic acid 23 (Scheme 3.2, Eq. 1). The apparent straightforward 
nature of the depicted cross-coupling reaction belies the enormous effort spent attempting to form the 
C2–C2' bond; a representative sampling of their efforts is shown in Eq. 2 and 3 in Scheme 3.2. For 
example, very similar couplings, such as between 22 and naphthalenes 24 or 25, were unsuccessful. 
Attempted cross-coupling of a variety of naphthyl organometallics (e.g., 26-28) with various 
electrophiles (e.g., 29-32) also proved fruitless (Scheme 3.2, Eq. 3). In addition to investigating other 
cross-coupling substrates and variants, Roush and coworkers also attempted to form the C2–C2' bond  
 
 
Scheme 3.2 Roush’s synthesis of the CDE-ring system and failed attempts to form the C2–C2' bond. 
                                                                                                                                                                       
78 Liau, B. B.; Milgram, B. C.; Shair, M. D. J. Am. Chem. Soc. 2012, 134, 16765–16772. 
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via intramolecular oxidative phenolic coupling reactions without success. 79  The difficulty 
encountered in forming the C2–C2' bond was rationalized by the hindered environment surrounding 
the reactive sites, which contains substituents at each position ortho to C2 and C2', and the electron-
rich nature of the naphthalene cross-coupling partners. This study demonstrated that forming the C2–
C2' bond of the hibarimicins via a late-stage cross-coupling reaction would be difficult. 
 In 2003, Sulikowski and coworkers reported the synthesis of DE-ring system 20a/b (Figure 
3.5).76b 20a/b was synthesized from dibenzofuran in eighteen steps and lacks the C2'–OMe 
substituent. Despite these shortcomings, the authors interestingly observed that the rotational barrier 
about the C2–C2' bond was dependent on the presence of the C1–OMOM group. More specifically, 
20a/b exist as a 1:1 mixture of atrop-diastereomers and fail to interconvert at temperatures up to 148 
°C while des-MOM compounds 33a/33b exhibited free rotation about their C2–C2' bonds at ambient 
temperature. The authors rationalize that rapid interconversion between atropisomers 33a and 33b can 
proceed via eclipsed conformation 34, which is stabilized by π-electron overlap; this stabilization is 
apparently attenuated in 20, which lacks a free phenol at C1. Although these model systems lack the 
critical C3'–OMe substituent, they suggested that the rotational barrier about the C2–C2' bond of a 
naphthazarin-naphthalene system may be influenced by the electronic nature of the C1-substituent. 
 
 
Figure 3.5 The C1-substituent influences the rotational barrier about the C2–C2' bond. 
                                                                                                                                                                       
79 Narayan, S. Ph.D. Thesis, University of Michigan, 2003. 
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 Concurrent with our own studies, Sulikowski and coworkers reported the enantioselective 
synthesis of HMP-Y1 model system 19 using a bidirectional bis-Michael–Claisen reaction sequence 
(Scheme 3.3).76i The synthesis commenced with readily available trialkoxytoluene 34, which was 
regioselectively lithiated at C2/C2' with n-butyllithium in the presence of TMEDA. Exposure of the 
resultant aryllithium intermediate to copper(I) bromide dimethylsulfide complex and lithium bromide, 
followed by a subsequent addition of amide 35 resulted in oxidative dimerization and formation of 
racemic biaryl 36. Removal of the MOM groups afforded racemic biphenol 37, which upon exposure 
to copper(I) complexed with O’Briens diamine was enriched to 80% ee by dynamic kinetic 
resolution. Enantioenriched 37 was then converted to bis-o-toluate 38 in three straightforward steps. 
The dianion of 38 was then formed by double deprotonation with LDA in the presence of TMEDA, 
and reacted with 2-cyclohexenone to generate the bis-Michael–Claisen reaction sequence product 39. 
39 was then oxidatively aromatized by DDQ to afford desired binaphthalene 19. By comparing the 
CD-spectra of model system 19 with HMP-Y6 (9), Sulikowski and coworkers provided supporting 
evidence that the stereochemical configuration about the C2–C2' bond is indeed aR for 9. This type of 
bidirectional synthesis strategy circumvents the need to form the hindered C2–C2' bond at a late-
stage, but possesses its own challenges due to the idiosyncracies of anionic annulation reactions. 
 
 
Scheme 3.3 A bidirectional double Michael–Claisen reaction sequence. 
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Scheme 3.4 Highlights from Tatsuta and coworker’s total synthesis of hibarimicinone (6). 
 Concurrent with our own studies, Tatsuta and coworkers reported the first total synthesis of 
hibarimicinone (6) in early 2012. Uncannily, the bond disconnections that Tatsuta and coworkers 
utilized are identical to those that we had also contemporaneously developed and employed. The key 
steps and completion of the synthesis are outlined in Scheme 3.4. AB/HG-enone 40 and biaryl 41 
were each prepared as single enantiomers by multi-step synthesis, which will not be discussed in the 
interest of brevity. Exposure of biaryl 41 to NaHMDS led to formation of the corresponding dianion, 
which reacted with two equivalents of enone 40 in an unsymmetrical bidirectional double annulation 
reaction to form a 1:1 mixture of 1,3-diketone 42 and dihydronaphthalene 43 after in situ methylation 
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of the intermediate bis-thiolate dianion. The unusual use of thiophthalides as aryl annulation partners 
critically required the use of pyridine as a co-solvent to suppress polymerization. This remarkable 
unprecedented transformation constructed the full carbon skeleton of hibarimicinone (6). 42 could be 
easily converted to 43 by treatment with lithium chloride. 
 Next, 43 was transformed to C-ring hydroquinone 44 by treatment with wet silver(I) nitrate 
and then subsequently with DBU. Treatment with silver(I) carbonate and iodomethane then promoted 
elimination of the C6-methylsulfide to aromatize the F-ring with concomitant oxidation of the C-ring 
to afford naphthazarin-naphthalene 45. Exposure of 45 to LiI then promoted formation of o-quinone 
methide 46, which was poised to undergo an etherification reaction with the proximal C13'-tertiary 
trimethylsilyether to rearomatize the C-ring and deliver nonacycle 47. Although the authors make no 
comment, I had proposed that this reaction was biomimetic in nature and may in part reflect how 
HMP-Y1 (8) is biosynthetically converted to hibarimicinone (6) (vide infra). Reoxidation of the C-
ring by DDQ then resulted in naphthazarin 48, which upon treatment with hydrochloric acid in 
aqueous methanol led to global silyl group deprotection, demethylation of the C4'–OMe group, and 
concomitant transposition of the quinone from the C- to D-ring to afford hibarimicinone (6) in 
remarkable yield. No isomerization about the C2–C2' was documented. 
This report was published approximately six months before our highly similar work was 
submitted for review. It is worth mentioning that despite the similarities between our syntheses and 
final intermediates, the conditions developed by Tatsuta and coworkers were not transferable to our 
system (vide infra). Furthermore, our ultimate goal was to not only prepare hibarimicinone (6) but 
eventually hibarimicin B (2) as well. Tatsuta’s synthesis would require a very challenging final 
glycosylation of 6 or a later derivative since the carbohydrates are not compatible with the conditions 
required for C4'–OMe demethylation (i.e., acidic methanol).73 This would be extremely challenging 
given the lability of the naphthalene-naphthazarin system, which easily isomerizes and cyclizes to 
give HMP-P1 (10) (vide infra). Nonetheless, Tatsuta’s synthesis of hibarimicinone (6) was a 
landmark achievement and confirmed the molecule’s absolute stereochemistry. The use of a 
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biomimetic etherification to install the C8'-ether bond allowed them to cleverly exploit the latent C2-
symmetry of 6 and employ a convergent bidirectional double annulation reaction to construct the full 
carbon skeleton in a one-pot operation. 
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II. Total Syntheses of HMP-Y1, Hibarimicinone, and HMP-P1 
 
 
 
 
 
 
Chapter 4 
Total Syntheses of HMP-Y1, Hibarimicinone, and HMP-P1 
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Introduction 
 As discussed in the introduction of chapter three, Hori and coworkers proposed a biosynthesis 
of the hibarimicins using evidence drawn from 13C-labeled feeding and blocked mutant studies 
(Scheme 3.1). Importantly, they identified that the C2-symmetric blocked mutant metabolite HMP-Y1 
(8) is the precursor to hibarimicinone (6) (Scheme 4.1). However, no proposal for how this 
transformation might occur or via what possible intermediates was offered. Ostensibly, this 
conversion (8 → 6) proceeds by breaking the C2-symmetry of 8 via oxidation of the B-, C-, and D-
rings as well as demethylation of the C4'–OMe methyl group. 
 I postulated that a single desymmetrizing oxidation of the C-ring of 8 to hypothetical quinone 
49 would be sufficient to relay oxidation to the B- and D-rings. This could be achieved via 
 
 
Scheme 4.1 Our proposed biosynthetic conversion of HMP-Y1 (8) to hibarimicinone (6). 
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(1) tautomerization of quinone 49 to C8'-o-quinone methide 50, (2) subsequent oxy-Michael addition 
of the C13'–OH to install the B-ring cyclic ether, (3) re-oxidation of the C-ring to give naphthazarin 
51, and (4) transposition of the C-ring quinone to the D-ring with concomitant chemoselective 
demethylation of the labile C4'–OMe group to give 6. HMP-P1 (10) arises from 6 via cyclization of 
C1–OH onto C3' of the D-ring quinone and subsequent expulsion of methanol. 
 This proposal was compelling for several reasons. First, only a single oxidation (8 → 49) was 
needed to facilitate the introduction of all of the differential oxidation; this is in contrast to a previous 
proposal where three separate oxidations in the B-, C-, and D-rings occur relatively independently of 
one another. Second, there was substantial literature precedence that both formation of the C8'-o-
quinone methide 50 and the subsequent oxy-Michael reaction would be feasible.80 In their elegant 
synthesis of rugulosin, Nicolaou et. al. demonstrated that putative o-quinone methide 54 could be 
accessed from naphthazarin 53 under either mild basic or acidic conditions (Scheme 4.2A).81 These 
species proved to be highly reactive, and 54 readily dimerized via a hetero-Diels-Alder reaction to 
afford heptacycle 55. In another example, Hart and Huang found that treatment of quinone 56 with  
 
 
Scheme 4.2 Related transformations utilizing o-quinone methide intermediates. 
                                                                                                                                                                       
80 This analysis was before Tatsuta et. al. reported their synthesis of hibarimicinone (6). 
 
81 Nicolaou, K. C.; Lim, Y. H.; Piper, J. L.; Papageorgiou, C. D. J. Am. Chem. Soc. 2007, 129, 4001–4013. 
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manganese dioxide triggered a sequence of reactions that led to formation of pleurotin (59).82 This 
presumably occurs via initial tautomerization of 56 to o-quinone methide 57, oxy-Michael addition by 
the pendant carboxylic acid to give hexacycle 58, and reoxidation of the resultant hydroquinone to 59. 
 We decided to embark on a total synthesis of hibarimicin B (2) due its structural complexity, 
promising biological activity, as well as the interesting potential mechanism of its biosynthesis. We 
were particularly interested in the proposed biosynthetic relay oxidation scheme discussed earlier in 
Scheme 4.1, and wondered if these transformations could be accomplished in the context of a 
biomimetic total synthesis. It is important to note that the carbohydrates are essential for the anti-
proliferative effects of hibarimicin B (2),72 and thus our ultimate goal was the total synthesis of 2. 
However, an important milestone would be the synthesis of the aglycon, hibarimicinone (6), which is 
discussed in the upcoming sections. 
  
                                                                                                                                                                       
82 Hart, D. J.; Huang, H.-C. J. Am. Chem. Soc. 1988, 110, 1634–1635. 
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Synthesis Plan 
 Inspired by our biosynthetic relay oxidation hypothesis, we envisioned that a similar set of 
biomimetic retrosynthetic disconnections could simplify hibarimicinone (6) to quinone 60. In the 
forward sense, this would involve: (1) tautomerization of quinone 60 to the corresponding C8'-o-
quinone methide with subsequent oxy-Michael addition of the C13'–OH to install the B-ring cyclic 
ether, (2) re-oxidation of the C-ring, and (3) transposition of the C-ring quinone to the D-ring to give 
6 (i.e., Scheme 4.1: 49 → 50 → 51 → 6). We imagined that 60 could be accessed from two possible 
precursors, C2-symmetric octacycle 61, and pseudo-C2-symmetric octacycle 62. Targeting 61 was 
attractive for two reasons: (1) global deprotection would yield HMP-Y1 (8) and (2) it would allow us  
 
 
Scheme 4.3 Synthesis plan for hibarimicinone (6) and HMP-Y1 (8). 
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to directly assess the feasibility of a biomimetic mono-oxidation to access quinone 60. In contrast to 
61, the C2-symmetry of 62 is perturbed by the presence of the C6'–OH and potentially a non-
methylether protecting group at C4' (both highlighted in red). The C6'–OH was included to facilitate 
chemoselective C-ring oxidation to quinone 60, obviating the need for a desymmetrizing mono-
oxidation. The potential use of a non-methylether protecting group at C4' (e.g., a benzyl group) was a 
strategic consideration to protect the sensitive naphthalene-naphthazarin core up until the last step of 
an eventual synthesis of hibarimicin B (2), without requiring a harsh C4'–OMe demethylation that 
would be ultimately incompatible with the carbohydrates. 
The most noteworthy feature shared by both 61 and 62 is the degeneracy of the AB- and HG-
ring systems that result from the retrosynthetic excision of the B-ring cyclic ether bond. Exploiting 
this degeneracy, it was next envisioned that both octacyclic systems could be constructed in single 
operations via a bidirectional double annulation, where the dianion of biaryl 64 would react with two 
equivalents of the AB/HG-enone 63. The use of a symmetric biaryl would lead to 61 whereas the 
employment of an unsymmetrical variant with additional oxidation at C6', would result in 62. Both of 
these strategies are convergent and avoid constructing the hindered C2–C2' bond at a late stage.83 At 
the outset of our studies, the configuration of the C2–C2' stereochemical axis of hibarimicinone (6) 
was only assigned based on its CD-spectra. Consequently, we elected to proceed with racemic biaryl 
64 to rigorously prepare and characterize both atropisomers of HMP-Y1 (8) and hibarimicinone (6). 
The next sections of this chapter describe: (1) completion of the ent-AB/HG-enone, (2) 
syntheses of the monomeric ABCD- and EFGH-ring systems and demonstration of a biomimetic 
etherification reaction, (3) completion of HMP-Y1 (8) and attempted desymmetrizing mono-
oxidation, (4) completion of hibarimicinone (6) via an unsymmetrical bidirectional annulation, and 
(5) conversion of 6 to HMP-P1 (10) and discovery of a pH-dependent rotational barrier about the C2–
C2' bond of 6. It is important to acknowledge that the synthesis of the ent-AB/HG-enone was 
                                                                                                                                                                       
83 As discussed earlier, efforts by the Roush group to form the C2–C2' bond in simple model systems via cross-
coupling were met with considerable difficulty (Scheme 3.2). 
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predominantly the work of my coworker, Mr. Benjamin Milgram. Our efforts then diverged as B. 
Milgram worked on the synthesis of the carbohydrates of hibarimicin B (2) while I performed the 
work presented in this document concerning the synthesis of the natural product aglycons, except 
where noted. Lastly, the aforementioned sections do not follow any particular chronological order, 
but are divided in a way to facilitate ease of discussion. 
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Completion of the ent-AB/HG-Enone 
 Our discussion begins with the synthesis of AB/HG-enone 63, a requisite building block for 
not only the ultimate synthesis of the hibarimicin aglycons but for crucial monomeric model studies 
investigating key transformations. At the outset of our synthetic studies, we were uncertain of the 
absolute stereochemistry of hibarimicin B (2). 84  B. Milgram, who initiated the AB/HG-enone 
synthesis, targeted the enantiomer of AB/HG-enone 63 (ent-63), which unfortunately corresponded to 
the unnatural enantiomer of hibarimicinone (6). This problem would later be rectified by synthesis of 
the correct enantiomer, but the AB/HG-enone and hibarimicinone (6) were in fact synthesized as the 
unnatural enantiomers first. In the interest of brevity, only the correct enantiomeric series will be 
discussed unless the experiments were only accomplished with the unnatural enantiomeric series. 
 
 
Scheme 4.4 B. Milgram’s synthesis of bicyclic ketone 71. 
 I joined the AB/HG-enone synthesis at a fairly advanced stage of its development. B. 
Milgram had accessed bicyclic ketone 71; the final, optimized route to 71 is summarized in Scheme 
4.4. In the interest of brevity and collegiality, the details of this work will not be discussed here.85 
After bringing up material to the forefront, my first contribution involved the addition of an n-propyl 
organometallic species to the C13-ketone of 71. I found that careful addition of 71 to a mixture of n-
                                                                                                                                                                       
84 Although Hori and coworkers had tentatively assigned the absolute stereochemistry of hibarimicin B (2), this 
crucial paper (in Japanese) was unfortunately unbeknownst to us at the time. See ref. 74. 
 
85 For a full discussion, see: Milgram, B. C.; Liau, B. B.; Shair, M. D. Org. Lett. 2011, 13, 6436–6439. 
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propylmagnesium chloride and cerium(III) chloride at –78 °C, followed by gradual warming to –40 
°C, afforded the desired n-propyl adduct 72 as a single diastereomer (Scheme 4.5). Longer reaction 
times or warmer temperatures led to significant amounts of pivaloyl ester cleaved product 73, an 
observation that would prove to be important later on (vide infra). The free C14-tertiary hydroxyl of 
71 was crucial to the success of this reaction, as B. Milgram had previously found that additions to 
the C14-TMS derivatives only afforded hydride reduction products. Next, I found that treatment of 72 
with m-CPBA led to allylic silyl ether 74. This transformation presumably occurs via epoxidation of 
the allylic silane, followed by in situ β-silicon promoted epoxide opening with concomitant 1,4-
transfer of silicon to the newly formed C15-secondary hydroxyl. Exposure of 74 to TBAF at –78 °C 
led to chemoselective removal of the dimethylphenylsilyl group, and the resultant allylic alcohol was 
oxidized with IBX to give desired AB/HG-enone 75. Unfortunately, attempts to protect the C13-
tertiary hydroxyl of 74 and 75 proved futile due to problems with poor reactivity or cyclization of the 
C13-tertiary hydroxyl onto C7, respectively. Since protection of the C13-tertiary hydroxyl was most 
likely critical for the ensuing anionic annulation reactions, a revised protecting group scheme was 
needed. 
 
 
Scheme 4.5 Synthesis of AB/HG-enone 75. 
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 I postulated that if the pivaloyl ester of 72 were purposefully removed, then a cyclic 
protecting group could be used to protect the otherwise inaccessible C13-tertiary hydroxyl by first 
attaching to the less hindered C12-secondary hydroxyl of 73. This strategy would also avoid the 
deprotection of the pivaloyl ester at a later stage in the synthesis, which we predicted to be 
challenging. B. Milgram found that addition of 71 to a mixture of n-propylmagnesium chloride, 
cerium chloride, and lithium chloride at –78 °C, followed by warming to 0 °C, facilitated formation 
of diol 73 in good yield (Scheme 4.6). With 73 in hand, I found that the diol could be protected using 
2-methoxypropene to afford acetonide 76. Similarly as before, treatment of 76 with m-CPBA led to 
allylic dimethylphenylsilyl ether 77. Exposure of 77 to TBAF and subsequent oxidation of the 
resultant allylic alcohol under Swern conditions gave desired enone 78. During the course of the 
subsequent annulation studies, I found that protection of the C14-tertiary hydroxyl was critical, and 
this was accomplished by deprotonation of 78 with LiHMDS, followed by silylation with TMSOTf, 
to yield fully protected ent-AB/HG-enone ent-63. 
 
 
Scheme 4.6 Completion of fully protected ent-AB/HG-enone ent-63. 
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 As mentioned earlier, the absolute stereochemistry of ent-AB/HG-enone ent-63 corresponds 
to the unnatural enantiomer of hibarimicinone (6). The AB/HG-enone 63 with stereochemistry 
corresponding to the natural enantiomer of 6 was ultimately prepared from key intermediate 
cyclohexenone ent-68 following an analogous series of diastereoselective transformations. The 
synthesis of ent-68 was developed and executed by B. Milgram, and for the reader’s interest, is 
briefly outlined in Scheme 4.7.  
 
 
Scheme 4.7 B. Milgram’s synthesis of the correct enantiomer of the AB/HG-Enone 63. 
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Synthesis of the ABCD- and EFGH-Ring Systems of Hibarimicinone 
 With AB/HG-enone in hand, a model ABCD-ring system was investigated to test the viability 
of our proposed late-stage biomimetic etherification to construct the pentacyclic western half of 
hibarimicinone (6). Kraus annulation86 of cyanophthalide 8387 with ent-AB/HG-enone ent-63 under 
rigorously oxygen-free conditions afforded ABCD-tetracycle 84 (Scheme 4.8).88 Deoxygenation was 
critical for the success of the annulation, as adventitious oxygen resulted in decomposition. 84 was 
then oxidized by DDQ to the corresponding C-ring quinone 85. Fortuitously, I discovered that 
exposure of 85 to anhydrous hydrochloric acid afforded pentacycle 87 in 69% yield from 84. As 
discussed earlier, this transformation presumably occurs through the intermediacy of o-quinone 
methide 86, which is trapped by the proximal acetonide oxygen with concomitant acetonide cleavage. 
Notably, this acid-mediated etherification required high dilution in order to avoid formation of 84 and 
decomposition products, potentially via intermolecular processes. Acetonide cleavage was most likely  
 
 
Scheme 4.8 Synthesis of a model ABCD-pentacyclic system. 
                                                                                                                                                                       
86 Kraus, G. A.; Sugimoto, H. Tetrahedron Lett. 1978, 19, 2263-2266. 
 
87 83 was prepared according to Wendt, J. A.; Gauvreau, P. J.; Bach, R. D. J. Am. Chem. Soc. 1994, 116, 9921–
9926. 
 
88 The Kraus annulation could be accomplished equally well with derivatives of 83 where R = MOM or R = Bn. 
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triggered by its proximity to the reactive o-quinone methide intermediate as suggested by the failure 
to isolate any acetonide cleavage products that lack the cyclic ether bond. This is further supported by 
later observations on the dimeric system, where only the acetonide of the A-ring is cleaved whereas 
the H-ring acetonide remained intact (vide infra, Scheme 4.16). Overall, the model oxidation-
etherification sequence afforded excellent precedence for subsequent studies. 
 
 
Figure 4.1 Michael–Claisen reaction sequence to construct the EFGH-ring system. 
Concurrently, I pursued model studies investigating the Michael–Claisen reaction sequence to 
construct the EFGH-ring system 89 (Figure 4.1). These studies were particularly crucial due to the 
lack of robust annulation sequences to generate naphthols (1-hydroxynaphthalenes rather than 1,4-
dihydroxynaphthalenes, i.e., hydroquinones).89 The ultimate success of Michael–Claisen reaction 
sequences90 hinges on numerous factors. These include, but are not limited to: (1) the stability and 
nucleophilicity of the reacting carbanion,91 (2) the stability of the electrophilic acceptor to the base 
required to deprotonate the donor,92 and (3) the steric bulk of the annulation donor (substituents at 
                                                                                                                                                                       
89 For reviews, see: (a) Mal, D.; Pahari, P. Chem. Rev. 2007, 107, 1892–1918. (b) Rathwell, K.; Brimble, M. A. 
Synthesis 2007, 5, 643–662. 
 
90 For other uses of Michael–Claisen reaction sequences to construct naphthalene derivatives, see: Sun, C.; 
Wang, Q.; Brubaker, J. D.; Wright, P. M.; Lerner, C. D.; Noson, K.; Charest, M.; Siegel, D. R.; Wang, Y.-M.; 
Myers, A. G. J. Am. Chem. Soc. 2008, 130, 17913–17927, and references therein. 
 
91 (a) o-Toluate and related carbanions will suffer from competitive bimolecular self-condensation reactions 
with the ester moiety if the Michael addition is not fast enough. See Brubaker, J. D. Ph.D. Thesis, Harvard 
University, 2007 and references therein. (b) In the case of a single annulation process, the instability of the 
deprotonated annulation donor can often be partially circumvented through the use of excess donor. However, 
due to the inherent stoichiometry of the bidirectional double annulation, the biaryl donor is used as the limiting 
reactant and thus the stability of its dianion is critical to the success of the reaction 
 
92 ent-63 is stable to LiTMP and LDA at –78 °C, and to LiHMDS at 0 °C in THF. At higher respective 
temperatures for prolonged reaction times, significant decomposition occurred. 
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C6/C6' and the ester side chain) and of the annulation acceptor. Furthermore, the slow step of the 
tandem reaction sequence will change based on the particular donor and acceptor used. Due to these 
challenges, numerous strategies were pursued with different substituents at C6 to stabilize the 
benzylic anion 88 and provide a functional group handle to later introduce the required C6–C7 
unsaturation. 
The syntheses of the E-ring aryl donors began with 5-methylvanillin 9093 (Scheme 4.9), 
which was converted to trialkoxytoluene 34 in a three step process involving: (1) O-methylation, (2) 
Dakin oxidation followed by in situ formate methanolysis, and (3) MOM protection of the resultant 
phenol. Regioselective electrophilic aromatic bromination of 34 at C18, followed by lithium-halogen 
exchange and trapping of the resultant aryllithium species with carbon dioxide, afforded the 
corresponding benzoic acid. Next, this acid could either be methylated or trifluoroethylated to obtain 
o-toluates 91 or 92. Benzylic radical bromination, followed by displacement with the appropriate 
nucleophile and oxidation as needed, then afforded the various E-ring aryls used in our studies. 
 
 
Scheme 4.9 Synthesis of E-ring aryl donors. 
                                                                                                                                                                       
93 5-Methylvanillin (90) was prepared from vanillin in two steps on multigram scale following a literature 
procedure: Sinhababu, A. K.; Borchardt, R. T. Syn. Comm. 1983, 13, 677–683. 
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o-Toluate 91 was the first E-ring aryl donor to be investigated. I soon determined that the 
desired Michael–Claisen reaction sequence was efficiently accomplished with 2-cyclohexenone 10094 
to afford dihydronaphthalene 101 (Scheme 4.10A). The aromatization of 101 could be accomplished 
by oxidation with DDQ, but difficulties with over-oxidation to the corresponding juglone were 
problematic.95 The remaining results of the Michael–Claisen reaction sequence study with model E-
ring aryl donors are summarized in Scheme 4.10B. Reaction of benzylic sulfoxide 97 with ent-63 in 
the presence of LiHMDS directly afforded desired EFGH-naphthol 89 in moderate yield.96 Quite 
peculiarly, 89 and more polar products (TLC analysis)—presumably either Michael adducts or 
Michael–Claisen product 103—were formed rapidly and simultaneously upon warming to 0 °C (ca. 1 
h), but no further conversion of these products to 89 was observed over several hours. This perhaps 
suggests that the Michael–Claisen reaction sequence is not diastereoselective97 and that 89 arose from 
the only diastereomer of 103 that can undergo syn-elimination. Additionally, significant amounts of 
starting materials ent-63 and 97 (ca. 50%, TLC analysis) also remained at this time. The presence of 
unreacted starting material despite the rapid formation of 89 suggested that only one enantiomer of 
racemic sulfoxide 97 reacted facilely with ent-63.98 Despite the relative success of the benzylic 
sulfoxide annulation, which directly afforded the aromatized F-ring, we continued to explore 
alternative annulations due to the challenging nature of our upcoming bidirectional double 
annulations. 
 
                                                                                                                                                                       
94 Model cyclohexenone 100 was used since this study preceded synthesis of ent-63. 
 
95  Alternatively, heating 101 in the presence of phenylselenyl chloride and pyridine also facilitated 
aromatization of the F-ring. 
 
96 For other examples of benzylic sulfoxide annulations, see: (a) Hauser, F. M.; Rhee, R. P. J. Org. Chem. 1978, 
43, 178–180. (b) Lee, H. G.; Ahn, J.-Y.; Lee, A. S.; Shair, M. D. Chem. Eur. J. 2010, 16, 13058–13062. 
 
97 This is consistent with results from other Michael–Claisen reaction sequences with ent-63. 
 
98 These suspicions were later confirmed with observations in our unsymmetrical bidirectional annulation 
studies (vide infra). 
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Aryl X R Condition A Condition B Yield of 8999 
97 S(O)Ph Me LiHMDS, THF, –78 → 0 °C N/A 48% 
98 SO2Ph CH2CF3 LiHMDS, THF, –78 → 0 °C NaHCO3, xylenes, 140 °C 29-54% 
96 SPh CH2CF3 LiHMDS, THF, –78 → 0 °C AgBF4, DTBMP, CH2Cl2, RT 87% 
99 F CH2CF3 LiTMP, THF, –78 °C; 
HMDS, –78 → 0 °C 
NaHCO3, TFE, 80 °C 83% 
 
Scheme 4.10 Michael–Claisen reaction sequence studies to construct the model EFGH-ring system. 
 
Next, reaction of benzylic sulfone 98 with ent-63 in the presence of LiHMDS afforded a 
complex mixture of diastereomers of presumably annulated products 103.100 After some investigation, 
I found that heating the mixture of products to 140 °C in xylenes with sodium bicarbonate promoted 
elimination of phenylsulfinic acid to afford desired 89, albeit in low to moderate yield. Benzylic 
sulfide 96 was also a competent partner and underwent annulation with ent-63 at 0 °C using LiHMDS 
as base. Fortunately, aromatization to 89 could also be achieved in high yield through the use of 
silver(I) tetrafluoroborate as a thiophilic Lewis acid and DTBMP as a non-coordinating proton 
scavenger.101 
Lastly, I had also envisaged that a benzylic fluoride Michael–Claisen reaction sequence could 
generate naphthalenes after subsequent dehydrohalogenation. Although there was no precedence for 
                                                                                                                                                                       
99 Isolated yield over two steps. 
 
100 For other examples of benzylic sulfone annulations, see: (a) Wildeman, J.; Borgen, P. C.; Pluim, H. 
Tetrahedron Lett. 1978, 25, 2213–2216. (b) Huang, X.; Xue, J. J. Org. Chem. 2007, 72, 3965–3968. 
 
101 The use of silver(I) salts to aromatize the F-ring was eventually replaced with DMTSF in the unsymmetrical 
bidirectional annulation studies (vide infra). 
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such a strategy, a benzylic fluoride annulation donor was attractive for several reasons: (1) the 
electronegative fluorine atom should stabilize the aryl anion, (2) the small atomic radius of fluorine 
should provide minimal steric hinderance to the initial Michael reaction, (3) the strength of C–F 
bonds would disfavor α-elimination and SN2 displacement of fluoride, and (4) despite the strength of 
C–F bonds, elimination of the benzylic fluoride under appropriate conditions could lead to C- and F-
ring aromatization. 102  To our satisfaction, annulation of benzylic fluoride 99 with ent-63 was 
facilitated by addition of LiTMP at –78 °C, followed by subsequent addition of HMDS and warming 
to 0 °C, affording dihydronaphthalene 103 as a mixture of diastereomers. I then discovered that 
simple heating of the crude mixture of 103 in TFE promoted formal elimination of HF to yield 
EFGH-ring system 89. In contrast to the other annulation reactions described, the use of a benzylic 
fluoride allowed the initial Michael reaction to occur at –78 °C, thus minimizing potential 
decomposition of the corresponding biaryl donor (vide infra). The employment of a benzylic fluoride 
annulation-elimination sequence to generate naphthalene derivatives is without precedence and may 
prove to be a general method for the synthesis of naphthols. 
  
                                                                                                                                                                       
102 Bitha, P.; Hlavka, J. J.; Boothe, J. H. J. Med. Chem. 1970, 13, 89–92. 
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Synthesis of HMP-Y1 and an Oxidative Desymmetrization Approach toward Hibarimicinone 
With model systems established for constructing the monomeric eastern and western halves 
of hibarimicinone (6), the synthesis of their dimeric counterparts will now be discussed. Our synthesis 
plan for HMP-Y1 (8) involved a symmetric bidirectional double annulation to generate the C2-
symmetric octacyclic skeleton (Scheme 4.3). Such an ambitious strategy required a flexible synthesis 
of symmetric biaryl annulation donors in which different substituents at C6/C6' could be introduced. 
The biaryl synthesis commenced with regioselective o-lithiation of 34 at C2' and FeCl3-mediated 
oxidative dimerization of the resultant aryllithium species delivered racemic biaryl 36 (Scheme 4.11). 
The ester groups were then installed in a two-step sequence involving bromination and lithium–
halogen exchange, followed by acylation, to afford either bis-methylester 104 or bis-phenylester 105. 
We found that 104 could be deprotonated twice by LiTMP and that the corresponding dianion 
seemed to undergo the bidirectional bis-Michael–Claisen reaction sequence with the AB/HG-enone 
ent-63 (Scheme 4.11). However, the slow rate of both the Michael and Claisen reactions103 of  
 
 
Scheme 4.11 Synthesis of bis-o-toluates and attempted double Michael–Claisen reaction sequences. 
                                                                                                                                                                       
103 Simple 2-cyclohexenones will undergo the Michael addition within seconds at –78 °C and eventual Claisen 
reaction at –10 °C with the o-toluate carbanion corresponding to the D/E-ring (Scheme 4.10: 100 → 101). In 
contrast, ent-63 underwent Michael addition after approximately 1 h at –78 °C and the Claisen reaction could 
never be driven to completion with the dianion of 104. 
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the sequence with sterically encumbered ent-63 led to minor amounts of the desired octacyclic 
dihydronaphthalene products 106. Attempts to facilitate the Claisen step of the reaction sequence by 
using activated phenylester 105 were somewhat successful, but other problems arose since the 
sterically larger activated esters slowed the initial Michael reaction and the dianions were more prone 
to decomposition. Most importantly, aromatization of the C/F-rings of 106 using my previously 
developed conditions was met with difficulty and led us to consider alternative approaches. 
We next envisioned that our newly discovered benzylic fluoride Michael–Claisen reaction 
sequence could be employed to form the binaphthalene core of HMP-Y1 (8). The dianion of 104 was 
brominated with (BrCF2)2 to yield the bis-benzylic bromide, which upon heating with TBAT104 
afforded bis-benzylic fluoride 108 (Scheme 4.12). After significant experimentation, the desired 
protected HMP-Y1 derivatives 107a and 107b105 were accessed from 63 and 108 in a two-step 
procedure involving: (1) a bis-Michael–Claisen reaction sequence promoted by LiTMP and 
MgBr2•OEt2 to afford octacycles 109a and 109b and (2) the formal elimination of hydrofluoric acid 
by heating the crude reaction products in TFE to achieve aromatization of the C/ F-rings and provide 
atropisomers 107a and 107b, which were readily separated and carried forward independently. 
Several features of this sequence deserve comment. As I had hoped, the use of a bis-benzylic fluoride 
108 allowed for the initial bis-Michael addition to occur at –78 °C, thus minimizing decomposition of 
the dianion intermediate and of 63. Addition of MgBr2•OEt2 mid annulation sequence was critical to 
promote the final intramolecular Claisen reactions and obviated the need to use an activated ester 
analog. This discovery should help expand the substrate scope of the Michael–Claisen reaction 
sequence. Finally, the unique ability of TFE to promote the desired elimination is presumably due to 
its ability to strongly hydrogen bond with fluorine, and thus activate it for mild solvolysis. Indeed, use 
of ethanol in place of TFE only led to trace elimination. 
                                                                                                                                                                       
104 Pilcher, A. S.; Ammon, H. L.; DeShong, P. J. Am. Chem. Soc. 1995, 117, 5166–5167. 
 
105 For brevity, each atropisomer is depicted as a single structure lacking stereochemistry about the C2–C2' 
bond. See Experimental Section for full details. 
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Scheme 4.12 Development of a benzylic fluoride Michael–Claisen reaction sequence to achieve the 
first total syntheses of HMP-Y1 (8) and atrop-HMP-Y1 (110). 
B. Milgram optimized the global deprotection of 107a and 107b in the correct enantiomeric 
series, which was accomplished with aqueous hydrofluoric acid followed by hydrogenolysis to afford 
HMP-Y1 (8) and atrop-HMP-Y1 (110), respectively.106 B. Milgram also demonstrated that heating 8 
or 110 to 90 °C led to no detectable isomerization about the C2–C2' bond. With no authentic CD-
spectra for natural 8 available, synthetic 8 and 110 were designated based on comparison of their CD-
spectra with the CD-spectrum of the glycosylated derivative of 8, HMP-Y6 (9).76i As discussed in the 
previous chapter, the axial stereochemistry of 8 has not been rigorously determined, although model 
studies and the CD-spectra of 9 and hibarimicinone (6) suggest that 8 possesses the aR configuration 
by the CD exciton chirality method.76i Additionally, 8, 6, and hibarimicin A–G are all isolated as 
single atropisomers. We have shown that the axial stereochemistry of 8 and 6 are not the result of 
                                                                                                                                                                       
106  No NMR or CD spectra for HMP-Y1 (8) have been previously recorded according to a personal 
communication with H. Hori and Y. Igarashi. 
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thermodynamic equilibration (vide infra), and thus their biosynthetic relationship also argues that they 
possess the same relative configuration about the C2–C2' bond. Therefore, since the axial chirality of 
6 was unambiguously determined,77 8 was assigned the aR configuration. 
With a route to protected derivatives of HMP-Y1 (8) and atrop-HMP-Y1 (110) established, I 
next attempted the biomimetic mono-oxidation. I discovered that the desired oxidation of ent-107a to 
the C-ring quinone 111 could be achieved in low yield with CAN (Scheme 4.13), demonstrating the 
plausibility of our proposed biomimetic desymmetrizing oxidation. We speculated that the congested 
biaryl may sterically occlude the approach of oxidants to the otherwise easily oxidized D/E-ring 
system,107 allowing oxidation of the more electron-deficient C/F-rings. Despite this initial success, my 
attempts to optimize the CAN oxidation were met with difficulty due to bis-oxidation and formation 
of nitrated byproducts. A survey of other oxidants and conditions also proved fruitless. 
 
 
Scheme 4.13 Biomimetic mono-oxidation of protected HMP-Y1. 
  
                                                                                                                                                                       
107 (a) Preferential oxidation of the D-ring occurred in simpler BCD-ring model systems (i.e., 102) and is 
suggested in the literature. (b) The 1H NMR signal of the MOM groups of ent-107a and ent-107b are shifted 
over 0.6 ppm up-field relative to the corresponding monomer, suggesting that they are positioned over the 
naphthyl ring systems and subject to anisotropic magnetic field effects. 
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Nevertheless, with naphthazarin 111 in hand, I next investigated the desired biomimetic 
etherification reaction (Scheme 4.14). Unfortunately, exposure of 111 to the optimized conditions 
developed on the ABCD-model system led to no observable etherification but rather only to rapid 
MOM group cleavage, and upon further heating ultimately decomposition. A screen of various acids 
and conditions also proved unsuccessful, including those developed by Tatsuta et. al.77 The resistance 
of 111 to undergo the desired etherification in contrast to the ABCD-ring system model quinone 85 
was surprising (Scheme 4.8). Since the major difference between the two systems is the lability of the 
MOM groups of 111 relative to the methyl group of 85, we postulated that a free phenol at C1' might 
disfavor either acetonide decomposition or formation of the necessary o-quinone methide 
intermediate. This prompted us to replace the MOM group with a more acid-stable protecting group. 
 
 
Scheme 4.14 Failure of 111 to undergo a biomimetic etherification reaction. 
Additionally, our current biomimetic strategy would inevitably require a late-stage 
demethylation of the C4'–OMe methyl group (Scheme 4.14). Ideally, one would remove the C4'–OMe 
methyl group as late in an eventual synthesis of hibarimicin B (2) as possible in order to protect the 
sensitive and stereochemically labile binaphthyl core (vide infra). However, the acidic conditions 
necessary to effect demethylation would be incompatible with the sensitive 2-deoxy- and 2,3-
dideoxyglycosides of 2. The aforementioned reasons prompted us to investigate our alternative 
strategy for the synthesis of hibarimicione (6) utilizing an unsymmetrical bidirectional annulation 
reaction. 
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Synthesis of Hibarimicinone 
 
Figure 4.2 Proposed unsymmetrical bidirectional double annulation reaction. 
In our alternative strategy, we envisaged that bidirectional double annulation reaction 
employing an unsymmetrical biaryl could be employed to construct the carbon framework of 
hibarimicinone (6) with the appropriate differential oxidation. More specifically, we anticipated that 
reaction of the lithiated cyanophthalide of 113 with AB/HG-enone 63 would directly construct the C-
ring hydroquinone via a Kraus annulation, and reaction of the lithiated substituted o-toluate of 113 
with a second equivalent of 63 would lead to the F-ring via a Michael–Claisen reaction sequence 
(Figure 4.2). The unsymmetrical fully substituted biaryl 113 presents unique synthetic challenges; 
cross-coupling technology to form sterically hindered biaryls from electron-rich aromatics is 
limited.76d In contrast, dimerization reactions to form hindered biaryls are robust and reliable (i.e., 
Scheme 4.11: 34 → 36). Thus I imagined that a practical synthetic approach to 113 would necessitate 
the desymmetrization of 104 (Scheme 4.15). A strategy to mono-functionalize 104 involving radical 
bromination would inevitably result in an inefficient statistical mixture of benzylic bromides. 
However, I hypothesized that selective mono-deprotonation of 104 would be feasible since the 
initially formed carbanion would elevate the pKa of the remaining o-toluate due to a field effect. 
Indeed, I discovered that selective mono-deprotonation of 104 at C6' could be achieved with 1.25 
equivalents of LiTMP. The resultant anion 114 was then brominated with (BrCF2)2 to afford mono-
benzylic bromide 115 in 82% yield. This single element of asymmetry was sufficient to introduce the 
remaining differential functionality. 115 was oxidized to aldehyde 116,108 which was then converted 
                                                                                                                                                                       
108 Kornblum, N.; Jones, W. J.; Anderson, G. J. J. Am. Chem. Soc. 1959, 81, 4113–4114. 
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to tri-benzyl-protected biaryl 117 by (1) cleavage of the MOM groups, (2) chemoselective cleavage of 
the C4'–OMe methyl group with BCl3, and (3) global reprotection with benzyl bromide. Treatment of 
117 with hydrogen cyanide afforded a cyanophthalide intermediate.109 Finally, double deprotonation 
of this intermediate with LiTMP, followed by short exposure110 to S-phenyl benzenethiosulfonate, 
chemoselectively installed the phenyl sulfide moiety at C6 to provide biaryl 118.111 The observed 
chemoselectivity is a result of the much higher reactivity of the o-toluate anion relative to the 
cyanophthalide anion. This chemoselectivity could also be exploited to chemoselectively introduce a 
bromide or phenyl sulfoxide at C6 using (Br2CF)2 or methyl benzenesulfinate, respectively. It is worth 
mentioning that although only the synthesis of the ultimately successful biaryl 118 is depicted, the 
general strategy delineated in Scheme 4.15 was amenable to the synthesis of many biaryls that were 
used during the course of the project (Figure 4.3). For brevity, the synthesis of these biaryls as well as 
the related annulation and downstream studies will not be discussed. 
 
 
Scheme 4.15 Synthesis of unsymmetrical biaryl 118 via a selective mono-deprotonation. 
                                                                                                                                                                       
109 Sakulsombat, M.; Angelin, M.; Ramström, O. Tetrahedron Lett. 2010, 51, 75–78. 
 
110 Approximately ten seconds. 
 
111 Benzylic phenylsulfide substituted o-toluates were ultimately employed in our synthesis of hibarimicinone 
(6) due to the inability to make the corresponding C6-fluoride of 118. 
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Figure 4.3 Biaryls synthesized and utilized in unsymmetrical bidirectional double annulation studies. 
After extensive studies, I eventually found that the desired transformations could be achieved 
by treating a mixture of 118 and 63 with LiHMDS, followed by subsequent addition of KHMDS mid 
annulation sequence under rigorously oxygen-free conditions, to yield octacycle 128a and 128b as a 
~1.3:1 mixture of atropisomers (Scheme 4.16).112 The addition of KHMDS was crucial in facilitating 
the final intramolecular Claisen reaction to construct the F-ring.113 At this stage, atropisomers 128a 
and 128b were separated and carried forward independently. The small coupling constant between the 
C6 and C7 hydrogen atoms of 128a and 128b suggest a syn relationship of the hydrogen atoms with 
respect to the ring system. This relative stereochemistry would preclude syn-elimination to aromatize 
the F-ring. In a related system, only one diastereomer of sulfoxide 126 underwent bidirectional 
annulation but failed to further undergo elimination to aromatize the F-ring, which occurred in situ 
during the corresponding monomer studies (Scheme 4.10).114 Additionally, it is worth mentioning 
here that although C6-sulfone dihydronaphthalene EFGH-model systems underwent thermal 
elimination (sodium bicarbonate, xylenes, 140 °C), the presumed sulfone analogs of 128a and 128b  
 
                                                                                                                                                                       
112 (a) For brevity, each atropisomer is depicted as a single structure lacking stereochemistry about the C2–C2' 
bond. See Experimental Section for full details. (b) The regioisomer of the enolized 1,3-diketone was not 
determined and is arbitrarily depicted. (c) The C4'–OMe, MOM-protected biaryl 121 underwent cleaner 
bidirectional double annulation reaction (~80% yield), but the benzyl protecting groups were ultimately desired 
for aforementioned reasons. 
 
113 Kummer, D. A.; Li, D.; Dion, A.; Myers, A. G. Chem. Sci. 2011, 2, 1710–1718. 
 
114 Interestingly, while the Michael addition of the monomeric E-ring substituted o-toluate anions to ent-63 were 
generally not diastereoselective, the corresponding bidirectional double annulations were completely 
diastereoselective. 
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Scheme 4.16 Completion of hibarimicinone (6) and atrop-hibarimicinone (7). 
could not tolerate these conditions. In contrast, elimination of the C6-benzylic phenyl sulfide was 
successfully accomplished with DMTSF to yield binaphthalenes 129a and 129b. 115  These 
observations highlight the difficulty in achieving naphthol annulations in the context of complex 
molecule synthesis. To the best of our knowledge, this is the first example of a benzylic sulfide 
Michael–Claisen reaction sequence to generate naphthalenes and together with the benzylic fluoride 
Michael–Claisen reaction sequence offer two new alternative strategies to accomplish challenging 
naphthol annulations. 
Oxidation of 129a and 129b by DDQ yielded the corresponding C-ring quinones. 
Gratifyingly, exposure of the respective quinones to anhydrous hydrochloric acid promoted the 
desired biomimetic etherification to yield nonacycles 130a and 130b. This successful etherification of 
                                                                                                                                                                       
115 Super stoichiometric amounts of silver(I) salts could also be employed, but the reactions were complicated 
by oxidation of the C-ring hydroquinone. 
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the benzyl protected naphthazarins, in contrast to MOM-protected 85, confirmed our suspicion that 
the nature of the C1'-phenol has far-reaching electronic effects on this system. With the complete 
skeletons of 6 and 7 in hand, all that remained to complete the syntheses was global deprotection and 
oxidation of the D-ring. Deprotection of the acid-labile protecting groups was accomplished upon 
exposure to hydrofluoric acid. Finally, the benzyl groups were removed via hydrogenolysis and, after 
addition of acidic methanol, filtering, and exposure to air, hibarimicinone (6) and atrop-
hibarimicinone (7) were formed. All of the spectroscopic data for 6 and 7 match those reported and 
thereby confirmed the structure of 7.73,77,116  
                                                                                                                                                                       
116 Provided in a personal communication with Prof. H. Hori and Prof. Y. Igarashi. 
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Discovery of a pH-Dependent Rotational Barrier and Synthesis of HMP-P1 
 During the final benzyl deprotection of 130a and 130b, it was discovered that the addition of 
acidic methanol prior to aerobic oxidation was crucial to prevent isomerization between 6 and 7 as 
well as formation of HMP-P1 (10). Upon prolonged handling or standing at ambient temperatures in 
acidic methanol (1 M HCl), I observed minor interconversion between 6 and 7 as well as minimal 
 
 
 
Figure 4.4 (A) Upon standing in acidic methanol (1 M HCl) at RT, hibarimicinone (6) and atrop-
hibarimicinone (7) undergo minor interconversion and minimal conversion to HMP-P1 (10) (orange 
HPLC traces). (B) Exposure of 6 to pH 7.5 aqueous phosphate buffer at RT (blue HPLC traces) or 
(C) acidic methanol (1 M HCl) at 60 °C (red HPLC traces) resulted in isomerization to 7 and eventual 
formation of 10.117 
                                                                                                                                                                       
117 See Figure S7 in Appendix C for HPLC time courses for 7. 
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formation of 10 (Figure 4.4A). However, independent exposure of 6 and 7 to pH 7.5 buffered 
methanol led to the formation of 10 in 84% yield in both cases (Figure 4.4B). Monitoring these 
transformations by HPLC revealed that nearly complete isomerization about the C2–C2' bond (6 ↔ 
7) had occurred within 4 hours, while formation of 10 was almost complete after 24 hours (Figure 
4.4B). Together, these observations suggest that the rotational barriers about C2–C2' for 6 and 7 are 
pH-dependent. 
These findings are particularly interesting due to prior observations that heating 6 in neutral 
methanol at 60 °C leads to nearly complete interconversion to 7 in 30 minutes, and ultimately 
complete cyclization to yield 10 after 90 minutes.118 However, we found that heating either 6 or 7 to 
60 °C in acidic methanol (1 M HCl) led to only partial interconversion between 6 and 7 and minor 
conversion to 10 after 90 minutes (Figure 4.4C). This suggests that the observed rapid rotation at 60 
°C in neutral methanol has less to do with providing the necessary thermal energy to surpass the 
intrinsic activation barrier for rotation about C2–C2' in the uncharged forms of 6/7 (131a/131b in 
Figure 4.5), but rather enables access to the deprotonated form of 6 and 7 (132a/132b in Figure 4.5) 
via inter- or intramolecular proton transfer. Rapid interconversion between 132a and 132b can then 
follow through a transition state that is stabilized by π-electron overlap,119 as depicted in cross-
conjugated resonance structures 133a and 133b. Consequently, variables that affect the equilibrium 
between 131a and 132a as well as between 131b and 132b, will affect the rate of isomerization. The 
addition of acid to the media inhibits access to species 132a and 132b by driving the equilibrium 
toward 131a and 131b, and thus disfavors isomerization. In contrast, heat (60 °C) should promote 
equilibration between the protonation states and thus facilitate isomerization. Our discovery of the 
                                                                                                                                                                       
118 Personal communication with Prof. H. Hori and Prof. Y. Igarashi. 
 
119 Eliel, E. L.; Wilen, S. H. Stereochemistry of Organic Compounds; John Wiley & Sons, Inc.: New York, 
1994. 
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pH-dependent barrier demonstrates the delicate nature of the C2–C2' bond, which must be 
accommodated in an eventual synthesis of hibarimicin B (2).120 
 
 
Figure 4.5 A proposed model to explain the pH-dependent rotational barrier about the C2–C2' bond 
of 6 and 7. Only the CDEF-ring system is depicted for brevity. 
  
                                                                                                                                                                       
120 The carbohydrates of the hibarimicin natural products are cleaved with acidic methanol (1 M HCl, 30 °C). 
These conditions are similar to those employed during the benzyl deprotection and oxidation of 130a and 130b. 
However, milder acidic conditions (i.e., aq. pH 3.5 phosphate buffer) in methanol may potentially be substituted 
during the analogous deprotection and oxidation of 2 since these conditions are employed in the HPLC 
purification of 2 and hibarimicin related natural products. See ref. 73 for the conditions used for carbohydrate 
cleavage and purification of the hibarimicin natural products. 
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Conclusion 
In conclusion, enantioselective syntheses of hibarimicinone (6) and atrop-hibarimicinone (7), 
and the first total syntheses of HMP-Y1 (8), atrop-HMP-Y1 (110), and HMP-P1 (10) have been 
accomplished. The complete carbon skeleton of each natural product was assembled via a convergent 
bidirectional annulation strategy. The use of a racemic biaryl in conjunction with the bidirectional 
annulation strategy enabled both atropisomers of the natural products to be separately constructed and 
fully characterized, thus providing the first reported full characterization of 7, 8, 110, and 10. 
Additionally, during the pursuit of this annulation strategy, we encountered numerous challenges 
when conducting naphthol annulation reactions. Consequently, we developed two valuable Michael–
Claisen reaction sequences to construct complex naphthols that might find use as general methods. 
The mild conditions needed to dehydrohalogenate the benzylic fluoride intermediates are particularly 
noteworthy given the thermodynamic strength of C–F bonds. 
The plausibility of our proposed biosynthesis was also validated by the demonstration that a 
desymmetrizing mono-oxidation of the C-ring could be conducted on protected HMP-Y1 derivatives. 
Over-oxidation to the bis-C/F-ring quinone was also observed, but natural products corresponding to 
such a double oxidation have not been isolated in nature or during mutagenesis studies. This perhaps 
suggests that an enzyme mediates this key biosynthetic transformation, but how HMP-Y1 (8) is only 
mono-oxidized remains unclear. 
After the key bidirectional annulations, only three and five steps were needed to complete 
HMP-Y1 (8) and hibarimicinone (6), respectively. In the case of 6, these steps include a biomimetic 
etherification to install the B-ring cyclic ether via an o-quinone methide intermediate. The success of 
this reaction required an acid-stable protecting group on the C1'-phenol due to subtle yet far-reaching 
electronic effects imparted by the naphthazarin-naphthalene system. The peculiarities and sensitivity 
of this system are also highlighted by our discovery of the pH-dependent rotational barrier about the 
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C2–C2' bond. These particular observations provide crucial information that will facilitate an eventual 
synthesis of hibarimicin B (2). 
Lastly, the intermediate 130a will be highly useful in an eventual total synthesis of 2; it is 
suitably protected with orthogonal protecting groups to allow for the sequential installation of the 2-
deoxy- and 2,3-dideoxyglycosides prior to deprotection of the sensitive binaphthyl core of the 
molecule. B. Milgram is already well advanced in this ultimate endeavor and hopefully a synthesis of 
2 will soon be accomplished. 
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Experimental Section 
General Procedures. All reactions were performed in oven-dried or flame-dried glassware 
under a positive pressure of argon unless otherwise noted. Where necessary (so noted), reactions were 
performed in Schlenk tubes fitted with a PTFE stopcock or pressure tubes fitted with a PTFE bushing. 
Flash column chromatography was performed as described by Still et al. employing silica gel 60 (40-
63 μm, Whatman).121 Preparatory thin-layer chromatography (PTLC) was performed using 0.25 or 
0.50 mm silica gel 60 F254 plates purchased from EMD Chemicals. Analytical thin-layer 
chromatography (TLC) was performed using 0.25 mm silica gel 60 F254 plates or 0.25 mm silica gel 
RP-18 F254s plates (so noted) purchased from EMD Chemicals. TLC plates were visualized by 
exposure to ultraviolet light (UV) and/or exposure to an acidic solution of p-anisaldehyde (anis) or an 
aqueous solution of ceric ammonium molybdate (CAM) followed by heating on a hot plate. HPLC 
purification was performed on an Agilent 1100 series HPLC. Hibarimicinone (6) and atrop-
hibarimicinone (7) isomerization studies were performed on the same instrument. HMP-Y1 (8) and 
atrop-HMP-Y1 (110) isomerization studies were conducted on an Agilent 1200 series 6120 
quadrupole LC/MS.  
 
Materials. Commercial reagents and solvents were used as received with the following 
exceptions: THF, diethyl ether (Et2O), dichloromethane (CH2Cl2), acetonitrile (MeCN), HMDS, 
toluene (PhMe), benzene (PhH), and DMF were degassed with argon and passed through a solvent 
purification system (designed by J.C. Meyer of Glass Contour) utilizing alumina columns as 
described by Grubbs et al. 122  Triethylamine (Et3N), diisopropylethylamine, 2,2,6,6-
tetramethylpiperidine, pyridine (Py), and chlorotrimethylsilane (TMSCl) were distilled over calcium 
hydride before use. N,N,N',N'-Tetramethylethylenediamine (TMEDA) was distilled over potassium 
                                                                                                                                                                       
121 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
 
122 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 
1518–1520. 
144
  
hydroxide immediately before use. TMSOTf was distilled before use. Methanol used for the CD and 
UV–vis measurements was HPLC grade purchased from EMD. The Celite used was Celite® 545, 
purchased from J.T. Baker. Where necessary (so noted), commercial m-CPBA (technical grade, 77% 
purity) was purified to >95% purity by the procedure described by Bartolini and coworkers.123 The 
molarities of n-butyllithium solutions were determined by titration using 1,10-phenanthroline as an 
indicator (average of three determinations). The molarity of n-propylmagnesium chloride solution 
was determined by titration with iodine according to the protocol of Knochel and Krasovsky (average 
of three determinations).124 Anhydrous cerium(III) chloride was obtained by drying cerium(III) 
chloride heptahydrate under reduced pressure according to the procedure of Dimitrov and 
coworkers.125 Where necessary (so noted), solutions were deoxygenated by alternating freeze (liquid 
nitrogen)/evacuation/thaw cycles (FPT, five iterations). 
 
Instrumentation. 1H NMR spectra were recorded with a Varian INOVA-600, Varian 
INOVA-500, or Varian Mercury 400 spectrometer, are reported in parts per million (δ), and are 
calibrated using residual undeuterated solvent as an internal reference (CDCl3: δ 7.26 (CHCl3), 
CD2Cl2: δ 5.32 (CDHCl2), CD3OD: δ 3.31 (CD2HOD), C6D6: δ 7.16 (C6D5H)). Data for 1H NMR 
spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad, or combinations thereof. 13C NMR spectra were recorded with a Varian 
INOVA-500 or Varian Mercury 400 spectrometer, are reported in parts per million (δ) and are 
referenced from the carbon resonances of the solvent (CDCl3: δ 77.00, CD2Cl2: δ 54.00, CD3OD: δ 
49.15, C6D6: δ 128.39, DMSO-d6: 39.51). Infrared (IR) data were recorded on a Varian 1000 Scimitar 
                                                                                                                                                                       
123 Bortolini, O.; Campestrini, S.; Di Fuiria, F.; Modena, G. J. Org. Chem. 1987, 52, 5093–5095. 
 
124 Krasovsky, A.; Knochel, P. Synthesis 2006, 5, 0890–0891. 
 
125 Dimitrov, V.; Kostova, K.; Genov, M. Tetrahedron Lett. 1996, 37, 6787–6790. 
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FT-IR spectrophotometer, were referenced to a polystyrene standard, and are reported in frequency of 
absorption (cm-1). High-resolution mass spectra (HRMS) were recorded using electrospray ionization 
(ESI) mass spectroscopy experiments on an Agilent 6210 TOF LC/MS. Optical rotations were 
measured on a Jasco P-2000 digital polarimeter with a sodium lamp (average of at least four 
measurements for each sample). Circular dichroism (CD) spectra were collected on a Jasco J-710 
spectropolarimeter equipped with a temperature controller (at 23 ± 0.1 °C) using the following 
standard measurement parameters: 0.5 nm step resolution, 50 nm/sec speed, 4 accumulations, 1 sec 
response, 1 nm bandwidth, 1.0 cm path length. All spectra were converted to a uniform scale of molar 
ellipticity after background subtraction. Curves shown are smoothed with standard parameters. The 
UV-vis absorption spectra were recorded on a Hitachi UV spectrophotometer, Model U-3010 at 
ambient temperature (23 ± 2 °C) using a quartz 1-cm cuvette (3 mL) and the following standard 
measurement parameters: 1.0 nm step resolution, 10 nm/sec speed, 1 accumulation, 1 sec response, 1 
nm bandwidth. Background was corrected with respect to a reference cuvette containing the same 
methanol as the sample cuvette. Curves shown are smoothed with standard parameters. 
 
(For clarity, intermediates that have not been assigned numbers in the text are numbered sequentially 
in the experimental section beginning with S1). 
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Diol 72: A 50-mL Schlenk flask was charged with anhydrous cerium(III) chloride (0.290 g, 1.18 
mmol, 15.0 equiv) and heated to 150 °C under reduced pressure (~0.1 Torr). After 2.5 h, the flask was 
allowed to cool to ambient temperature and flushed with argon. The flask was further cooled to 0 °C 
before THF (8 mL) was introduced via syringe. The resultant stirred heterogeneous, off-white slurry 
was allowed to warm to ambient temperature. After 10 h, the reaction mixture was cooled to –78 °C 
before a solution of n-propylmagnesium chloride in Et2O (1.72 M, 0.550 mL, 0.942 mmol, 12.0 
equiv) was added dropwise via syringe. After 3 h, a solution of ketone 71126 (50 mg, 0.079 mmol, 1.0 
equiv) in THF (1 mL) was added dropwise via syringe to the stirred reaction mixture at –78 °C. The 
transfer was completed with two additional portions of THF (2 × 500 µL). After 3 h, the stirred 
reaction mixture was slowly allowed to warm to –40 °C over 10 h, after which saturated aqueous 
NH4Cl solution (5 mL) was added. The resultant mixture was allowed to warm to ambient 
temperature before water (10 mL) and Et2O (20 mL) were added. The layers were separated, and the 
aqueous layer was extracted with Et2O (3 × 20 mL). The combined organic layers were washed with 
water (40 mL) and brine (40 mL), dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient, 5% → 10% → 17% → 33% EtOAc in hexanes) to afford diol 72 (28 mg, 53%). 1H NMR 
(600 MHz, C6D6) δ: 7.51–7.47 (m, 2H), 7.42 (d, J = 7.3 Hz, 2H), 7.28–7.23 (m, 3H), 7.20 (t, J = 7.8 
Hz, 2H), 7.04 (t, J = 7.5 Hz, 1H), 5.89 (d, J = 10.0 Hz, 1H), 5.73 (dd, J = 3.7, 10.1 Hz, 1H), 5.23 (dd, 
J = 2.6, 10.3 Hz, 1H), 4.98 (d, J = 12.3 Hz, 1H), 4.70 (d, J = 12.3 Hz, 1H), 4.44 (dd, J = 6.2, 10.0 Hz, 
1H), 4.07 (t, J = 9.8 Hz, 1H), 2.63 (dt, J = 8.5, 14.2 Hz, 1H), 2.34 (dd, J = 4.5, 13.9 Hz, 1H), 1.91–
1.83 (m, 2H), 1.67–1.51 (m, 4H), 1.41 (br. s., 1H), 1.15 (s, 9H), 0.93 (s, 9H), 0.90 (t, J = 7.3 Hz, 3H), 
                                                                                                                                                                       
126 For brevity, see Milgram, B. C.; Liau, B. B.; Shair, M. D. Org. Lett. 2011, 13, 6436–6439 for the preparation 
of 71. 
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0.32 (s, 3H), 0.33 (s, 3H), –0.02 (s, 3H), –0.06 (s, 3H). 13C NMR (126 MHz, C6D6) δ: 177.4, 140.1, 
138.4, 135.0, 134.6, 129.9, 128.7, 127.3, 127.1, 126.5, 79.7, 79.1, 75.9, 75.6, 75.2, 72.8, 48.9, 39.5, 
39.2, 30.6, 27.8, 26.8, 26.6, 20.3, 19.1, 18.5, 15.9, –3.2, –3.5, –4.1, –4.1. HRMS (ESI) (m/z) calc’d 
for C39H60NaO6Si2 [M+Na]+: 703.3821, found 703.3815. TLC (15% EtOAc in hexanes), Rf: 0.32 
(CAM).  
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Allylic silylether 74: A solution of m-CPBA (77 wt. %, 18.5 mg, 0.0830 mmol, 2.01 equiv) in 
CH2Cl2 (500 µL) was added dropwise via syringe to a stirred solution of diol 72 (28 mg, 0.041 mmol, 
1.0 equiv) and NaHCO3 (5.2 mg, 0.062 mmol, 1.5 equiv) in CH2Cl2 (1 mL) at –78 °C, which was 
subsequently allowed to warm to 0 °C. After 30 min, saturated aqueous Na2SO3 solution (1 mL) was 
added via syringe to the stirred reaction mixture, which was then allowed to warm to ambient 
temperature. Saturated aqueous Na2SO3 solution (5 mL) and Et2O (5 mL) were then added and the 
layers were separated. The aqueous layer was extracted with Et2O (5 mL) and EtOAc (2 × 5 mL), and 
the combined organic layers were washed with saturated aqueous NaHCO3 solution (2 × 10 mL), 
water (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 5% 
EtOAc in hexanes) to afford allylic silylether 74 (22.0 mg, 77%). 1H NMR (600 MHz, CDCl3) δ: 
7.59 (dd, J = 1.6, 7.8 Hz, 2H), 7.45–7.38 (m, 3H), 7.30–7.23 (m, 4H), 7.19 (t, J = 7.3 Hz, 1H), 6.00 
(ddd, J = 2.1, 4.7, 9.7 Hz, 1H), 5.71–5.66 (m, 1H), 5.44 (d, J = 9.7 Hz, 1H), 4.91 (d, J = 12.0 Hz, 1H), 
4.55 (d, J = 12.0 Hz, 1H), 4.39 (dd, J = 5.7, 9.5 Hz, 1H), 4.19 (d, J = 4.7 Hz, 1H), 3.78 (t, J = 9.5 Hz, 
1H), 3.16 (s, 1H), 2.44 (dd, J = 12.0, 18.7 Hz, 1H), 2.32 (td, J = 5.3, 19.0 Hz, 1H), 2.16 (td, J = 6.4, 
12.3 Hz, 1H), 1.74 (br. s, 1 H), 1.48–1.35 (m, 1H), 1.34–1.23 (m, 1H), 1.23–1.13 (m, 1H), 1.07 (s, 
9H), 0.88 (s, 9H), 0.71 (t, J = 7.3 Hz, 3H), 0.50 (s, 3H), 0.46 (s, 3H), 0.05 (s, 3H), –0.06 (s, 3H). 13C 
NMR (126MHz, CDCl3) δ: 176.7, 139.1, 136.7, 133.5, 133.0, 130.1, 128.1, 127.9, 126.6, 126.5, 
126.2, 79.4, 78.8, 76.5, 74.6, 74.2, 72.1, 66.9, 42.9, 38.9, 38.1, 27.2, 26.3, 26.0, 18.3, 18.0, 14.9, –0.8, 
–0.9, –4.7, –4.7. FTIR (thin film) cm-1: 3518, 2925, 1736, 1463, 1256, 1119, 836. HRMS (ESI) (m/z) 
calc’d for C39H60NaO7Si2 [M+Na]+: 719.3770, found 719.3735. TLC (25% EtOAc in hexanes), Rf: 
0.75 (CAM).  
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Enone 75: A solution of TBAF in THF (1.0 M, 8.0 µL, 8.0 µmol, 1.1 equiv) was added dropwise via 
syringe to a stirred solution of 74 (5.0 mg, 7.2 µmol, 1.0 equiv) in THF (400 µL) at –78 °C. After 35 
min, saturated aqueous NH4Cl solution (500 µL) was added to the stirred reaction mixture, which was 
allowed to warm to ambient temperature. Saturated aqueous NH4Cl solution (5 mL), Et2O (5 mL), 
and EtOAc (5 mL) were then added to the mixture and the layers were separated. The organic layer 
was washed water (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: gradient, 10% → 30% EtOAc in hexanes) to afford the alcohol S1 (3.9 mg, 96%). 
IBX (5.8 mg, 21 µmol, 3.0 equiv) was added to a stirred solution of S1 (3.9 mg, 6.9 µmol, 1.0 
equiv) in DMSO (400 µL). After 3 h, a 1:1 mixture of saturated aqueous Na2SO3 solution and 
saturated aqueous NaHCO3 solution (5 mL), Et2O (5 mL), and EtOAc (5 mL) were added to the 
reaction mixture. The layers were separated, and the organic layer was washed saturated aqueous 
NaHCO3 solution (2 × 10 mL), water (3 × 10 mL), and brine (10 mL), dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure. The residue was purified by preparatory thin-layer 
chromatography (silica gel, 0.25 mm, eluent: 20% EtOAc in hexanes) to afford enone 75127 (~3.5 mg, 
~90%). 1H NMR (600MHz, C6D6) δ: 7.42 (d, J = 7.3 Hz, 2H), 7.21 (t, J = 7.8 Hz, 2H), 7.06 (dd, J = 
7.3, 9.4 Hz, 1H), 6.59–6.53 (m, 1H), 6.12 (dd, J = 2.3, 10.0 Hz, 1H), 5.86 (d, J = 9.7 Hz, 1H), 5.00 (d, 
J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.49 (dd, J = 5.7, 9.5 Hz, 1H), 4.13 (s, 1H), 3.95 (t, J = 
9.7 Hz, 1H), 2.97– 2.87 (m, 1H), 2.58–2.45 (m, 2H), 1.47–1.28 (m, 4H), 1.03 (s, 9H), 0.93 (s, 9H), 
0.74 (t, J = 7.2 Hz, 3H), –0.05 (s, 3H), –0.08 (s, 3H). HRMS (ESI) (m/z) calc’d for C29H44NaO6Si 
[M+Na]+: 539.2799, found 539.2795. TLC (33% EtOAc in hexanes), Rf: 0.68 (UV, anis). 
                                                                                                                                                                       
127 Enone 75 was only characterized by HRMS and 1H NMR analysis. 
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Acetonide 76: Pyridinium p-toluenesulfonate (75.4 mg, 0.300 mmol, 0.100 equiv) was added in a 
single portion to a stirred solution of triol 73128 (92 mg, 0.15 mmol, 1.0 equiv) and 2-methoxypropene 
(294 µL, 3.08 mmol, 20.0 equiv) in benzene (3 mL). After 2 h, saturated aqueous NaHCO3 solution 
(5 mL) and Et2O (5 mL) were added to the stirred reaction mixture. The layers were separated and the 
aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 solution (15 mL) and brine (15 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, eluent: gradient, 5% → 6% EtOAc in hexanes) to afford acetonide 76 (78 
mg, 80%) as a colorless flocculent solid. 1H NMR (500 MHz, C6D6) δ: 7.54–7.50 (m, 2H), 7.43 (d, J 
= 7.4 Hz, 2H), 7.25–7.16 (m, 5H), 7.09 (t, J = 7.4 Hz, 1H), 6.08 (dd, J = 1.6, 10.3 Hz, 1H), 5.85 (dd, J 
= 1.4, 10.3 Hz, 1H), 4.97 (d, J = 11.9 Hz, 1H), 4.73 (d, J = 11.9 Hz, 1H), 4.12 (dd, J = 8.2, 11.0 Hz, 
1H), 4.10 (d, J = 6.2 Hz, 1H), 4.00 (dd, J = 6.2, 11.2 Hz, 1H), 2.38–2.27 (m, 3H), 2.06–1.96 (m, 2H), 
1.79 (dtdd, J = 5.2, 7.2, 12.6, 19.9 Hz, 1H), 1.70–1.58 (m, 1H), 1.55–1.47 (m, 4H), 1.30 (s, 3H), 0.98 
(s, 9H), 0.92 (t, J = 7.3 Hz, 3H), 0.32 (s, 3H), 0.32 (s, 3H), 0.15 (s, 3H), 0.09 (s, 3H). 13C NMR (126 
MHz, C6D6) δ: 139.9, 138.1, 134.7, 131.8, 130.7, 129.8, 128.9, 128.6, 128.5, 127.8, 109.3, 87.8, 87.2, 
81.0, 73.3, 72.9, 70.1, 43.3, 40.2, 28.0, 27.3, 26.8, 24.5, 21.1, 19.1, 18.9, 15.8, –3.7, –3.8, –4.1, –4.6. 
FTIR (thin film) cm-1: 3467, 2958, 2930, 2860, 1639, 1461, 1380, 1252, 1208, 1114, 1032, 837, 774, 
734, 699. HRMS (ESI) (m/z) calc’d for C37H56O5Si2Na [M+Na]+: 659.3559, found 659.3576. TLC 
(15% EtOAc in hexanes), Rf : 0.63 (UV, CAM, anis).  
                                                                                                                                                                       
128 For brevity, see Milgram, B. C.; Liau, B. B.; Shair, M. D. Org. Lett. 2011, 13, 6436–6439 for the preparation 
of 73. 
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Allylic silylether 77: A solution of m-CPBA (77 wt. %, 350 mg, 1.56 mmol, 2.00 equiv) in CH2Cl2 
(5 mL) was added dropwise via syringe to a stirred solution of acetonide 76 (497 mg, 0.780 mmol, 
1.00 equiv) and NaHCO3 (200 mg, 2.34 mmol, 3.00 equiv) in CH2Cl2 (25 mL) at –78 °C, which was 
subsequently allowed to warm to –5 °C over 30 min. After an additional 8.5 h, saturated aqueous 
Na2SO3 solution (20 mL) was added via syringe to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature. Et2O (20 mL) was then added to the resultant 
mixture and the layers were separated. The aqueous layer was extracted with EtOAc (2 × 20 mL), and 
the combined organic layers were washed with saturated aqueous Na2SO3 solution (50 mL), saturated 
aqueous NaHCO3 solution (2 × 50 mL), water (50 mL), and brine (50 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford allylic silylether 77 (448 mg, 
88%) as a colorless flocculent solid. 1H NMR (500 MHz, C6D6) δ: 7.54–7.50 (m, 4H), 7.23 (t, J = 7.6 
Hz, 2H), 7.20–7.16 (m, 3H), 7.11 (t, J = 7.6 Hz, 1H), 5.85–5.76 (m, 2H), 5.11 (d, J = 11.7 Hz, 1H), 
4.82 (d, J = 11.7 Hz, 1H), 4.72 (dd, J = 3.9, 9.3 Hz, 1H), 4.58 (d, J = 3.7 Hz, 1H), 4.39 (d, J = 5.1 Hz, 
1H), 3.94 (dd, J = 5.1, 9.3 Hz, 1H), 3.89 (s, 1H), 2.61–2.52 (m, 1H), 2.44–2.35 (m, 2H), 2.29 (ddd, J 
= 5.6, 12.0, 14.2 Hz, 1H), 1.63–1.43 (m, 2H), 1.29 (s, 3H), 1.27 (s, 3H), 1.01 (s, 9H), 0.85 (t, J = 7.2 
Hz, 3H), 0.32 (s, 3H), 0.30 (s, 3H), 0.21 (s, 3H), 0.16 (s, 3H). 13C NMR (126 MHz, C6D6) δ: 139.7, 
137.4, 133.9, 130.3, 130.2, 128.6, 128.4, 128.3, 128.2, 127.5, 109.4, 88.9, 87.0, 83.0, 73.8, 73.1, 71.2, 
68.1, 44.0, 41.3, 29.0, 28.5, 26.2, 25.5, 18.7, 18.4, 15.4, –0.7, –0.7, –4.0, –4.6. FTIR (thin film) cm-1: 
3490, 2956, 2929, 2894, 2856, 1456, 1429, 1378, 1254, 1234, 1118, 1038, 835, 787, 736, 698. 
HRMS (ESI) (m/z) calc’d for C37H56O6Si2Na [M+Na]+: 675.3508, found 675.3505. TLC (15% 
EtOAc in hexanes), Rf : 0.65 (UV, CAM, anis). 
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Enone 78: A solution of TBAF in THF (1.0 M, 1.0 mL, 1.0 mmol, 1.5 equiv) was added dropwise via 
syringe to a stirred solution of 77 (448 mg, 0.686 mmol, 1.00 equiv) in THF (7 mL) at –78 °C. After 
1.5 h, saturated aqueous NH4Cl solution (5 mL) was added to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature. Saturated aqueous NH4Cl solution (10 mL) 
and Et2O (20 mL) were then added to the resultant mixture and the layers were separated. The 
aqueous later was extracted with Et2O (3 × 10 mL), and the combined organic layers were washed 
water (40 mL) and brine (40 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient, 5% → 10% EtOAc in hexanes) to afford the corresponding allylic alcohol, which was 
carried forward to the next reaction. 
 Oxalyl chloride (465 µL, 5.49 mmol, 8.00 equiv) was added dropwise via syringe to a stirred 
solution of DMSO (780 µL, 11.0 mmol, 16.0 equiv) in CH2Cl2 (6 mL) at –78 °C. After 1 h, a solution 
of the allylic alcohol in CH2Cl2 (3 mL) at –78 °C was added dropwise via a dry-ice wrapped cannula 
to the stirred reaction mixture at –78 °C. The transfer was completed with three additional portions of 
CH2Cl2 (3 × 1 mL). After 3 h, Et3N (3.00 mL, 22.0 mmol, 32.0 equiv) was added down the flask wall 
into the stirred reaction mixture at –78 °C, which after 5 min was allowed to warm to 0 °C. After an 
additional 40 min at 0 °C, saturated aqueous NH4Cl solution (20 mL) and Et2O (25 mL) were added 
to the stirred reaction mixture, which was subsequently allowed to warm to ambient temperature. The 
layers were separated, and the aqueous phase was extracted with Et2O (15 mL) and EtOAc (2 × 15 
mL). The combined organic layers were then washed with saturated aqueous NH4Cl solution (50 
mL), water (3 × 50 mL), and brine (50 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
nPr
OTBS
OBn
77
H
O O
O
Me
Me
HO
Si
Ph
Me Me
1. TBAF, THF,
    –78 °C, 1.5 h
2. (COCl)2, DMSO,
    THF, –78 °C, 3 h;
    Et3N, 0 °C, 40 min
    (96%, 2 steps)
nPr
OTBS
OBn
78
H
O O
O
Me
Me
HO
153
  
gradient, 5% → 6% EtOAc in hexanes) to afford enone 78 (340 mg, 96%) as a white solid. 1H NMR 
(500 MHz, CDCl3) δ: 7.40 (d, J = 7.1 Hz, 2H), 7.32 (t, J = 7.4 Hz, 2H), 7.29–7.24 (m, J = 7.4, 7.4 Hz, 
1H), 6.97 (ddd, J = 2.2, 5.4, 9.9 Hz, 1H), 6.20 (dd, J = 2.1, 10.1 Hz, 1H), 4.91 (d, J = 11.7 Hz, 1H), 
4.71 (d, J = 11.5 Hz, 1H), 4.25 (s, 1H), 4.15 (dd, J = 4.9, 9.5 Hz, 1H), 4.06 (d, J = 5.9 Hz, 1H), 3.75 
(dd, J = 5.9, 9.5 Hz, 1H), 2.68 (tdd, J = 2.8, 11.2, 20.0 Hz, 1H), 2.57 (td, J = 5.6, 20.0 Hz, 1H), 2.32 
(td, J = 5.6, 11.0 Hz, 1H), 2.04 (ddd, J = 7.8, 10.0, 14.9 Hz, 1H), 1.59–1.51 (m, 2H), 1.38 (s, 3H), 
1.37 (s, 3H), 1.24–1.15 (m, 2H), 0.91–0.86 (m, 9H), 0.79 (t, J = 7.3 Hz, 3H), 0.05 (s, 3H), 0.04 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ: 201.0, 151.3, 138.7, 128.1, 127.9, 127.6, 127.3, 110.1, 88.0, 
85.9, 81.7, 76.0, 73.2, 70.1, 47.9, 37.8, 29.0, 28.4, 26.2, 25.9, 18.1, 16.1, 14.6, –4.5, –4.9. FTIR (thin 
film) cm-1: 3462, 2955, 2930, 2891, 2858, 1677, 1473, 1380, 1254, 1231, 1110, 1089, 1030, 853,837, 
777, 735, 697. HRMS (ESI) (m/z) calc’d for C29H44O6SiNa [M+Na]+: 539.2799, found 539.2796. 
TLC (15% EtOAc in hexanes), Rf: 0.55 (UV, CAM). 
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ent-AB/HG-Enone ent-63: A 25-mL round-bottom flask was charged with enone 78 (340 mg, 0.658 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. THF (13 mL) was 
introduced, and the resultant solution cooled to 0 °C. A freshly prepared solution of LiHMDS in 
THF/hexanes (1.00 M, 1.32 mL, 1.32 mmol, 2.00 equiv) was added dropwise via syringe to the 
stirred reaction mixture. After 30 min, a solution of TMSOTf (357 µL, 1.97 mmol, 3.00 equiv) in 
toluene (1.64 mL) was added dropwise via syringe to the stirred reaction mixture at 0 °C. After 30 
min, the reaction was allowed to warm to ambient temperature. After an additional 30 min, saturated 
aqueous NH4Cl solution (10 mL) and Et2O (20 mL) were added to the reaction mixture. The layers 
were separated and the aqueous layer was extracted with Et2O (10 mL) and EtOAc (2 × 10 mL). The 
combined organic layers were washed with brine (10 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The product was purified by flash column chromatography 
(silica gel, eluent: 4% EtOAc in hexanes) to afford ent-AB/HG-enone ent-63 (382 mg, 99%) as a 
colorless solid. 1H NMR (500 MHz, CDCl3) δ: 7.41 (d, J = 7.3 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 
7.29–7.24 (m, 1H), 6.88 (ddd, J = 2.2, 4.9, 9.8 Hz, 1H), 6.11 (dd, J = 2.4, 10.0 Hz, 1H), 4.91 (d, J = 
11.7 Hz, 1H), 4.70 (d, J = 11.7 Hz, 1H), 4.15 (dd, J = 5.0, 9.4 Hz, 1H), 4.07 (d, J = 5.6 Hz, 1H), 3.74 
(dd, J = 5.7, 9.4 Hz, 1H), 2.65 (tdd, J = 2.7, 11.0, 19.8 Hz, 1H), 2.57 (td, J = 5.9, 19.5 Hz, 1H), 2.34 
(td, J = 5.6, 10.9 Hz, 1H), 1.91 (ddd, J = 5.4, 12.2, 14.6 Hz, 1H), 1.76–1.65 (m, 1H), 1.41–1.29 (m, 
7H), 1.24–1.14 (m, 1H), 0.90 (s, 9H), 0.80 (t, J = 7.3 Hz, 3H), 0.16 (s, 9H), 0.06 (s, 6H). 13C NMR 
(126 MHz, CDCl3) δ: 199.2, 149.1, 138.7, 129.4, 128.0, 127.9, 127.3, 109.9, 87.1, 86.2, 81.9, 81.1, 
73.2, 70.4, 49.1, 38.3, 28.8, 28.4, 26.7, 25.9, 18.0, 16.7, 14.5, 2.2, –4.5, –4.7. FTIR (thin film) cm-1: 
2952, 1689, 1250, 1123, 1090, 840. HRMS (ESI) (m/z) calc’d for C32H53O6Si2 [M+H]+: 589.3375, 
found 589.3367. TLC (15% EtOAc in hexanes), Rf: 0.69 (UV, CAM). 
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ABCD-tetracycle (–)-84: A 10-mL Schlenk tube was charged with cyanophthalide 83129 (33.0 mg, 
132 µmol, 1.50 equiv) and ent-AB/HG-enone ent-63 (52.0 mg, 88.3 µmol, 1.00 equiv), which were 
then azeotropically dried with five portions of benzene. THF (2 mL) was then introduced, and the 
resultant solution was deoxygenated via FPT and then cooled to –78 °C. A solution of freshly 
prepared deoxygenated LiHMDS in THF/hexanes (1.00 M, 400 µL, 400 µmol, 4.53 equiv) was then 
added dropwise via syringe to the stirred reaction mixture, which was subsequently allowed to warm 
to 0 °C over 2 h. After 14 h, a saturated aqueous NH4Cl solution (3 mL) was added. The resultant 
mixture was subsequently allowed to warm to ambient temperature. The mixture was diluted with 
Et2O (10 mL), EtOAc (10 mL), and saturated aqueous NH4Cl solution (10 mL), and the layers were 
separated. The organic layers were then washed with saturated aqueous NH4Cl solution (20 mL) and 
brine (30 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: gradient, 11% → 25% 
EtOAc in hexanes) to afford ABCD-tetracycle (–)-84 (67.0 mg, 94%) as a yellow film. 1H NMR (600 
MHz, CD2Cl2) δ: 14.36 (br. s., 1H), 9.61 (br. s., 1H), 7.42 (d, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 
2H), 7.28 (t, J = 6.9 Hz, 1H), 6.60 (br. s., 1H), 4.88 (d, J = 11.6 Hz, 1H), 4.70 (d, J = 11.6 Hz, 1H), 
4.26 (dd, J = 4.7, 9.1 Hz, 1H), 4.19 (d, J = 4.4 Hz, 1H), 4.02 (s, 3H), 3.98 (s, 3H), 3.94 (s, 3H), 3.92 
(dd, J = 4.4, 9.1 Hz, 1H), 3.41–3.29 (m, 1H), 3.08–2.93 (m, 1H), 2.46–2.35 (m, 1H), 2.00–1.93 (m, 
1H), 1.91–1.84 (m, 1H), 1.56–1.46 (m, 1H), 1.36–1.29 (m, 1H), 1.25 (s, 3H), 1.18 (s, 3H), 0.93 (s, 
9H), 0.86 (t, J = 7.3 Hz, 6H), 0.18 (s, 9H), 0.08 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 203.2, 159.4, 
159.0, 152.8, 140.2, 139.6, 136.1, 128.6, 128.4, 127.8, 124.6, 120.2, 111.7, 110.8, 110.0, 95.3, 87.6, 
87.0, 83.5, 81.7, 73.5, 71.8, 62.8, 57.1, 56.9, 48.0, 40.3, 28.4, 27.8, 26.3, 21.5, 18.6, 17.9, 15.2, 2.4, –
                                                                                                                                                                       
129 Wendt, J. A.; Gauvreau, P. J.; Bach, R. D. J. Am. Chem. Soc. 1994, 116, 9921–9926. 
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4.1, –4.2. FTIR (thin film) cm-1: 3329, 2945, 1603, 1394, 1091, 1034, 846. HRMS (ESI): calc’d for 
C43H63O11Si2 [M+H]+: 811.3903, found 811.3852. [α]D22: –39.5 (c = 1.0, CHCl3). TLC (33% EtOAc 
in hexanes), Rf: 0.50 (UV, CAM). 
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Pentacyclic ether (+)-87: DDQ (5.8 mg, 26 µmol, 2.0 equiv) was added in one portion to a stirred 
solution of 84 (10.6 mg, 13.1 µmol, 1.00 equiv) in CH2Cl2 (1 mL) at –20 °C. After 30 min, a 1:1 
mixture of 1% (w/v) aqueous NaHSO3 solution (2.5 mL) and saturated aqueous NaHCO3 solution 
(2.5 mL) was added to the reaction mixture. The mixture was diluted with Et2O (10 mL) and EtOAc 
(10 mL), and the layers were separated. The combined organic layers were washed with a 1:1 mixture 
of a 1% (w/v) aqueous NaHSO3 solution and saturated aqueous NaHCO3 solution (2 × 10 mL), 
saturated NaHCO3 aqueous solution (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure to afford crude naphthazarin S2, which was used 
immediately without further purification. 
A 50-mL round-bottom flask was charged with crude S2 and was azeotropically dried with 
four portions of benzene. CH2Cl2 (11 mL) was then introduced, and the resultant solution was cooled 
to 0 °C. A solution of anhydrous HCl in Et2O (2.0 M, 160 µL, 330 µmol, 25 equiv) was added 
dropwise via syringe to the stirred solution. After 4 h, saturated aqueous NaHCO3 solution (10 mL) 
was added to the stirred reaction mixture. The mixture was diluted with EtOAc (25 mL) and the 
layers were separated. The combined organic layers were washed with saturated aqueous NaHCO3 
solution (2 × 20 mL), and brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was then purified by preparatory thin-layer chromatography 
(eluent: 33% EtOAc in hexanes) to afford pentacyclic ether (+)-87 (6.9 mg, 69% over two steps) as a 
yellow-green film. 1H NMR (600 MHz, CD2Cl2) δ: 14.35 (s, 1H), 9.60 (s, 1H), 7.42 (d, J = 7.2 Hz, 
2H), 7.35 (t, J = 7.5 Hz, 2H), 7.30–7.26 (m, 1H), 6.60 (s, 1H), 4.88 (d, J = 11.2 Hz, 1H), 4.70 (d, J = 
11.5 Hz, 1H), 4.25 (dd, J = 4.7, 9.0 Hz, 1H), 4.19 (d, J = 4.4 Hz, 1H), 4.02 (s, 3H), 3.98 (s, 3H), 3.94 
(s, 3H), 3.92 (dd, J = 4.5, 8.9 Hz, 1H), 3.35 (dd, J = 6.1, 17.9 Hz, 1H), 3.01 (dd, J = 13.4, 18.1 Hz, 
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1H), 2.40 (td, J = 5.6, 12.9 Hz, 1H), 1.96 (ddd, J = 4.1, 12.5, 14.3 Hz, 1H), 1.87 (ddd, J = 5.1, 12.0, 
14.3 Hz, 1H), 1.56–1.46 (m, 1H), 1.36–1.28 (m, 1H), 1.24 (s, 3H), 1.18 (s, 3H), 0.92 (s, 9H), 0.85 (t, 
J = 7.5 Hz, 3H), 0.18 (s, 9H), 0.08 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 202.5, 160.2, 159.1, 
153.6, 140.1, 139.3, 137.3, 128.8, 128.2, 127.9, 125.0, 122.2, 111.6, 108.3, 96.5, 88.1, 87.5, 85.1, 
75.5, 74.5, 72.5, 69.9, 62.9, 58.3, 57.2, 56.9, 35.7, 26.1, 18.3, 16.8, 15.1, 2.1, –4.1, –4.1. FTIR (thin 
film) cm-1: 3315, 2952, 1623, 1597, 1394, 1252, 1094, 887, 839. HRMS (ESI): calc’d for 
C40H57O11Si2 [M+H]+: 769.3434, found 769.3425. [α]D23: 22.7 (c = 0.50, CHCl3). TLC (33% EtOAc 
in hexanes), Rf: 0.36 (UV, CAM). 
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5-Methylveratraldehyde (S3): Dimethylsulfate (13.1 mL, 138 mmol, 1.20 equiv) was added 
dropwise via syringe to a stirred heterogeneous mixture of 5-methylvanillin (90)130 (19.1 g, 115 
mmol, 1.00 equiv) and potassium carbonate (32.0 g, 232 mmol, 2.01 equiv) in acetone (230 mL) at 
ambient temperature. After 3.5 h, Et2O (300 mL) was added to the reaction mixture, which was then 
filtered and concentrated under reduced pressure. The crude residue was then directly purified by 
flash column chromatography (silica gel, eluent: gradient, 10% → 20% EtOAc in hexanes) to afford 
5-methylveratraldehyde (S3) (20.3 g, 98%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ: 9.86 (s, 
1H), 7.30 (s, 2H), 3.92 (s, 3H), 3.89 (s, 3H), 2.33 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 191.4, 
153.2, 152.9, 132.4, 132.1, 127.3, 108.8, 60.3, 55.9, 15.9. FTIR (thin film) cm-1: 2939, 1695, 1300, 
1141, 857, 684. HRMS (ESI): calc’d for C10H12NaO3 [M+Na]+: 203.0679, found 203.0673. TLC 
(17% EtOAc in hexanes), Rf: 0.37 (UV, CAM). 
  
                                                                                                                                                                       
130 5-Methylvanillin (90) was prepared from vanillin in two steps on multigram scale following literature 
procedure: Sinhababu, A. K.; Borchardt, R. T. Syn. Comm. 1983, 13, 677–683. 
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Trialkoxytoluene 34: A 2-L round-bottom flask was charged with S3 (20.3 g, 113 mmol, 1.00 equiv) 
and azeotropically dried with three portions of benzene. NaHCO3 (945 mg, 11.3 mmol, 0.100 equiv) 
and CH2Cl2 (225 mL) were sequentially introduced. m-CPBA (>95% purity, 23.3 g, 135 mmol, 1.20 
equiv) was then added as a single portion to the stirred reaction mixture. After 1 h, MeOH (550 mL) 
and sodium carbonate (29.8 g, 281 mmol, 2.50 equiv) were sequentially added to the stirred reaction 
mixture. After stirring for an additional 4 h, the reaction mixture was concentrated under reduced 
pressure. The crude residue was then re-suspended in water (1 L) and CH2Cl2 (500 mL), and 
cautiously acidified with concentrated hydrochloric acid until pH 4 was reached. The layers were then 
separated, and the aqueous layer was extracted with CH2Cl2 (6 × 200 mL). The combined organic 
layers were then washed with saturated aqueous Na2SO3 solution (2 × 250 mL) and saturated aqueous 
NaHCO3 solution (3 × 250 mL), dried over anhydrous MgSO4, filtered, and concentrated under 
reduced pressure to yield crude phenol S4 as a faint orange solid, which was used without further 
purification. 
A 1-L flask was charged with crude S4 and azeotropically dried with three portions of 
benzene. DMF (300 mL) was introduced, and the resultant solution cooled to 0 °C. Sodium hydride 
(60% wt. in mineral oil, 5.36 g, 134 mmol, 1.20 equiv) was then added as a single portion to the 
stirred reaction mixture. After 15 min, the stirred reaction mixture was allowed to warm to ambient 
temperature. After 45 min, the reaction mixture was re-cooled to 0 °C. Chloromethyl methyl ether 
(12.2 mL, 161 mmol, 1.43 equiv) was then added dropwise via syringe to the stirred reaction mixture 
over 5 min. After 30 min, the reaction mixture was allowed to warm to ambient temperature and 
stirred for an additional 1 h. Water (300 mL) was then slowly added to the stirred reaction mixture, 
which was then partitioned with Et2O (300 mL). The layers were separated, and the aqueous layer 
was further extracted with Et2O (3 × 300 mL). The combined organic layers were then washed with 
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water (3 × 500 mL) and brine (500 mL), dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, 
eluent: gradient, 10% → 17% EtOAc in hexanes) to afford trialkoxytoluene 34 (21.7 g, 91%) as a 
pale yellow oil. 1H NMR (500 MHz, CDCl3) δ: 6.47 (d, J = 2.7 Hz, 1H), 6.45 (d, J = 2.7 Hz, 1H), 
5.12 (s, 2H), 3.83 (s, 3H), 3.74 (s, 3H), 3.49 (s, 3H), 2.25 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 
153.4, 153.2, 142.3, 132.2, 109.2, 99.6, 94.9, 60.2, 56.0, 55.7, 16.0. FTIR (thin film) cm-1: 2936, 
1600, 1495, 1225, 1146, 1030, 837, 770. HRMS (ESI): calc’d for C11H17O4 [M+H]+: 213.1121, found 
213.1119. TLC (17% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
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Aryl bromide S5: NBS (1.05 g, 5.88 mmol, 1.10 equiv) was added in a single portion to a stirred 
solution of trialkoxytoluene 34 (1.14 g, 5.35 mmol, 1.00 equiv) in DMF (11 mL). After 2 h, water (25 
mL) and Et2O (25 mL) were added to the stirred reaction mixture, and the layers were separated. The 
aqueous later was extracted with Et2O (4 × 25 mL), and the combined organic layers were washed 
with water (4 × 50 mL) and brine (100 mL), dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
10% EtOAc in hexanes) to afford aryl bromide S5 (1.40 g, 90%) as a white solid. 1H NMR (600 
MHz, CDCl3) δ: 6.69 (s, 1H), 5.20 (s, 2H), 3.84 (s, 3H), 3.74 (s, 3H), 3.54 (s, 3H), 2.36 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ: 152.1, 150.3, 142.8, 132.8, 106.4, 99.6, 95.8, 60.5, 56.3, 55.9, 16.3. 
FTIR (thin film) cm-1: 2934, 1579, 1475, 1331, 1233, 1151, 1040, 935, 793. HRMS (ESI) (m/z) 
calc’d for C11H15BrO4Na [M+Na]+: 313.0046, found 313.0061. TLC (30% EtOAc in hexanes), Rf: 
0.44 (UV, anis). 
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o-Toluate 91: A solution of n-butyllithium in hexanes (2.50 M, 3.11 mL, 7.78 mmol, 1.10 equiv) was 
added dropwise via syringe to a stirred solution of aryl bromide S5 (2.06 g, 7.08 mmol, 1.00 equiv) in 
THF (50 mL) at –78 °C. After 1 h, crushed dry-ice (~5 g) was added in a single portion to the stirred 
reaction mixture at –78 °C, which after 10 min was allowed to warm to –10 °C. After 2 h, the stirred 
reaction mixture was allowed to warm to 0 °C. After an additional 1 h, the stirred reaction mixture 
was allowed to warm to ambient temperature. After an additional 1 h, water (100 mL) and Et2O (25 
mL) were added to the stirred reaction mixture, and the layers were separated. The organic layer was 
extracted with water (2 × 50 mL). The combined aqueous layers were then acidified to pH 4 with 
aqueous HCl (1 M) and extracted with EtOAc (4 × 50 mL). The combined organic layers were then 
washed with water (100 mL) and brine (100 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure to afford benzoic acid S6 (1.69 g, 93%) as a white solid. 
 Dimethyl sulfate (621 µL, 6.56 mmol, 1.20 equiv) was added dropwise via syringe to a 
stirred solution of benzoic acid S6 (1.40 g, 5.46 mmol, 1.00 equiv) and potassium carbonate (1.51 g, 
10.9 mmol, 2.00 equiv) in acetone (16 mL). After 4.5 h, Et2O (50 mL) was added to the stirred 
reaction mixture, which was subsequently filtered through a pad of Celite with excess Et2O. The 
solution was then concentrated under reduced pressure, and the residue was directly purified by flash 
column chromatography (silica gel, eluent: gradient, 20% → 25% EtOAc in hexanes) to afford o-
toluate 91 (99%) as a colorless solid. 1H NMR (600 MHz, CDCl3) δ: 6.62 (s, 1H), 5.13 (s, 2H), 3.89 
(s, 3H), 3.85 (s, 3H), 3.73 (s, 3H), 3.48 (s, 3H), 2.21 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 168.1, 
154.1, 150.8, 142.1, 130.1, 117.7, 98.6, 95.5, 60.3, 56.1, 55.8, 52.0, 12.8. FTIR (thin film) cm-1: 
2995, 1725, 1597, 1489, 1453, 1330, 1266, 1152, 1043, 938, 772. HRMS (ESI) (m/z) calc’d for 
C13H18KO6 [M+K]+: 309.0735, found 309.0740. TLC (25% EtOAc in hexanes), Rf: 0.33 (UV, anis). 
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Benzylic sulfoxide 97: NBS (36 mg, 0.19 mmol, 1.1 equiv) was added in a single portion to a stirred 
solution of o-toluate 91 (50 mg, 0.20 mmol, 1.0 equiv) and AIBN (4.0 mg, 0.024 mmol, 0.13 equiv) 
in CCl4 (2 mL), and the resultant stirred reaction mixture was refluxed at 80 °C. After 2 h, the stirred 
reaction mixture was cooled to ambient temperature before additional AIBN (9.1 mg, 0.056 mmol, 
0.30 equiv) was added in a single portion. The stirred reaction mixture was then heated to 80 °C. 
After an additional 4.5 h, the stirred reaction mixture was cooled to ambient temperature before 
additional NBS (15 mg, 0.084 mmol, 0.46 equiv) was added in a single portion. The stirred reaction 
mixture was then heated to 80 °C. After an additional 14.5 h, the stirred reaction mixture was allowed 
to cool to ambient temperature before it was filtered through a pad of Celite. The Celite pad was 
washed with 1:1 Et2O/hexanes and the combined organic layers were concentrated. The crude residue 
was resuspended in 1:1 Et2O/hexanes and filtered through Celite to remove residual succinimide, and 
the resultant solution was concentrated under reduced pressure to afford crude benzylic bromide 93, 
which was used without further purification. 
 Cesium carbonate (96 mg, 0.30 mmol, 1.6 equiv) was added in a single portion to a stirred 
solution of crude 93 and thiophenol (31 µL, 0.30 mmol, 1.6 equiv) in DMF (2 mL). After 1 h, the 
stirred reaction mixture was diluted with saturated aqueous NH4Cl solution (5 mL) and Et2O (5 mL). 
The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The 
combined organic layers were washed with water (3 × 10 mL) and brine (10 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel, eluent: 17% EtOAc in hexanes) to afford benzylic 
phenylsulfide 95 (51 mg, 73%), which was directly used in the next step. 
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 Sodium periodate (35 mg, 0.16 mmol, 1.2 equiv) was added in a single portion to a stirred 
solution of the benzylic phenylsulfide 95 (51 mg, 0.14 mmol, 1.0 equiv) in 5:1 MeOH/water (1.4 
mL). After 23 h, additional sodium periodate (5.8 mg, 0.027 mmol, 0.20 equiv) was added in a single 
portion to the stirred reaction mixture. After an additional 5 h, the stirred reaction mixture was filtered 
through a pad of Celite. The pad of Celite was washed with MeOH, and the resultant combined 
filtrate was concentrated under reduced pressure. The residue was directly purified by flash column 
chromatography (silica gel, eluent: gradient, 33% → 50 % EtOAc in hexanes) to afford benzylic 
sulfoxide 97 (52 mg, 98%). 1H NMR (600 MHz, CDCl3) δ: 7.58–7.53 (m, 2H), 7.48–7.43 (m, 3H), 
6.74 (s, 1H), 5.11 (dd, J = 7.0, 13.2 Hz, 2H), 4.44 (d, J = 12.3 Hz, 1H), 4.20 (d, J = 12.6 Hz, 1H), 
3.85 (s, 3H), 3.82 (s, 3H), 3.73 (s, 3H), 3.48 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 167.3, 154.6, 
152.1, 144.0, 143.1, 131.0, 131.0, 128.9, 124.1, 117.0, 101.6, 95.9, 61.2, 56.3, 56.2, 55.8, 52.2. FTIR 
(thin film) cm-1: 2947, 1712, 1594, 1454, 1332, 1267, 1215, 1151, 1085, 1021, 940, 749. HRMS 
(ESI) calc’d for C19H23O7S [M+H]+: 395.1159, found 395.1161. TLC (67% EtOAc in hexanes), Rf: 
0.49 (UV, CAM). 
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o-Toluate 92: A solution of n-butyllithium in hexanes (2.63 M, 2.10 mL, 5.51 mmol, 1.15 equiv) was 
added dropwise via syringe to a stirred solution of aryl bromide S5 (1.40 g, 4.79 mmol, 1.00 equiv) in 
THF (48 mL) at –78 °C. After 1 h, crushed dry-ice (~5.5 g) was added in a single portion to the 
stirred reaction mixture at –78 °C, which after 10 min was allowed to gradually warm to –10 °C over 
1 h. After an additional 2 h, the stirred reaction mixture was allowed to warm to ambient temperature. 
After an additional 30 min, the stirred reaction mixture was concentrated under reduced pressure. 
DMF (24 mL) and potassium carbonate (1.32 g, 9.58 mmol, 2.00 equiv) were then sequentially 
introduced into the reaction vessel. 2,2,2-Trifluoroethyl perfluorobutylsulfonate (1.66 mL, 7.19 
mmol, 1.50 equiv) was then added dropwise via syringe to the stirred reaction mixture. After 2.5 h, 
saturated aqueous NH4Cl solution (25 mL) and Et2O (50 mL) were added to the stirred reaction 
mixture. The layers were separated, and the aqueous layer was extracted with Et2O (3 × 25 mL). The 
combined organic layers were washed with water (3 × 100 mL) and brine (100 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel, eluent: gradient, 10% → 17% EtOAc in hexanes) to afford 
o-toluate 92 (1.54 g, 95%) as a pale yellow oil. 1H NMR (500 MHz, CDCl3) δ: 6.64 (s, 1H), 5.13 (s, 
2H), 4.67 (q, J = 8.4 Hz, 2H), 3.86 (s, 3H), 3.73 (s, 3H), 3.47 (s, 3H), 2.23 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ: 165.9, 154.9, 151.6, 142.1, 130.9, 123.0 (q, J = 277 Hz), 115.2, 98.2, 95.2, 60.5 (q, J 
= 37 Hz), 60.4, 56.1, 55.8, 12.8. FTIR (thin film) cm-1: 2943, 1737, 1595, 1488, 1335, 1257, 1213, 
1030, 940. HRMS (ESI) calc’d for C14H18F3O6 [M+H]+: 339.1050, found 339.1053. TLC (25% 
EtOAc in hexanes), Rf: 0.41 (UV, anis). 
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Benzylic bromide 94: NBS (550 mg, 3.09 mmol, 1.20 equiv) was added in a single portion to a 
stirred solution of o-toluate 92 (870 mg, 2.57 mmol, 1.00 equiv) and AIBN (84 mg, 0.51 mmol, 0.20 
equiv) in CCl4 (26 mL), and the resultant reaction mixture was refluxed at 80 °C. After 3 h, the stirred 
reaction mixture was allowed to cool to ambient temperature before it was filtered through a pad of 
Celite. The Celite pad was washed with 1:1 Et2O/hexanes and the combined organic layers were 
concentrated under reduced pressure in the presence of five drops of Et3N. The crude residue was 
directly purified by flash column chromatography (silica gel, eluent: gradient, 10% → 15% EtOAc in 
hexanes) to yield benzylic bromide 94 (1.03 g, 96%) as a faint yellow oil. 1H NMR (500 MHz, 
CDCl3) δ: 6.76 (s, 1H), 5.13 (s, 2H), 4.70 (q, J = 8.5 Hz, 2H), 4.66 (s, 2H), 3.88 (s, 3H), 3.47 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ: 164.9, 155.2, 152.4, 142.1, 130.9, 123.0 (q, J = 278 Hz), 113.9, 
100.9, 95.3, 61.0, 60.8 (q, J = 37 Hz), 56.1, 55.9, 23.2. FTIR (thin film) cm-1: 2941, 1735, 1594, 
1483, 1332, 1258, 1144, 1025, 939, 743, 691. HRMS (ESI) calc’d for C14H17BrF3NaO6 [M+Na]+: 
438.9975, found 438.9976. TLC (25% EtOAc in hexanes), Rf: 0.45 (UV, CAM). 
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Benzylic phenylsulfide 96: NBS (121 mg, 0.680 mmol, 1.15 equiv) was added in a single portion to 
a stirred solution of o-toluate 92 (200 mg, 0.591 mmol, 1.00 equiv) and AIBN (19.4 mg, 0.118 mmol, 
0.20 equiv) in CCl4 (6 mL), and the resultant reaction mixture was refluxed at 80 °C. After 4 h, the 
stirred reaction mixture was allowed to cool to ambient temperature before it was filtered through a 
pad of Celite. The Celite pad was washed with 1:1 Et2O/hexanes and the combined organic layers 
were concentrated. The crude residue was resuspended in 1:1 Et2O/hexanes and filtered through 
Celite to remove residual succinimide, and the resultant solution was concentrated under reduced 
pressure to afford crude benzylic bromide 94, which was used without further purification. 
 Cesium carbonate (250 mg, 0.768 mmol, 1.30 equiv) was added in a single portion to a 
stirred solution of crude 94 and thiophenol (114 µL, 0.768 mmol, 1.30 equiv) in DMF (3 mL). After 1 
h, the stirred reaction mixture was diluted with water (10 mL) and Et2O (10 mL). The layers were 
separated, and the aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic layers 
were washed with water (4 × 20 mL) and brine (20 mL), dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: gradient, 11% → 17% EtOAc in hexanes) to afford benzylic phenylsulfide 96 (234 
mg, 89%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ: 7.40–7.36 (m, 2H), 7.28 (t, J = 7.8 Hz, 
2H), 7.20 (t, J = 7.6 Hz, 1H), 6.72 (s, 1H), 5.16 (s, 2H), 4.60 (q, J = 8.6 Hz, 2H), 4.34 (s, 2H), 3.88 (s, 
3H), 3.71 (s, 3H), 3.51 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 165.6, 155.0, 152.4, 142.2, 136.1, 
131.3, 130.5, 128.8, 126.6, 123.1 (q, J = 277 Hz), 114.3, 99.8, 95.4, 61.4, 60.9 (q, J = 37 Hz), 56.2, 
55.9, 30.1. FTIR (thin film) cm-1: 2943, 1745, 1598, 1491, 1335, 1256, 1149, 1046, 975, 935. HRMS 
(ESI) calc’d for C20H22F3O6S [M+H]+: 447.1084, found 447.1088. TLC (25% EtOAc in hexanes), Rf: 
0.45 (UV, CAM). 
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Benzylic sulfone 98: A solution of m-CPBA (77 wt. %, 75.0 mg, 0.336 mmol, 3.00 equiv) in CH2Cl2 
(500 µL) was added dropwise via syringe to a stirred solution of benzylic phenylsulfide 96 (50 mg, 
0.11 mmol, 1.0 equiv) and NaHCO3 (46 mg, 0.55 mmol, 5.0 equiv) in CH2Cl2 (2 mL). After 1.5 h, 
saturated aqueous Na2SO3 solution (5 mL), Et2O (5 mL), and EtOAc (5 mL) were added to the stirred 
reaction mixture and the layers were separated. The organic layer was washed with saturated aqueous 
Na2SO3 solution (10 mL), saturated aqueous NaHCO3 solution (3 × 10 mL), and brine (10 mL), dried 
over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified 
by flash column chromatography (silica gel, eluent: 20% EtOAc in hexanes) to afford benzylic 
sulfone 98 (49 mg, 93%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ: 7.82 (dd, J = 1.2, 8.3 Hz, 
2H), 7.62 (tt, J = 1.2, 7.6 Hz, 1H), 7.51 (t, J = 8.1 Hz, 2H), 6.81 (s, 1H), 5.16 (s, 2H), 4.85 (s, 2H), 
4.69 (q, J = 8.5 Hz, 2H), 3.86 (s, 3H), 3.70 (s, 3H), 3.51 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 
165.6, 155.2, 153.1, 143.4, 139.4, 133.7, 129.0, 128.3, 123.3 (q, J = 277 Hz), 121.2, 114.9, 101.9, 
95.7, 61.2, 61.1 (q, J = 37 Hz), 56.3, 55.9, 52.4. FTIR (thin film) cm-1: 2950, 1728, 1595, 1487, 
1282, 1151, 1040, 736. HRMS (ESI) calc’d for C20H22F3O8S [M+H]+: 479.0982, found 479.0985. 
TLC (50% EtOAc in hexanes), Rf: 0.59 (UV, CAM).  
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Benzylic fluoride 99: TBAT (1.20 g, 2.22 mmol, 2.00 equiv) was added in a single portion to a 
stirred solution of o-toluate 94 (460 mg, 1.11 mmol, 1.00 equiv) in MeCN (11 mL), which was 
subsequently refluxed at 80 °C. After 50 h, the stirred reaction mixture was cooled to ambient 
temperature, before saturated aqueous NaHCO3 solution (15 mL) and Et2O (30 mL) were added. The 
layers were separated, and the aqueous layer was extracted with EtOAc (2 × 20 mL). The combined 
organic layers were washed with water (50 mL) and brine (50 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, eluent: 25% EtOAc in hexanes) to afford benzylic fluoride 99 (314 mg, 
79%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ: 6.82 (s, 1H), 5.52 (d, J = 47.2 Hz, 2H), 5.15 
(s, 2H), 4.67 (q, J = 8.6 Hz, 3H), 3.89 (s, 3H), 3.80 (s, 3H), 3.48 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ: 165.0, 155.1 (d, J = 1.4 Hz), 152.1 (d, J = 2.8 Hz), 142.3 (d, J = 4.6 Hz), 128.6 (d, J = 16 
Hz), 123.0 (q, J = 277 Hz), 114.2 (d, J = 2.8 Hz), 101.4 (d, J = 2.8 Hz), 95.3, 76.8 (d, J = 165 Hz), 
61.8 (d, J = 1.4 Hz), 60.8 (q, J = 37 Hz), 56.2, 55.9. FTIR (thin film) cm-1: 2943, 1745, 1598, 1491, 
1335, 1256, 1149, 1046, 975, 935. HRMS (ESI) calc’d for C14H17F4O6 [M+H]+: 357.0956, found 
357.0953. TLC (25% EtOAc in hexanes), Rf: 0.35 (UV, CAM). 
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Dihydronaphthalene 101: A solution of n-butyllithium in hexanes (2.67 M, 711 µL, 1.90 mmol, 
2.50 equiv) was added dropwise via syringe to a stirred solution of diisopropylamine (320 µL, 2.27 
mmol, 3.00 equiv) in THF (4 mL) at –78 °C. After 1 h, a solution of o-toluate 91 (205 mg, 0.758 
mmol, 1.00 equiv) in THF (1 mL) at –78 °C was added dropwise via a dry-ice wrapped cannula to the 
stirred reaction mixture at –78 °C. The transfer was completed with two additional portions of THF (2 
× 500 µL). After an additional 3 h, HMPA (750 µL) was added dropwise via syringe to the stirred 
reaction mixture at –78 °C. After an additional 1 h, a solution of cyclohexenone 100131 (251 mg, 
0.990 mmol, 1.30 equiv) in THF (1 mL) at –78 °C was added dropwise via a dry-ice wrapped cannula 
to the stirred, deep red reaction mixture at –78 °C, whereupon the deep red color quickly dissipated to 
a faint orange-yellow color. The transfer was completed with two additional portions of THF (2 × 500 
µL). The resultant stirred reaction mixture was allowed to slowly warm to 0 °C over 2 h. A solution 
of KHMDS in toluene (1.0 M, 380 µL, 0.38 mmol, 0.50 equiv) was then added dropwise via syringe 
to the stirred reaction mixture at 0 °C, which was subsequently allowed to warm to ambient 
temperature. After an additional 1 h, saturated aqueous NH4Cl solution (25 mL), Et2O (25 mL), and 
EtOAc (25 mL) were added to the stirred reaction mixture. The layers were separated, and the organic 
layer was washed with water (3 × 50 mL) and brine (50 mL), dried over anhydrous Na2SO4, filtered, 
and concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: gradient, 6% → 10% EtOAc in hexanes) to afford dihydronaphthalene 101 (319 
                                                                                                                                                                       
131 Model cyclohexenone 100 was prepared from the known corresponding cyclohexanone in two steps via (1) 
trimethylsilylether formation and (2) Saegusa oxidation. 
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mg, 86%) as a single diastereomer.132 1H NMR (500 MHz, CDCl3) δ: 6.71 (s, 3H), 5.27 (d, J = 6.9 
Hz, 1H), 5.22 (d, J = 6.9 Hz, 1H), 3.90 (s, 3H), 3.73 (s, 3H), 3.70 (d, J = 3.4 Hz, 1H), 3.56 (s, 3H), 
3.16 (dd, J = 4.2, 15.2 Hz, 1H), 2.85 (ddd, J = 4.8, 10.4, 19.6 Hz, 1H), 2.17 (t, J = 14.8 Hz, 1H), 1.92 
(td, J = 5.0, 13.4 Hz, 1H), 1.71 (ddd, J = 1.5, 11.3, 13.3 Hz, 1H), 1.23 (s, 3H), 1.21 (s, 3H), 0.83 (s, 
9H), 0.06 (s, 3H), 0.05 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 189.1, 185.1, 156.3, 155.5, 140.0, 
137.4, 115.6, 106.3, 100.7, 96.6, 74.6, 60.7, 56.5, 55.7, 43.1, 33.7, 29.8, 27.8, 27.6, 25.8, 22.1, 18.1, –
4.4, –5.0. HRMS (ESI) calc’d for C26H40NaO7Si [M+Na]+: 515.2436, found 515.2435. TLC (25% 
EtOAc in hexanes), Rf: 0.33 (UV, CAM).  
                                                                                                                                                                       
132 The regioisomer of the enolized 1,3-diketone was not determined and is arbitrarily depicted. 
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Naphthalene 102: DDQ (12.5 mg, 0.055 mmol, 1.50 equiv) was added in a single portion to a stirred 
solution of dihydronaphthalene 101 (18 mg, 0.037 mmol, 1.0 equiv) in benzene (1.8 mL). The 
heterogeneous solution was stirred vigorously and protected from light for 66 h. Saturated aqueous 
NaHCO3 solution (5 mL) and Et2O (5 mL) were then added to the stirred reaction mixture. The layers 
were separated, and the organic layer was washed with water (5 mL) and brine (5 mL), dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (silica gel, eluent: gradient, 7% → 15% EtOAc in hexanes) to afford 
naphthalene 102 (11 mg, 61%) as a fluorescent yellow film. 1H NMR (500 MHz, CDCl3) δ: 7.22 (s, 
1H), 6.88 (s, 1H), 5.35–5.29 (m, 2H), 3.99 (s, 3H), 3.96 (dd, J = 4.0, 8.4 Hz, 1H), 3.88 (s, 3H), 3.61 
(s, 3H), 3.17 (dd, J = 3.9, 16.5 Hz, 1H), 3.04 (dd, J = 8.2, 16.3 Hz, 1H), 1.28 (s, 3H), 1.24 (s, 3H), 
0.85 (s, 9H), 0.11 (s, 3H), 0.08 (s, 3 H). 13C NMR (126 MHz, CDCl3) δ: 208.5, 166.1, 154.4, 152.4, 
137.0, 135.2, 134.3, 111.4, 110.1, 108.8, 101.0, 96.9, 74.2, 61.0, 56.5, 56.2, 48.3, 35.4, 25.7, 22.8, 
19.8, 18.0, –4.2, –4.9. FTIR (thin film) cm-1: 2929, 1619, 1492, 1386, 1341, 1075, 837, 775. HRMS 
(ESI) calc’d for C26H38NaO7Si [M+Na]+: 513.2280, found 513.2277. TLC (25% EtOAc in hexanes), 
Rf: 0.40 (UV, CAM). 
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Annulation of Benzylic Sulfoxide 97 with ent-63: A 10-mL round-bottom flask was charged with 
ent-63 (25 mg, 0.042 mmol, 1.0 equiv) and sulfoxide 97 (25 mg, 0.063 mmol, 1.50 equiv), which 
were azeotropically dried with four portions of benzene. THF (1 mL) was then introduced, and the 
resultant stirred solution was cooled to 0 °C. A solution of freshly prepared LiHMDS in THF/hexanes 
(1.0 M, 170 µL, 0.17 mmol, 4.0 equiv) was then added dropwise via syringe to the stirred solution. 
After 27 h, saturated aqueous NH4Cl solution (5 mL) was added to the reaction mixture, which was 
allowed to warm to ambient temperature. The resultant mixture was diluted with Et2O (5 mL) and 
EtOAc (5 mL), and the layers were separated. The organic layer was washed with saturated aqueous 
NH4Cl solution (10 mL) and brine (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient 5% → 10% EtOAc in hexanes) to afford naphthol 89 (17 mg, 48%) as a fluorescent yellow-
green film. 1H NMR (500 MHz, CD2Cl2) δ: 14.95 (s, 1H), 7.42 (dd, J = 0.9, 7.9 Hz, 2H), 7.37–7.33 
(m, 2 H), 7.31–7.26 (m, 1H), 7.23 (s, 1H), 6.84 (s, 1H), 5.30 (s, 2H), 4.87 (d, J = 11.4 Hz, 1H), 4.69 
(d, J = 11.4 Hz, 1H), 4.26–4.22 (m, 2H), 3.97 (s, 3H), 3.85–3.82 (m, 4H), 3.59 (s, 3H), 3.47 (ddd, J = 
1.7, 14.3, 16.5 Hz, 2H), 3.19 (dd, J = 5.2, 16.9 Hz, 1H), 2.44 (td, J = 4.9, 13.9 Hz, 1H), 2.12 (ddd, J = 
4.2, 12.2, 14.3 Hz, 1H), 1.80 (ddd, J = 5.1, 12.0, 14.2 Hz, 1H), 1.61–1.50 (m, 1 H), 1.45–1.37 (m, 
1H), 1.26 (s, 3H), 1.13 (s, 3H), 0.93 (s, 9H), 0.89 (t, J = 7.3 Hz, 3H), 0.17 (s, 9H), 0.081 (s, 3H), 
0.079 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 203.4, 166.8, 155.1, 153.5, 139.4, 139.0, 137.4, 135.2, 
128.7, 128.4, 127.9, 111.8, 111.3, 109.9, 109.7, 101.2, 97.3, 87.8, 86.3, 83.3, 81.9, 73.3, 71.7, 61.3, 
56.9, 56.8, 49.3, 40.8, 28.0, 27.6, 27.5, 26.3, 18.6, 18.3, 15.3, 2.3, –4.1, –4.2. FTIR (thin film) cm-1: 
2951, 1734, 1420, 1279, 1215, 1048, 986, 924, 736. HRMS (ESI) calc’d for C44H65O11Si2 [M+H]+: 
825.4060, found 825.4062. TLC (33% EtOAc in hexanes), Rf: 0.30 (UV, CAM). 
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Annulation of Benzylic Sulfone 98 with ent-63: A 5-mL round-bottom flask was charged with ent-
63 (10.2 mg, 0.0170 mmol, 1.00 equiv) and benzylic sulfone 98 (12.4 mg, 0.0260 mmol, 1.50 equiv), 
which were azeotropically dried with four portions of benzene. THF (500 µL) was then introduced, 
and the resultant stirred solution was cooled to 0 °C. A solution of freshly prepared LiHMDS in 
THF/hexanes (1.0 M, 69 µL, 0.070 mmol, 4.0 equiv) was then added dropwise via syringe to the 
stirred solution. After 3 h, saturated aqueous NH4Cl solution (5 mL) was added to the stirred reaction 
mixture, which was allowed to warm to ambient temperature. The resultant mixture was diluted with 
Et2O (5 mL) and EtOAc (5 mL), and the layers were separated. The organic layer was washed with 
saturated aqueous NH4Cl solution (10 mL) and brine (10 mL), dried over anhydrous Na2SO4, filtered, 
and concentrated under reduced pressure. The residue was passed through a plug of silica gel (eluent: 
Et2O) to afford crude annulated product, which was carried forward without further purification. 
A stirred solution of crude annulated product and NaHCO3 (72.5 mg, 0.864 mmol, 50.0 
equiv) in xylenes (3 mL) was heated to 140 °C in a sealed vial. After 2 h, the stirred reaction mixture 
was allowed to cool to ambient temperature before it was filtered and concentrated under reduced 
pressure. The residue was then directly purified by flash column chromatography (silica gel, eluent: 
gradient 5% → 10% EtOAc in hexanes) to afford naphthol 89 (4.1 mg, 29%) as a fluorescent yellow-
green film. See page 175 for characterization data for 89.  
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Annulation of Benzylic Phenylsulfide 96 with ent-63: A 5-mL round-bottom flask was charged 
with ent-63 (12.1 mg, 0.0210 mmol, 1.00 equiv) and benzylic phenylsulfide 96 (13.8 mg, 0.0310 
mmol, 1.50 equiv), which were azeotropically dried with four portions of benzene. THF (500 µL) was 
then introduced, and the resultant stirred solution was cooled to 0 °C. A solution of freshly prepared 
LiHMDS in THF/hexanes (1.0 M, 82 µL, 0.082 mmol, 4.0 equiv) was then added dropwise via 
syringe to the stirred solution. After 3 h, saturated aqueous NH4Cl solution (5 mL) was added to the 
stirred reaction mixture, which was allowed to warm to ambient temperature. The resultant mixture 
was diluted with Et2O (5 mL) and EtOAc (5 mL), and the layers were separated. The organic layer 
was washed with saturated aqueous NH4Cl solution (10 mL) and brine (10 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was passed through a plug of 
silica gel (eluent: Et2O) to afford crude annulated product, which was carried forward without further 
purification. 
 Silver(I) tetrafluoroborate (16 mg, 0.082 mmol, 4.0 equiv) was added in a single portion to a 
stirred solution of crude annulated product and DTBMP (17 mg, 0.082 mmol, 4.0 equiv) in toluene (2 
mL) in the dark. After 18 h, saturated aqueous NH4Cl solution (5 mL), Et2O (5 mL), and EtOAc (5 
mL) were added to the stirred reaction mixture. The layers were separated, and the organic layer was 
washed with a 9:1 mixture of saturated aqueous NH4Cl solution and 30% (w/v) NH4OH solution (3 × 
10 mL) and brine (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was then purified by flash column chromatography (silica gel, eluent: gradient 
5% → 10% EtOAc in hexanes) to afford naphthol 89 (15.7 mg, 87%) as a fluorescent yellow-green 
film. See page 175 for characterization data for 89.  
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Annulation of Benzylic Fluoride 99 with ent-63: A 10-mL round-bottom flask was charged with 
ent-AB-/HG-enone ent-63 (50 mg, 0.085 mmol, 1.0 equiv) and benzylic fluoride 99 (42 mg, 0.120 
mmol, 1.4 equiv), which were azeotropically dried with four portions of benzene. THF (2.8 mL) was 
then introduced, and the resultant stirred solution was cooled to –78 °C. A solution of freshly 
prepared LiTMP in THF/hexanes (1.0 M, 340 µL, 0.34 mmol, 4.0 equiv) was added dropwise via 
syringe to the stirred solution. The stirred reaction mixture was allowed to gradually warm from –78 
°C to –40 °C over 2 h, at which point HMDS (71 µL, 0.34 mmol, 4.0 equiv) was added dropwise via 
syringe. The resultant stirred reaction mixture was then allowed to warm to 0 °C. After 3 h, saturated 
aqueous NH4Cl solution (5 mL) was added to the stirred reaction mixture, which was allowed to 
warm to ambient temperature. The resultant mixture was diluted with Et2O (10 mL) and EtOAc (10 
mL), and the layers were separated. The organic layer was washed with saturated aqueous NH4Cl 
solution (20 mL) and brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was passed through a plug of silica gel (eluent: 25% EtOAc in hexanes) 
to afford crude annulated product, which was carried forward without further purification. 
 A stirred solution of crude annulated product and NaHCO3 (143 mg, 1.70 mmol, 20.0 equiv) 
in 19:1 TFE/water (7.4 mL) was heated to 80 °C. After 5 h, the stirred reaction mixture was allowed 
to cool to ambient temperature before Et2O (10 mL), hexanes (10 mL), and water (10 mL) were 
added. The layers were separated, and the organic layer was washed with saturated aqueous NH4Cl 
solution (20 mL) and brine (20 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 
gradient, 11% → 13% EtOAc in hexanes) to afford naphthalene 89 (58 mg, 83%) as a fluorescent 
yellow-green film. See page 175 for characterization of 89. 
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Biaryl (±)-36: A 100-mL round-bottom flask was charged with 34 (3.12 g, 14.7 mmol, 1.00 equiv) 
and azeotropically dried with three portions of benzene. THF (25 mL) and TMEDA (2.65 mL, 17.7 
mmol, 1.20 equiv) were introduced, and the resultant solution cooled to –78 °C. A solution of n-
butylithium in hexanes (2.64 M, 6.12 mL, 16.2 mmol, 1.10 equiv) was then added dropwise via 
syringe to the stirred reaction mixture. After 15 min, the reaction mixture was allowed to warm to 0 
°C. After 3 h, a solution of iron(III) chloride (2.87 g, 17.7 mmol, 1.20 equiv) in THF (20 mL) was 
added via cannula to the stirred reaction mixture over 7 minutes. The transfer was completed with an 
additional portion of THF (5 mL). After 15 min, the stirred reaction mixture was allowed to warm to 
ambient temperature. After an additional 18 h, aqueous HCl solution (1.2 M, 50 mL) and Et2O (100 
mL) were added to the reaction mixture. The layers were separated, and the aqueous layer was further 
extracted with Et2O (100 mL) and EtOAc (2 × 100 mL). The combined organic layers were then 
washed with aqueous HCl solution (1.2 M, 100 mL), water (100 mL), saturated aqueous NaHCO3 
solution (100 mL), and brine (100 mL), dried over anhydrous Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, 
eluent: gradient, 5% → 10% → 13% → 17% EtOAc in hexanes) to afford biaryl (±)-36 (2.35 g, 76%) 
as a white solid. 1H NMR (500 MHz, CDCl3) δ: 6.78 (s, 2H), 4.98 (s, 4H), 3.80 (s, 6H), 3.67 (s, 6H), 
3.33 (s, 6H), 2.31 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 151.6, 151.2, 146.3, 131.5, 117.4, 112.5, 
95.3, 60.2, 60.1, 55.7, 16.3. FTIR (thin film) cm-1: 2939, 1473, 1394, 1233, 1067, 1017, 927, 738. 
HRMS (ESI) calc’d for C22H30NaO8 [M+Na]+: 445.1838, found 445.1836. TLC (20% EtOAc in 
hexanes), Rf: 0.35 (UV, CAM). 
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Dibromide (±)-S6: A 200-mL round-bottom flask was charged with (±)-36 (2.35 g, 5.56 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (56 mL) and pyridine (3.38 
mL, 41.7 mmol, 7.50 equiv) were introduced, and the resultant solution cooled to 0 °C. A solution of 
bromine (1.42 mL, 27.8 mmol, 5.00 equiv) in CH2Cl2 (13 mL) was then added via syringe down the 
vessel wall to the stirred reaction mixture. After 20 min, saturated aqueous Na2SO3 solution (50 mL) 
and Et2O (100 mL) were added to the stirred reaction mixture, which was subsequently allowed to 
warm to ambient temperature. The layers were separated, and the aqueous layer was further extracted 
with EtOAc (3 × 50 mL). The combined organic layers were then washed with saturated aqueous 
NaHSO3 solution (100 mL), aqueous HCl solution (1.2 M, 2 × 100 mL), water (100 mL), saturated 
aqueous NaHCO3 solution (100 mL), and brine (100 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: 9% EtOAc in hexanes) to afford dibromide (±)-S6 (2.95 g, 91%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 4.87 (d, J = 5.6 Hz, 2H), 4.85 (d, J = 5.6 Hz, 2H), 3.80 (s, 6H), 3.75 
(s, 6H), 3.03 (s, 6H), 2.42 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 150.8, 148.9, 148.2, 133.0, 122.3, 
114.8, 99.1, 60.2, 60.2, 56.6, 16.7. FTIR (thin film) cm-1: 2937, 1456, 1387, 1217, 1158, 1098, 1006, 
930. HRMS (ESI) calc’d for C22H29Br2O8 [M+H]+: 579.0229, found 579.0223. TLC (17% EtOAc in 
hexanes), Rf: 0.39 (UV, CAM).  
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Bis-o-toluate (±)-104: A 200-mL round-bottom flask was charged with (±)-S6 (3.86 g, 6.65 mmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. THF (60 mL) was introduced, 
and the resultant solution cooled to –78 °C. A solution of n-butyllithium in hexanes (2.50 M, 6.12 
mL, 15.3 mmol, 2.30 equiv) was then added dropwise via syringe to the stirred reaction mixture. 
After 1.5 h, methyl chloroformate (1.54 mL, 19.9 mmol, 3.00 equiv) was added dropwise via syringe 
to the stirred reaction mixture, which was subsequently allowed to gradually warm to ambient 
temperature over 2.5 h. Saturated aqueous NaHCO3 solution (50 mL) and Et2O (100 mL) were then 
added to the reaction mixture. The layers were separated, and the aqueous layer was further extracted 
with EtOAc (3 × 50 mL). The combined organic layers were then washed with saturated aqueous 
NaHCO3 solution (100 mL) and brine (100 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: gradient, 17% → 33% EtOAc in hexanes) to afford bis-o-toluate (±)-104 (3.19 g, 
89%) as a white solid. 1H NMR (500 MHz, CDCl3) δ: 4.77 (d, J = 5.9 Hz, 2H), 4.75 (d, J = 5.9 Hz, 
2H), 3.88 (s, 6H), 3.78 (s, 6H), 3.76 (s, 6H), 3.07 (s, 6H), 2.26 (s, 6H). 13C NMR (126 MHz, CDCl3) 
δ: 168.1, 152.8, 148.7, 147.8, 130.2, 125.3, 121.4, 100.0, 60.2, 60.0, 56.5, 52.2, 13.1. FTIR (thin 
film) cm-1: 2949, 1732, 1454, 1393, 1213, 1007, 930, 738. HRMS (ESI) calc’d for C26H34NaO12 
[M+Na]+: 561.1948, found 561.1943. TLC (33% EtOAc in hexanes), Rf: 0.35 (UV, CAM). 
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Bis-benzyl bromide (±)-S7: A 50-mL round-bottom flask was charged with (±)-104 (274 mg, 509 
µmol, 1.00 equiv) and azeotropically dried with three portions of benzene. THF (17 mL) was 
introduced, and the resultant solution cooled to –78 °C. In a separate 10-mL round-bottom flask, a 
solution of n-butyllithium in hexanes (2.69 M, 567 μL, 1.53 mmol, 3.00 equiv) was added dropwise 
via syringe to a stirred solution of 2,2,6,6-tetramethylpiperidine (283 μL, 1.68 mmol, 3.30 equiv) in 
THF (2.1 mL) at 0 °C. After 30 min, the resultant solution of lithium 2,2,6,6-tetramethylpiperidide 
was cooled to –78 °C and transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled 
solution of (±)-104 over 5 min. The transfer was completed with an additional portion of THF (2 mL). 
After 30 min, 1,2-dibromotetrafluoroethane (250 μL, 2.10 mmol, 4.12 equiv) was added rapidly via 
syringe to the vigorously stirred deep red reaction mixture, whereupon the reaction mixture turned 
colorless. After 45 sec, saturated aqueous NH4Cl solution (10 mL) was added to the reaction mixture, 
which was subsequently allowed to warm to ambient temperature. The mixture was diluted with Et2O 
(20 mL) and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 10 mL) and 
the combined organic layers were then washed with saturated aqueous NH4Cl solution (25 mL) and 
brine (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: 5% EtOAc in CH2Cl2) 
to afford bis-benzyl bromide (±)-S7 (219 mg, 62%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ: 
4.81 (d, J = 6.0 Hz, 2H), 4.78 (d, J = 6.0 Hz, 2H), 4.71 (d, J = 9.8 Hz, 2H), 4.64 (d, J = 9.8 Hz, 2H), 
3.94 (s, 6H), 3.93 (s, 6H), 3.79 (s, 6H), 3.01 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 166.9, 153.0, 
149.7, 147.9, 130.7, 124.6, 124.5, 100.6, 60.6, 60.1, 56.5, 52.6, 23.8. FTIR (thin film) cm-1: 2949, 
1729, 1453, 1392, 1225, 1016, 927, 738. HRMS (ESI) calc’d for C26H36Br2NO12 [M+NH4]+: 
712.0604, found 712.0580. TLC (33% EtOAc in hexanes), Rf: 0.43 (UV, CAM). 
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Bis-benzyl fluoride (±)-108: A 15-mL round-bottom flask was charged with (±)-S7 (219 mg, 315 
µmol, 1.00 equiv) and azeotropically dried with three portions of benzene. The flask was equipped 
with a reflux condenser and then purged with argon before MeCN (3.1 mL) was introduced. TBAT 
(850 mg, 1.57 mmol, 5.00 equiv) was then added in a single portion to the stirred reaction mixture, 
which was subsequently heated to 82 °C. After 18 h, saturated aqueous NaHCO3 solution (10 mL) 
and Et2O (10 mL) were added to the reaction mixture. The layers were separated, and the aqueous 
layer was further extracted with EtOAc (3 × 10 mL). The combined organic layers were then washed 
with water (25 mL) and brine (25 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 20% → 25% EtOAc in hexanes) to afford bis-benzyl fluoride (±)-108 (135 mg, 75%) as a 
colorless oil. 1H NMR (600 MHz, CDCl3) δ: 5.52 (dd, J = 48, 1.8 Hz, 2H), 4.80 (s, 4H), 3.90 (s, 6H), 
3.86 (s, 6H), 3.79 (s, 6H), 3.03 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 167.0, 153.0, 149.5 (d, J = 
1.8 Hz), 148.3 (d, J = 3.7 Hz), 128.3 (d, J = 15.6 Hz), 125.2 (d, J = 2.7 Hz), 124.9 (d, J = 3.7 Hz), 
100.5, 77.0 (d, J = 165 Hz), 61.4, 60.2, 56.6, 52.6. FTIR (thin film) cm-1: 2951, 1734, 1420, 1279, 
1215, 1048, 986, 924, 736. HRMS (ESI) calc’d for C26H32F2NaO12 [M+Na]+: 597.1760, found 
597.1735. TLC (33% EtOAc in hexanes), Rf: 0.30 (UV, CAM).  
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Protected HMP-Y1 (–)-107a and atrop-HMP-Y1 (+)-107b: A 10-mL round-bottom flask was 
charged with (±)-108 (26.4 mg, 0.046 mmol, 1.00 equiv) and (+)-63 (59.5 mg, 0.100 mmol, 2.20 
equiv) and azeotropically dried with four portions of benzene. THF (1 mL) was introduced, and the 
resultant solution cooled to –78 °C. A solution of n-butyllithium in hexanes (2.42 M, 95.0 µL, 0.230 
mmol, 5.00 equiv) was added via syringe to a stirred solution of 2,2,6,6-tetramethylpiperidine (42.3 
μL, 0.250 mmol, 5.43 equiv) in THF (0.46 mL) at –78 °C in a 5-mL round-bottom flask. The 
resultant solution was allowed to warm to 0 °C. After 30 min, the solution of lithium 2,2,6,6-
tetramethylpiperidide was cooled to –78 °C and transferred dropwise to the stirred, cooled solution of 
(±)-108 and (+)-63 via a dry-ice wrapped cannula. The transfer was completed with one additional 
portion of THF (0.10 mL). After 1.5 h, HMDS (48.0 µL, 0.230 mmol, 5.00 equiv) was added to the 
stirred, light orange reaction mixture, which was then allowed to warm to –35 °C. After 30 min, a 
solution of freshly prepared magnesium bromide diethyletherate in 2:1 Et2O/PhH (1.00 M, 83.0 µL, 
0.083 mmol, 1.80 equiv) was added dropwise to the stirred reaction mixture, which was then allowed 
to warm to –3 °C. After 1.5 h, saturated aqueous NH4Cl solution (1 mL) and EtOAc (5 mL) were 
added to the reaction mixture, and the layers were separated. The aqueous layer was extracted with 
EtOAc (3 × 5 mL) and the combined organic layers were washed with saturated aqueous NH4Cl 
solution (10 mL), water (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was then quickly passed through a plug of silica gel 
(eluent: 15% EtOAc in hexanes) and concentrated under reduced pressure. 
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The crude product was then resuspended in 2,2,2-trifluoroethanol (3.5 mL) and water (0.18 
mL). NaHCO3 (77.3 mg, 0.92 mmol, 20.0 equiv) was then added to the stirred solution, which was 
subsequently heated to 80 °C. After 5 h, water (5 mL) and EtOAc (25 mL) were added to the orange 
reaction mixture, and the layers were separated. The organic layer was washed with saturated aqueous 
NaHCO3 solution (10 mL), water (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, 
and concentrated under reduced pressure. The orange residue was then purified by flash column 
chromatography (silica gel, eluent: 6% → 8% EtOAc in hexanes) to yield protected HMP-Y1 (–)-
107a (21 mg, 28%) and protected atrop-HMP-Y1 (+)-107b (20.8 mg, 27%) as fluorescent yellow 
oils.133 
Protected HMP-Y1 (–)-107a: 1H NMR (600 MHz, CDCl3) δ: 14.84 (s, 2H), 7.43 (d, J = 7.3 Hz, 
4H), 7.39 (s, 2H), 7.37 (t, J = 7.5 Hz, 4H), 7.30 (t, J = 7.3 Hz, 2H), 5.01 (d, J = 6.1 Hz, 2H), 4.94 (d, J 
= 6.1 Hz, 2H), 4.87 (d, J = 11.6 Hz, 2H), 4.70 (d, J = 11.6 Hz, 2H), 4.31 (d, J = 3.4 Hz, 2H), 4.26 (dd, 
J = 4.3, 8.9 Hz, 2H), 3.92 (s, 6H), 3.91 (s, 6H), 3.86 (dd, J = 3.2, 8.7 Hz, 3H), 3.55 (t, J = 15.4 Hz, 
2H), 3.26 (dd, J = 5.2, 17.1 Hz, 2H), 2.67 (s, 6H), 2.47 (td, J = 4.8, 13.8 Hz, 2H), 2.22 (ddd, J = 4.1, 
12.1, 14.0 Hz, 2H), 1.75 (ddd, J = 4.9, 12.0, 14.0 Hz, 2H), 1.63–1.53 (m, 2H), 1.52–1.43 (m, 2H), 
1.28 (s, 6H), 1.06 (s, 6H), 0.95 (s, 18H), 0.92 (t, J = 7.5 Hz, 6H), 0.17 (s, 18H), 0.10 (s, 12H). 13C 
NMR (126 MHz, CDCl3) δ: 204.2, 165.3, 153.2, 151.4, 142.6, 139.3, 138.9, 135.5, 128.7, 128.4, 
127.9, 123.1, 115.2, 112.7, 110.4, 109.3, 101.3, 87.8, 85.8, 83.4, 82.2, 73.2, 71.8, 61.2, 60.9, 56.3, 
49.4, 41.4, 27.6, 27.4, 27.1, 26.3, 18.6, 18.5, 15.3, 2.2, –4.1, –4.2. FTIR (thin film) cm-1: 2953, 1616, 
1457, 1374, 1252, 1117, 1079, 1034, 844. HRMS (ESI) calc’d for C88H127O22Si4 [M+H]+: 1647.7891, 
found 1647.7880. [α]D23: –68 (c = 1.24, CH2Cl2). TLC (20% EtOAc in hexanes), Rf: 0.58 (UV, 
CAM). 
                                                                                                                                                                       
133 The stereochemistry about the C2–C2' axis of (–)-107a and (+)-107b is inferred from our assignment of 
HMP-Y1 (8). 
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Protected atrop-HMP-Y1 (+)-107b: 1H NMR (600 MHz, CDCl3) δ: 14.73 (s, 2H), 7.43 (d, J = 7.6 
Hz, 4H), 7.37 (s, 6H), 7.29 (t, J = 7.3 Hz, 2H), 5.00 (d, J = 6.1 Hz, 2H), 4.95 (d, J = 6.1 Hz, 2H), 4.90 
(d, J = 11.6 Hz, 2H), 4.71 (d, J = 11.6 Hz, 2H), 4.28–4.24 (m, 4H), 3.95 (s, 6H), 3.93 (s, 6H), 3.87 
(dd, J = 4.0, 8.9 Hz, 2H), 3.54 (ddd, J = 1.5, 14.0, 16.8 Hz, 2H), 3.25 (dd, J = 5.3, 17.2 Hz, 2H), 2.72 
(s, 6H), 2.50 (td, J = 5.1, 13.7 Hz, 2H), 2.09 (ddd, J = 4.0, 12.3, 14.3 Hz, 2H), 1.84 (ddd, J = 4.9, 
12.0, 14.3 Hz, 2H), 1.28 (s, 6H), 1.19 (s, 6H), 0.95 (s, 18H), 0.88 (t, J = 7.3 Hz, 6H), 0.19 (s, 18H), 
0.10 (s, 6H), 0.10 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 204.2, 165.2, 153.1, 151.3, 142.5, 139.4, 
139.0, 135.6, 128.7, 128.4, 127.9, 123.0, 115.0, 112.8, 110.4, 109.9, 101.3, 87.8, 86.5, 83.3, 82.0, 
73.3, 71.7, 61.1, 60.9, 56.6, 49.2, 40.6, 28.1, 27.8, 27.7, 26.3, 18.6, 18.1, 15.2, 2.3, –4.1, –4.2. FTIR 
(thin film) cm-1: 2989, 1616, 1456, 1373, 1252, 1118, 1078, 1036, 843. HRMS (ESI) calc’d for 
C88H126O22NaSi4 [M+Na]+: 1669.7710, found 1669.7619. [α]D23: +195 (c = 0.94, CH2Cl2). TLC 
(20% EtOAc in hexanes), Rf: 0.53 (UV, CAM).  
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HMP-Y1 (8): Aqueous HF solution (48 wt. %, 3 mL) was slowly added to a stirred solution of (–)-
107a (9.00 mg, 5.46 µmol, 1.00 equiv) in 1:1 MeCN/THF (6 mL) in a polyethylene vessel and heated 
to 50 °C. After 20 h, the reaction mixture was cooled to ambient temperature and cautiously poured 
into a vigorously stirred mixture of saturated aqueous NaHCO3 solution (50 mL), EtOAc (30 mL), 
and ice at 0 °C. After gas evolution ceased, the stirred mixture was diluted with EtOAc (50 mL) and 
the layers were separated. The organic layer was washed with saturated aqueous NaHCO3 solution (3 
× 50 mL), and brine (50 mL), dried over anhydrous Na2SO4, filtered through a cotton plug, and 
concentrated under reduced pressure to afford crude octacycle S8 as an orange film, which was used 
without further purification. 
A 50-mL round-bottom flask was charged with a solution of crude S8 and THF (18.0 mL). 
Palladium hydroxide on carbon (20 wt. %, 18.0 mg, 25.6 µmol, 4.70 equiv) was added in a single 
portion to the stirred solution and the reaction mixture was subsequently sparged with hydrogen gas 
for 5 min. The stirred reaction mixture was maintained under a balloon of hydrogen for 1 h before the 
balloon was removed and the stirred reaction mixture was sparged with argon. After 2 min, the 
mixture was filtered through a 0.2 µm PVDF syringe filter and rinsed with excess methanol to give an 
HF, MeCN/THF/H2O, 50 °C, 20 h
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orange-yellow homogeneous solution. The solution was concentrated and the resultant orange film 
was purified by semi-preparative HPLC on a Cosmosil 5C18-AR-II packed column [5 μm, 10.0 × 250 
mm, UV detection at 254 nm, 23 ± 2 °C column temperature, solvent A: methanol, solvent B: 0.05% 
(v/v) trifluoroacetic acid in water (pH 2.4), injection volume 300 μL (150 μL 0.05% (v/v) 
trifluoroacetic acid in water, 150 μL methanol), isocratic elution with 60% A for 20 min, flow rate: 
4.0 mL/min]. Fractions eluting at 13–14.5 min were collected and concentrated under reduced 
pressure to afford HMP-Y1 (8) (3.0 mg, 59%) as a yellow film. 1H NMR (600 MHz, CD3OD) δ: 7.34 
(s, 2H), 4.08 (dd, J = 5.5, 9.6 Hz, 2H), 3.94 (t, J = 9.4 Hz, 2H), 3.88 (s, 6H), 3.84 (s, 6H), 3.78–3.68 
(m, 4H), 3.18 (dd, J = 4.6, 16.5 Hz, 2H), 2.66 (dt, J = 5.3, 13.3 Hz, 2H), 1.88–1.79 (m, 2H), 1.79–
1.65 (m, 4H), 1.44–1.32 (m, 2H), 0.89 (t, J = 6.6 Hz, 6H). 13C NMR (126 MHz, CD3OD) δ: 207.3, 
165.8, 155.7, 153.7, 140.9, 140.5, 135.3, 113.3, 112.4, 112.3, 110.2, 80.8, 80.2, 76.1, 74.3, 71.8, 61.7, 
61.3, 48.4, 39.2, 28.6, 19.4, 15.7. FTIR (thin film) cm-1: 3336, 2951, 2923, 2842, 1647, 1451, 1410, 
1367, 1236, 1203, 1176, 1016, 847, 783. HRMS (ESI) calc’d for C46H54 NaO20 [M+Na]+: 949.3106, 
found 949.3084. TLC (silica gel RP-18, 45% water in MeCN), Rf: 0.69 (UV). 
 
The stereochemistry about the C2–C2' bond was assigned by comparing the CD spectra of 8 and 
HMP-Y6 (9); the periodicity and shape of the curves showed a high degree of similarity (See 
Appendix C Figure S15). See Appendix C Table S4–S6 and Figure S12–S14 for further comparison 
to related natural products. 
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Atrop-HMP-Y1 (110): Concentrated aqueous HF solution (48 wt. %, 3 mL) was slowly added to a 
stirred solution of (+)-107b (12.4 mg, 7.52 µmol, 1.00 equiv) in 1:1 MeCN/THF (6 mL) in a 
polyethylene vessel and heated to 50 °C. After 20 h, the reaction mixture was cooled to ambient 
temperature and cautiously poured into a vigorously stirred mixture of saturated aqueous NaHCO3 
solution (50 mL), EtOAc (30 mL), and ice at 0 °C. After gas evolution ceased, the stirred mixture was 
diluted with EtOAc (50 mL) and the layers were separated. The organic layer was washed with 
saturated aqueous NaHCO3 solution (3 × 50 mL), and brine (50 mL), dried over anhydrous Na2SO4, 
filtered through a cotton plug, and concentrated under reduced pressure to afford crude octacycle S9 
as an orange film, which was used without further purification. 
A 50-mL round-bottom flask was charged with crude S9 and THF (25.0 mL). Palladium 
hydroxide on carbon (20 wt. % loading, 25.0 mg, 35.6 µmol, 4.70 equiv) was added in a single 
portion to the stirred solution, which was subsequently sparged with hydrogen gas for 5 min. The 
stirred reaction mixture was maintained under a balloon of hydrogen for 1 h before the balloon was 
removed and the stirred reaction mixture was sparged with argon. After 2 min, the mixture was 
filtered through a 0.2 µm PVDF syringe filter and rinsed with excess methanol to give an orange-
HF, MeCN/THF/H2O, 50 °C, 20 h
H2, Pd(OH)2/C, THF, 1 h (62% overall)
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yellow homogeneous solution. The solution was concentrated and the resultant orange film was 
purified by semi-preparative HPLC on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 250 mm, UV 
detection at 254 nm, 23 ± 2 °C column temperature, solvent A: methanol, solvent B: 0.05% (v/v) 
trifluoroacetic acid in water (pH 2.4), injection volume 300 μL (150 μL 0.05% (v/v) trifluoroacetic 
acid in water, 150 μL methanol), isocratic elution with 60% A for 20 min, flow rate: 4.0 mL/min]. 
Fractions eluting at 17.5–19.5 min were collected and concentrated under reduced pressure to afford 
atrop-HMP-Y1 (110) (4.3 mg, 62%) as a yellow film. 1H NMR (600 MHz, CD3OD) δ: 7.35 (s, 2H), 
4.09 (dd, J = 5.4, 9.8 Hz, 2H), 3.94 (t, J = 9.5 Hz, 2H), 3.88 (s, 6H), 3.83 (s, 6H), 3.77–3.70 (m, 4H), 
3.18 (dd, J = 5.9, 17.0 Hz, 2H), 2.66 (td, J = 5.9, 13.2 Hz, 2H), 1.86–1.79 (m, 2H), 1.79–1.66 (m, 
4H), 1.42–1.32 (m, 2H), 0.89 (t, J = 7.0 Hz, 6H). 13C NMR (126 MHz, CD3OD) δ: 207.3, 165.8, 
155.7, 153.7, 140.8, 140.4, 135.3, 113.2, 112.4, 112.3, 110.2, 80.8, 80.2, 76.1, 74.3, 71.8, 61.7, 61.3, 
48.5, 39.2, 28.6, 19.4, 15.8. FTIR (thin film) cm-1: 3391, 3006, 2923, 2852, 1656, 1634, 1522, 1457, 
1411, 1336, 1206, 1143, 1024, 847, 803. HRMS (ESI) calc’d for C46H54 NaO20 [M+Na]+: 949.3106, 
found 949.3085. TLC (silica gel RP-18, 45% water in MeCN), Rf: 0.72 (UV). 
 
The stereochemistry about the C2–C2' bond was assigned by comparing the CD spectra of 110 and 
HMP-Y6 (9) (Appendix C, Table S4); the periodicity and shape of the curves showed a low degree of 
similarity (See Appendix C, Figure S15). 
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C-ring quinone (–)-111: To a stirred solution of binaphthol ent-107a134 (12.5 mg, 7.58 µmol, 1.00 
equiv) in 3:2:1 MeCN/THF/water (0.75 mL) at –10 °C was added ammonium cerium(IV) nitrate (8.3 
mg, 15 µmol, 2.0 equiv) in a single portion. The resultant stirred solution was allowed to warm to 0 
°C. After 10 min, the reaction mixture was partitioned with CH2Cl2 (2 mL) and saturated aqueous 
NaHCO3 solution (1 mL), and the layers were separated. The aqueous layer was further extracted 
with CH2Cl2 (3 × 1 mL) and the combined organic layers were then dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash preparatory 
thin-layer chromatography [(run 1: eluent: 13% EtOAc in hexanes), (run 2: eluent: 3% EtOAc in 
benzene)] to afford C-ring quinone (–)-111 (~1.9 mg, ~15%) as a yellow film. 1H NMR (600 MHz, 
CDCl3) δ: 14.83 (s, 1 H), 7.44–7.41 (m, 3H), 7.37–7.33 (m, 5H), 7.31–7.27 (m, 2H), 5.06 (d, J = 6.3 
Hz, 1H), 5.05 (d, J = 6.3 Hz, 1H), 5.02 (d, J = 6.6 Hz, 1H), 5.00 (d, J = 6.6 Hz, 1H), 4.95 (d, J = 11.6 
Hz, 1H), 4.90 (d, J = 11.6 Hz, 1H), 4.72 (d, J = 6.3 Hz, 1H), 4.70 (d, J = 6.3 Hz, 1H), 4.26–4.22 (m, 
2H), 4.03 (d, J = 6.3 Hz, 1H), 3.97 (s, 3H), 3.96 (s, 3H), 3.93 (s, 3H), 3.87–3.82 (m, 2H), 3.52 (dt, J = 
1.4, 15.3 Hz, 1H), 3.22 (dd, J = 5.5, 17.4 Hz, 1H), 3.08–3.00 (m, 4H), 2.92 (dd, J = 7.2, 13.2 Hz, 1H), 
2.80 (s, 3H), 2.46 (td, J = 5.0, 13.6 Hz, 1H), 2.42–2.34 (m, 1H), 2.10 (ddd, J = 4.2, 12.4, 14.1 Hz, 
1H), 2.04 (ddd, J = 5.5, 12.4, 14.7 Hz, 1H), 1.81 (ddd, J = 4.7, 12.1, 14.3 Hz, 1H), 1.55–1.48 (m, 2H), 
1.32 (s, 3H), 1.32 (s, 3H), 1.28 (s, 3H), 1.39–1.21 (m, 2H), 1.17 (s, 3H), 1.14–1.07 (m, 1H), 0.94 (s, 
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9H), 0.92 (s, 9H), 0.88 (t, J = 7.4 Hz, 3H), 0.78 (t, J = 7.4 Hz, 3H), 0.22 (s, 9H), 0.16 (s, 9H), 0.09 (s, 
3H), 0.09 (s, 3H), 0.08 (s, 6H). 13C NMR (126 MHz, CDCl3) δ: 203.6, 198.0, 185.5, 179.2, 164.7, 
158.0, 153.7, 151.8, 151.6, 150.3, 149.1, 142.0, 138.7, 138.7, 138.6, 135.9, 135.3, 133.0, 128.2, 
128.1, 128.0, 127.9, 127.4, 127.3, 126.1, 120.9, 114.6, 112.1, 110.7, 109.7, 109.2, 101.5, 101.0, 88.2, 
87.2, 86.1, 85.8, 82.5, 81.6, 81.5, 81.3, 73.5, 72.9, 70.9, 70.6, 61.2, 60.9, 60.7, 60.6, 56.6, 56.5, 48.8, 
46.4, 40.0, 37.5, 29.3, 28.7, 27.8, 27.5, 27.1, 26.0, 25.9, 24.3, 18.11, 18.09, 17.7, 15.5, 14.9, 14.4, 2.7, 
2.0, –4.4, –4.4, –4.6, –4.6.135 FTIR (thin film) cm-1: 2953, 1716, 1667, 1617, 1459, 1378, 1252, 1085, 
843. HRMS (ESI) calc’d for C88H124O23Si4 [M+H]+: 1661.7683, found 1661.7650. [α]D24: –72 (c = 
0.40, CH2Cl2). TLC (17% EtOAc in hexanes), Rf: 0.43 (UV, CAM). 
                                                                                                                                                                       
135 Due to the pseudo-C2-symmetric nature of (–)-111, one carbon resonance of (–)-111 is unresolved. 
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Benzyl bromide (±)-115: A 200-mL round-bottom flask was charged with (±)-107 (996 mg, 1.85 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. THF (62 mL) was 
introduced, and the resultant solution cooled to –78 °C. In a separate 10-mL round-bottom flask, a 
solution of n-butyllithium in hexanes (2.50 M, 930 μL, 2.33 mmol, 1.26 equiv) was added dropwise 
via syringe to a stirred solution of 2,2,6,6-tetramethylpiperidine (421 μL, 2.49 mmol, 1.35 equiv) in 
THF (3.3 mL) at 0 °C. After 30 min, the solution of lithium 2,2,6,6-tetramethylpiperidide was cooled 
to –78 °C and transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled solution of 
(±)-107 over 5 min. The transfer was completed with an additional portion of THF (3 mL). After 30 
min, 1,2-dibromotetrafluoroethane (445 μL, 3.73 mmol, 2.02 equiv) was added rapidly via syringe to 
the vigorously stirred deep red reaction mixture, whereupon the reaction mixture quickly turned 
colorless. After 30 sec, saturated aqueous NH4Cl solution (30 mL) was rapidly added to the stirred 
reaction mixture, which was subsequently allowed to warm to ambient temperature. The mixture was 
diluted with Et2O (100 mL) and the layers were separated. The aqueous layer was further extracted 
with EtOAc (3 × 30 mL) and the combined organic layers were then washed with saturated aqueous 
NH4Cl solution (100 mL) and brine (100 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: 5% → 6% EtOAc in CH2Cl2) to afford bis-benzyl bromide (±)-S7 (114 mg, 9%) as 
a colorless oil and benzyl bromide (±)-115 (934 mg, 82%) as a colorless oil. 1H NMR (600 MHz, 
CDCl3) δ: 4.80–4.76 (m, 3H), 4.74 (d, J = 5.6 Hz, 1H), 4.70 (d, J = 9.7 Hz, 1H), 4.63 (d, J = 10.0 Hz, 
1H), 3.93 (s, 3H), 3.92 (s, 3H), 3.87 (s, 3H), 3.78 (s, 3H), 3.77 (s, 3H), 3.76 (s, 3H), 2.25 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ: 168.0, 167.0, 153.2, 152.5, 149.5, 148.9, 147.8, 147.7, 130.7, 130.1, 
125.3, 125.1, 124.5, 120.9, 100.4, 100.1, 60.6, 60.2, 60.0, 60.0, 56.6, 56.4, 52.5, 52.2, 23.9, 13.1. 
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FTIR (thin film) cm-1: 2950, 1731, 1392, 1220, 1017, 928, 738. HRMS (ESI) calc’d for 
C26H37BrNO12 [M+NH4]+: 634.1494, found 634.1498. TLC (33% EtOAc in hexanes), Rf: 0.38 (UV, 
CAM). 
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Aldehyde (±)-116: A 100-mL round-bottom flask was charged with (±)-115 (2.74 g, 4.44 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene before DMSO (90 mL) was 
introduced. Diisopropylethylamine (2.32 mL, 13.3 mmol, 3.00 equiv) was added dropwise via syringe 
to the stirred solution at ambient temperature, which was subsequently warmed to 70 °C. After 2 h, 
the reaction mixture was cooled to ambient temperature before a saturated aqueous NH4Cl solution 
(90 mL) was cautiously added to the stirred reaction mixture. The mixture was partitioned with 
EtOAc (100 mL) and the layers were separated. The aqueous layer was further extracted with EtOAc 
(3 × 75 mL) and the combined organic layers were then washed with saturated aqueous NH4Cl 
solution (3 × 200 mL), water (3 × 200 mL), and brine (200 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 20% → 25% → 33% EtOAc in hexanes) to afford 
aldehyde (±)-116 (2.13 g, 87%) as a white solid.1H NMR (600 MHz, CDCl3) δ: 10.38 (s, 1H), 4.80–
4.79 (m, 4H), 3.97 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 3.80 (s, 3H), 3.78 (s, 6H), 3.03 (s, 3H), 3.03 (s, 
3H), 2.27 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 188.5, 167.9, 167.3, 153.2, 152.7, 152.3, 149.4, 
148.7, 147.7, 131.6, 131.2, 127.2, 125.3, 123.6, 120.4, 100.5, 100.5, 62.2, 60.4, 60.2, 60.0, 56.6, 56.5, 
52.8, 52.3, 13.1. FTIR (thin film) cm-1: 2950, 1734, 1694, 1454, 1217, 1031, 928, 739. HRMS (ESI) 
calc’d for C26H36NO13 [M+NH4]+: 570.2181, found 570.2181. TLC (33% EtOAc in hexanes), Rf: 0.22 
(UV, CAM). 
DMSO, 70 °C
(87%)
OMe
OMe
O
OMe
MeO
O
Me
MeO
OMe
O
MeO
O
OMe
(±)-116
OMe
OMe
O
OMe
MeO
O
Me
MeO
OMe
O
MeO
O
OMe
(±)-115
H
i-Pr2NEt
Br
O
196
  
 
Tribenzyl-Protected Aldehyde (±)-117: A 200-mL round-bottom flask was charged with (±)-116 
(2.12 g, 3.83 mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (75 
mL) was introduced, and the resultant solution cooled to 0 °C. Trifluoroacetic acid (1.48 mL, 19.2 
mmol, 5.00 equiv) was then added dropwise via syringe to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature. After 2 h, saturated aqueous NaHCO3 solution 
(100 mL) was added to the stirred reaction mixture. The layers were separated, and the aqueous layer 
was further extracted with CH2Cl2 (3 × 75 mL). The combined organic layers were then dried over 
anhydrous MgSO4, filtered, and concentrated under reduced pressure to afford crude bis-phenol (±)-
S10 as a white flocculent solid, which was used without further purification. 
A 200-mL round-bottom flask was charged with crude (±)-S10 and azeotropically dried with 
three portions of benzene. CH2Cl2 (75 mL) was introduced, and the resultant solution cooled to –78 
°C. A solution of boron trichloride in CH2Cl2 (1.0 M, 15 mL, 15 mmol, 3.9 equiv) was then added 
dropwise via syringe to the stirred reaction mixture, which was subsequently allowed to warm to 0 
°C. After 1 h, water (100 mL) and Et2O (150 mL) were added to the stirred reaction mixture, which 
was subsequently warmed to ambient temperature. The layers were separated, and the aqueous layer 
was further extracted with EtOAc (3 × 75 mL). The combined organic layers were then washed with 
water (3 × 200 mL) and brine (200 mL), dried over anhydrous MgSO4, filtered, and concentrated 
under reduced pressure to afford crude hydroquinone (±)-S11 as a yellow flocculent solid, which was 
used without further purification. 
A 200-mL round-bottom flask was charged with crude (±)-S11 and azeotropically dried with 
three portions of benzene. DMF (40 mL) was introduced, and the resultant solution cooled to 0 °C. 
Benzyl bromide (2.28 mL, 19.2 mmol, 5.00 equiv) and potassium carbonate (3.71 g, 26.8 mmol, 7.00 
CH2Cl2,
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equiv) were then sequentially added to the stirred reaction mixture, which was subsequently allowed 
to warm to ambient temperature and then heated to 60 °C. After 12 h the stirred reaction mixture was 
allowed to cool to ambient temperature before saturated aqueous NH4Cl solution (100 mL) and Et2O 
(100 mL) were added. The layers were separated, and the aqueous layer was further extracted with 
EtOAc (3 × 75 mL). The combined organic layers were then washed with saturated aqueous NH4Cl 
solution (2 × 200 mL), water (3 × 200 mL) and brine (200 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 15% → 17% → 20% EtOAc in hexanes) to afford 
tribenzyl-protected aldehyde (±)-117 (2.59 g, 94% over three steps) as a white flocculent solid. 1H 
NMR (600 MHz, CDCl3) d: 10.20 (s, 1H), 7.34–7.33 (m, 3H), 7.29–7.27 (m, 2H), 7.24–7.18 (m, 6H), 
7.03 (dd, J = 1.8, 7.9 Hz, 2H), 6.97 (dd, J = 2.5, 6.9 Hz, 2H), 5.01 (d, J = 11.1 Hz, 1H), 4.88–4.80 (m, 
5H), 3.85 (s, 3H), 3.82 (s, 3H), 3.77 (s, 3H), 3.76 (s, 3H), 3.67 (s, 3H), 2.31 (s, 3H).13C NMR (126 
MHz, CDCl3) δ: 188.4, 168.0, 167.4, 153.4, 152.2, 151.5, 151.1, 150.2, 147.8, 137.2, 136.9, 135.7, 
131.5, 131.3, 128.7, 128.7, 128.5, 128.2, 128.1, 127.7, 127.7, 127.6, 127.2, 125.4, 124.0, 120.0, 76.9, 
76.8, 76.4, 61.0, 60.5, 60.0, 52.8, 52.3, 13.1.136 FTIR (thin film) cm-1: 2949, 1734, 1694, 1418, 1218, 
1016, 739, 700. HRMS (ESI) calc’d for C42H44NO11 [M+NH4]+: 738.2909, found 738.2910. TLC 
(25% EtOAc in hexanes), Rf: 0.30 (UV, CAM). 
1D NOESY (600 MHz, CDCl3): 
 
                                                                                                                                                                       
136 Due to the pseudo-C2-symmetric nature of (±)-117 and the presence of multiple benzyl groups, one carbon 
resonance of a benzyl group of (±)-117 is unresolved as determined by comparison with related structures. 
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Cyanophthalide (±)-S12: To a solution of (±)-117 (1.11 g, 1.54 mmol, 1.00 equiv) in chloroform (30 
mL) was sequentially added triethylamine (428 μL, 3.07 mmol, 2.00 equiv) and acetone cyanohydrin 
(280 μL, 3.07 mmol, 2.00 equiv) at ambient temperature. After 1 h, saturated aqueous NH4Cl solution 
(30 mL) was added to the reaction mixture, which was stirred vigorously for 5 min. The layers were 
then separated, and the aqueous layer was further extracted with CH2Cl2 (3 × 30 mL). The combined 
organic layers were dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. 
The residue was then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 
20% EtOAc in hexanes) to afford cyanophthalide (±)-S12 (1.06 g, 97%) as a white flocculent solid 
(inseparable ~3:2 mixture of C6'-epimers). 1H NMR (600 MHz, CDCl3, ~3:2 mixture of C6'-epimers; 
major epimer noted by *) d: 7.40–7.12 (m, 13H*, 13H), 7.01–6.98 (m, 2H), 6.88–6.84 (m, 2H*), 5.45 
(s, 1H*), 5.33–5.28 (m, 1H*, 1H), 5.21–5.17 (m, 1H*, 1H), 5.16–5.12 (m, 2H), 5.02 (d, J = 10.8 Hz, 
1H*), 4.96–4.92 (m, 1H*, 1H), 4.76–4.70 (m, 1H*, 1H), 4.65 (d, J = 11.4 Hz, 1H), 4.60 (d, J = 11.1 
Hz, 1H*), 3.93 (s, 3H), 3.88 (s, 3H*), 3.88 (s, 3H*), 3.82 (s, 3H), 3.71 (s, 3H*, 3H), 3.68 (s, 3H*, 
3H), 2.33 (s, 3H*), 2.32 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 168.0, 168.0, 164.9, 164.8, 158.5, 
158.5, 153.5, 153.5, 152.4, 152.3, 150.5, 150.4, 147.8, 147.8, 141.31, 141.26, 137.3, 136.9, 136.7, 
136.6, 136.5, 136.4, 135.8, 135.8, 131.1, 131.1, 129.0, 129.0, 128.9, 128.8, 128.8, 128.3, 128.2, 
128.1, 127.9, 127.8, 127.8, 127.8, 127.8, 127.4, 126.9, 126.8, 126.8, 126.7, 125.3, 125.2, 119.9, 
119.9, 113.7, 113.7, 110.8, 110.6, 76.7, 76.6, 76.5, 76.2, 75.2, 74.9, 63.3, 63.3, 61.1, 61.0, 60.5, 60.4, 
60.2, 60.1, 52.3, 52.3, 13.1, 13.1.137 FTIR (thin film) cm-1: 2949, 1785, 1731, 1455, 1265, 1004, 737, 
                                                                                                                                                                       
137 Due to the pseudo-C2-symmetric nature of (±)-S12, the presence of multiple benzyl groups, and C6'-epimers, 
two carbon resonances of the benzyl group(s) of (±)-S12 are unresolved as determined by comparison with 
related structures. 
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698. HRMS (ESI) calc’d for C42H41N2O10 [M+NH4]+: 733.2756, found 738.2753. TLC (25% EtOAc 
in hexanes), Rf: 0.30 (UV, CAM). 
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Unsymmetrical biaryl (±)-118: A 50-mL round-bottom flask was charged with (±)-S12 (210 mg, 
291 µmol, 1.00 equiv) and azeotropically dried with four portions of benzene. THF (10 mL) was 
introduced, and the resultant solution cooled to –78 °C. In a separate 10-mL round-bottom flask, a 
solution of n-butyllithium in hexanes (2.56 M, 284 μL, 727 µmol, 2.50 equiv) was added dropwise 
via syringe to a stirred solution of 2,2,6,6-tetramethylpiperidine (135 μL, 800 µmol, 2.75 equiv) in 
THF (1.2 mL) at 0 °C. After 30 min, the resultant solution of lithium 2,2,6,6-tetramethylpiperidide 
was cooled to –78 °C and transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled 
solution of (±)-S12 over 3 min. The transfer was completed with an additional portion of THF (1 
mL). After 30 min, a solution of S-phenyl benzenethiosulfonate (76.5 mg, 306 µmol, 1.05 equiv) in 
THF (1.5 mL) was added via syringe rapidly down the vessel wall to the vigorously stirred deep red 
reaction mixture, whereupon the reaction mixture quickly turns yellow. After 10 sec, a solution of 
acetic acid (50 µL) in THF (1.0 mL) was rapidly added to the reaction mixture, followed immediately 
by addition of saturated aqueous NH4Cl solution (5 mL). The resultant mixture was subsequently 
allowed to warm to ambient temperature. The mixture was diluted with Et2O (20 mL) and EtOAc (20 
mL) and the layers were separated. The combined organic layers were then washed with saturated 
aqueous NH4Cl solution (30 mL) and brine (30 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: gradient, 1% → 2% EtOAc in 9:1 benzene/hexanes) to afford unsymmetrical biaryl 
(±)-118 (170 mg, 71%) as a white flocculent solid (inseparable ~2:1 mixture of C6'-epimers). 1H 
NMR (600 MHz, CDCl3, ~2:1 mixture of C6'-epimers; major epimer noted by *) d: 7.43–7.14 (m, 
13H*, 13H), 6.99 (dd, J = 2.3, 5.9 Hz, 2H), 6.85 (dd, J = 2.2, 7.2 Hz, 2H*), 5.43 (s, 1H*), 5.33– 5.30 
(m, 1H*, 1H), 5.22–63 (m, 1H*, 1H), 5.17–5.11 (m, 2H), 5.01 (d, J = 10.8 Hz, 1H*), 4.94 (d, J = 10.8 
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Hz, 1H*, 1H), 4.76–4.72 (m, 1H*, 1H), 4.64 (d, J = 11.7 Hz, 1H), 4.58 (d, J = 11.1 Hz, 1H*), 4.41–
4.36 (m, 1H*, 1H), 4.33 (d, J = 12.0 Hz, 1H*, 1H), 3.92 (s, 3H), 3.86 (s, 3H*), 3.81 (s, 3H*), 3.74 (s, 
3H), 3.68 (s, 3H*, 3H), 3.61 (s, 3H), 3.61 (s, 3H). 13C NMR (126 MHz, CDCl3) δ: 167.4, 164.8, 
164.8, 158.4, 158.4, 153.4, 153.4, 152.6, 152.5, 151.2, 151.0, 148.0, 148.0, 141.3, 141.3, 137.3, 
136.9, 136.7, 136.6, 136.6, 136.6, 136.0, 136.0, 135.8, 135.8, 131.5, 131.3, 131.2, 129.1, 129.1, 
129.0, 129.0, 128.9, 128.8, 128.8, 128.4, 128.3, 128.1, 128.0, 128.0, 128.0, 127.8, 127.5, 126.9, 
126.9, 126.9, 126.6, 126.5, 126.5, 124.6, 124.5, 122.0, 121.9, 113.7, 113.6, 110.9, 110.6, 76.8, 76.7, 
76.7, 76.3, 75.2, 74.9, 63.4, 63.3, 61.1, 61.0, 61.0, 61.0, 60.3, 60.3, 52.4, 52.4, 31.0, 30.9.138 FTIR 
(thin film) cm-1: 2295, 1787, 1730, 1455, 1266, 1027, 739, 699. HRMS (ESI) calc’d for 
C48H41NNaO10S [M+Na]+: 846.2343, found 846.2350. TLC (25% EtOAc in hexanes), Rf: 0.30 (UV, 
CAM). 
  
                                                                                                                                                                       
138 Due to the pseudo-C2-symmetric nature of (±)-118, the presence of multiple benzyl groups, and epimers at 
C6', five carbon resonances of the benzyl group(s) and/or benzylic phenylsulfide(s) of (±)-118 are unresolved as 
determined by comparison with related structures. 
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Octacycle (–)-128a and Octacycle (+)-128b: A 10-mL Schlenk tube was charged with (±)-118 (66.5 
mg, 80.7 µmol, 1.00 equiv) and AB-/HG-enone (+)-63 (143 mg, 242 µmol, 3.01 equiv), which were 
then azeotropically dried with five portions of benzene. THF (2.7 mL) was then introduced, and the 
resultant solution was deoxygenated and then cooled to –78 °C. A solution of freshly prepared 
deoxygenated lithium hexamethyldisilazide in THF (1.00 M, 807 µL, 807 µmol, 10.0 equiv) was then 
added dropwise via syringe to the stirred reaction mixture, which was subsequently allowed to warm 
to 0 °C over 30 min. After 19 h, a solution of deoxygenated potassium hexamethyldisilazide in THF 
(1.0 M, 2.00 mL, 2.00 mmol, 24.8 equiv) was added dropwise via cannula to the vigorously stirred 
purple reaction mixture, which was subsequently allowed to warm to ambient temperature. After 12 
h, the reaction mixture was cooled to –50 °C before a solution of acetic acid (200 µL) in THF (1.0 
mL) was added via syringe rapidly down the vessel-wall to the vigorously stirred purple reaction 
mixture. After the reaction mixture turned fluorescent orange, a saturated aqueous NH4Cl solution (2 
mL) was added. The resultant mixture was subsequently allowed to warm to ambient temperature. 
The mixture was diluted with Et2O (20 mL), hexanes (20 mL) and saturated aqueous NH4Cl solution 
(10 mL), and the layers were separated. The organic layers were then washed with saturated aqueous 
NH4Cl solution (20 mL), saturated aqueous NaHCO3 solution (20 mL), and brine (30 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was then purified 
by flash column chromatography (silica gel, eluent: gradient, 5% → 6% → 10% EtOAc in hexanes) 
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to afford octacycle (–)-128a139 (53.0 mg, 34%) as an orange flocculent solid and impure octacycle 
(+)-128b. The mixture containing (+)-128b was further purified by preparatory thin-layer 
chromatography (eluent: 10% EtOAc in hexanes) to afford octacycle (+)-128b139,140 (38.9 mg, 25%) 
as an orange flocculent solid.141 
Octacycle (–)-128a: 1H NMR (600 MHz, CD2Cl2) d: 17.39 (s, 1H), 14.22 (s, 1H), 9.45 (s, 1H), 7.46–
7.39 (m, 9H), 7.39–7.32 (m, 6H), 7.31–7.27 (m, 2H), 7.25–7.20 (m, 3H), 7.19–7.15 (m, 3H), 7.07 (m, 
1H), 7.01–6.98 (m, 2H), 6.96–6.93 (m, 4H), 5.13 (d, J = 11.2 Hz, 1H), 5.02 (d, J = 10.4 Hz, 1H), 4.95 
(d, J = 11.5 Hz, 1H), 4.94–4.89 (m, 4H), 4.81 (d, J = 3.8 Hz, 1H), 4.75 (d, J = 11.5 Hz, 1H), 4.71 (d, J 
= 11.5 Hz, 1H), 4.64 (d, J = 10.6 Hz, 1H), 4.29–4.23 (m, 3H), 4.16 (d, J = 5.9 Hz, 1H), 3.95 (dd, J = 
3.8, 9.0 Hz, 1H), 3.90 (s, 3H), 3.87 (dd, J = 5.8, 9.6 Hz, 1H), 3.54 (s, 3H), 3.40–3.34 (m, 2H), 3.24 (s, 
3H), 3.09 (dd, J = 13.3, 18.0 Hz, 1H), 2.73–2.67 (m, 1H), 2.55 (dt, J = 10.6, 14.5 Hz, 1H), 2.47–2.38 
(m, 2H), 2.08–1.96 (m, 2H), 1.96–1.83 (m, 2H), 1.66–1.51 (m, 5H), 1.42–1.32 (m, 8H), 1.27 (s, 3H), 
0.96 (s, 9H), 0.92 (s, 9H), 0.88 (t, J = 7.3 Hz, 3H), 0.82 (t, J = 7.3 Hz, 3H), 0.27 (s, 9H), 0.20 (s, 9H), 
0.15 (s, 3H), 0.10 (s, 3H), 0.09 (s, 6H). 13C NMR (126 MHz, CD2Cl2) δ: 204.3, 189.4, 182.5, 157.4, 
155.4, 154.6, 154.2, 151.9, 145.4, 142.4, 140.8, 139.6, 139.3, 138.4, 138.4, 138.2, 135.6, 135.5, 
133.8, 129.5, 129.4, 129.2, 128.8, 128.5, 128.4, 128.3, 128.3, 128.2, 128.2, 128.1, 128.1, 127.7, 
127.6, 127.5, 127.4, 124.8, 124.4, 122.6, 120.5, 120.0, 117.1, 112.8, 110.6, 109.6, 107.3, 107.3, 88.0, 
87.6, 87.4, 86.5, 83.5, 82.9, 81.8, 79.3, 77.6, 76.0, 76.0, 73.6, 73.3, 71.8, 71.5, 61.5, 60.3, 60.3, 50.9, 
47.8, 47.3, 40.5, 38.8, 34.3, 29.5, 28.9, 28.1, 27.5, 26.3, 26.0, 24.1, 21.4, 18.5, 18.4, 17.9, 17.6, 15.0, 
                                                                                                                                                                       
139 Minor oxidation of (–)-128a and (+)-128b occurs during purification and handling. Purification of highly 
oxygenated naphthalenes by flash column chromatography is difficult due to their adherence to silica gel 
(streaking). 
 
140 A significant loss of material is observed upon purification of highly oxygenated naphthalenes utilizing 
preparatory thin-layer chromatography (as determined by purification of pure material), but was necessary to 
purify (+)-128b. It was later determined that minor impurities could be carried forward and removed more 
easily at subsequent stages without severe detriment to the overall yield. 
 
141 The stereochemistry about the C2–C2' axis of (–)-128a, (+)-128b, and further intermediates was inferred 
from the stereochemistry of hibarimicinone (6), which was unambiguously assigned by Tatsuta et al. by total 
synthesis. See ref. 77. 
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14.8, 2.5, 2.2, –4.1, –4.2, –4.4, –4.5. FTIR (thin film) cm-1: 3364, 2953, 1624, 1594, 1370, 1251, 
1078, 843, 740, 698. HRMS (ESI) calc’d for C110H141O21SSi4 [M+H]+: 1941.8758, found 1941.8776. 
[α]D23: –119 (c = 0.40, CH2Cl2). TLC (13% EtOAc in hexanes), Rf: 0.55 (UV, CAM). 
 
Octacycle (+)-128b: 1H NMR (600 MHz, CD2Cl2) d: 17.35 (s, 1H), 14.20 (s, 1H), 9.46 (s, 1H), 7.45–
7.39 (m, 9H), 7.38–7.32 (m, 8H), 7.31–7.27 (m, 2H), 7.27–7.24 (m, 1H), 7.17 (d, J = 0.9 Hz, 1H), 
7.16 (d, J = 1.3 Hz, 1H), 7.11 (tt, J = 1.3, 7.5 Hz, 1H), 7.08–7.05 (m, 3H), 7.04–6.99 (m, 4H), 5.12–
5.07 (m, 2H), 5.06 (d, J = 10.8 Hz, 1H), 5.02 (d, J = 10.6 Hz, 1H), 4.94 (d, J = 11.5 Hz, 1H), 4.90 (d, 
J = 11.5 Hz, 1H), 4.85 (d, J = 10.6 Hz, 1H), 4.81 (d, J = 10.4 Hz, 1H), 4.77 (d, J = 3.8 Hz, 1H), 4.73 
(d, J = 6.6 Hz, 1H), 4.71 (d, J = 6.6 Hz, 1H), 4.29 (dd, J = 4.6, 9.0 Hz, 1H), 4.25–4.22 (m, 2H), 4.17 
(d, J = 5.7 Hz, 1H), 3.93 (dd, J = 4.4, 9.0 Hz, 1H), 3.86 (dd, J = 5.8, 9.4 Hz, 1H), 3.83 (s, 3H), 3.59 
(s, 3H), 3.42–3.36 (m, 2H), 3.16 (s, 3H), 3.07 (dd, J = 13.3, 17.9 Hz, 1H), 2.71 (ddd, J = 4.5, 7.9, 13.3 
Hz, 1H), 2.56–2.43 (m, 3H), 2.05–1.94 (m, 3H), 1.89 (ddd, J = 5.1, 12.0, 14.3 Hz, 1H), 1.66–1.58 (m, 
1H), 1.54–1.51 (m, 4H), 1.41 (s, 3H), 1.40–1.32 (m, 2H), 1.29 (s, 3H), 1.25 (s, 3H), 0.96 (s, 9H), 0.92 
(s, 9H), 0.88 (t, J = 7.3 Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H), 0.27 (s, 9H), 0.21 (s, 9H), 0.13 (s, 3H), 0.11 
(s, 3H), 0.10 (s, 3H), 0.08 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ: 204.5, 190.2, 182.5, 157.6, 155.6, 
154.6, 154.1, 152.2, 145.4, 142.5, 141.1, 139.8, 139.6, 139.2, 138.7, 138.5, 135.7, 134.7, 134.3, 
129.8, 129.6, 129.4, 129.2, 128.7, 128.6, 128.4, 128.4, 128.4, 128.4, 128.2, 127.9, 127.81, 127.75, 
127.7, 127.7, 125.0, 124.7, 122.6, 120.8, 120.0, 117.2, 113.1, 110.8, 110.1, 107.6, 107.6, 88.1, 87.7, 
87.6, 87.0, 83.6, 83.2, 81.8, 79.6, 77.8, 76.4, 76.3, 73.8, 73.6, 71.9, 71.7, 61.7, 60.5, 60.4, 51.6, 48.1, 
47.4, 40.3, 39.2, 34.3, 29.6, 28.9, 28.5, 27.9, 26.4, 26.3, 24.4, 21.7, 18.6, 18.6, 18.0, 18.0, 15.2, 15.0, 
2.6, 2.4, –3.9, –4.0, –4.2, –4.3. FTIR (thin film) cm-1: 3364, 2967, 1624, 1591, 1379, 1252, 1077, 
1006, 842, 739, 698. HRMS (ESI) calc’d for C110H141O21SSi4 [M+H]+: 1941.8758, found 1941.8795. 
[α]D23: +45 (c = 0.37, CH2Cl2). TLC (13% EtOAc in hexanes), Rf: 0.38 (UV, CAM). 
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Binaphthalene (–)-129a: A 25-mL round-bottom flask was charged with (–)-128a (30.0 mg, 15.4 
µmol, 1.00 equiv) and DTBMP (15.9 mg, 77.2 µmol, 5.00 equiv) and was then azeotropically dried 
with five portions of benzene. MeCN (3.5 mL) was introduced, and the resultant solution cooled to 0 
°C. A solution of DMTSF (6.05 mg, 30.9 µmol, 2.00 equiv) in MeCN (200 µL) was then added 
dropwise via syringe to the stirred reaction mixture. The transfer was completed with two additional 
portions of MeCN (100 µL). After 105 min, an additional portion of DMTSF (3.03 mg, 15.5 µmol, 
1.00 equiv) in MeCN (200 µL) was added dropwise via syringe to the stirred reaction mixture. The 
transfer was completed with two additional portions of MeCN (100 µL). After 15 min, the stirred 
reaction mixture was allowed to warm to ambient temperature. After 30 min, saturated aqueous 
NaHCO3 solution (5 mL) was added to the stirred reaction mixture. The mixture was partitioned with 
Et2O (10 mL) and hexanes (10 mL) and the layers were separated. The organic layers were washed 
with saturated aqueous NaHCO3 solution (2 × 10 mL) and brine (10 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was then purified by flash 
column chromatography (silica gel, eluent: gradient, 3% → 5% EtOAc in hexanes) to afford 
binaphthalene (–)-129a142 (21.3 mg, 75%) as an orange film. 1H NMR (600 MHz, CD2Cl2) d: 14.93 
(s, 1H), 14.25 (s, 1H), 9.51 (s, 1H), 7.45–7.36 (m, 13H), 7.33–7.28 (m, 2H), 7.11–7.00 (m, 8H), 6.94 
(d, J = 6.9 Hz, 2H), 5.13 (d, J = 10.9 Hz, 1H), 5.08–5.01 (m, 4H), 4.91 (d, J = 4.7 Hz, 1H), 4.89 (d, J 
                                                                                                                                                                       
142 Minor oxidation of (–)-129a occurs during purification and handling. Minor etherification to (–)-130a is also 
observed. 
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= 4.7 Hz, 1H), 4.73–4.71 (m, 3H), 4.32 (d, J = 3.4 Hz, 1H), 4.31–4.26 (m, 3H), 3.96 (dd, J = 4.0, 8.7 
Hz, 1H), 3.89 (dd, J = 3.6, 8.6 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.76 (s, 3H), 3.62 (ddd, J = 1.2, 
14.5, 16.4 Hz, 1H), 3.39 (dd, J = 6.2, 18.1 Hz, 1H), 3.29 (dd, J = 5.0, 17.1 Hz, 1H), 3.10 (dd, J = 
13.4, 18.1 Hz, 1H), 2.50 (td, J = 4.9, 13.8 Hz, 1H), 2.43 (ddd, J = 4.7, 5.9, 13.4 Hz, 1H), 2.21 (ddd, J 
= 3.9, 11.9, 14.4 Hz, 1H), 2.05 (ddd, J = 4.0, 12.1, 14.3 Hz, 1H), 1.87 (ddd, J = 5.1, 12.1, 14.2 Hz, 
1H), 1.79 (ddd, J = 5.0, 11.9, 14.2 Hz, 1H), 1.63–1.45 (m, 3H), 1.45–1.37 (m, 1H), 1.32 (s, 6H), 1.27 
(s, 3H), 1.21 (s, 3H), 0.96 (s, 9H), 0.94 (s, 9H), 0.91 (t, J = 7.5 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H), 0.21 
(s, 9H), 0.19 (s, 9H), 0.11 (s, 6H), 0.10 (s, 3H), 0.10 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ: 204.1, 
204.0, 165.2, 157.4, 154.1, 152.9, 152.4, 152.2, 142.7, 142.3, 140.7, 139.2, 139.0, 138.8, 138.4, 
138.3, 135.5, 135.3, 129.4, 129.2, 129.0, 128.4, 128.3, 128.1, 128.1, 128.0, 127.7, 127.6, 127.5, 
127.4, 124.2, 123.3, 121.9, 120.1, 116.9, 115.9, 112.6, 112.6, 110.2, 109.5, 109.1, 87.5, 87.3, 86.4, 
85.6, 83.3, 83.1, 81.9, 81.6, 77.5, 75.9, 75.7, 73.1, 72.9, 71.7, 71.5, 61.3, 60.9, 60.8, 49.1, 47.7, 40.9, 
40.3, 27.9, 27.4, 27.3, 27.3, 27.2, 25.9, 25.9, 21.2, 21.2, 18.2, 18.2, 18.1, 17.7, 15.0, 14.9, 2.1, 1.9, –
4.3, –4.4, –4.6, –4.7.143 FTIR (thin film) cm-1: 3359, 2952, 1618, 1590, 1371, 1252, 1076, 1035, 844, 
698. HRMS (ESI) calc’d for C104H135O21Si4 [M+H]+: 1831.8567, found 1831.8516. [α]D23: –148 (c = 
0.40, CH2Cl2). TLC (13% EtOAc in hexanes), Rf: 0.58 (UV, CAM). 
  
                                                                                                                                                                       
143 Due to the pseudo-C2-symmetric nature of (–)-129a and the presence of multiple benzyl groups, two carbon 
resonances of the benzyl group(s) of (–)-129a are unresolved as determined by comparison with related 
structures. 
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Binaphthalene (+)-129b: A 25-mL round-bottom flask was charged with (+)-128b (32.0 mg, 16.5 
µmol, 1.00 equiv) and DTBMP (15.0 mg, 73.0 µmol, 4.44 equiv) and was then azeotropically dried 
with five portions of benzene. MeCN (3.5 mL) was introduced, and the resultant solution cooled to 0 
°C. A solution of DMTSF (17.7 mg, 90.3 µmol, 5.48 equiv) in MeCN (200 µL) was then added 
dropwise via syringe to the stirred reaction mixture. The transfer was completed with two additional 
portions of MeCN (100 µL). After 30 min, the stirred reaction mixture was allowed to warm to 
ambient temperature before saturated aqueous NaHCO3 solution (5 mL) was added. The mixture was 
partitioned with Et2O (10 mL) and hexanes (10 mL) and the layers were separated. The combined 
organic layers were washed with saturated aqueous NaHCO3 solution (2 × 10 mL) and brine (10 mL), 
dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was 
then purified by flash column chromatography (silica gel, eluent: gradient, 2% → 9% EtOAc in 
hexanes) to afford binaphthalene (+)-129b144 (27.0 mg, 89%) as an orange film.1H NMR (600 MHz, 
CD2Cl2) d: 14.84 (s, 1H), 14.16 (s, 1H), 9.49 (s, 1H), 7.46–7.35 (m, 13H), 7.32–7.27 (m, J = 5.1, 7.3 
Hz, 2H), 7.11–7.04 (m, 8H), 7.02 (dd, J = 1.2, 7.8 Hz, 2H), 5.09 (d, J = 4.4 Hz, 1H), 5.08 (d, J = 4.4 
Hz, 1H), 5.06–5.00 (m, 3H), 4.91 (d, J = 11.5 Hz, 2H), 4.80 (d, J = 10.6 Hz, 1H), 4.73 (d, J = 4.7 Hz, 
1H), 4.71 (d, J = 4.7 Hz, 1H), 4.31–4.27 (m, 3H), 4.23 (d, J = 4.7 Hz, 1H), 3.96–3.92 (m, 4H), 3.90–
3.88 (m, 4H), 3.83 (s, 3H), 3.58 (dt, J = 1.2, 15.4 Hz, 1H), 3.08 (dd, J = 13.4, 18.1 Hz, 1H), 2.54 (td, J 
                                                                                                                                                                       
144 Minor oxidation of (+)-129b occurs during purification and handling. 
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= 4.8, 13.9 Hz, 1H), 2.48 (td, J = 5.4, 13.2 Hz, 1H), 2.15 (ddd, J = 4.1, 12.5, 14.3 Hz, 1H), 2.04–1.97 
(ddd, J = 4.1, 12.5, 14.6 Hz, 1H), 1.90 (ddd, J = 5.0, 12.1, 14.1 Hz, 1H), 1.83 (ddd, J = 4.8, 12.0, 14.3 
Hz, 1H), 1.61–1.48 (m, 2H), 1.47–1.40 (m, 1H), 1.38–1.33 (m, 1H), 1.31 (s, 3H), 1.30 (s, 3H), 1.26 
(s, 3H), 1.23 (s, 3H), 0.98 (s, 9H), 0.97 (s, 9H), 0.87 (t, J = 7.3 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H), 0.22 
(s, 9H), 0.20 (s, 9H), 0.14 (s, 6H), 0.12 (s, 3H), 0.12 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ: 204.4, 
204.3, 165.5, 157.6, 154.4, 153.2, 152.7, 152.4, 143.0, 142.5, 141.1, 139.6, 139.4, 139.2, 138.8, 
138.6, 135.8, 135.7, 129.8, 129.6, 129.4, 128.7, 128.7, 128.5, 128.4, 128.4, 128.4, 128.0, 127.9, 
127.8, 127.7, 127.7, 124.6, 123.4, 122.1, 120.5, 117.2, 116.2, 113.0, 112.9, 110.5, 110.2, 109.8, 87.9, 
87.7, 87.0, 86.3, 83.6, 83.3, 82.0, 81.8, 77.8, 76.3, 76.1, 73.6, 73.4, 71.9, 71.7, 61.6, 61.3, 61.2, 49.5, 
48.1, 40.8, 40.2, 28.5, 28.1, 28.0, 27.8, 27.6, 26.3, 26.3, 21.7, 18.6, 18.6, 18.3, 18.0, 15.3, 15.2, 2.4, 
2.3, –4.0, –4.0, –4.2, –4.3.145 FTIR (thin film) cm-1: 3369, 2991, 1618, 1590, 1372, 1252, 1076, 1037, 
842, 738, 698. HRMS (ESI) calc’d for C110H135O21Si4 [M+H]+: 1831.8567, found 1831.8497. [α]D23: 
+319 (c = 0.40, CH2Cl2). TLC (13% EtOAc in hexanes), Rf: 0.41 (UV, CAM). 
  
                                                                                                                                                                       
145 Due to the pseudo-C2-symmetric nature of (+)-129b and the presence of multiple benzyl groups, one carbon 
resonance of a benzyl group of (+)-129b is unresolved as determined by comparison with related structures. 
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Nonacycle (–)-130a: A 10-mL round-bottom flask was charged with (–)-129a (27.0 mg, 14.7 µmol, 
1.00 equiv) and was azeotropically dried with four portions of benzene. PhMe (3 mL) was introduced 
and the resultant solution was cooled to 0 °C. A solution of DDQ (12.5 mg, 55.1 µmol, 3.74 equiv) in 
PhMe (500 µL) was added dropwise via cannula to the stirred reaction mixture. The transfer was 
completed with two additional portions of PhMe (100 µL). After 3 h, a 1:1 mixture of 1% (w/v) 
aqueous NaHSO3 solution (5 mL) and saturated aqueous NaHCO3 solution (5 mL) was added to the 
reaction mixture. The mixture was diluted with Et2O (10 mL) and hexanes (10 mL), and the layers 
were separated. The combined organic layers were washed with a 1:1 mixture of 1% (w/v) aqueous 
NaHSO3 solution and saturated aqueous NaHCO3 solution (2 × 10 mL), saturated aqueous NaHCO3 
solution (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure to afford crude naphthazarin S13, which was used without further purification. 
A 100-mL round-bottom flask was charged with crude S13 and azeotropically dried with five 
portions of benzene. 1,2-dichloroethane was then introduced (35 mL), and the resultant solution was 
cooled to 0 °C. A solution of anhydrous HCl in Et2O (2.0 M, 370 µL, 740 µmol, 50 equiv) was added 
dropwise via syringe to the stirred solution. After 15 h, saturated aqueous NaHCO3 solution (10 mL) 
was added to the stirred reaction mixture. The mixture was diluted with Et2O (35 mL) and hexanes 
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(35 mL), and the layers were separated. The combined organic layers were washed with saturated 
aqueous NaHCO3 solution (2 × 40 mL), and brine (40 mL), dried over anhydrous Na2SO4, filtered, 
and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 5% → 10% EtOAc in hexanes) to afford nonacycle (–)-
130a (20.2 mg, 77% over two steps) as an orange film. 1H NMR (600 MHz, CD2Cl2) d: 14.92 (s, 
1H), 13.76 (s, 1H), 9.58 (s, 1H), 7.49–7.42 (m, 9H), 7.38 (t, J = 7.7 Hz, 4H), 7.32–7.29 (m, 2H), 
7.12–7.05 (m, 6H), 7.02 (t, J = 7.5 Hz, 2H), 6.93 (d, J = 7.2 Hz, 2H), 5.89 (s, 1H), 5.12 (d, J = 10.6 
Hz, 1H), 5.08–4.99 (m, 4H), 4.95–4.86 (m, 4H), 4.72 (d, J = 11.6 Hz, 1H), 4.32 (d, J = 3.4 Hz, 1H), 
4.28 (dd, J = 4.4, 8.7 Hz, 1H), 4.17 (dd, J = 3.7, 7.8 Hz, 1H), 4.10 (d, J = 7.8 Hz, 1H), 3.89 (dd, J = 
3.4, 8.7 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.78–3.74 (m, 4H), 3.62 (dd, J = 14.4, 15.3 Hz, 1H), 3.29 
(dd, J = 5.2, 17.0 Hz, 1H), 2.50 (td, J = 5.0, 13.7 Hz, 1H), 2.44 (d, J = 3.7 Hz, 1H), 2.20 (ddd, J = 4.1, 
12.0, 14.2 Hz, 1H), 1.89 (dt, J = 4.4, 13.3 Hz, 1H), 1.84–1.71 (m, 2H), 1.69–1.42 (m, 3H), 1.31 (s, 
3H), 1.23–1.20 (m, 4H), 1.07 (dt, J = 3.6, 13.0 Hz, 1H), 0.95 (s, 9H), 0.94 (s, 9H), 0.91 (t, J = 7.5 Hz, 
3H), 0.81 (t, J = 7.3 Hz, 3H), 0.25 (s, 9H), 0.18 (s, 9H), 0.13 (s, 3H), 0.11 (s, 6H), 0.06 (s, 3H). 13C 
NMR (126 MHz, CD2Cl2) δ: 204.4, 203.8, 165.5, 158.5, 154.6, 153.24, 153.17, 152.6, 143.8, 143.0, 
140.05, 139.99, 139.4, 139.3, 138.6, 138.4, 135.8, 135.7, 129.9, 129.7, 129.5, 128.8, 128.7, 128.5, 
128.4, 128.2, 128.1, 127.9, 127.8, 127.7, 125.3, 124.9, 122.6, 121.8, 118.7, 116.2, 113.0, 110.5, 
109.9, 109.4, 88.1, 87.9, 87.8, 85.9, 85.1, 83.5, 82.2, 78.1, 76.5, 76.1, 75.5, 74.5, 73.2, 72.6, 71.8, 
69.9, 61.7, 61.2, 61.2, 58.6, 49.5, 41.2, 35.8, 27.7, 27.6, 27.5, 26.3, 26.2, 18.6, 18.5, 18.4, 16.8, 15.3, 
15.2, 2.3, 2.1, –4.0, –4.0, –4.1, –4.2.146 FTIR (thin film) cm-1: 3348, 2953, 1617, 1372, 1252, 1080, 
842, 738, 698. HRMS (ESI) calc’d for C101H128O21NaSi4 [M+Na]+: 1811.7917, found 1811.7824. 
[α]D23: –195 (c = 0.40, CH2Cl2). TLC (17% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
                                                                                                                                                                       
146 Due to the pseudo-C2-symmetric nature of (–)-130a and the presence of multiple benzyl groups, three carbon 
resonances of the benzyl group(s) of (–)-130a are unresolved as determined by comparison with related 
structures. 
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Nonacycle (+)-130b: A 25-mL round-bottom flask was charged with (+)-129b (21.1 mg, 11.5 µmol, 
1.00 equiv) and was azeotropically dried with four portions of benzene. PhMe (2.5 mL) was 
introduced and the resultant solution was cooled to 0 °C. A solution of DDQ (10.0 mg, 44.0 µmol, 
3.83 equiv) in PhMe (500 µL) was added dropwise via cannula to the stirred reaction mixture. The 
transfer was completed with two additional portions of PhMe (100 µL), and the stirred reaction was 
subsequently allowed to warm to ambient temperature. After 4 h, a 1:1 mixture of 1% (w/v) aqueous 
NaHSO3 solution (5 mL) and saturated aqueous NaHCO3 solution (5 mL) was added to the reaction 
mixture. The mixture was diluted with Et2O (10 mL) and hexanes (10 mL), and the layers were 
separated. The combined organic layers were washed with a 1:1 mixture of a 1% (w/v) aqueous 
NaHSO3 solution and saturated aqueous NaHCO3 solution (2 × 10 mL), saturated NaHCO3 aqueous 
solution (10 mL), and brine (10 mL), dried over anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure to afford crude naphthazarin S14, which was used immediately without further 
purification. 
A 100-mL round-bottom flask was charged with crude S14 and was azeotropically dried with 
four portions of benzene. 1,2-dichloroethane (25 mL) was then introduced, and the resultant solution 
was cooled to 4 °C. A solution of anhydrous HCl in Et2O (2.0 M, 350 µL, 690 µmol, 60 equiv) was 
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added dropwise via syringe to the stirred solution. After 25 h, saturated aqueous NaHCO3 solution (10 
mL) was added to the stirred reaction mixture. The mixture was diluted with Et2O (25 mL) and 
hexanes (25 mL), and the layers were separated. The combined organic layers were washed with 
saturated aqueous NaHCO3 solution (2 × 40 mL), and brine (40 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 10% → 13% → 17% EtOAc in hexanes) to afford 
nonacycle (+)-130b (17.9 mg, 86% over two steps) as an orange film. 1H NMR (600 MHz, CD2Cl2) 
d: 14.84 (s, 1H), 13.73 (s, 1H), 9.55 (s, 1H), 7.49–7.40 (m, 10H), 7.37 (td, J = 7.5, 2.2 Hz 4H), 7.30 
(t, J =7.5 Hz, 2H), 7.10–7.02 (m, 9H), 5.89 (s, 1H), 5.11 (d, J = 10.9 Hz, 1H), 5.08 (d, J = 5.6 Hz, 
1H), 5.07–5.04 (m, 2H), 5.01 (d, J = 10.3 Hz, 1H), 4.95 (d, J = 13.7 Hz, 1H), 4.90 (d, J = 12.2 Hz, 
1H), 4.88 (d, J = 12.2 Hz, 1H), 4.74 (d, J = 5.3 Hz, 1H), 4.72 (d, J = 6.9 Hz, 1H), 4.31–4.26 (m, 3H), 
4.20 (dd, J = 3.8, 7.5 Hz, 1H), 4.09 (br. t, J = 6.2 Hz, 1H), 3.91 (s, 3H), 3.90–3.86 (m, 4H), 3.83 (s, 
3H), 3.75 (t, J = 7.7 Hz, 1H), 3.59 (t, J = 15.3 Hz, 1H), 3.29 (dd, J = 5.3, 17.2 Hz, 1H), 2.53 (td, J = 
5.0, 13.8 Hz, 1H), 2.50 (d, J = 3.7 Hz, 1H), 2.15 (ddd, J = 3.9, 12.1, 14.3 Hz, 1H), 1.88–1.79 (m, 2H), 
1.76 (br. d, J = 7.2 Hz, 1H), 1.67–1.51 (m, 2H), 1.49–1.37 (m, 1H), 1.31 (s, 3H), 1.24–1.18 (m, 4H), 
1.04–0.98 (m, 10H), 0.97 (s, 9H), 0.89 (t, J = 7.3 Hz, 3H), 0.79 (t, J = 7.3 Hz, 3H), 0.27 (s, 9H), 0.19 
(s, 9H), 0.16 (s, 3H), 0.13 (s, 3H), 0.13 (s, 3H), 0.12 (s, 3H). 13C NMR (126 MHz, CD2Cl2) δ: 204.4, 
203.7, 165.4, 158.5, 154.6, 153.3, 153.2, 152.5, 143.8, 143.1, 140.0, 139.9, 139.4, 139.3, 138.9, 
138.5, 135.8, 135.6, 130.0, 129.8, 129.5, 128.8, 128.7, 128.4, 128.4, 128.3, 128.2, 128.0, 127.9, 
127.9, 127.8, 127.5, 127.3, 125.2, 125.0, 122.5, 121.9, 118.7, 116.1, 112.9, 110.6, 109.8, 109.8, 88.1, 
87.9, 87.9, 86.3, 85.1, 83.3, 82.1, 78.1, 76.4, 76.1, 75.5, 74.5, 73.4, 72.6, 71.7, 69.9, 61.8, 61.3, 61.1, 
58.6, 49.5, 40.8, 35.8, 28.1, 27.8, 27.7, 26.3, 26.2, 18.6, 18.5, 18.3, 16.8, 15.3, 15.2, 2.3, 2.1, –4.0, –
4.0, –4.0, –4.2. FTIR (thin film) cm-1: 3356, 2953, 1653, 1373, 1252, 1081, 844, 737, 697. HRMS 
(ESI) calc’d for C101H129O21Si4 [M+H]+: 1789.8098, found 1789.8146. [α]D23: +233 (c = 0.40, 
CH2Cl2). TLC (17% EtOAc in hexanes), Rf: 0.21 (UV, CAM).  
213
  
  
Hibarimicinone (6): Concentrated aqueous HF solution (48 wt. %, 3 mL) was slowly added to a 
stirred solution of (–)-130a (11.5 mg, 6.40 µmol, 1.00 equiv) in 1:1 MeCN/THF (6 mL) in a 
polyethylene vessel at ambient temperature. After 13 h, the reaction mixture was cautiously poured 
into a vigorously stirred mixture of saturated aqueous NaHCO3 solution (50 mL), Et2O (30 mL), and 
ice at 0 °C. After gas evolution ceased, the stirred mixture was diluted with EtOAc (50 mL) and the 
layers were separated. The organic layer was washed with a saturated aqueous NaHCO3 solution (3 × 
50 mL), and brine (50 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was then quickly passed through a plug of silica gel (eluent: gradient, 20% → 
50% EtOAc in hexanes) to afford crude nonacycle S15 as an orange film, which was used without 
further purification. 
A 25-mL round-bottom flask was charged with crude S15 and EtOAc (8.5 mL). Palladium 
hydroxide on carbon (20 wt. % loading (dry basis), 88.0 mg, 125 µmol, 19.6 equiv) was added in a 
single portion to the stirred solution, which was subsequently sparged with hydrogen gas for 5 min. 
The stirred reaction mixture was maintained under a balloon of hydrogen gas for an additional 5 min 
before the balloon was removed. After an additional 10 min, the hydrogen balloon was removed and 
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the stirred reaction mixture was sparged with argon gas. After 2 min, a solution of HCl in MeOH (1.5 
M, 8.5 mL) was rapidly added via syringe to the stirred reaction mixture, which was then immediately 
filtered through a 0.2 µm PVDF syringe filter to give an orange-yellow homogeneous solution. The 
resultant orange-yellow solution was stirred under ambient atmosphere and turned red over time. 
After 8 h, the solution was partitioned with EtOAc (50 mL) and brine (25 mL), and the layers were 
separated. The organic layer was washed with brine (2 × 25 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The resultant maroon film was purified by semi-
preparatory HPLC on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 250 mm, UV detection at 254 
nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: aqueous 0.15% (v/v) KH2PO4 pH 
3.5 buffer, isocratic elution with 60% A for 20 min, flow rate: 4.0 mL/min]. Fractions eluting at 10–
13 min were collected and washed with hexanes (5 × 100 mL) and concentrated under reduced 
pressure. The residue was dissolved in EtOAc (50 mL) and washed with brine (3 × 25 mL), dried 
over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford hibarimicinone 
(6) (4.8 mg, 81%) as a dark maroon film. 1H NMR (600 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, 
pD ~1) d: 7.35 (s, 1H), 5.83 (s, 1H), 4.10–4.05 (m, 2H), 3.98 (d, J = 7.9 Hz, 1H), 3.97 (s, 3H), 3.94 (s, 
3H), 3.96–3.92 (m, 1H), 3.85 (s, 3H), 3.80 (t, J = 8.5 Hz, 1H), 3.73 (d, J = 9.4 Hz, 1H), 3.75–3.69 (m, 
1H), 3.18 (dd, J = 6.0, 17.1 Hz, 1H), 2.65 (td, J = 5.6, 13.3 Hz, 1H), 2.57 (d, J = 3.8 Hz, 1H), 1.88 (dt, 
J = 4.2, 13.4 Hz, 1H), 1.81 (dt, J = 4.2, 13.4 Hz, 1H), 1.77–1.65 (m, 2H), 1.51–1.41 (m, 1H), 1.39–
1.30 (m, 1H), 1.26–1.18 (m, 1H), 1.01 (dt, J = 4.2, 13.4 Hz, 1H), 0.88 (t, J = 7.0 Hz, 3H), 0.79 (t, J = 
7.2 Hz, 3H). 13C NMR (126 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, pD ~1) δ: 207.4, 198.4, 
189.1, 186.3, 165.4, 160.0, 158.0, 154.2, 153.3, 151.9, 149.4, 142.1, 139.7, 136.3, 127.5, 126.7, 
117.7, 114.3, 112.6, 112.3, 109.7, 109.2, 87.6, 84.9, 80.7, 80.1, 79.2, 76.0, 75.1, 74.1, 71.6, 71.3, 
69.1, 61.7, 61.7, 61.6, 58.7, 48.1, 39.0, 36.1, 28.6, 19.3, 17.6, 15.7, 15.3. FTIR (thin film) cm-1: 3389, 
2944, 1692, 1625, 1412, 1188, 1032. HRMS (ESI) calc’d for C45H49O21 [M+H]+: 925.2761, found 
925.2747. TLC (silica gel RP-18, 45% water in MeCN), Rf: 0.55 (UV).  
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atrop-Hibarimicinone (7): Concentrated aqueous HF solution (48 wt. %, 3 mL) was slowly added to 
a stirred solution of (–)-130b (9.7 mg, 5.4 µmol, 1.0 equiv) in 1:1 MeCN/THF (6 mL) in a 
polyethylene vessel at ambient temperature. After 13 h, the reaction mixture was cautiously poured 
into a vigorously stirred mixture of saturated aqueous NaHCO3 solution (50 mL), Et2O (30 mL), and 
ice at 0 °C. After gas evolution ceased, the stirred mixture was diluted with EtOAc (50 mL) and the 
layers were separated. The organic layer was washed with a saturated aqueous NaHCO3 solution (3 × 
50 mL), and brine (50 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was then quickly passed through a plug of silica gel (eluent: gradient, 20% → 
50% EtOAc in hexanes) to afford crude nonacycle S16 as an orange film, which was used without 
further purification. 
A 25-mL round-bottom flask was charged with crude S16 and EtOAc (7 mL). Palladium 
hydroxide on carbon (20 wt. % loading (dry basis), 75.0 mg, 105 µmol, 19.3 equiv) was added in a 
single portion to the stirred solution, which was subsequently sparged with hydrogen gas for 5 min. 
The stirred reaction mixture was maintained under a balloon of hydrogen gas for an additional 5 min 
before the balloon was removed. After an additional 10 min, the hydrogen balloon was removed and 
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the stirred reaction mixture was sparged with argon gas. After 2 min, a solution of HCl in MeOH (1.5 
M, 7 mL) was rapidly added via syringe to the stirred reaction mixture, which was then immediately 
filtered through a 0.2 µm PVDF syringe filter to give an orange-yellow homogeneous solution. The 
resultant orange-yellow solution was stirred under ambient atmosphere and turned red over time. 
After 8 h, the solution was partitioned with EtOAc (50 mL) and brine (25 mL), and the layers were 
separated. The organic layer was washed with brine (2 × 25 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The resultant maroon film was purified by semi-
preparatory HPLC on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 250 mm, UV detection at 254 
nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: aqueous 0.15% (v/v) KH2PO4 pH 
3.5 buffer, isocratic elution with 60% A for 20 min, flow rate: 3.5 mL/min]. Fractions eluting at 10–
13 min were collected and washed with hexanes (5 × 100 mL) and concentrated under reduced 
pressure. The residue was dissolved in EtOAc (50 mL) and washed with brine (3 × 25 mL), dried 
over anhydrous Na2SO4, filtered, and concentrated under reduced pressure to afford atrop-
hibarimicinone (7) (3.0 mg, 60%) as a dark maroon film. 1H NMR (600 MHz, ~50:1 CD3OD/20 
wt.% DCl in D2O, pD ~1) d: 7.35 (s, 1H), 5.84 (s, 1H), 4.11–4.06 (m, 2H), 3.99 (d, J = 7.9 Hz, 1H), 
3.96 (s, 3H), 3.94 (s, 3H), 3.95–3.91 (m, 1 H), 3.85 (s, 3H), 3.80 (t, J = 8.2 Hz, 1H), 3.74 (d, J = 9.4 
Hz, 1H), 3.76–3.68 (m, 1H), 2.66 (td, J = 5.7, 13.4 Hz, 1H), 2.58 (d, J = 3.5 Hz, 1H), 1.89 (dt, J = 4.1, 
13.8 Hz, 1H), 1.80 (dt, J = 4.4, 13.5 Hz, 3 H), 1.77–1.66 (m, 2H), 1.53–1.43 (m, 1H), 1.39–1.30 (m, 
1H), 1.28–1.19 (m, 1H), 1.00 (dt, J = 4.5, 13.3 Hz, 1H), 0.89 (t, J = 7.3 Hz, 3H), 0.80 (t, J = 7.3 Hz, 
3H). 13C NMR (126 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, pD ~1) δ: 207.4, 198.4, 189.2, 186.2, 
165.3, 160.0, 157.9, 154.3, 153.2, 151.9, 149.4, 142.1, 139.8, 136.2, 127.2, 126.7, 117.6, 114.3, 
112.6, 112.3, 109.7, 109.3, 87.6, 84.9, 80.7, 80.0, 79.2, 76.0, 75.1, 74.1, 71.7, 71.3, 69.1, 61.7, 61.7, 
61.6, 58.7, 48.0, 39.0, 36.2, 28.6, 19.3, 17.6, 15.7, 15.3. FTIR (thin film) cm-1: 3489, 2956, 1694, 
1625, 1408, 1200, 1057. HRMS (ESI) calc’d for C45H49O21 [M+H]+: 925.2761, found 925.2745. 
TLC (silica gel RP-18, 45% water in MeCN), Rf: 0.55 (UV).  
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HMP-P1 (10), and Hibarimicinone (6) and atrop-hibarimicinone (7) isomerization studies: 
From 6: To a stirred solution of 6 (3.2 mg, 3.5 µmol, 1.0 equiv) in MeOH (5 mL) was added 
an aqueous NaH2PO4/NaOH pH 7.5 buffered solution (0.20 M, 25 µL). The progress of the reaction 
was monitored by HPLC analysis of small aliquots on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 
250 mm, UV detection at 254 nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: 
0.05% (v/v) trifluoroacetic acid in water, injection volume 200 μL (methanol/10% (v/v) HCl in 
water), isocratic elution with 60% A for 25 min, flow rate: 3.0 mL/min]. See Appendix C Figure S6 
for HPLC traces. During this time, the reaction color changes from brownish red to indigo. After 27 
h, the reaction mixture was acidified with a solution of HCl in MeOH (1.5 N, 100 µL), whereupon the 
reaction turns purple. The reaction mixture was then concentrated under reduced pressure. The 
residue was then purified by semi-preparatory HPLC on a Cosmosil 5C18-AR-II column [5 μm, 10.0 
× 250 mm, UV detection at 254 nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: 
0.05% (v/v) trifluoroacetic acid in water, isocratic elution with 60% A for 25 min, flow rate: 3.5 
mL/min]. Fractions eluting at 17–21 min were collected and concentrated under reduced pressure to 
afford HMP-P1 (10) (2.6 mg, 84%) as a dark purple film. 
From 7: To a stirred solution of 7 (2.7 mg, 3.5 µmol, 1.0 equiv) in MeOH (5 mL) was added 
an aqueous NaH2PO4/NaOH pH 7.5 buffered solution (0.20 M, 25 µL). The progress of the reaction 
was monitored by HPLC analysis of small aliquots on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 
250 mm, UV detection at 254 nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: 
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0.05% (v/v) trifluoroacetic acid in water, injection volume 200 μL (methanol/10% (v/v) HCl in 
water), isocratic elution with 60% A for 25 min, flow rate: 3.0 mL/min]. See Appendix C Figure S7 
for HPLC traces. During this time, the reaction color changes from brownish red to indigo. After 27 
h, the reaction mixture was acidified with a solution of HCl in MeOH (1.5 N, 100 µL), whereupon the 
reaction turns purple. The reaction mixture was then concentrated under reduced pressure. The 
residue was then purified by semi-preparatory HPLC on a Cosmosil 5C18-AR-II column [5 μm, 10.0 
× 250 mm, UV detection at 254 nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: 
0.05% (v/v) trifluoroacetic acid in water, isocratic elution with 60% A for 25 min, flow rate: 3.5 
mL/min]. Fractions eluting at 17–21 min were collected and concentrated under reduced pressure to 
afford HMP-P1 (10) (2.2 mg, 84%) as a dark purple film. 
2-mL vials were charged with either a dilute solution of 6 or 7 in acidic methanol (1.0 M) and 
were heated to 60 °C for 90 minutes. The solutions were then cooled to room temperature and 
analyzed by HPLC analysis on a Cosmosil 5C18-AR-II column [5 μm, 10.0 × 250 mm, UV detection 
at 254 nm, 23 ± 2 °C column temperature, solvent A: MeOH, solvent B: 0.05% (v/v) trifluoroacetic 
acid in water, injection volume 200 μL (methanol/10% (v/v) HCl in water), isocratic elution with 
60% A for 25 min, flow rate: 3.0 mL/min]. See Appendix C Figure S8–S11 for HPLC traces. 1H 
NMR (600 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, pD ~1) d: 7.30 (s, 1H), 5.87 (s, 1H), 4.20 (dd, 
J = 3.7, 8.3 Hz, 1H), 4.11 (dd, J = 5.9, 10.0 Hz, 1H), 4.08 (s, 3H), 4.05 (s, 3H), 4.02 (d, J = 7.9 Hz, 
1H), 3.93 (t, J = 9.5 Hz, 1H), 3.85 (t, J = 7.9 Hz, 1H), 3.71 (d, J = 9.1 Hz, 1H), 3.67 (dd, J = 14.4, 
17.6 Hz, 1H), 3.17 (dd, J = 5.3, 17.0 Hz, 1H), 2.94 (d, J = 3.8 Hz, 1H), 2.68 (td, J = 5.8, 13.0 Hz, 
1H), 1.87 (dt, J = 3.5, 13.3 Hz, 1H), 1.75–1.64 (m, 2H), 1.63–1.55 (m, 1H), 1.50–1.39 (m, 1H), 1.33–
1.18 (m, 2H), 0.98 (dt, J = 3.8, 13.2 Hz, 1H), 0.87 (t, J = 7.2 Hz, 3H), 0.78 (t, J = 7.3 Hz, 3H). 13C 
NMR (126 MHz, DMSO-d6) δ: 207.7, 196.8, 183.0, 177.1, 160.7, 157.7, 152.2, 151.0, 150.3, 148.9, 
146.9, 144.9, 144.4, 134.3, 125.6, 125.5, 116.9, 115.8, 114.5, 113.8, 111.4, 107.2, 86.1, 83.4, 79.3, 
78.5, 77.3, 73.8, 72.8, 72.2, 69.5, 69.5, 66.9, 62.2, 61.6, 57.1, 46.4, 37.5, 34.9, 28.2, 17.7, 15.8, 15.3, 
14.9. FTIR (thin film) cm-1: 3421, 2925, 1697, 1633, 1458, 1415, 1123, 1031. HRMS (ESI) calc’d 
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for C44H45O21 [M+H]+: 893.2499, found 823.2485. TLC (silica gel RP-18, 45% water in MeCN), Rf: 
0.60 (UV). 
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Table S1. 13C NMR data comparison between reported natural and synthetic (+)-fastigiatine (37). 
Literature Report147 (13C, 101 MHz, CDCl3) This Report (13C, 126 MHz, CDCl3) 
21.1 21.3 
21.5 21.7 
22.3 22.5 
23.0 23.1 
25.5 25.7 
33.9 34.0 
34.6 34.7 
35.0 35.2 
37.4 37.5 
38.3 38.5 
40.2 40.3 
45.3 45.5 
45.5 45.6 
55.0 55.2 
59.6 59.8 
65.4 65.6 
123.1 123.3 
139.2 139.3 
170.0 170.2 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Comparison of 13C NMR spectra of natural and synthetic (+)-fastigiatine (37). 
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
147 Gerard, R. V.; MacLean, D. B.; Fagianni, R.; Lock, C. J. Can. J. Chem. 1986, 64, 943–949. Tabulated 1H 
NMR data was not provided. 
Synthetic (+)-Fastigiatine (37) 
Natural (+)-Fastigiatine (37) 
222
 
 
Figure S2. Comparison of 1H NMR spectra of natural and synthetic (+)-fastigiatine (37). 
  
Fastigiatine-H.esp
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)
Synthetic (+)-Fastigiatine (37) 
Natural (+)-Fastigiatine (37) 
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View 1: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
View 2: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. X-Ray crystal structure of (+)-fastigiatine (37). 
224
 
X-Ray Crystallography.  A crystal mounted on a diffractometer was collected data at 100 K.  The 
intensities of the reflections were collected by means of a Bruker APEX II CCD diffractometer (MoKα 
radiation, λ=0.71073 Å), and equipped with an Oxford Cryosystems nitrogen flow apparatus.  The 
collection method involved 0.5° scans in ω at 28° in 2θ.  Data integration down to 0.78 Å resolution 
was carried out using SAINT V7.46 A (Bruker diffractometer, 2009) with reflection spot size 
optimisation.  Absorption corrections were made with the program SADABS (Bruker diffractometer, 
2009).  The structure was solved by the direct methods procedure and refined by least-squares 
methods again F2 using SHELXS-97 and SHELXL-97 (Sheldrick, 2008).  Non-hydrogen atoms were 
refined anisotropically, and hydrogen atoms were allowed to ride on the respective atoms.  Crystal 
data as well as details of data collection and refinement are summarized in Table 1, and geometric 
parameters are shown in Table 2.  The Ortep plots produced with SHELXL-97 program, and the other 
drawings were produced with Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
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Table S2. Experimental details. 
Crystal data 
Chemical formula C19H28N2O 
Mr 300.43 
Crystal system, space group ORTHORHOMBIC, P212121 
Temperature (K) 100 
a, b, c (Å) 8.3421 (5), 8.7999 (5), 22.1725 (12) 
V (Å3) 1627.68 (16) 
Z 4 
Radiation type Mo Ka 
m (mm-1) 0.08 
Crystal size (mm) 0.38 × 0.24 × 0.08 
Data collection 
Diffractometer CCD area detector 
Absorption correction Multi-scan SADABS 
 Tmin, Tmax 0.972, 0.994 
No. of measured, independent 
and observed [I > 2s(I)] 
reflections 
47047, 3894, 3780   
Rint 0.041 
Refinement 
R[F2 > 2s(F2)], wR(F2), S 0.036,  0.094,  1.06 
No. of reflections 3894 
No. of parameters 202 
No. of restraints 0 
H-atom treatment H-atom parameters constrained 
Dρmax, Dρmin (e Å-3) 0.38, -0.16 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter -1.1 (11) 
 
Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
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Table S3. Selected geometric parameters (Å, º) 
O1—C17 1.2306 (14) C9—C14 1.5370 (16) 
N1—C16 1.4613 (15) C9—C10 1.5426 (16) 
N1—C1 1.4906 (15) C9—H9 1.0000 
N1—C13 1.4919 (14) C10—C11 1.5357 (16) 
N2—C17 1.3655 (14) C10—H10A 0.9900 
N2—C7 1.4298 (14) C10—H10B 0.9900 
N2—C6 1.4759 (14) C11—C19 1.5290 (15) 
C1—C2 1.5213 (16) C11—C12 1.5323 (16) 
C1—H1B 0.9900 C11—H11 1.0000 
C1—H1A 0.9900 C12—C13 1.5260 (14) 
C2—C15 1.5520 (16) C12—H12A 0.9900 
C2—C3 1.5567 (15) C12—H12B 0.9900 
C2—H2 1.0000 C13—C14 1.5481 (15) 
C3—C7 1.5184 (15) C14—C15 1.5564 (15) 
C3—C4 1.5433 (15) C14—H14 1.0000 
C3—C13 1.5593 (15) C15—H15B 0.9900 
C4—C5 1.5291 (16) C15—H15A 0.9900 
C4—H4B 0.9900 C16—H16A 0.9800 
C4—H4A 0.9900 C16—H16B 0.9800 
C5—C6 1.5234 (15) C16—H16C 0.9800 
C5—H5B 0.9900 C17—C18 1.5104 (16) 
C5—H5A 0.9900 C18—H18A 0.9800 
C6—H6B 0.9900 C18—H18C 0.9800 
C6—H6A 0.9900 C18—H18B 0.9800 
C7—C8 1.3348 (15) C19—H19A 0.9800 
C8—C9 1.5109 (16) C19—H19B 0.9800 
C8—H8 0.9500 C19—H19C 0.9800 
C16—N1—C1 112.32 (9) C9—C10—H10A 109.3 
C16—N1—C13 116.88 (9) C11—C10—H10B 109.3 
C1—N1—C13 106.28 (8) C9—C10—H10B 109.3 
C17—N2—C7 124.84 (9) H10A—C10—H10B 108.0 
C17—N2—C6 117.62 (9) C19—C11—C12 109.98 (10) 
C7—N2—C6 117.55 (9) C19—C11—C10 111.36 (9) 
227
 
Table S3. (continued) 
N1—C1—C2 103.02 (9) C12—C11—C10 111.12 (10) 
N1—C1—H1B 111.2 C19—C11—H11 108.1 
C2—C1—H1B 111.2 C12—C11—H11 108.1 
N1—C1—H1A 111.2 C10—C11—H11 108.1 
C2—C1—H1A 111.2 C13—C12—C11 115.78 (9) 
H1B—C1—H1A 109.1 C13—C12—H12A 108.3 
C1—C2—C15 107.09 (10) C11—C12—H12A 108.3 
C1—C2—C3 100.70 (9) C13—C12—H12B 108.3 
C15—C2—C3 102.40 (9) C11—C12—H12B 108.3 
C1—C2—H2 115.0 H12A—C12—H12B 107.4 
C15—C2—H2 115.0 N1—C13—C12 110.05 (9) 
C3—C2—H2 115.0 N1—C13—C14 112.07 (9) 
C7—C3—C4 110.15 (9) C12—C13—C14 113.58 (9) 
C7—C3—C2 110.56 (9) N1—C13—C3 100.68 (8) 
C4—C3—C2 114.56 (9) C12—C13—C3 119.95 (9) 
C7—C3—C13 112.99 (9) C14—C13—C3 99.58 (8) 
C4—C3—C13 115.01 (9) C9—C14—C13 108.08 (9) 
C2—C3—C13 92.58 (8) C9—C14—C15 113.09 (9) 
C5—C4—C3 110.57 (9) C13—C14—C15 102.04 (9) 
C5—C4—H4B 109.5 C9—C14—H14 111.1 
C3—C4—H4B 109.5 C13—C14—H14 111.1 
C5—C4—H4A 109.5 C15—C14—H14 111.1 
C3—C4—H4A 109.5 C2—C15—C14 103.42 (9) 
H4B—C4—H4A 108.1 C2—C15—H15B 111.1 
C6—C5—C4 110.27 (9) C14—C15—H15B 111.1 
C6—C5—H5B 109.6 C2—C15—H15A 111.1 
C4—C5—H5B 109.6 C14—C15—H15A 111.1 
C6—C5—H5A 109.6 H15B—C15—H15A 109.0 
C4—C5—H5A 109.6 N1—C16—H16A 109.5 
H5B—C5—H5A 108.1 N1—C16—H16B 109.5 
N2—C6—C5 109.59 (9) H16A—C16—H16B 109.5 
N2—C6—H6B 109.8 N1—C16—H16C 109.5 
C5—C6—H6B 109.8 H16A—C16—H16C 109.5 
N2—C6—H6A 109.8 H16B—C16—H16C 109.5 
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Table S3. (continued) 
C5—C6—H6A 109.8 O1—C17—N2 120.14 (10) 
H6B—C6—H6A 108.2 O1—C17—C18 120.89 (10) 
C8—C7—N2 122.02 (10) N2—C17—C18 118.90 (10) 
C8—C7—C3 123.25 (10) C17—C18—H18A 109.5 
N2—C7—C3 114.71 (9) C17—C18—H18C 109.5 
C7—C8—C9 120.25 (10) H18A—C18—H18C 109.5 
C7—C8—H8 119.9 C17—C18—H18B 109.5 
C9—C8—H8 119.9 H18A—C18—H18B 109.5 
C8—C9—C14 109.54 (9) H18C—C18—H18B 109.5 
C8—C9—C10 109.91 (10) C11—C19—H19A 109.5 
C14—C9—C10 110.07 (9) C11—C19—H19B 109.5 
C8—C9—H9 109.1 H19A—C19—H19B 109.5 
C14—C9—H9 109.1 C11—C19—H19C 109.5 
C10—C9—H9 109.1 H19A—C19—H19C 109.5 
C11—C10—C9 111.48 (9) H19B—C19—H19C 109.5 
C11—C10—H10A 109.3   
C16—N1—C1—C2 127.40 (10) C16—N1—C13—C12 71.61 (12) 
C13—N1—C1—C2 -1.59 (11) C1—N1—C13—C12 -162.12 (9) 
N1—C1—C2—C15 -69.42 (11) C16—N1—C13—C14 -55.80 (13) 
N1—C1—C2—C3 37.25 (10) C1—N1—C13—C14 70.47 (11) 
C1—C2—C3—C7 -171.62 (9) C16—N1—C13—C3 -160.82 (10) 
C15—C2—C3—C7 -61.26 (11) C1—N1—C13—C3 -34.55 (10) 
C1—C2—C3—C4 63.21 (11) C11—C12—C13—N1 -173.19 (9) 
C15—C2—C3—C4 173.57 (9) C11—C12—C13—C14 -46.63 (13) 
C1—C2—C3—C13 -55.86 (9) C11—C12—C13—C3 70.83 (13) 
C15—C2—C3—C13 54.49 (10) C7—C3—C13—N1 168.23 (8) 
C7—C3—C4—C5 24.71 (12) C4—C3—C13—N1 -64.11 (11) 
C2—C3—C4—C5 150.10 (9) C2—C3—C13—N1 54.59 (9) 
C13—C3—C4—C5 -104.36 (11) C7—C3—C13—C12 -71.02 (12) 
C3—C4—C5—C6 -65.30 (12) C4—C3—C13—C12 56.64 (13) 
C17—N2—C6—C5 -165.71 (10) C2—C3—C13—C12 175.34 (10) 
C7—N2—C6—C5 14.43 (13) C7—C3—C13—C14 53.43 (11) 
C4—C5—C6—N2 44.39 (12) C4—C3—C13—C14 -178.91 (9) 
C17—N2—C7—C8 -54.47 (16) C2—C3—C13—C14 -60.21 (9) 
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Table S3. (continued) 
C6—N2—C7—C8 125.37 (12) C8—C9—C14—C13 59.78 (11) 
C17—N2—C7—C3 123.82 (11) C10—C9—C14—C13 -61.18 (11) 
C6—N2—C7—C3 -56.34 (13) C8—C9—C14—C15 -52.42 (12) 
C4—C3—C7—C8 -148.97 (10) C10—C9—C14—C15 -173.38 (9) 
C2—C3—C7—C8 83.40 (13) N1—C13—C14—C9 178.98 (9) 
C13—C3—C7—C8 -18.81 (15) C12—C13—C14—C9 53.49 (12) 
C4—C3—C7—N2 32.76 (12) C3—C13—C14—C9 -75.29 (10) 
C2—C3—C7—N2 -94.87 (10) N1—C13—C14—C15 -61.58 (11) 
C13—C3—C7—N2 162.92 (9) C12—C13—C14—C15 172.92 (9) 
N2—C7—C8—C9 177.43 (10) C3—C13—C14—C15 44.15 (10) 
C3—C7—C8—C9 -0.71 (16) C1—C2—C15—C14 76.37 (11) 
C7—C8—C9—C14 -19.20 (14) C3—C2—C15—C14 -29.09 (11) 
C7—C8—C9—C10 101.86 (12) C9—C14—C15—C2 106.68 (10) 
C8—C9—C10—C11 -58.49 (13) C13—C14—C15—C2 -9.16 (11) 
C14—C9—C10—C11 62.25 (12) C7—N2—C17—O1 172.09 (10) 
C9—C10—C11—C19 -174.81 (10) C6—N2—C17—O1 -7.76 (15) 
C9—C10—C11—C12 -51.83 (13) C7—N2—C17—C18 -11.01 (16) 
C19—C11—C12—C13 168.35 (10) C6—N2—C17—C18 169.14 (10) 
C10—C11—C12—C13 44.58 (13)   
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Figure S4. Perspective views showing 50%. 
 
 
 
 
 
Figure S5. Three-dimensional supramolecular architecture viewed along the a-axis direction. 


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Chapter Two Catalog of 1H and 13C NMR Spectra 
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Figure S6. 
Time
*Minor amounts of atrop-Hibarimicinone form during handling at ambient temperatures.
Conversion of Hibarimicinone (6) to atrop-Hibarimicinone (7) and HMP-P1 (10) at RT
With pH 7.5 Aqueous Phosphate Buffer in MeOH.
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Figure S7. Conversion of atrop-Hibarimicinone (7) to Hibarimicinone (6) and HMP-P1 (10) at RT
With pH 7.5 Aqueous Phosphate Buffer in MeOH.
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*Minor amounts of atrop-Hibarimicinone form during handling at ambient temperatures.
Figure S8. Minor Conversion of Hibarimicinone (6) to atrop-Hibarimicinone (7) and HMP-P1 (10)
at RT With HCl in MeOH (1.0 M).
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*Minor amounts of Hibarimicinone form during handling at ambient temperatures.
Figure S9. Minor Conversion of atrop-Hibarimicinone (7) to Hibarimicinone (6) and HMP-P1 (10)
at RT With HCl in MeOH (1.0 M).
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*Minor amounts of atrop-Hibarimicinone form during handling at ambient temperatures.
Figure S10. Conversion of Hibarimicinone (6) to Hibarimicinone (7) and HMP-P1 (10)
at 60 °C With HCl in MeOH (1.0 M).
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*Minor amounts of Hibarimicinone form during handling at ambient temperatures.
Figure S11. Conversion of atrop-Hibarimicinone (7) to Hibarimicinone (6) and HMP-P1 (10)
at 60 °C With HCl in MeOH (1.0 M).
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Table S4. 13C NMR data comparison between synthetic HMP-Y1 (8) and natural HMP-Y6 
(9) aglycon carbon resonances.148 
 
 
 HMP-Y6 (9), Igarashi et. al.149 
(13C, 100 MHz, CDCl3) 
This Work, HMP-Y1 (8) 
(13C, 126 MHz, CD3OD)150 
203.2 (C15) 207.3 
165.0 (C17) 165.8 
155.1 (C3) 155.7 
152.6 (C1) 153.7 
139.5 (C7) 140.9 
138.1 (C4) 140.5 
134.6 (C5) 135.3 
112.21 (C6) 113.3 
112.21 (C2) 112.4 
110.4 (C16) 112.3 
109.0 (C18) 110.2 
86.9 (C12) 80.8 
79.7 (C13) 80.2 
77.4 (C10) 76.1 
76.7 (C10) 74.3 
71.0 (C11) 71.8 
61.5 (4-OMe) 61.7 
61.0 (3-OMe) 61.3 
44.9 (C9) 48.4 
37.4 (C19) 39.2 
28.0 (C8) 28.6 
18.3 (C20) 19.4 
15.4 (C21) 15.7 
  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
148 No 13C NMR data for HMP-Y1 (8) was previously recorded according to a private communication with Prof. 
Y. Igarashi. 
 
149 Igarashi, Y.; Kajiura, T.; Furumai, T.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. 
J. Antibiot. 2002, 55, 61–70. The reference points for the residual protium and carbon resonances of the NMR 
solvent were not listed. 
 
150 The 13C NMR of 8 was taken in CD3OD due to low solubility in CDCl3. 
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!  
Figure S12. 13C NMR data comparison between synthetic HMP-Y1 (8) in CD3OD and natural HMP-
Y6 (9) in CDCl3.148,150,151 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
151 13C NMR spectrum of HMP-Y6 (9) was obtained through a private communication with Y. Igarashi. 
Natural HMP-Y6 (9) 
 
Synthetic HMP-Y1 (8) 
This Work 
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Table S5. 13C NMR data comparison between synthetic HMP-Y1 (8) and hibarimicinone (6). 
Hibarimicinone (6) 
(13C, 126 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, pD ~1) 
HMP-Y1 (8) 
(13C, 126 MHz, CD3OD) 
207.4 207.3 
198.4  
189.1  
186.3  
165.4 165.8 
160.0  
158.0  
154.2 155.7 
153.3 153.7 
151.9  
149.4  
142.1 140.9 
139.7 140.5 
136.3 135.3 
127.5  
126.7  
117.7  
114.3 113.3 
112.6 112.4 
112.3 112.3 
109.7 110.2 
109.2  
87.6  
84.9  
80.7 80.8 
80.1 80.2 
79.2  
76.0 76.1 
75.1  
74.1 74.3 
71.6 71.8 
71.3  
69.1  
61.7  
61.7 61.7 
61.6 61.3 
58.7  
48.1 48.4 
39.0 39.2 
36.1  
28.6 28.6 
19.3 19.4 
17.6  
15.7  
15.3 15.7 
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!  
Figure S13. Comparison of 13C NMR (126 MHz) spectra of synthetic hibarimicinone (6) and 
HMP-Y1 (8). 
 
 
*Denotes carbon resonances of 6 that are similar to that of 8. 
Synthetic HMP-Y1 (8) 
This Work 
Synthetic Hibarimicinone (6) 
This Work 
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Table S6. 1H NMR data comparison between synthetic HMP-Y1 (8) and hibarimicinone (6). 
Hibarimicinone (6) 
(1H, 600 MHz, ~50:1 CD3OD/20 wt.% DCl in D2O, pD ~1) 
HMP-Y1 (8) 
(1H, 600 MHz, CD3OD) 
7.35 (s, 1H) 7.34 (s, 2H) 
5.83 (s, 1H)  
4.10–4.05 (m, 2H) 
 
4.08 (dd, J = 5.5, 9.6 Hz, 2H) 
3.98 (d, J = 7.9 Hz, 1H)  
3.97 (s, 3H)  
3.96–3.92 (m, 1H) 3.94 (t, J = 9.4 Hz, 2H) 
3.94 (s, 3H) 3.88 (s, 6H) 
3.85 (s, 3H) 3.84 (s, 6H) 
3.80 (t, J = 8.5 Hz, 1H)  
3.73 (d, J = 9.4 Hz, 1H) 
3.75–3.69 (m, 1H) 
3.78–3.68 (m, 4H), 
3.18 (dd, J = 6.0, 17.1 Hz, 1H) 3.18 (dd, J = 4.6, 16.5 Hz, 2H) 
2.65 (td, J = 5.6, 13.3 Hz, 1H) 2.66 (dt, J = 5.3, 13.3 Hz, 2H) 
2.57 (d, J = 3.8 Hz, 1H)  
1.88 (dt, J = 4.2, 13.4 Hz, 1H) 1.88–1.79 (m, 2H) 
1.81 (dt, J = 4.2, 13.4 Hz, 1H) 
1.77–1.65 (m, 2H) 
1.79–1.65 (m, 4H) 
1.51–1.41 (m, 1H)  
1.39–1.30 (m, 1H) 1.44–1.32 (m, 2H) 
1.26–1.18 (m, 1H)  
1.01 (dt, J = 4.2, 13.4 Hz, 1H)  
0.88 (t, J = 7.0 Hz, 2H) 0.89 (t, J = 6.6 Hz, 6H) 
0.79 (t, J = 7.2 Hz, 2H)  
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!  
Figure S14. 1H NMR data (600 Mhz) comparison between synthetic HMP-Y1 (8) and hibarimicinone 
(6). 
 
 
 
Synthetic HMP-Y1 (8) 
This Work 
Synthetic Hibarimicinone (6) 
This Work 
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Table S7. 1H NMR data comparison between reported synthetic hibarimicinone (6) and our synthetic 
hibarimicinone (6). 
Tatsuta et. al. Report152,153 
(1H, 400 MHz, CD3OD, pH 1) 
This Work 
(1H, 400 MHz, ~50:1 CD3OD/20 wt.% DCl 
in D2O, pD ~1) 
7.35 (s, 1H) 7.35 (s, 1H) 
5.84 (s, 1H) 5.84 (s, 1H) 
4.09 (dd, J = 5.5 Hz, 10.0 Hz, 1H) 
4.08 (dd, J = 3.5, 8.0 Hz, 1H) 
4.12–4.04 (m, 2H) 
 
3.99 (d, J = 8.0 Hz, 1H) 
3.99–3.93 (m, 1H) 
4.01–3.92 (m, 2H) 
3.97 (s, 3H) 3.97 (s, 3H) 
3.95 (s, 3H) 3.95 (s, 3H) 
3.85 (s, 3H) 3.85 (s, 3H) 
3.81 (t, J = 8.0, 8.0 Hz, 1H) 3.80 (t, J = 8.2 Hz, 1H) 
3.74 (d, J = 9.0 Hz, 1H) 3.73 (d, J = 9.1 Hz, 1H) 
3.73 (dd, J = 13.5, 17.0 Hz, 1H) 3.78–3.68 (m, 1H) 
3.19 (dd, J = 5.5, 17.0 Hz, 1H) 3.18 (dd, J = 5.8, 17.2 Hz, 1H) 
2.66 (td, J = 5.5, 13.5, Hz, 1H) 2.65 (td, J = 5.7, 13.4 Hz, 1H) 
2.59 (d, J = 3.5 Hz, 1H) 2.57 (d, J = 3.7 Hz, 1H) 
1.89 (dt, J = 4.0, 13.0 Hz, 1H) 1.88 (dt, J = 3.8, 13.0 Hz, 1H) 
1.81 (dt, J = 4.0, 11.0 Hz, 1H) 
1.75 (dt, J = 3.5, 11.0 Hz, 1H) 
1.78–1.64 (m, 1H) 
1.83–1.63 (m, 3H) 
1.53–1.40 (m, 1H) 1.53–1.41 (m, 1H) 
1.40–1.16 (m, 2H) 1.40–1.29 (m, 1H) 
1.28–1.15 (m, 1H) 
1.01 (dt, J = 4.0, 13.0 Hz, 1H) 1.01 (dt, J = 3.9, 13.0 Hz, 1H) 
0.89 (t, J = 7.0 Hz, 3H) 0.89 (t, J = 7.0 Hz, 3H) 
0.79 (t, J = 7.0 Hz, 3H) 0.79 (t, J = 7.2 Hz, 3H) 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
152 Tatsuta, K.; Fukuda, T.; Ishimori, T.; Yachi, R.; Yoshida, S.; Hashimoto, H.; Hosokawa, S. Tetrahedron 
Lett. 2012, 53, 422–425. 
 
153 The reference points for the residual protium and carbon resonances of the NMR solvent were not listed. 
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Figure S16. Comparison of 1H NMR spectra (400 MHz) of natural and synthetic hibarimicinone (6).!
Natural Hibarimicinone (6) 
Tatsuta et. al.152 
Synthetic Hibarimicinone (6) 
This Work 
Synthetic Hibarimicinone (6) 
Tatsuta et. al.152 
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Table S8. 13C NMR data comparison between reported synthetic hibarimicinone (6) and our synthetic 
hibarimicinone (6). 
Tatsuta et. al. Report152,153 
(13C, 150 MHz, CD3OD, pH 1) 
This Work 
(13C, 126 MHz, ~50:1 CD3OD/20 wt.% DCl 
in D2O, pD ~1) 
207.3 207.4 
198.5 198.4 
189.0 189.1 
186.2 186.3 
165.2 165.4 
159.9 160.0 
157.8 158.0 
154.1 154.2 
153.1 153.3 
151.8 151.9 
149.2 149.4 
142.0 142.1 
139.6 139.7 
136.2 136.3 
127.4 127.5 
126.5 126.7 
117.6 117.7 
114.3 114.3 
112.5 112.6 
112.1 112.3 
109.6 109.7 
109.1 109.2 
87.5 87.6 
84.8 84.9 
80.6 80.7 
80.0 80.1 
79.0 79.2 
75.8 76.0 
75.0 75.1 
74.0 74.1 
71.5 71.6 
71.2 71.3 
69.0 69.1 
61.5 61.7 
61.5 61.7 
61.5 61.6 
58.6 58.7 
48.0 48.1 
38.9 39.0 
35.9 36.1 
28.5 28.6 
19.1 19.3 
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Table S8. (continued) 
17.4 17.6 
15.5 15.7 
15.2 15.3 
 
 
 
Figure S17. Comparison of 13C NMR spectra of synthetic hibarimicinone (6). 
 
 
!
Synthetic Hibarimicinone (6) 
Tatsuta et. al.152 
Synthetic Hibarimicinone (6) 
This Work 
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Table S9. 13C NMR data comparison between synthetic HMP-P1 (10) and natural HMP-P4 (11) 
aglycon carbon resonances.154 
!
 
HMP-P4 (11), Igarashi et. al.155,156 
(13C, 100 MHz, acetone-d6) 
HMP-P1 (10) 
(13C, 126 MHz, DMSO-d6)157 
206.5 (C15) 207.7 
195.6 (C15') 196.8 
183.8 (C4') 183.0 
177.0 (C1') 177.1 
161.7 (C17) 160.7 
159.3 (C17') 157.7 
152.7 (C3') 152.2 
152.5 (C1) 151.0 
152.4 (C6') 150.3 
150.5 (C7') 148.9 
148.3 (C3) 146.9 
146.4 (C4) 144.9 
145.1 (C7) 144.4 
136.6 (C5) 134.3 
126.4 (C16') 125.6 
126.1 (C2') 125.5 
117.2 (C5') 116.9 
116.9 (C2) 115.8 
114.5 (C18') 114.5 
114.3 (C16) 113.8 
113.0 (C6) 111.4 
108.0 (C18) 107.2 
87.2 (C12) 86.1 
87.0 (C14') 83.4 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
154 No 13C NMR data for 10 was previously recorded according to a private communication with Prof. Y. 
Igarashi. 
 
155 Igarashi, Y.; Kajiura, T.; Furumai, T.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. 
J. Antibiot. 2002, 55, 61–70. 
 
156 The reference point for the residual carbon resonances of the NMR solvent were not listed. 
 
157 The 13C NMR of 10 was taken in DMSO-d6 due to low solubility in acetone-d6 and CD3OD. 
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Table S9. (continued) 
86.6 (C12') 79.3 
83.9 (C13') 78.5 
80.4 (C13) 77.3 
78.8 (C14) 73.8 
77.8 (C10') 72.8 
77.0 (C10) 72.2 
75.7 (C11') 69.52 
71.6 (C11) 69.49 
68.8 (C8') 66.9 
62.6 (3-OMe) 62.2 
62.0 (4-OMe) 61.6 
56.2 (C9') 57.1 
45.4 (C9) 46.4 
37.3 (C19) 37.5 
35.1 (C19') 34.9 
29.6 (C8) 28.1 
18.3 (C20) 17.7 
17.1 (C20') 15.8 
15.4 (C21) 15.3 
15.1 (C21') 14.9 
!
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Appendix D 
Chapter Four Catalog of CD, UV–Vis, 1H and 13C NMR Spectra 
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